data_1nla_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1nla _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.997 -0.371 . . . . 43.64 109.997 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.509 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.0 Cg_endo -72.61 143.77 38.61 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.736 1.387 . . . . 29.79 110.478 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -61.05 -17.61 53.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.833 . . . . 0.0 110.15 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.486 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 69.6 t80 -67.9 -37.48 81.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 12.57 110.36 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.47 HD23 ' CD2' ' A' ' 14' ' ' TRP . 80.8 mt -91.6 21.52 4.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.352 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -74.23 -19.26 60.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.08 -17.93 21.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.134 -0.979 . . . . 0.0 110.653 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.489 ' CZ3' HG13 ' B' ' 41' ' ' VAL . 13.8 m0 -64.9 144.03 98.93 Favored Pre-proline 0 C--N 1.304 -1.387 0 O-C-N 121.145 -0.972 . . . . 11.57 109.171 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 40.1 Cg_endo -69.23 169.45 18.22 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.384 1.202 . . . . 13.83 110.56 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -25.81 43.94 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.572 -0.705 . . . . 48.43 109.592 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -69.14 -19.26 64.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.173 -0.955 . . . . 46.64 110.078 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.438 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 59.9 t -102.76 -36.27 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 16.14 109.888 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.5 mt -66.51 -33.91 76.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.416 -0.802 . . . . 12.61 110.509 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.31 -30.28 70.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 23.17 109.851 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.485 HD23 ' CD1' ' B' ' 45' ' ' PHE . 28.0 tp -80.76 -38.0 29.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.521 -0.737 . . . . 19.0 109.852 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.66 -51.72 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 18.87 110.211 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.63 -41.77 82.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.421 -0.799 . . . . 23.61 110.781 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -73.41 -18.2 61.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.118 -0.989 . . . . 30.11 110.841 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 21' ' ' LEU . 59.2 t -84.15 -35.73 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.081 -1.012 . . . . 16.22 110.481 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.23 82.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 26.6 109.712 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -72.59 -23.31 60.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.811 . . . . 45.21 109.935 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -78.1 -42.21 32.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 37.85 109.863 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -67.86 -44.48 77.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 35.36 110.105 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.35 37.08 0.95 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.076 -1.21 . . . . 35.1 110.076 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.74 -165.43 1.65 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.042 -1.27 . . . . 32.72 110.601 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -84.0 174.41 10.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 19.61 110.372 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.0 t -84.44 -26.72 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.39 -0.818 . . . . 17.56 110.235 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' B' ' 13' ' ' ARG . 5.4 t30 -59.18 -27.1 65.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 21.3 108.977 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.2 t -89.81 -29.71 18.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.519 -0.738 . . . . 16.38 109.536 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.49 -57.47 12.02 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.116 -0.99 . . . . 12.61 109.519 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 41.1 mm -58.12 -27.1 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.359 -0.838 . . . . 10.95 109.711 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.496 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 38.9 t80 -70.69 -34.37 71.9 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.135 -0.978 . . . . 18.87 110.15 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -75.06 -53.73 8.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 36.88 110.169 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -57.64 -23.06 49.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.114 -0.991 . . . . 22.85 109.802 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.492 HG13 ' CZ3' ' B' ' 14' ' ' TRP . 39.8 t -89.42 -27.5 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.396 -0.815 . . . . 13.02 109.51 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -25.86 60.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.528 -0.733 . . . . 18.84 110.569 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.78 -21.62 29.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.088 -1.008 . . . . 29.96 110.555 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -66.18 -47.47 73.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 18.65 110.165 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' HD21 ' B' ' 21' ' ' LEU . 28.5 m-85 -61.01 -37.44 82.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 16.26 110.373 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 mttt . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 36.71 110.314 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.486 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 44.6 Cg_endo -72.72 143.77 38.15 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.721 1.38 . . . . 0.0 110.523 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -60.9 -17.58 51.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.242 -0.911 . . . . 0.0 110.16 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.509 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 68.4 t80 -67.83 -37.63 82.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 110.375 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.477 HD23 ' CD2' ' B' ' 14' ' ' TRP . 80.6 mt -91.57 21.79 4.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.363 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -74.41 -19.29 60.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.421 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.417 ' HB2' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -94.99 -18.11 21.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.16 -0.962 . . . . 0.0 110.613 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.496 ' CZ2' ' HA ' ' A' ' 38' ' ' TYR . 14.0 m0 -64.83 144.2 98.89 Favored Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.023 -1.048 . . . . 0.0 109.229 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.455 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.4 Cg_endo -69.28 169.64 17.84 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.519 1.273 . . . . 0.0 110.651 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.17 -25.46 42.82 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.384 -0.822 . . . . 0.0 109.474 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -69.35 -19.34 63.85 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' B' ' 15' ' ' PRO . 58.2 t -102.6 -36.65 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.16 -0.963 . . . . 0.0 109.756 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 17.9 mt -65.76 -33.99 77.15 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.16 -0.963 . . . . 0.0 110.662 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.4 -30.6 71.01 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.826 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.493 HD21 ' CD2' ' A' ' 45' ' ' PHE . 26.9 tp -80.44 -38.05 30.84 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.862 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 48.2 t -59.77 -51.52 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 110.258 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.62 -41.85 82.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.783 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -73.42 -18.2 61.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.18 -0.95 . . . . 0.0 110.851 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' B' ' 21' ' ' LEU . 58.3 t -84.15 -35.88 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.164 -0.96 . . . . 0.0 110.473 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.41 -36.14 82.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.043 -1.036 . . . . 0.0 109.828 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -72.58 -23.21 60.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.928 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -78.24 -42.17 31.99 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.342 -0.849 . . . . 0.0 109.923 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.04 -44.42 76.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.83 . . . . 0.0 110.025 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.34 36.99 0.96 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.64 -165.47 1.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.019 -1.283 . . . . 0.0 110.571 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m -84.04 174.4 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.356 -0.84 . . . . 0.0 110.364 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 85.8 t -84.52 -26.46 7.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.411 -0.806 . . . . 0.0 110.278 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -59.4 -27.01 65.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.179 -0.95 . . . . 0.0 108.942 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 6.2 t -89.85 -29.9 18.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.72 . . . . 0.0 109.465 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.21 -57.61 11.71 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.132 -0.98 . . . . 0.0 109.532 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' B' ' 41' ' ' VAL . 40.8 mm -58.19 -27.45 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.38 -0.825 . . . . 0.0 109.65 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.459 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 36.5 t80 -70.19 -34.52 73.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.196 -0.94 . . . . 0.0 110.133 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -75.02 -53.72 8.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 110.183 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -57.6 -23.13 49.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.843 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.489 HG13 ' CZ3' ' A' ' 14' ' ' TRP . 39.6 t -89.15 -27.72 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.436 -0.79 . . . . 0.0 109.523 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -26.01 60.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.745 . . . . 0.0 110.61 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.86 -21.6 29.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.212 -0.93 . . . . 0.0 110.508 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -66.1 -47.47 74.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 110.163 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.485 ' CD1' HD23 ' A' ' 21' ' ' LEU . 27.8 m-85 -61.17 -37.46 83.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttt . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.361 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.4 mtp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.206 -0.294 . . . . 43.64 110.206 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 48.9 Cg_endo -75.79 160.22 37.76 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.627 1.33 . . . . 29.79 110.431 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -18.28 60.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.115 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.444 ' CE1' ' OD1' ' B' ' 34' ' ' ASN . 56.3 t80 -71.3 -35.8 71.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 12.57 110.348 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.465 HD21 ' CE3' ' A' ' 14' ' ' TRP . 93.8 mt -89.64 16.77 7.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.44 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.55 -31.22 66.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 110.024 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -12.47 59.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.35 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.506 ' CZ3' HG12 ' B' ' 41' ' ' VAL . 16.5 m0 -77.48 142.2 66.56 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.173 -0.955 . . . . 11.57 109.451 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.38 173.63 10.36 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.586 1.309 . . . . 13.83 110.551 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -22.66 42.18 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.396 -0.815 . . . . 48.43 109.605 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' HG3' HG23 ' A' ' 18' ' ' VAL . 10.2 pt-20 -71.5 -36.37 71.07 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.149 -0.969 . . . . 46.64 110.35 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.403 HG23 ' HG3' ' A' ' 17' ' ' GLU . 93.8 t -81.27 -43.06 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 16.14 110.254 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.3 mt -65.1 -32.03 73.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 12.61 110.28 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.45 -24.39 66.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 23.17 109.68 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.5 HD22 ' CD1' ' B' ' 45' ' ' PHE . 26.9 tp -87.09 -40.06 15.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.791 . . . . 19.0 109.895 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.402 HG23 HD13 ' A' ' 37' ' ' ILE . 38.5 t -56.48 -40.62 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 18.87 109.488 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -59.81 4.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.675 -0.641 . . . . 23.61 110.297 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.26 -28.67 59.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.229 -0.92 . . . . 30.11 110.937 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 21' ' ' LEU . 50.7 t -71.82 -39.31 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.991 -1.068 . . . . 16.22 110.423 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.72 -40.29 88.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.067 -1.021 . . . . 26.6 109.539 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -71.69 -20.99 61.85 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.449 -0.782 . . . . 45.21 109.941 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -54.41 9.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 37.85 109.809 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -71.38 -25.02 62.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.873 . . . . 35.36 110.26 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.48 69.53 1.04 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.71 -1.356 . . . . 35.1 109.71 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.73 -162.91 0.13 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.254 -1.145 . . . . 32.72 110.287 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.8 t -93.2 171.97 8.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 19.61 110.091 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.2 t -83.89 -23.33 7.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.23 -0.919 . . . . 17.56 110.073 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' OD1' ' CE1' ' B' ' 10' ' ' PHE . 0.8 OUTLIER -63.78 -28.14 69.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 21.3 109.255 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -90.15 -32.24 16.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.446 -0.784 . . . . 16.38 109.825 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' CG ' HG13 ' A' ' 25' ' ' VAL . 11.0 tp10 -61.67 -37.95 85.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.144 -0.973 . . . . 12.61 109.319 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 21.6 mm -76.95 -25.3 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.529 -0.732 . . . . 10.95 109.156 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.452 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 33.4 t80 -74.72 -27.38 60.35 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.271 -0.893 . . . . 18.87 110.198 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -81.71 -49.34 10.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 36.88 109.512 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.404 ' CZ ' HG11 ' A' ' 25' ' ' VAL . 55.9 mtt-85 -59.0 -28.79 66.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 22.85 109.189 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.462 HG12 ' CZ3' ' B' ' 14' ' ' TRP . 42.5 t -82.82 -26.95 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.581 -0.699 . . . . 13.02 109.329 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp -76.68 -23.82 53.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.467 -0.77 . . . . 18.84 110.27 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.14 -33.91 56.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.264 -0.897 . . . . 29.96 110.294 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.413 ' CB ' ' HD3' ' B' ' 40' ' ' ARG . 81.8 p -58.47 -41.22 84.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 18.65 110.278 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.481 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 25.5 m-85 -74.43 -35.5 63.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 16.26 110.371 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 36.71 110.476 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtp . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.42 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 48.9 Cg_endo -75.66 159.6 38.79 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.632 1.332 . . . . 0.0 110.422 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -18.32 61.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.156 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.478 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 58.3 t80 -71.27 -36.0 71.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.971 . . . . 0.0 110.453 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.457 HD21 ' CE3' ' B' ' 14' ' ' TRP . 94.4 mt -89.37 16.78 6.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.928 . . . . 0.0 110.571 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.48 -31.26 66.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.128 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -12.36 59.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 110.337 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.462 ' CZ3' HG12 ' A' ' 41' ' ' VAL . 16.0 m0 -77.52 141.94 66.04 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.246 -0.909 . . . . 0.0 109.489 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.446 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.5 Cg_endo -69.38 173.89 9.98 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.625 1.329 . . . . 0.0 110.543 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -23.26 41.82 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.402 ' HG3' HG23 ' B' ' 18' ' ' VAL . 10.2 pt-20 -71.34 -36.39 71.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.851 . . . . 0.0 110.368 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.402 HG23 ' HG3' ' B' ' 17' ' ' GLU . 92.9 t -81.23 -43.48 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 O-C-N 121.072 -1.017 . . . . 0.0 110.014 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 72.8 mt -64.35 -32.54 74.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.05 -24.73 66.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.747 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.481 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 27.9 tp -86.71 -40.1 15.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.404 -0.81 . . . . 0.0 109.904 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 35.1 t -56.4 -40.45 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.597 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.22 -59.63 5.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.645 -0.66 . . . . 0.0 110.267 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -28.27 59.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.267 -0.895 . . . . 0.0 110.963 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' B' ' 21' ' ' LEU . 53.2 t -72.17 -39.48 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.013 . . . . 0.0 110.361 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.11 88.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.14 -0.975 . . . . 0.0 109.509 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -71.79 -20.85 61.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.341 -0.849 . . . . 0.0 110.044 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -54.23 9.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.863 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.34 -25.32 62.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.42 -0.8 . . . . 0.0 110.089 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.43 69.99 1.06 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.01 -163.27 0.13 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.321 -1.106 . . . . 0.0 110.191 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -92.9 172.93 8.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 110.082 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 68.4 t -85.08 -22.69 7.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.278 -0.889 . . . . 0.0 110.001 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.444 ' OD1' ' CE1' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -64.26 -27.85 69.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.157 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -90.2 -33.56 16.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.487 -0.758 . . . . 0.0 109.707 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.403 ' CG ' HG13 ' B' ' 25' ' ' VAL . 10.8 tp10 -60.31 -38.18 82.87 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.157 -0.964 . . . . 0.0 109.403 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' B' ' 41' ' ' VAL . 21.2 mm -77.11 -24.85 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.51 -0.744 . . . . 0.0 109.228 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.444 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 34.0 t80 -75.32 -26.58 58.77 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.261 -0.899 . . . . 0.0 110.109 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -82.28 -49.53 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.58 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 0.413 ' HD3' ' CB ' ' A' ' 44' ' ' SER . 55.7 mtt-85 -58.81 -28.98 66.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.442 -0.786 . . . . 0.0 109.184 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.506 HG12 ' CZ3' ' A' ' 14' ' ' TRP . 45.1 t -82.54 -27.46 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.546 0.688 . . . . 0.0 109.414 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp -76.08 -23.41 55.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.468 -0.77 . . . . 0.0 110.269 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.47 -34.31 54.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.158 -0.964 . . . . 0.0 110.24 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 85.4 p -57.86 -41.5 82.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 110.156 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.5 ' CD1' HD22 ' A' ' 21' ' ' LEU . 25.3 m-85 -74.5 -35.78 63.22 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.37 -179.855 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 110.244 -0.28 . . . . 43.64 110.244 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 43.0 Cg_endo -71.47 147.52 52.32 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.626 1.33 . . . . 29.79 110.545 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.49 -19.38 61.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 110.631 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.489 ' CE1' ' HG3' ' B' ' 8' ' ' PRO . 87.3 t80 -69.25 -32.09 71.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.952 . . . . 12.57 110.11 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.468 HD23 ' CD2' ' A' ' 14' ' ' TRP . 96.8 mt -91.99 19.07 7.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.371 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -71.65 -25.52 62.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 110.205 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -16.12 46.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.477 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.476 ' CZ3' HD13 ' A' ' 37' ' ' ILE . 15.1 m0 -72.69 145.59 87.28 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.306 -0.871 . . . . 11.57 109.815 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 43.1 Cg_endo -73.4 166.33 30.18 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.559 1.294 . . . . 13.83 111.24 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.87 85.68 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.995 0.902 . . . . 48.43 110.33 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.46 -34.76 74.49 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.918 -0.583 . . . . 46.64 111.575 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.427 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 91.2 t -82.84 -44.91 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.924 -1.11 . . . . 16.14 110.817 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.2 mt -64.54 -27.31 68.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.143 -0.973 . . . . 12.61 110.722 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.44 -23.15 63.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 23.17 109.76 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.525 ' CD2' ' CG ' ' B' ' 45' ' ' PHE . 4.8 tp -89.39 -42.22 11.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.45 -0.781 . . . . 19.0 109.985 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.428 ' CG1' HD11 ' A' ' 37' ' ' ILE . 48.0 t -51.8 -46.22 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 18.87 110.699 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -54.59 -58.5 7.27 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.361 -0.837 . . . . 23.61 110.85 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -54.12 -22.65 11.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.908 . . . . 30.11 111.054 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -82.54 -38.61 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 16.22 110.961 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.67 74.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.036 . . . . 26.6 110.112 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.39 -9.86 58.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -0.887 . . . . 45.21 110.528 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -88.88 -53.59 4.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.083 -1.011 . . . . 37.85 110.095 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.34 -32.45 73.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 35.36 110.117 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.73 30.81 4.15 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.414 -1.475 . . . . 35.1 109.414 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -133.44 -155.18 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -1.137 . . . . 32.72 110.164 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -107.56 175.34 5.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.539 -0.725 . . . . 19.61 109.55 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.97 -23.58 16.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.105 -0.997 . . . . 17.56 110.138 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.442 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 44.0 t30 -77.15 -28.11 54.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 21.3 108.843 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.07 -27.31 24.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.557 -0.714 . . . . 16.38 109.203 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.98 -42.96 65.87 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.277 -0.89 . . . . 12.61 108.916 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.476 HD13 ' CZ3' ' A' ' 14' ' ' TRP . 24.5 mm -66.59 -31.07 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.595 -0.891 . . . . 10.95 108.595 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.469 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 32.6 t80 -63.56 -36.78 84.92 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.62 -0.675 . . . . 18.87 109.968 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -73.96 -43.99 56.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 36.88 109.716 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -61.09 -25.59 67.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 22.85 109.289 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.434 HG21 HG21 ' B' ' 41' ' ' VAL . 62.4 t -88.18 -25.14 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.547 0.689 . . . . 13.02 109.635 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtp -77.56 -25.33 49.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.529 -0.732 . . . . 18.84 110.299 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -83.24 -27.48 29.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.194 -0.941 . . . . 29.96 110.353 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.8 p -67.1 -48.91 66.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.255 -0.903 . . . . 18.65 110.357 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.522 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 22.4 m-85 -62.89 -22.5 66.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.958 . . . . 16.26 110.417 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 36.71 110.455 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.489 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 43.4 Cg_endo -71.38 147.65 53.15 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.717 1.377 . . . . 0.0 110.483 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -19.5 62.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.36 -0.837 . . . . 0.0 110.577 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.49 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 87.2 t80 -69.01 -32.13 71.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.039 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.471 HD23 ' CD2' ' B' ' 14' ' ' TRP . 96.5 mt -91.94 19.12 6.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.448 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.66 -25.36 62.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 110.303 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.71 -16.16 45.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 110.412 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.471 ' CD2' HD23 ' B' ' 11' ' ' LEU . 15.1 m0 -72.88 145.65 86.86 Favored Pre-proline 0 C--N 1.304 -1.389 0 O-C-N 121.242 -0.911 . . . . 0.0 109.831 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.428 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 42.5 Cg_endo -73.45 166.66 29.3 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.258 1.136 . . . . 0.0 111.21 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -37.94 85.11 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 110.321 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -60.3 -34.72 74.17 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.907 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.428 ' CG2' ' HG2' ' B' ' 15' ' ' PRO . 91.1 t -82.72 -45.22 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.86 -1.15 . . . . 0.0 110.591 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 61.1 mt -64.39 -27.28 68.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.031 -1.043 . . . . 0.0 110.763 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.27 -23.4 63.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 109.738 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.522 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 4.7 tp -89.34 -42.11 11.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.502 -0.748 . . . . 0.0 109.992 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' B' ' 37' ' ' ILE . 47.9 t -51.71 -46.1 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 110.733 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -54.83 -58.44 7.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.333 -0.854 . . . . 0.0 110.849 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -54.14 -22.27 10.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.065 -1.022 . . . . 0.0 111.037 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.93 -38.77 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.001 . . . . 0.0 110.873 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.87 -32.6 74.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.061 -1.024 . . . . 0.0 110.11 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.46 -10.07 58.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 110.383 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -88.64 -53.57 4.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.133 -0.98 . . . . 0.0 110.113 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.34 -32.47 73.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.142 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.75 30.82 4.14 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -133.53 -155.69 0.69 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -1.103 . . . . 0.0 110.208 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -107.03 175.41 5.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.409 -0.807 . . . . 0.0 109.658 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 85.9 t -76.1 -23.33 15.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 44.1 t30 -77.35 -28.34 52.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 108.844 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.91 -27.42 25.0 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.194 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.94 -42.6 66.44 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.372 -0.83 . . . . 0.0 108.997 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.471 HD13 ' CZ3' ' B' ' 14' ' ' TRP . 24.7 mm -66.84 -30.89 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 32.6 t80 -63.8 -37.08 86.05 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.614 -0.679 . . . . 0.0 109.771 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -73.57 -44.39 57.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 109.687 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -60.64 -25.75 66.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.94 . . . . 0.0 109.243 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.434 HG21 HG21 ' A' ' 41' ' ' VAL . 63.5 t -88.16 -25.23 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.575 0.703 . . . . 0.0 109.688 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtp -77.47 -25.17 50.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.494 -0.754 . . . . 0.0 110.387 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -83.42 -27.46 29.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.189 -0.944 . . . . 0.0 110.437 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 77.8 p -67.16 -48.7 67.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.415 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.525 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 21.9 m-85 -63.08 -22.6 66.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.128 -0.982 . . . . 0.0 110.286 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.167 -0.958 . . . . 0.0 110.37 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.494 -0.558 . . . . 43.64 109.494 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HG3' ' CE1' ' B' ' 10' ' ' PHE . 45.7 Cg_endo -71.68 158.16 54.03 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.378 1.199 . . . . 29.79 110.671 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -82.1 -19.4 40.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.379 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.483 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 73.1 t80 -58.95 -23.84 61.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 12.57 110.448 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.464 HD23 ' CD2' ' A' ' 14' ' ' TRP . 42.7 mt -98.52 31.65 2.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.148 -0.97 . . . . 0.0 110.478 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -30.99 67.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.224 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -81.01 -22.9 39.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 110.155 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.509 ' CZ3' HG12 ' B' ' 41' ' ' VAL . 13.8 m0 -64.64 136.98 96.99 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.345 -0.847 . . . . 11.57 109.259 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 39.0 Cg_endo -70.36 153.34 66.26 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.365 1.192 . . . . 13.83 111.054 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -41.62 73.29 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.664 0.745 . . . . 48.43 110.897 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.24 -41.05 75.09 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.548 -0.72 . . . . 46.64 111.507 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.446 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 85.5 t -76.42 -49.87 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.888 -1.132 . . . . 16.14 111.087 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.413 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 13.3 mt -53.7 -36.5 62.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 12.61 110.673 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -62.57 -38.03 88.51 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.436 -0.79 . . . . 23.17 109.864 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.495 HD22 ' CG ' ' B' ' 45' ' ' PHE . 40.8 tp -69.42 -40.59 77.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.494 -0.754 . . . . 19.0 109.893 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.417 ' CG1' HD13 ' A' ' 37' ' ' ILE . 40.3 t -58.94 -48.26 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 18.87 110.512 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 10.9 mtm180 -53.67 -49.36 68.14 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 23.61 110.54 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -29.33 70.72 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 30.11 110.682 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.1 t -77.03 -29.19 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 16.22 110.479 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.04 -46.0 46.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.169 -0.957 . . . . 26.6 109.215 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.95 -12.63 61.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.348 -0.845 . . . . 45.21 110.135 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -78.61 -58.73 3.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 37.85 110.001 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -66.06 -22.36 66.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 35.36 110.115 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.54 16.17 20.85 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.027 -1.229 . . . . 35.1 110.027 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -116.53 -162.84 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.132 -1.216 . . . . 32.72 110.387 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.7 m -102.81 -176.77 3.19 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.419 -0.8 . . . . 19.61 109.411 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -81.23 -16.65 12.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.222 -0.924 . . . . 17.56 110.281 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -77.84 -32.08 51.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.978 . . . . 21.3 108.752 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 t -79.71 -36.56 37.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.572 -0.705 . . . . 16.38 109.335 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.78 -51.74 60.65 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 121.255 -0.903 . . . . 12.61 109.366 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.417 HD13 ' CG1' ' A' ' 22' ' ' VAL . 37.9 mm -63.3 -32.93 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.784 . . . . 10.95 109.517 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.431 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 26.6 t80 -65.79 -33.76 76.61 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.429 -0.795 . . . . 18.87 110.226 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -47.38 42.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 36.88 109.536 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -60.87 -23.36 65.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.46 -0.775 . . . . 22.85 109.642 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.488 HG12 ' CZ3' ' B' ' 14' ' ' TRP . 53.0 t -87.95 -28.24 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.518 -0.739 . . . . 13.02 109.554 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -20.36 52.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.539 -0.725 . . . . 18.84 110.272 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.92 -18.77 53.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 29.96 110.348 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.89 -46.89 16.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.073 -1.017 . . . . 18.65 110.215 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.501 ' CD1' ' CD2' ' B' ' 21' ' ' LEU . 37.9 m-85 -67.72 -12.01 59.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 16.26 110.734 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.03 -1.044 . . . . 36.71 110.417 -179.725 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.483 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 45.1 Cg_endo -71.64 157.76 55.04 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.439 1.231 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -81.83 -19.4 41.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.364 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.484 ' CE1' ' HG3' ' A' ' 8' ' ' PRO . 72.8 t80 -58.95 -23.85 61.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 110.454 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.475 HD23 ' CD2' ' B' ' 14' ' ' TRP . 42.3 mt -98.37 31.62 2.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 110.489 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.06 -31.1 67.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 110.108 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -80.95 -22.89 39.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.22 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.488 ' CZ3' HG12 ' A' ' 41' ' ' VAL . 13.8 m0 -64.71 136.51 96.8 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.394 -0.816 . . . . 0.0 109.306 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.443 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 39.5 Cg_endo -70.24 152.45 66.83 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.626 1.33 . . . . 0.0 111.368 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -42.13 69.75 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.631 0.729 . . . . 0.0 110.905 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.17 -40.91 74.65 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.614 -0.679 . . . . 0.0 111.29 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.443 ' CG2' ' HG2' ' B' ' 15' ' ' PRO . 85.5 t -76.59 -50.0 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.917 -1.114 . . . . 0.0 110.754 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.406 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 13.4 mt -53.67 -36.32 61.99 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 110.682 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -62.99 -37.77 88.48 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.298 -0.876 . . . . 0.0 109.973 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.501 ' CD2' ' CD1' ' A' ' 45' ' ' PHE . 40.5 tp -69.63 -40.31 76.64 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.415 -0.803 . . . . 0.0 109.858 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.42 ' CG1' HD13 ' B' ' 37' ' ' ILE . 40.3 t -59.31 -48.07 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 110.467 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' B' ' 19' ' ' LEU . 11.0 mtm180 -53.7 -49.41 68.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.215 -0.928 . . . . 0.0 110.535 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -29.13 70.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.4 -0.812 . . . . 0.0 110.698 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.08 -29.25 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.501 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.04 -46.06 45.7 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 109.196 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.97 -12.58 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 110.152 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.41 -59.0 2.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 109.97 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -65.88 -22.33 66.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.059 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.48 16.26 20.74 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -116.65 -162.64 0.86 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.012 -1.287 . . . . 0.0 110.405 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.2 m -102.95 -176.76 3.18 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.352 -0.843 . . . . 0.0 109.375 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 62.2 t -81.2 -16.64 12.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 110.407 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -77.84 -32.14 51.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.067 -1.021 . . . . 0.0 108.695 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 41.0 t -79.67 -36.39 37.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.585 -0.697 . . . . 0.0 109.294 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -65.0 -51.64 60.55 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.381 -0.824 . . . . 0.0 109.295 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.42 HD13 ' CG1' ' B' ' 22' ' ' VAL . 37.3 mm -63.39 -32.59 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.576 -0.703 . . . . 0.0 109.428 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.48 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 26.5 t80 -65.97 -33.82 76.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.442 -0.787 . . . . 0.0 110.308 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -47.1 45.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.52 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -61.17 -23.42 65.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 0.0 109.639 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.509 HG12 ' CZ3' ' A' ' 14' ' ' TRP . 56.4 t -88.08 -28.3 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.749 . . . . 0.0 109.502 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -20.14 53.35 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.566 -0.708 . . . . 0.0 110.161 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.17 -18.73 52.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.082 -1.011 . . . . 0.0 110.36 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.82 -47.27 15.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.046 -1.034 . . . . 0.0 110.097 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.495 ' CG ' HD22 ' A' ' 21' ' ' LEU . 38.5 m-85 -67.42 -11.96 59.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 110.799 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 110.389 -179.694 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 120.594 0.235 . . . . 43.64 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 48.3 Cg_endo -76.55 164.79 30.03 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.852 1.448 . . . . 29.79 110.343 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -74.98 -13.7 60.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.394 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.503 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 90.8 t80 -81.16 -29.15 34.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 12.57 110.46 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.467 HD23 ' CD2' ' A' ' 14' ' ' TRP . 57.0 mt -92.69 14.68 16.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.784 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.94 -24.56 64.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 0.0 109.816 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.96 -21.89 43.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.314 -0.866 . . . . 0.0 110.163 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.479 ' CZ3' HD12 ' A' ' 37' ' ' ILE . 15.0 m0 -73.54 143.59 82.5 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.453 -0.779 . . . . 11.57 109.67 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' CD ' ' OH ' ' B' ' 38' ' ' TYR . 42.3 Cg_endo -71.11 176.44 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.562 1.296 . . . . 13.83 110.726 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -24.29 37.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.402 -0.811 . . . . 48.43 109.372 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.6 -20.15 64.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 46.64 110.463 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.3 t -99.82 -46.3 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 16.14 109.961 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.13 -25.91 68.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.339 -0.851 . . . . 12.61 110.806 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -74.02 -31.74 63.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.299 -0.876 . . . . 23.17 110.068 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.539 ' CD2' ' CG ' ' B' ' 45' ' ' PHE . 7.4 tp -79.82 -47.39 15.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 19.0 109.971 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.436 ' CG1' HG13 ' A' ' 33' ' ' VAL . 27.9 t -51.68 -45.93 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 18.87 109.918 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -51.44 -63.02 1.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.682 -0.636 . . . . 23.61 110.695 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -52.75 -33.88 50.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.283 -0.885 . . . . 30.11 110.969 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.404 ' CG1' ' HG2' ' A' ' 36' ' ' GLU . 61.9 t -66.93 -36.48 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 16.22 110.523 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.91 79.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 26.6 109.896 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -71.69 -14.7 62.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 45.21 110.359 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.79 -59.99 2.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.084 -1.01 . . . . 37.85 110.114 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -65.8 -22.03 66.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 35.36 110.358 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.39 16.69 24.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.85 -1.3 . . . . 35.1 109.85 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -114.15 -156.53 0.6 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.085 -1.244 . . . . 32.72 110.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -111.21 171.11 7.67 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.332 -0.855 . . . . 19.61 109.652 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.436 HG13 ' CG1' ' A' ' 22' ' ' VAL . 48.5 t -70.59 -18.89 21.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.204 -0.935 . . . . 17.56 110.451 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.78 -35.04 39.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.133 -0.98 . . . . 21.3 109.3 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.6 m -76.48 -33.54 58.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.811 . . . . 16.38 109.543 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.404 ' HG2' ' CG1' ' A' ' 25' ' ' VAL . 2.9 tp10 -63.37 -51.94 63.8 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.348 -0.845 . . . . 12.61 109.245 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.479 HD12 ' CZ3' ' A' ' 14' ' ' TRP . 4.9 mt -68.4 -21.34 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.465 -0.772 . . . . 10.95 109.62 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.405 ' OH ' ' CD ' ' B' ' 15' ' ' PRO . 32.0 t80 -75.4 -29.54 59.83 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.267 -0.896 . . . . 18.87 109.716 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.01 -45.36 18.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.498 -0.751 . . . . 36.88 109.744 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt-85 -60.7 -45.06 95.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 22.85 109.159 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 61.2 t -68.93 -24.2 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.625 -0.672 . . . . 13.02 109.997 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -65.21 0.79 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.422 -0.799 . . . . 18.84 110.908 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -54.73 -31.75 58.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.332 -0.855 . . . . 29.96 111.037 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.15 -56.63 10.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.95 -1.094 . . . . 18.65 110.679 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.546 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 27.4 m-85 -61.99 -39.12 91.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 16.26 110.817 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.127 -0.983 . . . . 36.71 110.871 -179.12 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 120.775 0.321 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.503 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 48.5 Cg_endo -76.84 164.62 29.76 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.792 1.417 . . . . 0.0 110.318 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -74.89 -13.84 60.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.429 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.497 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 90.6 t80 -81.13 -28.79 34.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 110.47 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.469 HD23 ' CD2' ' B' ' 14' ' ' TRP . 55.8 mt -93.09 15.0 16.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.709 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.38 -24.19 63.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.919 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -22.2 42.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 110.114 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.48 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 14.9 m0 -73.27 143.71 83.49 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.493 -0.754 . . . . 0.0 109.723 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.405 ' CD ' ' OH ' ' A' ' 38' ' ' TYR . 42.6 Cg_endo -71.23 176.39 7.94 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.56 1.295 . . . . 0.0 110.827 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -24.44 37.1 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.562 -0.711 . . . . 0.0 109.443 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' B' ' 18' ' ' VAL . 1.0 OUTLIER -68.21 -20.89 64.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 110.712 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.403 ' N ' ' HG3' ' B' ' 17' ' ' GLU . 76.9 t -98.98 -47.05 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.139 -0.976 . . . . 0.0 109.883 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.51 -26.08 67.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 110.863 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.01 -31.45 62.94 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.546 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 7.7 tp -79.88 -48.02 14.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.467 -0.771 . . . . 0.0 109.942 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.423 ' CG1' HG13 ' B' ' 33' ' ' VAL . 27.5 t -51.16 -45.57 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 109.938 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -52.12 -62.6 1.53 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.552 -0.717 . . . . 0.0 110.651 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -52.93 -33.82 52.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.931 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.405 ' CG1' ' HG2' ' B' ' 36' ' ' GLU . 61.2 t -67.13 -36.03 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.084 -1.01 . . . . 0.0 110.577 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.64 77.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.872 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -71.66 -15.05 62.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.963 . . . . 0.0 110.393 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.53 -60.2 2.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.044 . . . . 0.0 110.016 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -65.72 -21.93 66.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.266 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.33 16.68 24.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -114.39 -156.88 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.276 . . . . 0.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -110.73 171.04 7.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.565 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.423 HG13 ' CG1' ' B' ' 22' ' ' VAL . 49.3 t -70.23 -19.82 22.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.245 -0.91 . . . . 0.0 110.365 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 -35.61 43.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 64.5 m -75.84 -33.85 60.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' CG1' ' B' ' 25' ' ' VAL . 2.8 tp10 -63.26 -51.59 65.55 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.342 -0.849 . . . . 0.0 109.351 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.472 HD12 ' CZ3' ' B' ' 14' ' ' TRP . 4.9 mt -68.74 -21.6 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.613 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.41 ' OH ' ' CD ' ' A' ' 15' ' ' PRO . 33.4 t80 -75.18 -29.25 60.34 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.22 -0.925 . . . . 0.0 109.775 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -45.54 17.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.671 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -60.53 -44.94 95.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.118 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.469 HG11 ' CZ3' ' A' ' 14' ' ' TRP . 58.0 t -68.88 -24.4 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.647 -0.658 . . . . 0.0 109.958 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -65.15 0.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.379 -0.826 . . . . 0.0 110.83 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -54.66 -31.73 58.09 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.247 -0.908 . . . . 0.0 111.001 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.34 -56.61 10.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.064 -1.023 . . . . 0.0 110.89 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.539 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 29.0 m-85 -62.05 -38.65 89.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 110.792 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.183 -0.948 . . . . 0.0 110.978 -179.288 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.415 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 13.1 ptp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.922 -0.399 . . . . 43.64 109.922 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 41.4 Cg_endo -68.79 151.56 74.27 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.553 1.291 . . . . 29.79 110.557 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -66.05 -20.32 66.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.246 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 91.2 t80 -68.38 -20.99 64.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 12.57 110.394 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.49 HD23 ' CD2' ' A' ' 14' ' ' TRP . 89.0 mt -100.54 20.91 14.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.596 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.19 -26.9 62.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -83.18 -23.51 32.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.107 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.49 ' CD2' HD23 ' A' ' 11' ' ' LEU . 14.0 m0 -67.09 139.55 95.36 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.363 -0.836 . . . . 11.57 109.384 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 42.0 Cg_endo -70.21 168.76 21.21 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.528 1.278 . . . . 13.83 110.904 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.21 -20.47 55.28 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.513 -0.742 . . . . 48.43 109.433 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -72.84 -28.63 62.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 46.64 109.758 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.434 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 77.1 t -87.33 -45.15 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 16.14 109.865 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.1 mt -63.26 -30.48 71.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -0.857 . . . . 12.61 110.593 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -66.01 -25.88 67.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -0.962 . . . . 23.17 109.605 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.519 ' CD2' ' CG ' ' B' ' 45' ' ' PHE . 15.1 tp -86.78 -44.83 11.46 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.446 -0.784 . . . . 19.0 109.745 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.415 ' CG1' HG11 ' A' ' 33' ' ' VAL . 44.4 t -52.83 -43.14 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.263 -0.898 . . . . 18.87 109.778 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -51.01 -61.69 2.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.562 -0.711 . . . . 23.61 110.594 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -54.35 -24.9 21.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.577 -0.702 . . . . 30.11 110.901 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.432 ' CG1' ' HG3' ' A' ' 36' ' ' GLU . 38.4 t -80.48 -30.72 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.168 -0.957 . . . . 16.22 110.783 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.01 -27.72 49.01 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.11 -0.994 . . . . 26.6 110.0 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.38 -15.31 33.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 45.21 110.713 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 29' ' ' ASN . 19.8 pt-20 -90.73 -33.13 15.88 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.882 -1.136 . . . . 37.85 110.436 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.423 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 9.7 m-80 -79.48 -26.88 41.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 35.36 110.159 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.84 23.72 8.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.538 -1.425 . . . . 35.1 109.538 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -131.73 -158.97 0.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.21 -1.171 . . . . 32.72 109.93 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.4 -178.61 3.6 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.525 -0.734 . . . . 19.61 109.086 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.415 HG11 ' CG1' ' A' ' 22' ' ' VAL . 97.8 t -76.79 -19.18 14.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.184 -0.947 . . . . 17.56 110.29 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.457 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 42.2 t30 -74.66 -30.65 61.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 21.3 108.747 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -37.85 23.61 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.501 -0.749 . . . . 16.38 109.214 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' HG3' ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -59.78 -51.55 69.26 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.322 -0.861 . . . . 12.61 109.574 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 38.6 mm -62.95 -28.01 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.325 -0.859 . . . . 10.95 109.2 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.417 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 37.5 t80 -74.17 -24.83 59.44 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.395 -0.816 . . . . 18.87 110.175 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -50.91 9.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.45 -0.781 . . . . 36.88 109.833 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -60.74 -28.82 68.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.816 . . . . 22.85 109.255 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 65.4 t -84.35 -22.43 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.622 -0.674 . . . . 13.02 109.676 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -74.31 -51.23 15.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 18.84 111.101 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -69.52 -23.79 63.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.257 -0.902 . . . . 29.96 111.473 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.5 p -57.31 -52.61 64.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.014 -1.054 . . . . 18.65 110.282 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.495 ' CD2' HD22 ' B' ' 21' ' ' LEU . 36.9 m-85 -63.12 -40.1 96.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -0.999 . . . . 16.26 110.311 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.318 -0.864 . . . . 36.71 110.599 -179.633 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' MET . . . . . 0.427 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 13.2 ptp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.476 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 42.6 Cg_endo -68.68 151.79 74.63 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.538 1.283 . . . . 0.0 110.518 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.01 -20.72 66.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.883 . . . . 0.0 110.211 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.498 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 91.9 t80 -67.93 -21.24 65.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 0.0 110.458 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.479 HD23 ' CD2' ' B' ' 14' ' ' TRP . 88.1 mt -100.35 20.82 14.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 110.611 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -26.72 62.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.979 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -83.34 -23.3 32.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 110.103 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.479 ' CD2' HD23 ' B' ' 11' ' ' LEU . 13.8 m0 -67.42 139.56 94.53 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.384 -0.823 . . . . 0.0 109.355 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.421 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 41.0 Cg_endo -70.3 168.84 21.11 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.412 1.217 . . . . 0.0 110.543 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.27 -20.51 54.99 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.578 -0.701 . . . . 0.0 109.307 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -72.73 -28.8 62.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.164 -0.96 . . . . 0.0 109.448 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' B' ' 15' ' ' PRO . 74.6 t -87.45 -45.18 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 109.637 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 54.0 mt -63.28 -30.1 71.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 110.581 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -66.32 -26.19 67.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.116 -0.99 . . . . 0.0 109.429 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.495 HD22 ' CD2' ' A' ' 45' ' ' PHE . 15.4 tp -86.57 -44.54 11.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.221 0.534 . . . . 0.0 109.61 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.413 ' CG1' HG11 ' B' ' 33' ' ' VAL . 44.1 t -53.37 -43.25 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.815 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -50.78 -61.39 2.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.554 -0.716 . . . . 0.0 110.675 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -54.59 -24.75 22.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.749 . . . . 0.0 111.01 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' HG3' ' B' ' 36' ' ' GLU . 38.2 t -80.61 -30.91 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.092 -1.005 . . . . 0.0 110.667 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.84 -27.75 49.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.097 -1.002 . . . . 0.0 109.955 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.37 -15.16 33.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 110.733 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' B' ' 29' ' ' ASN . 19.7 pt-20 -90.84 -33.11 15.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.006 -1.059 . . . . 0.0 110.49 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.421 ' N ' ' HG3' ' B' ' 28' ' ' GLU . 9.5 m-80 -79.54 -26.7 41.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.72 23.98 8.0 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -132.09 -159.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.203 -1.175 . . . . 0.0 109.836 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.36 -178.81 3.66 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.459 -0.776 . . . . 0.0 109.187 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.413 HG11 ' CG1' ' B' ' 22' ' ' VAL . 97.4 t -76.4 -19.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 110.191 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 41.7 t30 -74.66 -29.99 61.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 108.825 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.52 -38.35 21.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.562 -0.711 . . . . 0.0 109.115 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.426 ' HG3' ' CG1' ' B' ' 25' ' ' VAL . 0.5 OUTLIER -58.97 -51.76 68.67 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.315 -0.865 . . . . 0.0 109.648 179.017 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.428 ' O ' ' CG2' ' B' ' 41' ' ' VAL . 39.1 mm -63.0 -27.6 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.457 -0.777 . . . . 0.0 109.235 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.488 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 36.3 t80 -74.62 -24.96 58.93 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.38 -0.825 . . . . 0.0 110.103 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -50.63 10.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.875 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -61.11 -28.72 69.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.372 -0.83 . . . . 0.0 109.246 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.474 HG12 ' CZ3' ' A' ' 14' ' ' TRP . 62.5 t -84.45 -21.91 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.516 0.674 . . . . 0.0 109.873 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' B' ' 38' ' ' TYR . 0.0 OUTLIER -74.66 -51.21 15.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 111.088 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -69.4 -24.28 63.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.166 -0.959 . . . . 0.0 111.42 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 56.3 p -56.9 -52.73 64.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.92 -1.113 . . . . 0.0 110.199 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.519 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 38.6 m-85 -62.98 -40.48 97.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 110.382 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 110.645 -179.422 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 110.242 -0.281 . . . . 43.64 110.242 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 50.8 Cg_endo -77.05 157.93 34.17 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.508 1.267 . . . . 29.79 110.551 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.01 0.38 35.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.409 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.4 ' CB ' ' HB3' ' B' ' 10' ' ' PHE . 75.1 t80 -88.67 -23.59 22.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.994 -1.066 . . . . 12.57 109.881 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.481 HD21 ' CE3' ' A' ' 14' ' ' TRP . 54.7 mt -99.6 28.18 4.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 110.312 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.48 -22.12 57.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.168 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.08 -10.28 45.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.512 ' CZ3' HG12 ' B' ' 41' ' ' VAL . 13.9 m0 -75.61 142.43 73.98 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.092 -1.005 . . . . 11.57 109.874 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.1 176.25 8.72 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.568 1.299 . . . . 13.83 110.744 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.0 -23.31 38.76 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.381 -0.824 . . . . 48.43 109.437 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -70.26 -27.45 64.44 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.248 -0.907 . . . . 46.64 109.885 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -93.2 -43.82 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -0.858 . . . . 16.14 110.086 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.1 mt -63.74 -31.86 73.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 12.61 110.531 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -66.94 -31.21 71.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 23.17 109.92 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.526 ' CD2' ' CG ' ' B' ' 45' ' ' PHE . 52.6 tp -79.88 -40.21 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.841 . . . . 19.0 110.111 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.426 ' CG1' HG12 ' A' ' 33' ' ' VAL . 39.7 t -54.43 -50.13 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.905 . . . . 18.87 110.139 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -58.33 -49.32 77.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.763 . . . . 23.61 110.437 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -18.57 63.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 30.11 110.635 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.414 HG12 ' CG ' ' A' ' 36' ' ' GLU . 90.6 t -88.94 -29.21 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 16.22 110.44 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.02 -26.98 36.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.168 -0.958 . . . . 26.6 109.818 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -89.51 -15.87 32.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.405 -0.81 . . . . 45.21 110.688 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 18.6 pt-20 -90.69 -28.18 18.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.983 -1.073 . . . . 37.85 110.396 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -90.92 -18.72 24.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 35.36 110.392 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.9 23.66 22.35 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.484 -1.446 . . . . 35.1 109.484 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -121.17 -164.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.119 . . . . 32.72 110.211 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.0 m -106.61 168.58 9.07 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.819 -0.808 . . . . 19.61 108.819 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.426 HG12 ' CG1' ' A' ' 22' ' ' VAL . 92.2 t -73.82 -23.21 18.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.05 -1.031 . . . . 17.56 110.086 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -75.22 -28.93 60.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 21.3 108.896 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.1 m -85.42 -27.84 25.49 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.484 -0.76 . . . . 16.38 109.589 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.414 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.6 tp10 -70.96 -38.47 72.82 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.249 -0.907 . . . . 12.61 109.171 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.46 HD11 ' CH2' ' A' ' 14' ' ' TRP . 17.5 mm -80.13 -25.16 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.564 -0.71 . . . . 10.95 109.345 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.476 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 22.3 t80 -72.99 -38.26 66.72 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.265 -0.897 . . . . 18.87 110.218 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -42.7 65.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.192 -0.943 . . . . 36.88 109.911 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -64.65 -27.08 68.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 22.85 109.304 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.487 HG12 ' CZ3' ' B' ' 14' ' ' TRP . 42.8 t -82.65 -26.97 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.627 0.727 . . . . 13.02 109.329 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -40.44 65.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.668 -0.645 . . . . 18.84 110.736 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.89 -20.99 61.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 29.96 110.599 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 t -64.94 -53.13 51.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -0.976 . . . . 18.65 110.433 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.513 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 31.5 m-85 -62.58 -27.27 69.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 16.26 110.775 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 36.71 110.637 -179.42 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.4 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 50.2 Cg_endo -76.87 157.39 34.93 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.612 1.322 . . . . 0.0 110.627 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.49 0.63 32.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 110.576 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.411 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 74.7 t80 -88.83 -23.85 22.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.07 -1.019 . . . . 0.0 109.826 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.469 HD21 ' CE3' ' B' ' 14' ' ' TRP . 54.7 mt -99.36 28.18 4.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.328 -0.858 . . . . 0.0 110.219 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.47 -21.89 57.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.918 . . . . 0.0 110.219 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -10.32 44.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.18 -0.95 . . . . 0.0 110.5 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.487 ' CZ3' HG12 ' A' ' 41' ' ' VAL . 13.8 m0 -75.79 142.28 73.15 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.133 -0.979 . . . . 0.0 109.858 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.04 176.25 8.69 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.24 1.126 . . . . 0.0 110.721 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.04 -23.47 38.56 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 109.446 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.94 -27.44 64.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.129 -0.982 . . . . 0.0 110.071 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 90.1 t -93.38 -44.07 13.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.989 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.31 -31.87 73.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.542 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -67.16 -30.96 71.07 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.513 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 53.5 tp -79.85 -40.2 28.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.411 -0.805 . . . . 0.0 110.163 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.426 ' CG1' HG12 ' B' ' 33' ' ' VAL . 40.2 t -54.51 -50.2 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.857 . . . . 0.0 109.952 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -58.26 -49.75 76.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.432 -0.793 . . . . 0.0 110.268 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -18.91 63.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 110.775 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.426 HG12 ' CG ' ' B' ' 36' ' ' GLU . 92.2 t -88.66 -28.83 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.083 -1.011 . . . . 0.0 110.542 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.5 -26.4 35.18 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.87 -15.99 31.0 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.435 -0.791 . . . . 0.0 110.555 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -90.68 -27.97 18.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.36 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -91.19 -18.64 24.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 0.0 110.471 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.85 23.61 22.61 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -121.2 -164.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -1.141 . . . . 0.0 110.217 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -106.35 168.4 9.18 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.426 HG12 ' CG1' ' B' ' 22' ' ' VAL . 92.1 t -73.65 -23.25 19.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.018 -1.051 . . . . 0.0 110.157 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -75.27 -28.64 59.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 108.925 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -85.59 -27.85 25.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.54 -0.725 . . . . 0.0 109.518 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.426 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.6 tp10 -70.9 -38.32 73.02 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.262 -0.899 . . . . 0.0 109.366 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.456 HD11 ' CH2' ' B' ' 14' ' ' TRP . 17.6 mm -80.19 -25.19 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 0.0 109.297 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.47 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 22.6 t80 -73.01 -38.02 66.75 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.8 -42.34 64.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -64.94 -26.9 68.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.512 HG12 ' CZ3' ' A' ' 14' ' ' TRP . 42.7 t -82.83 -26.92 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.464 -0.772 . . . . 0.0 109.154 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -39.95 65.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.639 -0.663 . . . . 0.0 110.785 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.26 -21.03 61.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 110.538 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -64.71 -53.28 49.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.435 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.526 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 31.3 m-85 -62.66 -27.23 69.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.973 . . . . 0.0 110.816 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.066 -1.021 . . . . 0.0 110.639 -179.501 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.341 -0.244 . . . . 43.64 110.341 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.427 ' HG3' ' CE1' ' B' ' 10' ' ' PHE . 46.2 Cg_endo -72.88 157.61 51.28 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.635 1.334 . . . . 29.79 110.347 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -75.98 -10.54 59.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.873 . . . . 0.0 110.705 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' B' ' 10' ' ' PHE . 79.1 t80 -74.78 -27.63 60.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.063 -1.023 . . . . 12.57 110.331 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.0 mt -96.17 23.43 6.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 110.203 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.2 -18.26 61.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.675 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -97.24 1.22 49.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.947 . . . . 0.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.493 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.4 m0 -82.32 153.81 68.9 Favored Pre-proline 0 N--CA 1.485 1.313 0 O-C-N 121.076 -1.015 . . . . 11.57 109.796 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.445 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 42.0 Cg_endo -70.61 162.5 42.27 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.535 1.281 . . . . 13.83 111.379 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -40.76 97.6 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.615 0.721 . . . . 48.43 110.67 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -53.78 53.25 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.815 -0.553 . . . . 46.64 111.086 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.445 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 85.7 t -60.96 -44.59 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.099 -1.0 . . . . 16.14 110.737 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.7 mt -62.57 -30.66 71.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.218 -0.926 . . . . 12.61 110.779 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -72.64 -23.13 60.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.987 . . . . 23.17 110.264 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.543 ' CD2' ' CG ' ' B' ' 45' ' ' PHE . 1.2 tp -87.3 -37.46 17.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.32 -0.862 . . . . 19.0 110.21 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 HG12 ' CG1' ' A' ' 33' ' ' VAL . 27.3 t -57.15 -45.23 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 18.87 110.267 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 24' ' ' LYS . 8.8 ptp180 -65.56 -29.87 70.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -0.906 . . . . 23.61 110.681 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -83.58 -10.46 58.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.043 -1.036 . . . . 30.11 110.563 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -100.15 -28.0 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 16.22 110.453 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -76.06 -30.55 58.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 26.6 109.742 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.92 -12.17 58.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.2 -0.938 . . . . 45.21 110.387 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -87.23 -54.13 4.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.068 -1.02 . . . . 37.85 110.536 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -61.01 -22.44 64.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.128 -0.982 . . . . 35.36 110.561 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.2 36.99 4.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.529 -1.428 . . . . 35.1 109.529 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -141.5 -154.89 0.54 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.378 -1.072 . . . . 32.72 110.104 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 p -113.43 171.67 7.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.52 -0.738 . . . . 19.61 109.253 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG22 ' CB ' ' A' ' 26' ' ' ALA . 71.4 t -72.64 -23.04 20.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.097 -1.002 . . . . 17.56 110.412 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -70.08 -29.88 66.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.998 . . . . 21.3 109.021 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.71 -29.33 21.17 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.454 -0.778 . . . . 16.38 109.432 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -64.36 -59.43 4.38 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.306 -0.871 . . . . 12.61 109.349 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.482 HD12 ' CZ3' ' A' ' 14' ' ' TRP . 24.9 mm -60.31 -22.56 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.369 -0.832 . . . . 10.95 109.284 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.423 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 20.0 t80 -73.62 -33.25 64.48 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.367 -0.833 . . . . 18.87 110.065 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -46.36 21.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 36.88 109.817 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 mtt-85 -61.31 -25.94 67.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.445 -0.784 . . . . 22.85 109.601 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.507 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 53.9 t -88.66 -29.81 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.506 -0.747 . . . . 13.02 109.999 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.0 -67.48 0.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 18.84 110.54 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -55.82 -20.68 16.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.975 . . . . 29.96 110.479 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.0 t -60.35 -53.66 54.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 18.65 109.998 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.537 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 17.0 m-85 -60.52 -30.46 69.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.352 -0.843 . . . . 16.26 110.129 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 36.71 110.579 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.461 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 45.8 Cg_endo -73.02 157.57 50.83 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.75 1.395 . . . . 0.0 110.35 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -75.86 -10.55 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 79.0 t80 -74.84 -27.8 60.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.29 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 41.7 mt -96.09 23.36 6.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.179 -0.951 . . . . 0.0 110.225 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.18 -18.35 61.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.134 -0.979 . . . . 0.0 110.601 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -97.13 1.22 49.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.048 -1.032 . . . . 0.0 110.855 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.507 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.3 m0 -82.48 153.82 68.46 Favored Pre-proline 0 N--CA 1.485 1.31 0 O-C-N 120.986 -1.071 . . . . 0.0 109.852 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.446 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 42.2 Cg_endo -70.47 162.11 43.62 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.419 1.221 . . . . 0.0 111.525 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -40.6 97.18 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.784 0.802 . . . . 0.0 110.768 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -53.87 52.14 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.037 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.446 ' CG2' ' HG2' ' B' ' 15' ' ' PRO . 85.8 t -60.7 -45.09 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.586 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 71.6 mt -61.92 -30.8 71.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.827 -1.171 . . . . 0.0 111.111 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -72.73 -23.32 60.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.097 -1.002 . . . . 0.0 110.287 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.537 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 1.2 tp -87.0 -37.58 17.38 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.423 -0.798 . . . . 0.0 110.301 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.418 HG12 ' CG1' ' B' ' 33' ' ' VAL . 26.3 t -57.02 -45.28 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 110.267 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' B' ' 24' ' ' LYS . 8.8 ptp180 -65.59 -29.73 70.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.24 -0.913 . . . . 0.0 110.709 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 0.0 OUTLIER -83.7 -10.45 58.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.064 -1.022 . . . . 0.0 110.527 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -100.12 -27.94 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 110.459 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.422 ' CB ' HG22 ' B' ' 33' ' ' VAL . . . -76.05 -30.54 58.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.12 -0.987 . . . . 0.0 109.734 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.0 -11.96 58.57 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.378 -0.826 . . . . 0.0 110.46 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.38 -54.0 4.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.991 . . . . 0.0 110.545 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -61.2 -22.35 64.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 110.63 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.15 37.1 4.72 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -141.53 -154.88 0.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.399 -1.059 . . . . 0.0 110.094 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 2.2 p -113.32 171.66 7.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.528 -0.732 . . . . 0.0 109.311 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.422 HG22 ' CB ' ' B' ' 26' ' ' ALA . 70.9 t -72.64 -23.17 20.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.124 -0.985 . . . . 0.0 110.454 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -69.96 -29.75 66.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.0 109.042 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.87 -29.46 20.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.497 -0.752 . . . . 0.0 109.356 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -64.3 -59.4 4.43 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.297 -0.877 . . . . 0.0 109.295 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.487 HD12 ' CZ3' ' B' ' 14' ' ' TRP . 24.9 mm -60.37 -22.64 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.315 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.433 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 19.5 t80 -73.71 -33.24 64.3 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.265 -0.897 . . . . 0.0 109.977 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -46.52 21.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 109.723 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 mtt-85 -61.14 -25.84 67.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.81 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.493 HG11 ' CZ3' ' A' ' 14' ' ' TRP . 54.7 t -88.66 -29.85 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.968 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -67.41 0.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 110.465 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -55.86 -20.83 17.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.95 . . . . 0.0 110.396 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 19.6 t -60.25 -53.65 55.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.235 -0.915 . . . . 0.0 109.97 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.543 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 17.4 m-85 -60.36 -30.75 69.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 0.0 110.575 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 110.191 -0.3 . . . . 43.64 110.191 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 11' ' ' LEU . 44.1 Cg_endo -70.3 145.83 55.12 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.594 1.313 . . . . 29.79 110.426 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -64.16 -14.49 55.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 110.729 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.48 ' CE1' ' HG3' ' B' ' 8' ' ' PRO . 89.9 t80 -71.77 -28.79 63.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.108 -0.995 . . . . 12.57 110.169 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.483 HD22 ' CE3' ' A' ' 14' ' ' TRP . 65.9 mt -93.77 30.21 1.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.176 -0.953 . . . . 0.0 110.272 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.82 -23.91 61.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -19.63 25.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.91 . . . . 0.0 110.449 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.486 ' CZ2' ' HA ' ' B' ' 38' ' ' TYR . 13.1 m0 -69.56 132.47 89.3 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.256 -0.903 . . . . 11.57 109.236 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.66 167.2 23.51 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.411 1.216 . . . . 13.83 111.082 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -67.98 -25.77 65.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.614 -0.679 . . . . 48.43 110.791 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.5 -51.92 51.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 46.64 110.611 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.49 -39.5 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 16.14 110.526 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.7 -29.92 70.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 12.61 110.639 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.08 -27.47 68.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.059 -1.026 . . . . 23.17 109.504 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.478 HD21 ' CD2' ' B' ' 45' ' ' PHE . 50.1 tp -84.88 -39.53 18.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.561 -0.712 . . . . 19.0 110.066 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.26 -47.25 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.44 -0.788 . . . . 18.87 110.574 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 24' ' ' LYS . 9.6 ptp180 -61.52 -28.62 69.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.316 -0.865 . . . . 23.61 110.849 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.453 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -86.01 -20.68 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.029 -1.044 . . . . 30.11 110.14 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.4 -23.75 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.873 . . . . 16.22 110.204 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.76 -34.61 67.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.305 -0.872 . . . . 26.6 109.528 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.44 -9.78 59.3 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.333 -0.854 . . . . 45.21 110.425 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.47 -59.96 2.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 37.85 110.399 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -58.61 -30.17 67.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 35.36 110.444 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.04 32.68 3.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 35.1 109.555 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -136.74 -165.13 1.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.122 . . . . 32.72 109.94 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.24 -173.36 2.65 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.408 -0.807 . . . . 19.61 108.842 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -83.44 -15.5 11.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.171 -0.956 . . . . 17.56 110.099 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.469 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 60.6 t30 -80.84 -33.18 34.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 21.3 108.496 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.84 -40.0 49.27 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.835 -0.802 . . . . 16.38 108.835 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 40' ' ' ARG . 1.5 tt0 -59.53 -51.24 70.71 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.247 -0.908 . . . . 12.61 109.256 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.415 HD13 ' CH2' ' A' ' 14' ' ' TRP . 35.3 mm -64.0 -24.42 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.373 -0.829 . . . . 10.95 109.584 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.485 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 35.2 t80 -73.98 -30.35 62.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.297 -0.877 . . . . 18.87 110.427 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 -78.12 -46.09 21.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.083 -1.011 . . . . 36.88 110.137 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.417 ' CD ' ' O ' ' A' ' 36' ' ' GLU . 2.7 mpt_? -60.98 -26.68 67.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 22.85 109.697 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.505 HG12 ' CZ3' ' B' ' 14' ' ' TRP . 19.2 t -85.63 -30.58 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.491 -0.756 . . . . 13.02 109.352 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.5 mtp -71.4 -20.33 62.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.759 . . . . 18.84 110.487 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.04 -26.65 26.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 29.96 110.532 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.48 -58.81 6.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 18.65 110.317 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.504 ' CG ' HD21 ' B' ' 21' ' ' LEU . 30.1 m-85 -55.13 -42.31 72.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 16.26 110.374 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mttt . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.161 -0.962 . . . . 36.71 110.615 -179.795 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.48 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 45.0 Cg_endo -70.65 145.25 51.53 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.678 1.357 . . . . 0.0 110.392 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -63.62 -14.46 51.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 0.0 110.749 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 34' ' ' ASN . 90.7 t80 -71.8 -28.46 63.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.047 -1.033 . . . . 0.0 110.209 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.479 HD22 ' CE3' ' B' ' 14' ' ' TRP . 64.2 mt -94.05 30.31 1.91 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.248 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.99 -23.95 61.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -0.847 . . . . 0.0 110.221 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -19.58 25.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.928 . . . . 0.0 110.451 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.505 ' CZ3' HG12 ' A' ' 41' ' ' VAL . 13.2 m0 -69.86 132.18 88.9 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.351 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.5 167.24 23.11 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.551 1.29 . . . . 0.0 111.153 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -68.07 -25.67 65.46 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.735 -0.603 . . . . 0.0 110.698 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.98 -51.72 51.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 110.526 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.64 -39.48 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.103 -0.998 . . . . 0.0 110.237 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 14.3 mt -65.77 -29.83 70.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 110.715 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.37 -27.61 68.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.041 -1.037 . . . . 0.0 109.617 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.504 HD21 ' CG ' ' A' ' 45' ' ' PHE . 45.7 tp -84.87 -39.1 18.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.633 -0.667 . . . . 0.0 110.03 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.88 -46.32 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.0 110.606 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' B' ' 24' ' ' LYS . 9.6 ptp180 -62.31 -28.31 69.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.197 -0.939 . . . . 0.0 110.759 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.451 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 0.1 OUTLIER -86.06 -20.82 28.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.031 -1.043 . . . . 0.0 110.116 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 95.3 t -87.42 -23.75 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.853 . . . . 0.0 110.119 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.27 66.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.52 -9.91 59.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.46 -0.775 . . . . 0.0 110.371 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -86.51 -59.99 2.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.015 . . . . 0.0 110.379 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -58.56 -30.09 66.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.87 . . . . 0.0 110.345 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.94 32.56 3.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -136.44 -164.82 1.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -1.183 . . . . 0.0 109.973 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.54 -173.55 2.67 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.37 -0.831 . . . . 0.0 108.879 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 69.4 t -83.26 -15.65 11.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.175 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 60.2 t30 -80.86 -32.98 34.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.097 -1.002 . . . . 0.0 108.436 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -40.47 48.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' B' ' 40' ' ' ARG . 1.5 tt0 -59.1 -51.55 69.55 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.214 -0.929 . . . . 0.0 109.273 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.403 HD13 ' CH2' ' B' ' 14' ' ' TRP . 37.0 mm -63.53 -24.58 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.58 -0.7 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.486 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 37.8 t80 -74.2 -29.84 61.93 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 110.508 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -78.6 -46.2 19.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 0.404 ' CD ' ' O ' ' B' ' 36' ' ' GLU . 2.7 mpt_? -60.36 -27.64 67.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.567 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.485 HG12 ' CZ3' ' A' ' 14' ' ' TRP . 18.6 t -84.9 -30.42 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.512 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.5 mtp -72.19 -19.54 61.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 110.499 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.45 -26.94 26.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 110.354 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -58.9 6.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 0.0 110.391 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.478 ' CD2' HD21 ' A' ' 21' ' ' LEU . 31.2 m-85 -55.23 -41.93 72.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.469 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mttt . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.249 -0.907 . . . . 0.0 110.518 -179.638 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 18.4 mtp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 110.209 -0.293 . . . . 43.64 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.423 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.0 Cg_endo -71.33 153.5 61.44 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.569 1.3 . . . . 29.79 110.487 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.15 -17.58 64.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 110.456 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.434 ' HB3' ' CB ' ' B' ' 10' ' ' PHE . 87.7 t80 -76.26 -28.45 57.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 12.57 110.352 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.477 HD21 ' CD2' ' A' ' 14' ' ' TRP . 81.5 mt -91.53 21.14 4.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.954 . . . . 0.0 110.455 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -72.45 -22.65 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 110.059 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.79 -11.99 46.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.635 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.479 ' CZ3' HG13 ' B' ' 41' ' ' VAL . 14.2 m0 -79.73 141.94 56.39 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.029 -1.045 . . . . 11.57 109.682 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.19 177.83 7.33 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.572 1.301 . . . . 13.83 110.685 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.77 -21.95 34.46 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.385 -0.822 . . . . 48.43 109.153 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -69.32 -28.01 65.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.885 . . . . 46.64 109.887 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.5 t -94.85 -40.46 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 16.14 110.034 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.89 -28.79 69.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 12.61 110.547 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -73.08 -22.61 60.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 23.17 109.936 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.485 HD23 ' CG ' ' B' ' 45' ' ' PHE . 50.6 tp -90.1 -33.52 16.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 19.0 110.018 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.423 ' CG1' HD12 ' A' ' 37' ' ' ILE . 24.0 t -67.14 -50.18 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.419 -0.801 . . . . 18.87 110.345 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -59.17 -27.25 65.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.309 -0.869 . . . . 23.61 110.788 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -24.11 33.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 30.11 110.165 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.4 t -78.83 -39.34 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.433 -0.792 . . . . 16.22 110.351 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.425 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -63.53 -40.76 97.86 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.204 -0.935 . . . . 26.6 109.654 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -68.13 -16.09 63.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 45.21 110.452 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.78 -59.84 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.979 -1.076 . . . . 37.85 110.411 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -59.07 -28.03 66.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 35.36 110.703 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.59 41.03 3.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.461 -1.456 . . . . 35.1 109.461 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mtt-85 -141.96 -154.01 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -1.121 . . . . 32.72 110.069 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 t -108.59 175.94 5.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.48 -0.763 . . . . 19.61 109.476 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG21 ' CB ' ' A' ' 26' ' ' ALA . 88.9 t -78.64 -20.56 13.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.157 -0.965 . . . . 17.56 110.229 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.18 -26.57 63.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.069 -1.019 . . . . 21.3 109.104 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.82 -30.53 22.9 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.384 -0.823 . . . . 16.38 109.566 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -48.48 67.86 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.251 -0.906 . . . . 12.61 109.724 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.423 HD12 ' CG1' ' A' ' 22' ' ' VAL . 47.3 mm -66.36 -30.88 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.837 . . . . 10.95 109.679 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.475 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 36.9 t80 -67.67 -39.4 84.51 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 18.87 110.635 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.53 -45.81 61.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.185 -0.947 . . . . 36.88 109.743 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -60.84 -24.69 66.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 22.85 109.4 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.502 HG13 ' CZ3' ' B' ' 14' ' ' TRP . 52.1 t -90.14 -23.36 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.586 -0.696 . . . . 13.02 110.161 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -56.99 4.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.505 -0.747 . . . . 18.84 110.977 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -50.74 -33.22 22.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.121 -0.987 . . . . 29.96 111.189 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.3 m -60.79 -51.24 70.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.121 -0.987 . . . . 18.65 110.598 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.5 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 15.0 m-85 -59.77 -29.88 68.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.98 . . . . 16.26 110.814 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.006 -1.059 . . . . 36.71 110.677 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 18.3 mtp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.421 ' CG ' HD12 ' B' ' 11' ' ' LEU . 45.4 Cg_endo -71.46 153.55 60.71 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.65 1.342 . . . . 0.0 110.42 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.04 -17.74 65.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.458 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.434 ' CB ' ' HB3' ' A' ' 10' ' ' PHE . 87.6 t80 -76.15 -28.32 57.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.157 -0.964 . . . . 0.0 110.326 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.478 HD21 ' CD2' ' B' ' 14' ' ' TRP . 83.5 mt -91.8 21.7 4.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 110.407 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.09 -22.53 60.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.974 . . . . 0.0 110.015 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.74 -12.02 46.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 110.644 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.502 ' CZ3' HG13 ' A' ' 41' ' ' VAL . 14.2 m0 -79.83 142.05 56.1 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.841 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.21 177.42 7.86 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.551 1.29 . . . . 0.0 110.18 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -21.6 34.61 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.439 -0.788 . . . . 0.0 109.226 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -69.38 -28.02 65.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.978 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 80.2 t -94.66 -40.64 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.551 -0.718 . . . . 0.0 109.845 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.95 -28.44 68.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.563 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.38 -22.85 60.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.845 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.5 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 51.7 tp -89.82 -33.73 16.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.704 -0.623 . . . . 0.0 110.12 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.43 ' CG1' HD12 ' B' ' 37' ' ' ILE . 24.0 t -66.92 -50.1 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -0.829 . . . . 0.0 110.37 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -59.14 -27.52 65.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.289 -0.882 . . . . 0.0 110.801 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -24.3 34.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 110.114 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' B' ' 21' ' ' LEU . 88.8 t -78.66 -39.46 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.804 . . . . 0.0 110.299 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.423 ' CB ' HG21 ' B' ' 33' ' ' VAL . . . -63.18 -41.47 99.22 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.342 -0.849 . . . . 0.0 109.59 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -67.53 -16.24 64.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.528 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -82.56 -59.94 2.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.041 -1.037 . . . . 0.0 110.503 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -58.97 -28.16 66.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.136 -0.978 . . . . 0.0 110.794 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.47 41.7 2.9 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -142.6 -154.19 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.433 -1.04 . . . . 0.0 110.002 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.7 t -108.87 175.8 5.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.451 -0.781 . . . . 0.0 109.466 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.423 HG21 ' CB ' ' B' ' 26' ' ' ALA . 93.7 t -78.27 -20.5 13.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 110.451 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.6 -26.32 62.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.079 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.02 -30.38 22.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.429 -0.794 . . . . 0.0 109.467 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -48.35 67.61 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.43 HD12 ' CG1' ' B' ' 22' ' ' VAL . 47.2 mm -66.81 -30.31 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -68.0 -39.41 83.22 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.381 -0.825 . . . . 0.0 110.608 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -45.83 61.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.895 . . . . 0.0 109.759 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -60.93 -24.52 66.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 109.383 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.479 HG13 ' CZ3' ' A' ' 14' ' ' TRP . 49.9 t -90.22 -23.4 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.62 -0.675 . . . . 0.0 110.011 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -57.66 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.507 -0.746 . . . . 0.0 111.081 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -50.22 -33.37 19.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.163 -0.961 . . . . 0.0 111.249 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 38.1 m -60.96 -50.85 71.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.1 -1.0 . . . . 0.0 110.637 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.485 ' CG ' HD23 ' A' ' 21' ' ' LEU . 15.9 m-85 -60.04 -30.04 68.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.79 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.251 -0.905 . . . . 0.0 110.835 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.405 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 1.9 ptm . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 110.358 -0.238 . . . . 43.64 110.358 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 44.0 Cg_endo -70.86 157.77 57.34 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.711 1.374 . . . . 29.79 110.466 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.28 -21.59 62.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.891 . . . . 0.0 110.449 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.496 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 87.4 t80 -70.12 -22.16 63.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.843 . . . . 12.57 110.574 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD21 ' CD2' ' A' ' 14' ' ' TRP . 85.1 mt -100.23 27.43 5.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.139 -0.975 . . . . 0.0 110.541 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.81 -21.64 44.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.952 . . . . 0.0 110.006 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -85.58 -22.9 27.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.494 ' CZ3' HG12 ' B' ' 41' ' ' VAL . 14.7 m0 -66.16 144.81 98.9 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 121.424 -0.798 . . . . 11.57 109.533 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HD2' ' CE1' ' B' ' 38' ' ' TYR . 40.6 Cg_endo -70.85 160.35 49.67 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.496 1.261 . . . . 13.83 111.336 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -40.15 88.9 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.603 0.716 . . . . 48.43 110.934 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.09 -47.29 86.51 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.69 -0.631 . . . . 46.64 111.49 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.429 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 77.0 t -66.89 -48.82 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.038 -1.039 . . . . 16.14 111.021 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 74.8 mt -64.02 -24.97 67.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.069 -1.019 . . . . 12.61 110.685 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.69 -23.68 61.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 23.17 109.898 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.513 HD22 ' CD1' ' B' ' 45' ' ' PHE . 0.8 OUTLIER -90.29 -43.72 10.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 19.0 110.043 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.405 ' CG1' ' CG1' ' A' ' 33' ' ' VAL . 40.6 t -51.32 -39.44 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.392 -0.818 . . . . 18.87 110.477 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -66.03 -36.21 82.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 23.61 110.622 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -19.4 58.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 30.11 110.524 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -86.88 -35.09 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.263 -0.898 . . . . 16.22 110.184 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.91 83.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -0.909 . . . . 26.6 109.738 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.98 -19.45 63.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 45.21 110.271 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -82.77 -56.53 3.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 37.85 110.35 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -53.41 -42.64 67.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 35.36 110.386 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.73 44.54 0.54 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.541 -1.424 . . . . 35.1 109.541 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.33 -158.58 0.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -1.123 . . . . 32.72 110.189 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.83 176.93 5.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 19.61 109.561 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.405 ' CG1' ' CG1' ' A' ' 22' ' ' VAL . 75.1 t -76.14 -19.42 15.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.356 -0.84 . . . . 17.56 110.265 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -71.12 -27.72 63.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 21.3 108.869 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 m -86.3 -33.64 20.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.555 -0.716 . . . . 16.38 109.531 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.55 -53.59 49.42 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.187 -0.946 . . . . 12.61 109.412 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 25.8 mm -63.37 -21.73 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.458 -0.776 . . . . 10.95 109.653 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.492 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 32.9 t80 -76.2 -35.59 59.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.155 -0.966 . . . . 18.87 110.362 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -76.8 -52.03 10.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 36.88 109.6 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -55.46 -24.56 31.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.456 -0.778 . . . . 22.85 109.732 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.503 HG12 ' CZ3' ' B' ' 14' ' ' TRP . 37.5 t -89.97 -29.79 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 13.02 109.867 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -64.07 0.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 18.84 110.48 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.88 -29.13 18.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.19 -0.944 . . . . 29.96 110.425 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.65 -46.45 81.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 18.65 109.928 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.511 ' CD1' HD22 ' B' ' 21' ' ' LEU . 15.4 m-85 -66.75 -29.07 68.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 16.26 110.167 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 36.71 110.502 -179.807 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' MET . . . . . 0.416 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 2.0 ptm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.496 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 43.9 Cg_endo -71.04 157.99 56.41 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.621 1.327 . . . . 0.0 110.449 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.53 -21.23 61.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 110.386 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.489 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 86.6 t80 -70.53 -22.08 62.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.441 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.45 HD21 ' CD2' ' B' ' 14' ' ' TRP . 85.1 mt -100.37 27.55 5.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 110.542 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.01 -21.4 43.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 110.034 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -85.86 -22.9 27.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.873 . . . . 0.0 110.189 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.503 ' CZ3' HG12 ' A' ' 41' ' ' VAL . 14.8 m0 -66.34 145.2 98.96 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.288 -0.883 . . . . 0.0 109.425 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.437 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 41.0 Cg_endo -71.4 159.71 50.77 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.308 1.162 . . . . 0.0 111.341 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -40.4 86.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.676 0.75 . . . . 0.0 110.997 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.15 -47.21 86.87 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.774 -0.579 . . . . 0.0 111.481 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.437 ' CG2' ' HG2' ' B' ' 15' ' ' PRO . 78.9 t -67.11 -48.61 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.304 -0.872 . . . . 0.0 110.902 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.04 -24.63 67.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.079 -1.013 . . . . 0.0 110.662 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -71.99 -24.14 61.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.231 -0.918 . . . . 0.0 109.754 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.511 HD22 ' CD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -90.03 -43.45 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.502 -0.748 . . . . 0.0 110.096 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.412 ' CG1' ' CG1' ' B' ' 33' ' ' VAL . 40.7 t -51.6 -39.62 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.41 -0.806 . . . . 0.0 110.458 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -65.84 -36.29 83.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.706 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -19.57 58.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.459 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -86.71 -35.25 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.923 . . . . 0.0 110.32 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 -39.35 84.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 109.701 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.49 -19.92 63.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 110.245 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -82.45 -56.53 3.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.128 -0.982 . . . . 0.0 110.373 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -53.6 -42.38 67.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 110.46 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.51 44.48 0.55 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.35 -158.68 0.69 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -1.176 . . . . 0.0 110.258 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.69 176.92 5.06 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.363 -0.835 . . . . 0.0 109.617 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.412 ' CG1' ' CG1' ' B' ' 22' ' ' VAL . 76.3 t -76.14 -19.26 15.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.261 -0.899 . . . . 0.0 110.308 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -71.18 -27.84 63.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -0.989 . . . . 0.0 108.856 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 45.6 m -86.15 -33.72 20.77 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.549 -0.719 . . . . 0.0 109.536 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.4 -53.66 48.88 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.249 -0.907 . . . . 0.0 109.492 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' B' ' 41' ' ' VAL . 26.4 mm -63.32 -21.81 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.528 -0.732 . . . . 0.0 109.596 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.487 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 33.3 t80 -76.15 -35.51 59.17 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.113 -0.992 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -76.78 -52.08 10.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.146 -0.971 . . . . 0.0 109.645 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -55.44 -24.46 30.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.461 -0.774 . . . . 0.0 109.817 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.494 HG12 ' CZ3' ' A' ' 14' ' ' TRP . 37.7 t -90.07 -29.97 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 0.0 109.898 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -63.92 1.01 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 110.451 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.03 -29.35 20.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.156 -0.965 . . . . 0.0 110.325 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -46.7 80.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 110.011 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.513 ' CD1' HD22 ' A' ' 21' ' ' LEU . 15.7 m-85 -66.73 -28.95 68.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 110.125 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 110.481 -179.82 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 mtp . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 110.381 -0.229 . . . . 43.64 110.381 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.9 Cg_endo -71.12 170.59 17.79 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.565 1.297 . . . . 29.79 110.791 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -87.0 -17.55 32.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 110.327 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.502 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 74.2 t80 -72.62 -26.12 61.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 12.57 110.564 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.48 HD22 ' CD2' ' A' ' 14' ' ' TRP . 71.6 mt -94.34 27.1 3.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 110.14 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.7 -18.11 61.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 110.414 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.7 -3.84 29.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.086 -1.008 . . . . 0.0 110.726 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.48 ' CD2' HD22 ' A' ' 11' ' ' LEU . 13.8 m0 -81.87 138.33 46.69 Favored Pre-proline 0 C--N 1.305 -1.332 0 O-C-N 120.95 -1.094 . . . . 11.57 109.635 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.23 159.59 51.5 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.482 1.254 . . . . 13.83 111.228 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -40.97 96.93 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.856 0.836 . . . . 48.43 110.382 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -52.71 -21.01 3.56 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.691 -0.631 . . . . 46.64 111.223 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.6 t -104.0 -44.77 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.974 -1.079 . . . . 16.14 111.227 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.0 mt -63.12 -24.64 67.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.134 -0.979 . . . . 12.61 111.11 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -25.75 60.48 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.248 -0.907 . . . . 23.17 109.56 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.484 HD21 ' CG ' ' B' ' 45' ' ' PHE . 42.9 tp -85.54 -42.47 14.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.599 -0.688 . . . . 19.0 109.849 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.419 HG12 ' CG1' ' A' ' 37' ' ' ILE . 25.3 t -55.3 -37.94 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 18.87 110.205 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -67.5 -50.49 58.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 23.61 110.439 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -19.48 65.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.218 -0.926 . . . . 30.11 110.338 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.84 -32.58 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 16.22 110.061 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 33' ' ' VAL . . . -71.74 -39.13 70.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.199 -0.938 . . . . 26.6 109.306 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 -19.37 62.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.529 -0.732 . . . . 45.21 109.77 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.84 -57.12 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 37.85 110.153 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -56.29 -53.69 54.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 35.36 110.227 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.75 52.43 0.08 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.669 -1.372 . . . . 35.1 109.669 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -169.33 -159.19 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -1.21 . . . . 32.72 110.223 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.8 p -98.4 -176.43 3.39 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.462 -0.774 . . . . 19.61 109.778 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.417 ' CG1' HG11 ' A' ' 22' ' ' VAL . 86.4 t -81.5 -9.94 12.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.155 -0.966 . . . . 17.56 110.708 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.72 -29.87 59.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.007 -1.058 . . . . 21.3 109.318 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -90.42 -28.63 18.51 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.372 -0.83 . . . . 16.38 110.058 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -65.05 -51.15 63.12 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.134 -0.979 . . . . 12.61 109.66 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.464 HD11 ' CZ3' ' A' ' 14' ' ' TRP . 2.7 mt -67.08 -20.6 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.398 -0.814 . . . . 10.95 109.729 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -69.61 -39.15 77.41 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.112 -0.992 . . . . 18.87 110.27 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -71.82 -43.5 65.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 36.88 110.223 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.0 mtt-85 -63.3 -31.98 73.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 22.85 109.519 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 71.3 t -83.33 -22.8 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.626 -0.671 . . . . 13.02 110.284 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.25 -34.89 48.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.408 -0.807 . . . . 18.84 110.587 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -72.48 -32.4 66.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 29.96 110.268 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -54.79 40.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 18.65 110.071 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.508 ' CG ' HD21 ' B' ' 21' ' ' LEU . 27.0 m-85 -62.02 -19.46 62.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 16.26 110.572 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 36.71 110.162 179.894 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 120.554 0.216 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.502 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 45.6 Cg_endo -71.19 170.71 17.55 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.555 1.292 . . . . 0.0 110.782 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -87.27 -17.51 32.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.408 -0.808 . . . . 0.0 110.398 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 76.9 t80 -72.69 -26.0 61.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.867 . . . . 0.0 110.477 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.475 HD22 ' CD2' ' B' ' 14' ' ' TRP . 71.8 mt -94.57 27.22 3.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.181 -0.949 . . . . 0.0 110.174 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.82 -18.12 60.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 110.489 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.6 -3.7 29.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.086 -1.009 . . . . 0.0 110.786 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.496 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.9 m0 -82.13 138.6 45.71 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.103 -0.998 . . . . 0.0 109.67 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.36 159.54 51.38 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.175 1.092 . . . . 0.0 110.95 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.74 96.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.636 0.731 . . . . 0.0 110.301 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -52.65 -21.09 3.58 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.701 -0.624 . . . . 0.0 111.105 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -104.05 -44.61 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.441 -1.412 . . . . 0.0 111.14 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 19.9 mt -63.26 -24.76 68.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.132 -0.98 . . . . 0.0 111.081 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -25.37 60.07 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.251 -0.906 . . . . 0.0 109.683 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.508 HD21 ' CG ' ' A' ' 45' ' ' PHE . 44.8 tp -85.7 -42.29 14.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.577 -0.702 . . . . 0.0 109.968 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.424 HG12 ' CG1' ' B' ' 37' ' ' ILE . 26.2 t -55.42 -37.97 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.107 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -67.3 -50.81 58.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.305 -0.872 . . . . 0.0 110.455 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -19.55 64.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.229 -0.919 . . . . 0.0 110.5 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 87.6 t -86.7 -32.62 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 110.1 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' B' ' 33' ' ' VAL . . . -71.52 -39.09 70.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.25 -19.34 62.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.529 -0.732 . . . . 0.0 109.764 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.83 -57.12 3.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 110.227 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -56.37 -53.82 52.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 110.284 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.09 52.44 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -169.36 -159.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.267 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 54.5 p -98.31 -176.32 3.37 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.314 -0.866 . . . . 0.0 109.867 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.418 ' CG1' HG11 ' B' ' 22' ' ' VAL . 88.0 t -81.62 -9.97 12.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.17 -0.956 . . . . 0.0 110.819 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.61 -29.88 59.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.982 . . . . 0.0 109.367 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -90.39 -28.68 18.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.952 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -65.14 -50.96 63.99 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.194 -0.941 . . . . 0.0 109.732 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.473 HD11 ' CZ3' ' B' ' 14' ' ' TRP . 2.5 mt -67.13 -20.82 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -69.66 -39.3 77.13 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.214 -0.929 . . . . 0.0 110.252 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -71.51 -43.48 66.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.83 . . . . 0.0 110.198 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -63.5 -32.05 73.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.95 . . . . 0.0 109.502 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.454 HG11 ' CZ3' ' A' ' 14' ' ' TRP . 76.9 t -82.92 -22.87 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 110.34 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.36 -34.98 47.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.819 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.45 -32.35 66.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.136 -0.977 . . . . 0.0 110.208 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.22 -54.78 41.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 110.105 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.484 ' CG ' HD21 ' A' ' 21' ' ' LEU . 27.2 m-85 -61.85 -19.42 62.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 110.54 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.219 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 110.114 -0.328 . . . . 43.64 110.114 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.4 156.8 50.12 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.516 1.272 . . . . 29.79 110.495 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -76.53 -11.64 59.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.614 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' B' ' 11' ' ' LEU . 89.1 t80 -79.31 -34.35 42.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.014 -1.054 . . . . 12.57 110.291 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.477 HD11 ' CE1' ' B' ' 10' ' ' PHE . 66.1 mt -88.27 14.89 8.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.096 -1.003 . . . . 0.0 110.586 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.58 -27.44 69.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -82.34 -23.78 34.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.92 . . . . 0.0 110.519 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.488 ' CZ3' HG13 ' B' ' 41' ' ' VAL . 13.0 m0 -63.43 141.72 97.86 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.312 -0.867 . . . . 11.57 109.21 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.39 173.63 9.41 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.458 1.241 . . . . 13.83 111.082 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -77.82 -22.03 50.63 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.499 -0.751 . . . . 48.43 109.769 -179.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.7 -46.22 39.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 46.64 110.428 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -68.72 -39.58 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 16.14 110.157 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.26 -31.52 72.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 12.61 110.654 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 3.4 t0 -70.75 -22.33 62.42 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 23.17 110.074 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.492 ' CD2' ' CG ' ' B' ' 45' ' ' PHE . 51.0 tp -88.83 -37.62 15.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.372 -0.83 . . . . 19.0 109.951 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.424 ' CG1' HD13 ' A' ' 37' ' ' ILE . 15.6 t -65.84 -49.51 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 18.87 109.959 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.45 ' CD ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -59.91 -35.76 75.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 23.61 110.483 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 23' ' ' ARG . 2.1 tmtt? -73.43 -24.55 60.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.113 -0.992 . . . . 30.11 109.943 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 21' ' ' LEU . 99.4 t -86.63 -20.89 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.497 -0.752 . . . . 16.22 110.311 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.22 -30.21 30.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.217 -0.927 . . . . 26.6 109.539 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.43 -19.51 49.78 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.471 -0.768 . . . . 45.21 110.307 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 29' ' ' ASN . 22.8 pt-20 -90.82 -30.82 16.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.191 -0.943 . . . . 37.85 110.279 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.41 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -82.97 7.68 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 35.36 110.558 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.45 23.98 70.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.517 -1.433 . . . . 35.1 109.517 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -129.19 -158.02 0.86 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -1.194 . . . . 32.72 110.362 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m -115.06 -179.65 3.69 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.511 -0.743 . . . . 19.61 109.286 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.1 t -77.97 -14.86 14.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.129 -0.982 . . . . 17.56 110.448 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -77.03 -41.69 41.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.102 -0.998 . . . . 21.3 109.004 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.8 t -71.18 -35.9 71.76 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.386 -0.821 . . . . 16.38 109.56 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.68 -50.54 66.6 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.233 -0.917 . . . . 12.61 109.405 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 HD13 ' CG1' ' A' ' 22' ' ' VAL . 35.6 mm -63.94 -26.82 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 10.95 109.53 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -71.89 -37.19 70.19 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.374 -0.829 . . . . 18.87 110.753 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.74 -36.34 59.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -0.932 . . . . 36.88 110.253 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -71.99 -24.16 61.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 22.85 109.64 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.508 HG13 ' CZ3' ' B' ' 14' ' ' TRP . 7.0 t -87.09 -28.68 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.8 . . . . 13.02 109.217 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -43.45 60.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.603 -0.685 . . . . 18.84 110.531 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -28.93 68.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 29.96 110.137 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -49.81 70.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.89 . . . . 18.65 110.07 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.52 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 31.1 m-85 -66.01 -22.87 66.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 16.26 110.371 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.19 -0.944 . . . . 36.71 110.525 -179.644 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.41 156.96 50.0 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.522 1.275 . . . . 0.0 110.384 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -76.8 -11.93 59.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.588 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . 0.477 ' CE1' HD11 ' A' ' 11' ' ' LEU . 89.5 t80 -79.01 -34.09 44.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.078 -1.014 . . . . 0.0 110.322 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.477 HD21 ' CD2' ' B' ' 14' ' ' TRP . 64.6 mt -88.84 15.62 8.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 110.601 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.49 -26.85 68.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -82.77 -23.98 33.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 110.382 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' TRP . . . . . 0.508 ' CZ3' HG13 ' A' ' 41' ' ' VAL . 13.0 m0 -63.17 142.07 97.75 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.278 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.9 173.97 9.42 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.431 1.227 . . . . 0.0 111.259 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' B' ' 20' ' ' ASP . 0.0 OUTLIER -78.36 -21.85 48.83 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.333 -0.854 . . . . 0.0 109.722 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.39 -46.11 42.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 110.696 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -68.8 -39.57 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.145 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.36 -31.33 72.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 110.574 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' B' ' 16' ' ' ARG . 3.5 t0 -70.83 -23.08 62.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.072 -1.018 . . . . 0.0 109.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.52 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 50.0 tp -87.83 -37.68 16.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -0.932 . . . . 0.0 109.936 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.407 ' CG1' HD13 ' B' ' 37' ' ' ILE . 15.7 t -66.05 -49.57 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.391 -0.818 . . . . 0.0 109.967 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.452 ' CD ' ' N ' ' B' ' 24' ' ' LYS . 0.0 OUTLIER -59.76 -35.52 74.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 110.52 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' B' ' 23' ' ' ARG . 2.1 tmtt? -73.94 -24.24 59.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.065 -1.022 . . . . 0.0 109.981 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' B' ' 21' ' ' LEU . 97.3 t -86.71 -20.75 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.256 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.59 -30.41 29.57 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.165 -0.959 . . . . 0.0 109.57 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.16 -19.63 50.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.481 -0.762 . . . . 0.0 110.254 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' B' ' 29' ' ' ASN . 22.5 pt-20 -90.72 -30.76 16.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.092 -1.005 . . . . 0.0 110.195 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.425 ' N ' ' HG3' ' B' ' 28' ' ' GLU . 0.5 OUTLIER -83.11 7.71 15.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.631 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.4 24.11 70.58 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -129.33 -157.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 110.235 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m -115.24 -179.38 3.62 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.451 -0.781 . . . . 0.0 109.258 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 98.1 t -78.15 -14.6 13.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.09 -1.006 . . . . 0.0 110.645 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -77.2 -41.67 40.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.123 -0.985 . . . . 0.0 109.06 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 8.7 t -71.29 -36.05 71.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.415 -0.803 . . . . 0.0 109.375 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.58 -50.52 66.89 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.407 HD13 ' CG1' ' B' ' 22' ' ' VAL . 34.0 mm -63.81 -27.2 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.404 -0.81 . . . . 0.0 109.526 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -71.54 -37.28 71.15 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 0.0 110.807 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.81 -36.32 59.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -71.92 -23.94 61.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.695 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.488 HG13 ' CZ3' ' A' ' 14' ' ' TRP . 6.5 t -87.54 -28.4 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -43.73 59.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.609 -0.682 . . . . 0.0 110.447 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -29.16 68.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -50.04 70.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.492 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 31.2 m-85 -65.88 -22.86 66.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.49 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.292 -0.88 . . . . 0.0 110.517 -179.628 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mtt . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.149 0.499 . . . . 50.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.95 85.81 6.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 50.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.34 155.07 20.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.56 -1.416 . . . . 50.0 109.56 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.53 -53.35 2.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -1.164 . . . . 50.0 110.221 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.4 p -68.13 168.12 12.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 50.0 110.231 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -166.12 143.26 5.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 50.0 110.206 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.63 142.32 77.82 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.169 -0.957 . . . . 43.64 109.997 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.509 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.0 Cg_endo -72.61 143.77 38.61 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.736 1.387 . . . . 29.79 110.478 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -61.05 -17.61 53.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.833 . . . . 0.0 110.15 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.486 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 69.6 t80 -67.9 -37.48 81.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 12.57 110.36 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.47 HD23 ' CD2' ' A' ' 14' ' ' TRP . 80.8 mt -91.6 21.52 4.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.352 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -74.23 -19.26 60.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.08 -17.93 21.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.134 -0.979 . . . . 0.0 110.653 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.489 ' CZ3' HG13 ' B' ' 41' ' ' VAL . 13.8 m0 -64.9 144.03 98.93 Favored Pre-proline 0 C--N 1.304 -1.387 0 O-C-N 121.145 -0.972 . . . . 11.57 109.171 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 40.1 Cg_endo -69.23 169.45 18.22 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.384 1.202 . . . . 13.83 110.56 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -25.81 43.94 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.572 -0.705 . . . . 48.43 109.592 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -69.14 -19.26 64.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.173 -0.955 . . . . 46.64 110.078 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.438 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 59.9 t -102.76 -36.27 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 16.14 109.888 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.5 mt -66.51 -33.91 76.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.416 -0.802 . . . . 12.61 110.509 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.31 -30.28 70.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 23.17 109.851 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.485 HD23 ' CD1' ' B' ' 45' ' ' PHE . 28.0 tp -80.76 -38.0 29.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.521 -0.737 . . . . 19.0 109.852 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.66 -51.72 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 18.87 110.211 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.63 -41.77 82.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.421 -0.799 . . . . 23.61 110.781 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -73.41 -18.2 61.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.118 -0.989 . . . . 30.11 110.841 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 21' ' ' LEU . 59.2 t -84.15 -35.73 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.081 -1.012 . . . . 16.22 110.481 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.23 82.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 26.6 109.712 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -72.59 -23.31 60.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.811 . . . . 45.21 109.935 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -78.1 -42.21 32.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 37.85 109.863 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -67.86 -44.48 77.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 35.36 110.105 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.35 37.08 0.95 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.076 -1.21 . . . . 35.1 110.076 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.74 -165.43 1.65 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.042 -1.27 . . . . 32.72 110.601 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -84.0 174.41 10.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 19.61 110.372 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.0 t -84.44 -26.72 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.39 -0.818 . . . . 17.56 110.235 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' B' ' 13' ' ' ARG . 5.4 t30 -59.18 -27.1 65.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 21.3 108.977 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.2 t -89.81 -29.71 18.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.519 -0.738 . . . . 16.38 109.536 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -61.49 -57.47 12.02 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.116 -0.99 . . . . 12.61 109.519 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 41.1 mm -58.12 -27.1 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.359 -0.838 . . . . 10.95 109.711 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.496 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 38.9 t80 -70.69 -34.37 71.9 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.135 -0.978 . . . . 18.87 110.15 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -75.06 -53.73 8.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 36.88 110.169 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -57.64 -23.06 49.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.114 -0.991 . . . . 22.85 109.802 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.492 HG13 ' CZ3' ' B' ' 14' ' ' TRP . 39.8 t -89.42 -27.5 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.396 -0.815 . . . . 13.02 109.51 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -25.86 60.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.528 -0.733 . . . . 18.84 110.569 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.78 -21.62 29.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.088 -1.008 . . . . 29.96 110.555 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -66.18 -47.47 73.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 18.65 110.165 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' HD21 ' B' ' 21' ' ' LEU . 28.5 m-85 -61.01 -37.44 82.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 16.26 110.373 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -65.98 -26.75 67.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 36.71 110.314 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -51.51 -42.75 61.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.183 -0.948 . . . . 41.6 110.454 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.71 -22.83 17.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 24.83 110.202 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.32 45.15 3.32 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.637 -1.385 . . . . 18.81 109.637 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -88.23 -33.38 18.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.606 -0.938 . . . . 23.01 110.52 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.0 mt -81.3 -48.63 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 119.61 -0.836 . . . . 27.08 110.468 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.57 50.58 0.6 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.731 -1.348 . . . . 32.03 109.731 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 O-C-N 120.996 -1.297 . . . . 0.0 110.165 179.981 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.8 mtt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.201 0.524 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.77 85.73 6.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.23 155.29 21.18 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.77 -53.3 2.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -1.124 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 27.9 p -68.34 168.23 12.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.228 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -166.2 143.15 5.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 110.186 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.43 142.53 76.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.018 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.486 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 44.6 Cg_endo -72.72 143.77 38.15 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.721 1.38 . . . . 0.0 110.523 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -60.9 -17.58 51.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.242 -0.911 . . . . 0.0 110.16 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.509 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 68.4 t80 -67.83 -37.63 82.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 110.375 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.477 HD23 ' CD2' ' B' ' 14' ' ' TRP . 80.6 mt -91.57 21.79 4.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.363 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -74.41 -19.29 60.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.421 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.417 ' HB2' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -94.99 -18.11 21.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.16 -0.962 . . . . 0.0 110.613 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.496 ' CZ2' ' HA ' ' A' ' 38' ' ' TYR . 14.0 m0 -64.83 144.2 98.89 Favored Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.023 -1.048 . . . . 0.0 109.229 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.455 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.4 Cg_endo -69.28 169.64 17.84 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.519 1.273 . . . . 0.0 110.651 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.17 -25.46 42.82 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.384 -0.822 . . . . 0.0 109.474 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -69.35 -19.34 63.85 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' B' ' 15' ' ' PRO . 58.2 t -102.6 -36.65 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.16 -0.963 . . . . 0.0 109.756 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 17.9 mt -65.76 -33.99 77.15 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.16 -0.963 . . . . 0.0 110.662 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.4 -30.6 71.01 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.826 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.493 HD21 ' CD2' ' A' ' 45' ' ' PHE . 26.9 tp -80.44 -38.05 30.84 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.862 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 48.2 t -59.77 -51.52 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 110.258 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.62 -41.85 82.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.783 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -73.42 -18.2 61.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.18 -0.95 . . . . 0.0 110.851 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' B' ' 21' ' ' LEU . 58.3 t -84.15 -35.88 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.164 -0.96 . . . . 0.0 110.473 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.41 -36.14 82.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.043 -1.036 . . . . 0.0 109.828 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -72.58 -23.21 60.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.928 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -78.24 -42.17 31.99 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.342 -0.849 . . . . 0.0 109.923 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.04 -44.42 76.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.83 . . . . 0.0 110.025 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.34 36.99 0.96 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.64 -165.47 1.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.019 -1.283 . . . . 0.0 110.571 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m -84.04 174.4 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.356 -0.84 . . . . 0.0 110.364 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 85.8 t -84.52 -26.46 7.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.411 -0.806 . . . . 0.0 110.278 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -59.4 -27.01 65.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.179 -0.95 . . . . 0.0 108.942 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 6.2 t -89.85 -29.9 18.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.72 . . . . 0.0 109.465 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.21 -57.61 11.71 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.132 -0.98 . . . . 0.0 109.532 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' B' ' 41' ' ' VAL . 40.8 mm -58.19 -27.45 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.38 -0.825 . . . . 0.0 109.65 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.459 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 36.5 t80 -70.19 -34.52 73.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.196 -0.94 . . . . 0.0 110.133 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -75.02 -53.72 8.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 110.183 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -57.6 -23.13 49.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.843 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.489 HG13 ' CZ3' ' A' ' 14' ' ' TRP . 39.6 t -89.15 -27.72 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.436 -0.79 . . . . 0.0 109.523 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -26.01 60.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.745 . . . . 0.0 110.61 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.86 -21.6 29.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.212 -0.93 . . . . 0.0 110.508 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -66.1 -47.47 74.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 110.163 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.485 ' CD1' HD23 ' A' ' 21' ' ' LEU . 27.8 m-85 -61.17 -37.46 83.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -65.72 -26.79 67.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.361 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -51.64 -42.55 62.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.887 . . . . 0.0 110.527 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.91 -22.87 17.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.153 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.34 45.53 3.23 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -88.62 -33.32 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.421 -1.046 . . . . 0.0 110.365 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 92.6 mt -81.47 -48.83 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.179 -0.95 . . . . 0.0 110.24 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.79 50.38 0.6 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 110.203 -179.948 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.243 0.544 . . . . 50.0 110.239 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.58 123.23 39.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 50.0 110.216 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 5' ' ' SER . . . -100.64 -25.56 8.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.467 -1.453 . . . . 50.0 109.467 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.3 mtm 55.42 -89.76 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.474 -1.015 . . . . 50.0 110.377 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.5 p -138.97 140.22 38.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.916 -1.115 . . . . 50.0 110.323 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -125.29 173.99 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 50.0 110.11 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.4 mtp -56.0 143.26 62.91 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 43.64 110.206 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 48.9 Cg_endo -75.79 160.22 37.76 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.627 1.33 . . . . 29.79 110.431 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -18.28 60.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.115 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.444 ' CE1' ' OD1' ' B' ' 34' ' ' ASN . 56.3 t80 -71.3 -35.8 71.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 12.57 110.348 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.465 HD21 ' CE3' ' A' ' 14' ' ' TRP . 93.8 mt -89.64 16.77 7.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.44 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.55 -31.22 66.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 110.024 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -12.47 59.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.35 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.506 ' CZ3' HG12 ' B' ' 41' ' ' VAL . 16.5 m0 -77.48 142.2 66.56 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.173 -0.955 . . . . 11.57 109.451 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.38 173.63 10.36 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.586 1.309 . . . . 13.83 110.551 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -22.66 42.18 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.396 -0.815 . . . . 48.43 109.605 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' HG3' HG23 ' A' ' 18' ' ' VAL . 10.2 pt-20 -71.5 -36.37 71.07 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.149 -0.969 . . . . 46.64 110.35 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.403 HG23 ' HG3' ' A' ' 17' ' ' GLU . 93.8 t -81.27 -43.06 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 16.14 110.254 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.3 mt -65.1 -32.03 73.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 12.61 110.28 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.45 -24.39 66.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 23.17 109.68 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.5 HD22 ' CD1' ' B' ' 45' ' ' PHE . 26.9 tp -87.09 -40.06 15.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.791 . . . . 19.0 109.895 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.402 HG23 HD13 ' A' ' 37' ' ' ILE . 38.5 t -56.48 -40.62 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 18.87 109.488 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -59.81 4.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.675 -0.641 . . . . 23.61 110.297 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.26 -28.67 59.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.229 -0.92 . . . . 30.11 110.937 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 21' ' ' LEU . 50.7 t -71.82 -39.31 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.991 -1.068 . . . . 16.22 110.423 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.72 -40.29 88.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.067 -1.021 . . . . 26.6 109.539 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -71.69 -20.99 61.85 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.449 -0.782 . . . . 45.21 109.941 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -54.41 9.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 37.85 109.809 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -71.38 -25.02 62.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.873 . . . . 35.36 110.26 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.48 69.53 1.04 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.71 -1.356 . . . . 35.1 109.71 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.73 -162.91 0.13 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.254 -1.145 . . . . 32.72 110.287 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.8 t -93.2 171.97 8.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 19.61 110.091 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.2 t -83.89 -23.33 7.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.23 -0.919 . . . . 17.56 110.073 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' OD1' ' CE1' ' B' ' 10' ' ' PHE . 0.8 OUTLIER -63.78 -28.14 69.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 21.3 109.255 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -90.15 -32.24 16.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.446 -0.784 . . . . 16.38 109.825 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' CG ' HG13 ' A' ' 25' ' ' VAL . 11.0 tp10 -61.67 -37.95 85.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.144 -0.973 . . . . 12.61 109.319 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 21.6 mm -76.95 -25.3 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.529 -0.732 . . . . 10.95 109.156 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.452 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 33.4 t80 -74.72 -27.38 60.35 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.271 -0.893 . . . . 18.87 110.198 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -81.71 -49.34 10.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 36.88 109.512 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.404 ' CZ ' HG11 ' A' ' 25' ' ' VAL . 55.9 mtt-85 -59.0 -28.79 66.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 22.85 109.189 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.462 HG12 ' CZ3' ' B' ' 14' ' ' TRP . 42.5 t -82.82 -26.95 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.581 -0.699 . . . . 13.02 109.329 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp -76.68 -23.82 53.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.467 -0.77 . . . . 18.84 110.27 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.14 -33.91 56.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.264 -0.897 . . . . 29.96 110.294 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.413 ' CB ' ' HD3' ' B' ' 40' ' ' ARG . 81.8 p -58.47 -41.22 84.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 18.65 110.278 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.481 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 25.5 m-85 -74.43 -35.5 63.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 16.26 110.371 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -57.95 -46.31 85.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 36.71 110.476 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -61.79 -33.74 74.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -0.949 . . . . 41.6 110.286 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -82.71 -14.2 55.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 24.83 110.473 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.7 23.19 70.49 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.813 -1.315 . . . . 18.81 109.813 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -33.59 71.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.306 -1.114 . . . . 23.01 110.252 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 mt -85.19 173.55 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 27.08 109.813 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.5 -37.65 1.07 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.516 -1.434 . . . . 32.03 109.516 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.186 -1.184 . . . . 0.0 110.371 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.261 0.553 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.48 122.88 38.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.313 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' B' ' 5' ' ' SER . . . -100.29 -25.36 8.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 40.4 mtm 55.1 -89.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.38 -1.07 . . . . 0.0 110.477 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.406 ' N ' ' O ' ' B' ' 3' ' ' GLY . 4.7 p -139.27 139.98 37.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.885 -1.134 . . . . 0.0 110.424 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -125.12 174.0 8.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.13 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtp -55.92 143.04 63.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.42 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 48.9 Cg_endo -75.66 159.6 38.79 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.632 1.332 . . . . 0.0 110.422 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -18.32 61.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.156 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.478 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 58.3 t80 -71.27 -36.0 71.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.971 . . . . 0.0 110.453 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.457 HD21 ' CE3' ' B' ' 14' ' ' TRP . 94.4 mt -89.37 16.78 6.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.928 . . . . 0.0 110.571 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.48 -31.26 66.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.128 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -12.36 59.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 110.337 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.462 ' CZ3' HG12 ' A' ' 41' ' ' VAL . 16.0 m0 -77.52 141.94 66.04 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.246 -0.909 . . . . 0.0 109.489 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.446 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.5 Cg_endo -69.38 173.89 9.98 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.625 1.329 . . . . 0.0 110.543 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -23.26 41.82 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.402 ' HG3' HG23 ' B' ' 18' ' ' VAL . 10.2 pt-20 -71.34 -36.39 71.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.851 . . . . 0.0 110.368 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.402 HG23 ' HG3' ' B' ' 17' ' ' GLU . 92.9 t -81.23 -43.48 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 O-C-N 121.072 -1.017 . . . . 0.0 110.014 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 72.8 mt -64.35 -32.54 74.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.05 -24.73 66.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.747 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.481 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 27.9 tp -86.71 -40.1 15.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.404 -0.81 . . . . 0.0 109.904 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 35.1 t -56.4 -40.45 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.597 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.22 -59.63 5.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.645 -0.66 . . . . 0.0 110.267 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -28.27 59.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.267 -0.895 . . . . 0.0 110.963 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' B' ' 21' ' ' LEU . 53.2 t -72.17 -39.48 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.013 . . . . 0.0 110.361 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.11 88.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.14 -0.975 . . . . 0.0 109.509 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -71.79 -20.85 61.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.341 -0.849 . . . . 0.0 110.044 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -54.23 9.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.863 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.34 -25.32 62.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.42 -0.8 . . . . 0.0 110.089 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.43 69.99 1.06 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.01 -163.27 0.13 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.321 -1.106 . . . . 0.0 110.191 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -92.9 172.93 8.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 110.082 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 68.4 t -85.08 -22.69 7.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.278 -0.889 . . . . 0.0 110.001 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.444 ' OD1' ' CE1' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -64.26 -27.85 69.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.157 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -90.2 -33.56 16.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.487 -0.758 . . . . 0.0 109.707 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.403 ' CG ' HG13 ' B' ' 25' ' ' VAL . 10.8 tp10 -60.31 -38.18 82.87 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.157 -0.964 . . . . 0.0 109.403 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' B' ' 41' ' ' VAL . 21.2 mm -77.11 -24.85 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.51 -0.744 . . . . 0.0 109.228 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.444 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 34.0 t80 -75.32 -26.58 58.77 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.261 -0.899 . . . . 0.0 110.109 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -82.28 -49.53 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.58 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.413 ' HD3' ' CB ' ' A' ' 44' ' ' SER . 55.7 mtt-85 -58.81 -28.98 66.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.442 -0.786 . . . . 0.0 109.184 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.506 HG12 ' CZ3' ' A' ' 14' ' ' TRP . 45.1 t -82.54 -27.46 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.546 0.688 . . . . 0.0 109.414 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp -76.08 -23.41 55.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.468 -0.77 . . . . 0.0 110.269 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.47 -34.31 54.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.158 -0.964 . . . . 0.0 110.24 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 85.4 p -57.86 -41.5 82.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 110.156 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.5 ' CD1' HD22 ' A' ' 21' ' ' LEU . 25.3 m-85 -74.5 -35.78 63.22 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -57.76 -46.36 84.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.37 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -61.45 -34.2 75.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.342 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -82.17 -14.66 55.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.207 -0.933 . . . . 0.0 110.606 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.11 23.5 68.61 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -33.51 70.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.184 -1.186 . . . . 0.0 110.06 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 40.1 mt -85.19 173.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.239 -0.913 . . . . 0.0 109.707 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.61 -37.61 1.06 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.238 -1.154 . . . . 0.0 110.272 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.236 0.541 . . . . 50.0 110.234 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt 53.06 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 50.0 110.229 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.09 -44.34 29.91 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.757 -1.337 . . . . 50.0 109.757 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 55.03 21.76 3.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.202 -1.175 . . . . 50.0 110.309 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -62.76 -179.3 0.26 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 50.0 110.184 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -73.67 -162.35 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 50.0 109.974 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.33 163.6 33.21 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.26 -0.9 . . . . 43.64 110.244 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 43.0 Cg_endo -71.47 147.52 52.32 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.626 1.33 . . . . 29.79 110.545 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.49 -19.38 61.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 110.631 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.489 ' CE1' ' HG3' ' B' ' 8' ' ' PRO . 87.3 t80 -69.25 -32.09 71.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.952 . . . . 12.57 110.11 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.468 HD23 ' CD2' ' A' ' 14' ' ' TRP . 96.8 mt -91.99 19.07 7.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.371 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -71.65 -25.52 62.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 110.205 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -16.12 46.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.477 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.476 ' CZ3' HD13 ' A' ' 37' ' ' ILE . 15.1 m0 -72.69 145.59 87.28 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.306 -0.871 . . . . 11.57 109.815 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 43.1 Cg_endo -73.4 166.33 30.18 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.559 1.294 . . . . 13.83 111.24 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.87 85.68 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.995 0.902 . . . . 48.43 110.33 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.46 -34.76 74.49 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.918 -0.583 . . . . 46.64 111.575 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.427 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 91.2 t -82.84 -44.91 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.924 -1.11 . . . . 16.14 110.817 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.2 mt -64.54 -27.31 68.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.143 -0.973 . . . . 12.61 110.722 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.44 -23.15 63.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 23.17 109.76 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.525 ' CD2' ' CG ' ' B' ' 45' ' ' PHE . 4.8 tp -89.39 -42.22 11.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.45 -0.781 . . . . 19.0 109.985 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.428 ' CG1' HD11 ' A' ' 37' ' ' ILE . 48.0 t -51.8 -46.22 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 18.87 110.699 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -54.59 -58.5 7.27 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.361 -0.837 . . . . 23.61 110.85 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -54.12 -22.65 11.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.908 . . . . 30.11 111.054 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -82.54 -38.61 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 16.22 110.961 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.67 74.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.036 . . . . 26.6 110.112 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.39 -9.86 58.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -0.887 . . . . 45.21 110.528 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -88.88 -53.59 4.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.083 -1.011 . . . . 37.85 110.095 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.34 -32.45 73.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 35.36 110.117 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.73 30.81 4.15 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.414 -1.475 . . . . 35.1 109.414 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -133.44 -155.18 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -1.137 . . . . 32.72 110.164 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -107.56 175.34 5.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.539 -0.725 . . . . 19.61 109.55 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.97 -23.58 16.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.105 -0.997 . . . . 17.56 110.138 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.442 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 44.0 t30 -77.15 -28.11 54.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 21.3 108.843 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.07 -27.31 24.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.557 -0.714 . . . . 16.38 109.203 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.98 -42.96 65.87 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.277 -0.89 . . . . 12.61 108.916 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.476 HD13 ' CZ3' ' A' ' 14' ' ' TRP . 24.5 mm -66.59 -31.07 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.595 -0.891 . . . . 10.95 108.595 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.469 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 32.6 t80 -63.56 -36.78 84.92 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.62 -0.675 . . . . 18.87 109.968 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -73.96 -43.99 56.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 36.88 109.716 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -61.09 -25.59 67.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 22.85 109.289 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.434 HG21 HG21 ' B' ' 41' ' ' VAL . 62.4 t -88.18 -25.14 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.547 0.689 . . . . 13.02 109.635 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtp -77.56 -25.33 49.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.529 -0.732 . . . . 18.84 110.299 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -83.24 -27.48 29.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.194 -0.941 . . . . 29.96 110.353 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.8 p -67.1 -48.91 66.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.255 -0.903 . . . . 18.65 110.357 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.522 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 22.4 m-85 -62.89 -22.5 66.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.958 . . . . 16.26 110.417 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.87 -25.75 60.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 36.71 110.455 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -55.72 -24.03 32.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.164 -0.96 . . . . 41.6 110.351 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -108.13 -37.21 6.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 24.83 110.23 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.11 32.25 2.25 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.376 -1.489 . . . . 18.81 109.376 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -47.63 23.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -1.177 . . . . 23.01 110.502 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 pt -100.9 146.6 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 119.541 -0.863 . . . . 27.08 110.701 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.12 -42.79 0.63 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.295 -1.522 . . . . 32.03 109.295 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.418 -1.048 . . . . 0.0 110.287 179.407 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 7.4 mtp . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.222 0.534 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt 52.96 94.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.27 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.2 -44.59 28.39 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 55.2 21.74 4.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.235 -1.156 . . . . 0.0 110.393 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -62.82 -179.22 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 110.14 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -73.66 -162.14 0.12 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 110.09 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.46 163.47 33.32 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.232 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.489 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 43.4 Cg_endo -71.38 147.65 53.15 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.717 1.377 . . . . 0.0 110.483 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -19.5 62.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.36 -0.837 . . . . 0.0 110.577 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.49 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 87.2 t80 -69.01 -32.13 71.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.039 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.471 HD23 ' CD2' ' B' ' 14' ' ' TRP . 96.5 mt -91.94 19.12 6.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.448 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.66 -25.36 62.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 110.303 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.71 -16.16 45.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 110.412 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.471 ' CD2' HD23 ' B' ' 11' ' ' LEU . 15.1 m0 -72.88 145.65 86.86 Favored Pre-proline 0 C--N 1.304 -1.389 0 O-C-N 121.242 -0.911 . . . . 0.0 109.831 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.428 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 42.5 Cg_endo -73.45 166.66 29.3 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.258 1.136 . . . . 0.0 111.21 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -37.94 85.11 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 110.321 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -60.3 -34.72 74.17 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.907 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.428 ' CG2' ' HG2' ' B' ' 15' ' ' PRO . 91.1 t -82.72 -45.22 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.86 -1.15 . . . . 0.0 110.591 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 61.1 mt -64.39 -27.28 68.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.031 -1.043 . . . . 0.0 110.763 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.27 -23.4 63.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 109.738 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.522 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 4.7 tp -89.34 -42.11 11.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.502 -0.748 . . . . 0.0 109.992 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' B' ' 37' ' ' ILE . 47.9 t -51.71 -46.1 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 110.733 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -54.83 -58.44 7.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.333 -0.854 . . . . 0.0 110.849 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -54.14 -22.27 10.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.065 -1.022 . . . . 0.0 111.037 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.93 -38.77 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.001 . . . . 0.0 110.873 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.87 -32.6 74.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.061 -1.024 . . . . 0.0 110.11 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.46 -10.07 58.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 110.383 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -88.64 -53.57 4.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.133 -0.98 . . . . 0.0 110.113 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.34 -32.47 73.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.142 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.75 30.82 4.14 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -133.53 -155.69 0.69 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -1.103 . . . . 0.0 110.208 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -107.03 175.41 5.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.409 -0.807 . . . . 0.0 109.658 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 85.9 t -76.1 -23.33 15.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 44.1 t30 -77.35 -28.34 52.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 108.844 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.91 -27.42 25.0 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.194 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -71.94 -42.6 66.44 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.372 -0.83 . . . . 0.0 108.997 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.471 HD13 ' CZ3' ' B' ' 14' ' ' TRP . 24.7 mm -66.84 -30.89 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 32.6 t80 -63.8 -37.08 86.05 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.614 -0.679 . . . . 0.0 109.771 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -73.57 -44.39 57.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 109.687 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -60.64 -25.75 66.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.94 . . . . 0.0 109.243 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.434 HG21 HG21 ' A' ' 41' ' ' VAL . 63.5 t -88.16 -25.23 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.575 0.703 . . . . 0.0 109.688 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtp -77.47 -25.17 50.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.494 -0.754 . . . . 0.0 110.387 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -83.42 -27.46 29.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.189 -0.944 . . . . 0.0 110.437 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 77.8 p -67.16 -48.7 67.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.415 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.525 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 21.9 m-85 -63.08 -22.6 66.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.128 -0.982 . . . . 0.0 110.286 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.79 -25.68 60.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.167 -0.958 . . . . 0.0 110.37 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -55.81 -24.09 34.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.317 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -108.04 -37.14 6.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.267 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.91 31.94 2.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.94 -47.68 24.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -1.126 . . . . 0.0 110.468 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 pt -101.02 146.66 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.593 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.06 -43.05 0.62 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.376 -1.073 . . . . 0.0 110.099 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.212 0.529 . . . . 50.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -128.28 52.38 1.9 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 50.0 110.22 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.59 99.86 2.45 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.461 -1.455 . . . . 50.0 109.461 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.5 ttm -136.55 151.14 49.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -1.138 . . . . 50.0 110.25 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 m -69.38 -179.39 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 50.0 109.984 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.22 53.37 1.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 50.0 110.569 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.52 126.45 7.43 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.151 -0.968 . . . . 43.64 109.494 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HG3' ' CE1' ' B' ' 10' ' ' PHE . 45.7 Cg_endo -71.68 158.16 54.03 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.378 1.199 . . . . 29.79 110.671 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -82.1 -19.4 40.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.379 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.483 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 73.1 t80 -58.95 -23.84 61.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 12.57 110.448 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.464 HD23 ' CD2' ' A' ' 14' ' ' TRP . 42.7 mt -98.52 31.65 2.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.148 -0.97 . . . . 0.0 110.478 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -30.99 67.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.224 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -81.01 -22.9 39.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 110.155 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.509 ' CZ3' HG12 ' B' ' 41' ' ' VAL . 13.8 m0 -64.64 136.98 96.99 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.345 -0.847 . . . . 11.57 109.259 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 39.0 Cg_endo -70.36 153.34 66.26 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.365 1.192 . . . . 13.83 111.054 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -41.62 73.29 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.664 0.745 . . . . 48.43 110.897 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.24 -41.05 75.09 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.548 -0.72 . . . . 46.64 111.507 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.446 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 85.5 t -76.42 -49.87 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.888 -1.132 . . . . 16.14 111.087 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.413 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 13.3 mt -53.7 -36.5 62.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 12.61 110.673 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -62.57 -38.03 88.51 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.436 -0.79 . . . . 23.17 109.864 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.495 HD22 ' CG ' ' B' ' 45' ' ' PHE . 40.8 tp -69.42 -40.59 77.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.494 -0.754 . . . . 19.0 109.893 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.417 ' CG1' HD13 ' A' ' 37' ' ' ILE . 40.3 t -58.94 -48.26 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 18.87 110.512 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 10.9 mtm180 -53.67 -49.36 68.14 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 23.61 110.54 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -29.33 70.72 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 30.11 110.682 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.1 t -77.03 -29.19 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 16.22 110.479 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.04 -46.0 46.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.169 -0.957 . . . . 26.6 109.215 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.95 -12.63 61.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.348 -0.845 . . . . 45.21 110.135 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -78.61 -58.73 3.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 37.85 110.001 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -66.06 -22.36 66.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 35.36 110.115 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.54 16.17 20.85 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.027 -1.229 . . . . 35.1 110.027 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -116.53 -162.84 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.132 -1.216 . . . . 32.72 110.387 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.7 m -102.81 -176.77 3.19 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.419 -0.8 . . . . 19.61 109.411 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -81.23 -16.65 12.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.222 -0.924 . . . . 17.56 110.281 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -77.84 -32.08 51.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.978 . . . . 21.3 108.752 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 t -79.71 -36.56 37.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.572 -0.705 . . . . 16.38 109.335 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.78 -51.74 60.65 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 121.255 -0.903 . . . . 12.61 109.366 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.417 HD13 ' CG1' ' A' ' 22' ' ' VAL . 37.9 mm -63.3 -32.93 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.784 . . . . 10.95 109.517 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.431 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 26.6 t80 -65.79 -33.76 76.61 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.429 -0.795 . . . . 18.87 110.226 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -47.38 42.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 36.88 109.536 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -60.87 -23.36 65.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.46 -0.775 . . . . 22.85 109.642 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.488 HG12 ' CZ3' ' B' ' 14' ' ' TRP . 53.0 t -87.95 -28.24 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.518 -0.739 . . . . 13.02 109.554 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -20.36 52.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.539 -0.725 . . . . 18.84 110.272 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.92 -18.77 53.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 29.96 110.348 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.89 -46.89 16.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.073 -1.017 . . . . 18.65 110.215 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.501 ' CD1' ' CD2' ' B' ' 21' ' ' LEU . 37.9 m-85 -67.72 -12.01 59.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 16.26 110.734 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -75.35 -38.42 60.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.03 -1.044 . . . . 36.71 110.417 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -55.53 -52.63 63.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 41.6 110.174 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -62.55 1.36 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 24.83 110.308 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.94 34.9 0.71 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.706 -1.235 . . . . 18.81 110.084 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -27.48 31.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -1.088 . . . . 23.01 109.97 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.6 pt -112.72 166.95 6.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.079 -1.013 . . . . 27.08 109.968 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.38 38.71 0.11 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.633 -1.387 . . . . 32.03 109.633 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.135 -1.214 . . . . 0.0 110.217 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.308 0.575 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -128.29 52.46 1.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.307 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.79 99.64 2.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 7.4 ttm -136.21 151.3 49.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -1.196 . . . . 0.0 110.313 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.9 m -69.46 -179.19 1.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.943 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.36 53.28 1.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 110.563 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.51 126.41 7.42 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.129 -0.982 . . . . 0.0 109.495 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.483 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 45.1 Cg_endo -71.64 157.76 55.04 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.439 1.231 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -81.83 -19.4 41.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.364 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.484 ' CE1' ' HG3' ' A' ' 8' ' ' PRO . 72.8 t80 -58.95 -23.85 61.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 110.454 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.475 HD23 ' CD2' ' B' ' 14' ' ' TRP . 42.3 mt -98.37 31.62 2.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 110.489 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.06 -31.1 67.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 110.108 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -80.95 -22.89 39.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.22 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.488 ' CZ3' HG12 ' A' ' 41' ' ' VAL . 13.8 m0 -64.71 136.51 96.8 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.394 -0.816 . . . . 0.0 109.306 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.443 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 39.5 Cg_endo -70.24 152.45 66.83 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.626 1.33 . . . . 0.0 111.368 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -42.13 69.75 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.631 0.729 . . . . 0.0 110.905 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.17 -40.91 74.65 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.614 -0.679 . . . . 0.0 111.29 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.443 ' CG2' ' HG2' ' B' ' 15' ' ' PRO . 85.5 t -76.59 -50.0 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.917 -1.114 . . . . 0.0 110.754 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.406 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 13.4 mt -53.67 -36.32 61.99 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 110.682 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -62.99 -37.77 88.48 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.298 -0.876 . . . . 0.0 109.973 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.501 ' CD2' ' CD1' ' A' ' 45' ' ' PHE . 40.5 tp -69.63 -40.31 76.64 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.415 -0.803 . . . . 0.0 109.858 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.42 ' CG1' HD13 ' B' ' 37' ' ' ILE . 40.3 t -59.31 -48.07 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 110.467 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' B' ' 19' ' ' LEU . 11.0 mtm180 -53.7 -49.41 68.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.215 -0.928 . . . . 0.0 110.535 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -29.13 70.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.4 -0.812 . . . . 0.0 110.698 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.08 -29.25 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.501 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.04 -46.06 45.7 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 109.196 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.97 -12.58 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 110.152 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.41 -59.0 2.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 109.97 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -65.88 -22.33 66.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.059 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.48 16.26 20.74 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -116.65 -162.64 0.86 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.012 -1.287 . . . . 0.0 110.405 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.2 m -102.95 -176.76 3.18 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.352 -0.843 . . . . 0.0 109.375 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 62.2 t -81.2 -16.64 12.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 110.407 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -77.84 -32.14 51.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.067 -1.021 . . . . 0.0 108.695 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 41.0 t -79.67 -36.39 37.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.585 -0.697 . . . . 0.0 109.294 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -65.0 -51.64 60.55 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.381 -0.824 . . . . 0.0 109.295 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.42 HD13 ' CG1' ' B' ' 22' ' ' VAL . 37.3 mm -63.39 -32.59 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.576 -0.703 . . . . 0.0 109.428 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.48 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 26.5 t80 -65.97 -33.82 76.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.442 -0.787 . . . . 0.0 110.308 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -47.1 45.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.52 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -61.17 -23.42 65.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 0.0 109.639 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.509 HG12 ' CZ3' ' A' ' 14' ' ' TRP . 56.4 t -88.08 -28.3 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.749 . . . . 0.0 109.502 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -20.14 53.35 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.566 -0.708 . . . . 0.0 110.161 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.17 -18.73 52.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.082 -1.011 . . . . 0.0 110.36 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.82 -47.27 15.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.046 -1.034 . . . . 0.0 110.097 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.495 ' CG ' HD22 ' A' ' 21' ' ' LEU . 38.5 m-85 -67.42 -11.96 59.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 110.799 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -75.59 -38.19 59.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 110.389 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -55.64 -52.77 62.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.82 -62.49 1.39 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.215 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.86 35.12 0.7 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 -27.93 31.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -1.2 . . . . 0.0 109.97 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.65 166.89 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.954 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.94 38.58 0.11 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.285 -1.126 . . . . 0.0 110.164 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.154 0.502 . . . . 50.0 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -171.69 71.81 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 50.0 110.239 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.26 178.38 40.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.513 -1.435 . . . . 50.0 109.513 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.2 mtm -100.64 27.14 6.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -1.102 . . . . 50.0 110.22 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m 53.19 179.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.91 . . . . 50.0 110.333 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -107.94 172.08 7.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 50.0 110.359 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mtt 57.87 162.26 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.384 -0.823 . . . . 43.64 110.906 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 48.3 Cg_endo -76.55 164.79 30.03 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.852 1.448 . . . . 29.79 110.343 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -74.98 -13.7 60.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.394 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.503 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 90.8 t80 -81.16 -29.15 34.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 12.57 110.46 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.467 HD23 ' CD2' ' A' ' 14' ' ' TRP . 57.0 mt -92.69 14.68 16.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.784 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.94 -24.56 64.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 0.0 109.816 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.96 -21.89 43.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.314 -0.866 . . . . 0.0 110.163 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.479 ' CZ3' HD12 ' A' ' 37' ' ' ILE . 15.0 m0 -73.54 143.59 82.5 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.453 -0.779 . . . . 11.57 109.67 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' CD ' ' OH ' ' B' ' 38' ' ' TYR . 42.3 Cg_endo -71.11 176.44 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.562 1.296 . . . . 13.83 110.726 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -24.29 37.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.402 -0.811 . . . . 48.43 109.372 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.6 -20.15 64.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 46.64 110.463 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.3 t -99.82 -46.3 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 16.14 109.961 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.13 -25.91 68.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.339 -0.851 . . . . 12.61 110.806 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -74.02 -31.74 63.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.299 -0.876 . . . . 23.17 110.068 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' CD2' ' CG ' ' B' ' 45' ' ' PHE . 7.4 tp -79.82 -47.39 15.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 19.0 109.971 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.436 ' CG1' HG13 ' A' ' 33' ' ' VAL . 27.9 t -51.68 -45.93 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 18.87 109.918 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -51.44 -63.02 1.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.682 -0.636 . . . . 23.61 110.695 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -52.75 -33.88 50.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.283 -0.885 . . . . 30.11 110.969 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.404 ' CG1' ' HG2' ' A' ' 36' ' ' GLU . 61.9 t -66.93 -36.48 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 16.22 110.523 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.02 -44.91 79.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 26.6 109.896 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -71.69 -14.7 62.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 45.21 110.359 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.79 -59.99 2.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.084 -1.01 . . . . 37.85 110.114 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -65.8 -22.03 66.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 35.36 110.358 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.39 16.69 24.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.85 -1.3 . . . . 35.1 109.85 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -114.15 -156.53 0.6 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.085 -1.244 . . . . 32.72 110.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -111.21 171.11 7.67 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.332 -0.855 . . . . 19.61 109.652 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.436 HG13 ' CG1' ' A' ' 22' ' ' VAL . 48.5 t -70.59 -18.89 21.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.204 -0.935 . . . . 17.56 110.451 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.78 -35.04 39.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.133 -0.98 . . . . 21.3 109.3 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.6 m -76.48 -33.54 58.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.811 . . . . 16.38 109.543 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.404 ' HG2' ' CG1' ' A' ' 25' ' ' VAL . 2.9 tp10 -63.37 -51.94 63.8 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.348 -0.845 . . . . 12.61 109.245 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.479 HD12 ' CZ3' ' A' ' 14' ' ' TRP . 4.9 mt -68.4 -21.34 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.465 -0.772 . . . . 10.95 109.62 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.405 ' OH ' ' CD ' ' B' ' 15' ' ' PRO . 32.0 t80 -75.4 -29.54 59.83 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.267 -0.896 . . . . 18.87 109.716 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.01 -45.36 18.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.498 -0.751 . . . . 36.88 109.744 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt-85 -60.7 -45.06 95.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 22.85 109.159 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 61.2 t -68.93 -24.2 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.625 -0.672 . . . . 13.02 109.997 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -65.21 0.79 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.422 -0.799 . . . . 18.84 110.908 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -54.73 -31.75 58.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.332 -0.855 . . . . 29.96 111.037 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.15 -56.63 10.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.95 -1.094 . . . . 18.65 110.679 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.546 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 27.4 m-85 -61.99 -39.12 91.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 16.26 110.817 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -58.47 -18.75 31.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.127 -0.983 . . . . 36.71 110.871 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -82.61 -47.28 12.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.033 -1.042 . . . . 41.6 110.602 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -58.57 -45.08 89.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.182 -0.949 . . . . 24.83 110.244 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.28 10.34 6.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.093 -1.203 . . . . 18.81 110.093 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.15 -52.28 14.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.304 . . . . 23.01 110.117 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.7 pt -104.93 -167.9 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.638 -0.825 . . . . 27.08 109.868 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.22 65.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.697 -1.361 . . . . 32.03 109.697 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.44 -1.036 . . . . 0.0 109.973 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.139 0.495 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -171.53 72.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.268 -0.895 . . . . 0.0 110.156 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.12 178.28 40.39 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mtm -100.6 27.24 5.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -1.124 . . . . 0.0 110.223 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m 53.05 179.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.16 -0.962 . . . . 0.0 110.232 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -107.92 172.27 6.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.345 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mtt 57.69 162.52 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.468 -0.77 . . . . 0.0 110.789 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.503 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 48.5 Cg_endo -76.84 164.62 29.76 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.792 1.417 . . . . 0.0 110.318 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -74.89 -13.84 60.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.429 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.497 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 90.6 t80 -81.13 -28.79 34.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 110.47 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.469 HD23 ' CD2' ' B' ' 14' ' ' TRP . 55.8 mt -93.09 15.0 16.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.709 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.38 -24.19 63.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.919 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -22.2 42.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 110.114 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.48 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 14.9 m0 -73.27 143.71 83.49 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.493 -0.754 . . . . 0.0 109.723 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.405 ' CD ' ' OH ' ' A' ' 38' ' ' TYR . 42.6 Cg_endo -71.23 176.39 7.94 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.56 1.295 . . . . 0.0 110.827 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -24.44 37.1 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.562 -0.711 . . . . 0.0 109.443 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' B' ' 18' ' ' VAL . 1.0 OUTLIER -68.21 -20.89 64.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 110.712 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.403 ' N ' ' HG3' ' B' ' 17' ' ' GLU . 76.9 t -98.98 -47.05 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.139 -0.976 . . . . 0.0 109.883 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.51 -26.08 67.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 110.863 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.01 -31.45 62.94 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.546 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 7.7 tp -79.88 -48.02 14.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.467 -0.771 . . . . 0.0 109.942 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.423 ' CG1' HG13 ' B' ' 33' ' ' VAL . 27.5 t -51.16 -45.57 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 109.938 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -52.12 -62.6 1.53 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.552 -0.717 . . . . 0.0 110.651 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -52.93 -33.82 52.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.931 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.405 ' CG1' ' HG2' ' B' ' 36' ' ' GLU . 61.2 t -67.13 -36.03 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.084 -1.01 . . . . 0.0 110.577 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.64 77.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.872 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -71.66 -15.05 62.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.963 . . . . 0.0 110.393 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.53 -60.2 2.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.044 . . . . 0.0 110.016 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -65.72 -21.93 66.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.266 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.33 16.68 24.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -114.39 -156.88 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.276 . . . . 0.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -110.73 171.04 7.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.565 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.423 HG13 ' CG1' ' B' ' 22' ' ' VAL . 49.3 t -70.23 -19.82 22.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.245 -0.91 . . . . 0.0 110.365 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 -35.61 43.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 64.5 m -75.84 -33.85 60.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' CG1' ' B' ' 25' ' ' VAL . 2.8 tp10 -63.26 -51.59 65.55 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.342 -0.849 . . . . 0.0 109.351 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.472 HD12 ' CZ3' ' B' ' 14' ' ' TRP . 4.9 mt -68.74 -21.6 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.613 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.41 ' OH ' ' CD ' ' A' ' 15' ' ' PRO . 33.4 t80 -75.18 -29.25 60.34 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.22 -0.925 . . . . 0.0 109.775 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -45.54 17.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.671 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -60.53 -44.94 95.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.118 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.469 HG11 ' CZ3' ' A' ' 14' ' ' TRP . 58.0 t -68.88 -24.4 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.647 -0.658 . . . . 0.0 109.958 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -65.15 0.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.379 -0.826 . . . . 0.0 110.83 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -54.66 -31.73 58.09 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.247 -0.908 . . . . 0.0 111.001 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.34 -56.61 10.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.064 -1.023 . . . . 0.0 110.89 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.539 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 29.0 m-85 -62.05 -38.65 89.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 110.792 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -58.5 -19.02 33.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.183 -0.948 . . . . 0.0 110.978 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -82.58 -47.59 11.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 110.54 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -58.13 -45.25 87.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.171 -0.956 . . . . 0.0 110.307 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.32 10.63 6.01 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.34 -52.55 13.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.959 -1.318 . . . . 0.0 109.896 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 pt -104.63 -168.27 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.929 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.33 66.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.264 -1.139 . . . . 0.0 110.131 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.8 mtp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.143 0.497 . . . . 50.0 110.285 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -114.61 -31.55 6.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.26 -0.9 . . . . 50.0 110.038 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.07 -97.54 0.12 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.398 -1.481 . . . . 50.0 109.398 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.32 30.02 7.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.185 -1.185 . . . . 50.0 110.363 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 m -132.35 166.61 21.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 50.0 110.118 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -156.65 69.52 0.61 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 50.0 110.243 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.415 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 13.1 ptp -140.05 164.26 38.73 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 43.64 109.922 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 41.4 Cg_endo -68.79 151.56 74.27 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.553 1.291 . . . . 29.79 110.557 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -66.05 -20.32 66.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.246 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 91.2 t80 -68.38 -20.99 64.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 12.57 110.394 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.49 HD23 ' CD2' ' A' ' 14' ' ' TRP . 89.0 mt -100.54 20.91 14.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.596 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.19 -26.9 62.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -83.18 -23.51 32.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.107 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.49 ' CD2' HD23 ' A' ' 11' ' ' LEU . 14.0 m0 -67.09 139.55 95.36 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.363 -0.836 . . . . 11.57 109.384 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 42.0 Cg_endo -70.21 168.76 21.21 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.528 1.278 . . . . 13.83 110.904 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.21 -20.47 55.28 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.513 -0.742 . . . . 48.43 109.433 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -72.84 -28.63 62.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 46.64 109.758 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.434 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 77.1 t -87.33 -45.15 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 16.14 109.865 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.1 mt -63.26 -30.48 71.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -0.857 . . . . 12.61 110.593 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -66.01 -25.88 67.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -0.962 . . . . 23.17 109.605 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.519 ' CD2' ' CG ' ' B' ' 45' ' ' PHE . 15.1 tp -86.78 -44.83 11.46 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.446 -0.784 . . . . 19.0 109.745 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.415 ' CG1' HG11 ' A' ' 33' ' ' VAL . 44.4 t -52.83 -43.14 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.263 -0.898 . . . . 18.87 109.778 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -51.01 -61.69 2.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.562 -0.711 . . . . 23.61 110.594 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -54.35 -24.9 21.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.577 -0.702 . . . . 30.11 110.901 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.432 ' CG1' ' HG3' ' A' ' 36' ' ' GLU . 38.4 t -80.48 -30.72 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.168 -0.957 . . . . 16.22 110.783 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.01 -27.72 49.01 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.11 -0.994 . . . . 26.6 110.0 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.38 -15.31 33.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 45.21 110.713 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 29' ' ' ASN . 19.8 pt-20 -90.73 -33.13 15.88 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.882 -1.136 . . . . 37.85 110.436 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.423 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 9.7 m-80 -79.48 -26.88 41.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 35.36 110.159 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.84 23.72 8.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.538 -1.425 . . . . 35.1 109.538 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -131.73 -158.97 0.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.21 -1.171 . . . . 32.72 109.93 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.4 -178.61 3.6 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.525 -0.734 . . . . 19.61 109.086 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.415 HG11 ' CG1' ' A' ' 22' ' ' VAL . 97.8 t -76.79 -19.18 14.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.184 -0.947 . . . . 17.56 110.29 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.457 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 42.2 t30 -74.66 -30.65 61.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 21.3 108.747 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -37.85 23.61 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.501 -0.749 . . . . 16.38 109.214 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' HG3' ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -59.78 -51.55 69.26 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.322 -0.861 . . . . 12.61 109.574 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 38.6 mm -62.95 -28.01 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.325 -0.859 . . . . 10.95 109.2 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.417 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 37.5 t80 -74.17 -24.83 59.44 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.395 -0.816 . . . . 18.87 110.175 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -50.91 9.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.45 -0.781 . . . . 36.88 109.833 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -60.74 -28.82 68.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.816 . . . . 22.85 109.255 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 37' ' ' ILE . 65.4 t -84.35 -22.43 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.622 -0.674 . . . . 13.02 109.676 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -74.31 -51.23 15.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 18.84 111.101 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -69.52 -23.79 63.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.257 -0.902 . . . . 29.96 111.473 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.5 p -57.31 -52.61 64.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.014 -1.054 . . . . 18.65 110.282 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.495 ' CD2' HD22 ' B' ' 21' ' ' LEU . 36.9 m-85 -63.12 -40.1 96.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -0.999 . . . . 16.26 110.311 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -57.29 -21.81 37.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.318 -0.864 . . . . 36.71 110.599 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -74.11 -61.82 1.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.993 -1.067 . . . . 41.6 110.251 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -56.04 -30.0 61.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 24.83 110.258 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.68 31.96 4.97 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.901 -1.28 . . . . 18.81 109.901 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -85.35 -45.25 12.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -1.128 . . . . 23.01 110.115 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.0 pt -108.09 167.59 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.836 -0.746 . . . . 27.08 110.299 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.54 -50.05 0.54 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.477 -1.449 . . . . 32.03 109.477 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.254 -1.144 . . . . 0.0 110.262 -179.613 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 42.3 mtp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.279 0.562 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -114.67 -31.49 6.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 110.121 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.98 -97.29 0.12 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.96 30.3 7.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.114 . . . . 0.0 110.494 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.5 m -132.5 166.58 21.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.489 -0.757 . . . . 0.0 109.855 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -156.58 69.52 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' MET . . . . . 0.427 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 13.2 ptp -139.95 164.09 40.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.843 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.476 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 42.6 Cg_endo -68.68 151.79 74.63 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.538 1.283 . . . . 0.0 110.518 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.01 -20.72 66.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.883 . . . . 0.0 110.211 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.498 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 91.9 t80 -67.93 -21.24 65.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 0.0 110.458 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.479 HD23 ' CD2' ' B' ' 14' ' ' TRP . 88.1 mt -100.35 20.82 14.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 110.611 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -26.72 62.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.979 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -83.34 -23.3 32.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 110.103 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.479 ' CD2' HD23 ' B' ' 11' ' ' LEU . 13.8 m0 -67.42 139.56 94.53 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.384 -0.823 . . . . 0.0 109.355 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.421 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 41.0 Cg_endo -70.3 168.84 21.11 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.412 1.217 . . . . 0.0 110.543 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.27 -20.51 54.99 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.578 -0.701 . . . . 0.0 109.307 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -72.73 -28.8 62.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.164 -0.96 . . . . 0.0 109.448 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' B' ' 15' ' ' PRO . 74.6 t -87.45 -45.18 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 109.637 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 54.0 mt -63.28 -30.1 71.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 110.581 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -66.32 -26.19 67.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.116 -0.99 . . . . 0.0 109.429 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.495 HD22 ' CD2' ' A' ' 45' ' ' PHE . 15.4 tp -86.57 -44.54 11.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.221 0.534 . . . . 0.0 109.61 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.413 ' CG1' HG11 ' B' ' 33' ' ' VAL . 44.1 t -53.37 -43.25 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.815 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -50.78 -61.39 2.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.554 -0.716 . . . . 0.0 110.675 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -54.59 -24.75 22.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.749 . . . . 0.0 111.01 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' HG3' ' B' ' 36' ' ' GLU . 38.2 t -80.61 -30.91 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.092 -1.005 . . . . 0.0 110.667 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.84 -27.75 49.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.097 -1.002 . . . . 0.0 109.955 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.37 -15.16 33.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 110.733 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' B' ' 29' ' ' ASN . 19.7 pt-20 -90.84 -33.11 15.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.006 -1.059 . . . . 0.0 110.49 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.421 ' N ' ' HG3' ' B' ' 28' ' ' GLU . 9.5 m-80 -79.54 -26.7 41.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.72 23.98 8.0 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -132.09 -159.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.203 -1.175 . . . . 0.0 109.836 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.36 -178.81 3.66 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.459 -0.776 . . . . 0.0 109.187 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.413 HG11 ' CG1' ' B' ' 22' ' ' VAL . 97.4 t -76.4 -19.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 110.191 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 41.7 t30 -74.66 -29.99 61.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 108.825 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.52 -38.35 21.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.562 -0.711 . . . . 0.0 109.115 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.426 ' HG3' ' CG1' ' B' ' 25' ' ' VAL . 0.5 OUTLIER -58.97 -51.76 68.67 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.315 -0.865 . . . . 0.0 109.648 179.017 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.428 ' O ' ' CG2' ' B' ' 41' ' ' VAL . 39.1 mm -63.0 -27.6 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.457 -0.777 . . . . 0.0 109.235 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.488 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 36.3 t80 -74.62 -24.96 58.93 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.38 -0.825 . . . . 0.0 110.103 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -50.63 10.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.875 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -61.11 -28.72 69.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.372 -0.83 . . . . 0.0 109.246 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.474 HG12 ' CZ3' ' A' ' 14' ' ' TRP . 62.5 t -84.45 -21.91 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.516 0.674 . . . . 0.0 109.873 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' B' ' 38' ' ' TYR . 0.0 OUTLIER -74.66 -51.21 15.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 111.088 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -69.4 -24.28 63.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.166 -0.959 . . . . 0.0 111.42 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 56.3 p -56.9 -52.73 64.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.92 -1.113 . . . . 0.0 110.199 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.519 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 38.6 m-85 -62.98 -40.48 97.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 110.382 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -57.0 -21.7 32.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 110.645 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -74.02 -61.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.978 . . . . 0.0 110.441 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.32 -29.89 61.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 110.243 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.68 32.18 4.89 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -85.59 -45.01 12.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.061 -1.258 . . . . 0.0 110.094 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.423 ' CG2' HD23 ' A' ' 21' ' ' LEU . 13.0 pt -108.22 167.47 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.72 -50.06 0.53 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.161 -1.2 . . . . 0.0 110.226 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 tpt . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.186 0.517 . . . . 50.0 110.168 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -172.53 131.02 0.56 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.37 -0.831 . . . . 50.0 110.113 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.78 38.07 12.41 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.443 -1.463 . . . . 50.0 109.443 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.28 -157.96 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -1.144 . . . . 50.0 110.128 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 m -89.01 -173.2 3.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 50.0 110.341 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.69 -163.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 50.0 110.495 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.5 mtt -56.38 141.56 70.63 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.353 -0.842 . . . . 43.64 110.242 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 50.8 Cg_endo -77.05 157.93 34.17 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.508 1.267 . . . . 29.79 110.551 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.01 0.38 35.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.409 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.4 ' CB ' ' HB3' ' B' ' 10' ' ' PHE . 75.1 t80 -88.67 -23.59 22.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.994 -1.066 . . . . 12.57 109.881 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.481 HD21 ' CE3' ' A' ' 14' ' ' TRP . 54.7 mt -99.6 28.18 4.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 110.312 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.48 -22.12 57.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.168 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.08 -10.28 45.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.512 ' CZ3' HG12 ' B' ' 41' ' ' VAL . 13.9 m0 -75.61 142.43 73.98 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.092 -1.005 . . . . 11.57 109.874 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.1 176.25 8.72 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.568 1.299 . . . . 13.83 110.744 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.0 -23.31 38.76 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.381 -0.824 . . . . 48.43 109.437 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -70.26 -27.45 64.44 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.248 -0.907 . . . . 46.64 109.885 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.2 t -93.2 -43.82 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -0.858 . . . . 16.14 110.086 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.1 mt -63.74 -31.86 73.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 12.61 110.531 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -66.94 -31.21 71.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 23.17 109.92 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.526 ' CD2' ' CG ' ' B' ' 45' ' ' PHE . 52.6 tp -79.88 -40.21 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.841 . . . . 19.0 110.111 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.426 ' CG1' HG12 ' A' ' 33' ' ' VAL . 39.7 t -54.43 -50.13 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.905 . . . . 18.87 110.139 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -58.33 -49.32 77.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.763 . . . . 23.61 110.437 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -18.57 63.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 30.11 110.635 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.414 HG12 ' CG ' ' A' ' 36' ' ' GLU . 90.6 t -88.94 -29.21 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 16.22 110.44 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.02 -26.98 36.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.168 -0.958 . . . . 26.6 109.818 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -89.51 -15.87 32.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.405 -0.81 . . . . 45.21 110.688 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 18.6 pt-20 -90.69 -28.18 18.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.983 -1.073 . . . . 37.85 110.396 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -90.92 -18.72 24.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 35.36 110.392 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.9 23.66 22.35 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.484 -1.446 . . . . 35.1 109.484 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -121.17 -164.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.119 . . . . 32.72 110.211 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.0 m -106.61 168.58 9.07 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.819 -0.808 . . . . 19.61 108.819 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.426 HG12 ' CG1' ' A' ' 22' ' ' VAL . 92.2 t -73.82 -23.21 18.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.05 -1.031 . . . . 17.56 110.086 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -75.22 -28.93 60.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 21.3 108.896 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.1 m -85.42 -27.84 25.49 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.484 -0.76 . . . . 16.38 109.589 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.414 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.6 tp10 -70.96 -38.47 72.82 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.249 -0.907 . . . . 12.61 109.171 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.46 HD11 ' CH2' ' A' ' 14' ' ' TRP . 17.5 mm -80.13 -25.16 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.564 -0.71 . . . . 10.95 109.345 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.476 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 22.3 t80 -72.99 -38.26 66.72 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.265 -0.897 . . . . 18.87 110.218 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -42.7 65.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.192 -0.943 . . . . 36.88 109.911 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -64.65 -27.08 68.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 22.85 109.304 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.487 HG12 ' CZ3' ' B' ' 14' ' ' TRP . 42.8 t -82.65 -26.97 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.627 0.727 . . . . 13.02 109.329 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -40.44 65.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.668 -0.645 . . . . 18.84 110.736 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.89 -20.99 61.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 29.96 110.599 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 t -64.94 -53.13 51.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -0.976 . . . . 18.65 110.433 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.513 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 31.5 m-85 -62.58 -27.27 69.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 16.26 110.775 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -67.32 -30.77 70.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 36.71 110.637 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -53.75 -29.87 41.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.182 -0.948 . . . . 41.6 110.477 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -105.51 -14.44 15.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 24.83 110.656 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.89 48.52 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.342 -1.503 . . . . 18.81 109.342 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -57.92 -42.97 85.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.115 -1.227 . . . . 23.01 110.055 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 22.8 pt -91.34 169.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.448 -0.782 . . . . 27.08 109.99 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.61 66.63 0.54 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.558 -1.417 . . . . 32.03 109.558 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.193 -1.181 . . . . 0.0 110.179 179.88 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.7 tpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.274 0.559 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -172.67 130.95 0.54 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.22 -0.925 . . . . 0.0 110.139 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.69 38.23 12.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.17 -158.16 0.18 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -1.071 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.8 m -88.72 -173.1 3.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 0.0 110.374 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -162.92 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.322 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 9.3 mtt -56.75 141.45 73.92 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.302 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.4 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 50.2 Cg_endo -76.87 157.39 34.93 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.612 1.322 . . . . 0.0 110.627 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.49 0.63 32.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 110.576 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.411 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 74.7 t80 -88.83 -23.85 22.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.07 -1.019 . . . . 0.0 109.826 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.469 HD21 ' CE3' ' B' ' 14' ' ' TRP . 54.7 mt -99.36 28.18 4.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.328 -0.858 . . . . 0.0 110.219 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.47 -21.89 57.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.918 . . . . 0.0 110.219 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -10.32 44.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.18 -0.95 . . . . 0.0 110.5 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.487 ' CZ3' HG12 ' A' ' 41' ' ' VAL . 13.8 m0 -75.79 142.28 73.15 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.133 -0.979 . . . . 0.0 109.858 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.04 176.25 8.69 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.24 1.126 . . . . 0.0 110.721 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.04 -23.47 38.56 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 109.446 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.94 -27.44 64.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.129 -0.982 . . . . 0.0 110.071 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 90.1 t -93.38 -44.07 13.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.989 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.31 -31.87 73.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.542 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -67.16 -30.96 71.07 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.513 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 53.5 tp -79.85 -40.2 28.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.411 -0.805 . . . . 0.0 110.163 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.426 ' CG1' HG12 ' B' ' 33' ' ' VAL . 40.2 t -54.51 -50.2 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.857 . . . . 0.0 109.952 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -58.26 -49.75 76.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.432 -0.793 . . . . 0.0 110.268 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -18.91 63.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 110.775 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.426 HG12 ' CG ' ' B' ' 36' ' ' GLU . 92.2 t -88.66 -28.83 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.083 -1.011 . . . . 0.0 110.542 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.5 -26.4 35.18 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.87 -15.99 31.0 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.435 -0.791 . . . . 0.0 110.555 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -90.68 -27.97 18.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.36 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -91.19 -18.64 24.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 0.0 110.471 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.85 23.61 22.61 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -121.2 -164.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -1.141 . . . . 0.0 110.217 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -106.35 168.4 9.18 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.426 HG12 ' CG1' ' B' ' 22' ' ' VAL . 92.1 t -73.65 -23.25 19.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.018 -1.051 . . . . 0.0 110.157 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -75.27 -28.64 59.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 108.925 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -85.59 -27.85 25.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.54 -0.725 . . . . 0.0 109.518 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.426 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.6 tp10 -70.9 -38.32 73.02 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.262 -0.899 . . . . 0.0 109.366 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.456 HD11 ' CH2' ' B' ' 14' ' ' TRP . 17.6 mm -80.19 -25.19 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 0.0 109.297 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.47 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 22.6 t80 -73.01 -38.02 66.75 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.8 -42.34 64.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -64.94 -26.9 68.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.512 HG12 ' CZ3' ' A' ' 14' ' ' TRP . 42.7 t -82.83 -26.92 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.464 -0.772 . . . . 0.0 109.154 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -39.95 65.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.639 -0.663 . . . . 0.0 110.785 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.26 -21.03 61.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 110.538 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -64.71 -53.28 49.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.435 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.526 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 31.3 m-85 -62.66 -27.23 69.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.973 . . . . 0.0 110.816 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -67.23 -30.76 70.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.066 -1.021 . . . . 0.0 110.639 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -53.87 -29.66 42.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.162 -0.961 . . . . 0.0 110.49 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -105.61 -14.45 15.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 110.654 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.8 20.78 49.44 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -57.88 -43.08 85.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -1.182 . . . . 0.0 109.941 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.4 pt -91.22 169.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 110.03 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.14 66.87 0.54 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.236 -1.155 . . . . 0.0 110.184 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.249 0.547 . . . . 50.0 110.218 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -101.87 35.9 2.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 50.0 110.214 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.76 119.3 0.87 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.693 -1.363 . . . . 50.0 109.693 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -114.86 171.09 7.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 50.0 109.795 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -159.39 152.13 21.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.188 -0.945 . . . . 50.0 110.486 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -154.39 -176.22 5.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.341 -0.849 . . . . 50.0 110.12 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.22 163.08 55.34 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 43.64 110.341 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.427 ' HG3' ' CE1' ' B' ' 10' ' ' PHE . 46.2 Cg_endo -72.88 157.61 51.28 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.635 1.334 . . . . 29.79 110.347 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -75.98 -10.54 59.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.873 . . . . 0.0 110.705 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' B' ' 10' ' ' PHE . 79.1 t80 -74.78 -27.63 60.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.063 -1.023 . . . . 12.57 110.331 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.0 mt -96.17 23.43 6.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 110.203 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.2 -18.26 61.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.675 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -97.24 1.22 49.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.947 . . . . 0.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.493 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.4 m0 -82.32 153.81 68.9 Favored Pre-proline 0 N--CA 1.485 1.313 0 O-C-N 121.076 -1.015 . . . . 11.57 109.796 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 42.0 Cg_endo -70.61 162.5 42.27 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.535 1.281 . . . . 13.83 111.379 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -40.76 97.6 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.615 0.721 . . . . 48.43 110.67 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -53.78 53.25 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.815 -0.553 . . . . 46.64 111.086 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.445 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 85.7 t -60.96 -44.59 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.099 -1.0 . . . . 16.14 110.737 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.7 mt -62.57 -30.66 71.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.218 -0.926 . . . . 12.61 110.779 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -72.64 -23.13 60.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.987 . . . . 23.17 110.264 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.543 ' CD2' ' CG ' ' B' ' 45' ' ' PHE . 1.2 tp -87.3 -37.46 17.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.32 -0.862 . . . . 19.0 110.21 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 HG12 ' CG1' ' A' ' 33' ' ' VAL . 27.3 t -57.15 -45.23 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 18.87 110.267 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 24' ' ' LYS . 8.8 ptp180 -65.56 -29.87 70.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -0.906 . . . . 23.61 110.681 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -83.58 -10.46 58.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.043 -1.036 . . . . 30.11 110.563 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -100.15 -28.0 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 16.22 110.453 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -76.06 -30.55 58.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 26.6 109.742 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.92 -12.17 58.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.2 -0.938 . . . . 45.21 110.387 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -87.23 -54.13 4.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.068 -1.02 . . . . 37.85 110.536 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -61.01 -22.44 64.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.128 -0.982 . . . . 35.36 110.561 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.2 36.99 4.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.529 -1.428 . . . . 35.1 109.529 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -141.5 -154.89 0.54 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.378 -1.072 . . . . 32.72 110.104 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 p -113.43 171.67 7.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.52 -0.738 . . . . 19.61 109.253 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG22 ' CB ' ' A' ' 26' ' ' ALA . 71.4 t -72.64 -23.04 20.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.097 -1.002 . . . . 17.56 110.412 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -70.08 -29.88 66.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.998 . . . . 21.3 109.021 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.71 -29.33 21.17 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.454 -0.778 . . . . 16.38 109.432 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -64.36 -59.43 4.38 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.306 -0.871 . . . . 12.61 109.349 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.482 HD12 ' CZ3' ' A' ' 14' ' ' TRP . 24.9 mm -60.31 -22.56 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.369 -0.832 . . . . 10.95 109.284 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.423 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 20.0 t80 -73.62 -33.25 64.48 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.367 -0.833 . . . . 18.87 110.065 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -46.36 21.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 36.88 109.817 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 mtt-85 -61.31 -25.94 67.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.445 -0.784 . . . . 22.85 109.601 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.507 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 53.9 t -88.66 -29.81 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.506 -0.747 . . . . 13.02 109.999 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.0 -67.48 0.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 18.84 110.54 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -55.82 -20.68 16.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.975 . . . . 29.96 110.479 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.0 t -60.35 -53.66 54.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 18.65 109.998 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.537 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 17.0 m-85 -60.52 -30.46 69.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.352 -0.843 . . . . 16.26 110.129 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.15 -30.49 68.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 36.71 110.579 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -29.61 69.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.145 -0.972 . . . . 41.6 110.473 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -95.12 -17.89 21.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.922 . . . . 24.83 110.558 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.1 17.49 61.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.785 -1.326 . . . . 18.81 109.785 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -59.48 -33.41 71.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.032 -1.276 . . . . 23.01 110.152 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 mt -90.83 -63.51 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.349 -0.844 . . . . 27.08 110.1 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.32 -38.24 2.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.426 -1.47 . . . . 32.03 109.426 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.119 -1.224 . . . . 0.0 110.357 179.795 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.187 0.518 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -101.75 35.89 2.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.416 -0.802 . . . . 0.0 110.333 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.8 119.2 0.86 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -114.77 170.97 7.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -1.128 . . . . 0.0 109.916 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -159.23 152.34 22.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.125 -0.985 . . . . 0.0 110.443 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -154.6 -176.21 5.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.207 -0.933 . . . . 0.0 110.017 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.29 163.16 55.01 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.331 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.461 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 45.8 Cg_endo -73.02 157.57 50.83 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.75 1.395 . . . . 0.0 110.35 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -75.86 -10.55 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 79.0 t80 -74.84 -27.8 60.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.29 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 41.7 mt -96.09 23.36 6.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.179 -0.951 . . . . 0.0 110.225 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.18 -18.35 61.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.134 -0.979 . . . . 0.0 110.601 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -97.13 1.22 49.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.048 -1.032 . . . . 0.0 110.855 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.507 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.3 m0 -82.48 153.82 68.46 Favored Pre-proline 0 N--CA 1.485 1.31 0 O-C-N 120.986 -1.071 . . . . 0.0 109.852 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.446 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 42.2 Cg_endo -70.47 162.11 43.62 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.419 1.221 . . . . 0.0 111.525 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -40.6 97.18 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.784 0.802 . . . . 0.0 110.768 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -53.87 52.14 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.037 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.446 ' CG2' ' HG2' ' B' ' 15' ' ' PRO . 85.8 t -60.7 -45.09 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.586 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 71.6 mt -61.92 -30.8 71.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.827 -1.171 . . . . 0.0 111.111 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -72.73 -23.32 60.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.097 -1.002 . . . . 0.0 110.287 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.537 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 1.2 tp -87.0 -37.58 17.38 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.423 -0.798 . . . . 0.0 110.301 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.418 HG12 ' CG1' ' B' ' 33' ' ' VAL . 26.3 t -57.02 -45.28 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 110.267 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' B' ' 24' ' ' LYS . 8.8 ptp180 -65.59 -29.73 70.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.24 -0.913 . . . . 0.0 110.709 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 0.0 OUTLIER -83.7 -10.45 58.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.064 -1.022 . . . . 0.0 110.527 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -100.12 -27.94 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 110.459 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.422 ' CB ' HG22 ' B' ' 33' ' ' VAL . . . -76.05 -30.54 58.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.12 -0.987 . . . . 0.0 109.734 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.0 -11.96 58.57 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.378 -0.826 . . . . 0.0 110.46 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.38 -54.0 4.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.991 . . . . 0.0 110.545 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -61.2 -22.35 64.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 110.63 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.15 37.1 4.72 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -141.53 -154.88 0.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.399 -1.059 . . . . 0.0 110.094 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 2.2 p -113.32 171.66 7.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.528 -0.732 . . . . 0.0 109.311 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.422 HG22 ' CB ' ' B' ' 26' ' ' ALA . 70.9 t -72.64 -23.17 20.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.124 -0.985 . . . . 0.0 110.454 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -69.96 -29.75 66.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.0 109.042 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.87 -29.46 20.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.497 -0.752 . . . . 0.0 109.356 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -64.3 -59.4 4.43 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.297 -0.877 . . . . 0.0 109.295 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.487 HD12 ' CZ3' ' B' ' 14' ' ' TRP . 24.9 mm -60.37 -22.64 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.315 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.433 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 19.5 t80 -73.71 -33.24 64.3 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.265 -0.897 . . . . 0.0 109.977 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -46.52 21.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 109.723 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 mtt-85 -61.14 -25.84 67.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.81 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.493 HG11 ' CZ3' ' A' ' 14' ' ' TRP . 54.7 t -88.66 -29.85 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.968 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -67.41 0.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 110.465 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -55.86 -20.83 17.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.95 . . . . 0.0 110.396 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 19.6 t -60.25 -53.65 55.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.235 -0.915 . . . . 0.0 109.97 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.543 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 17.4 m-85 -60.36 -30.75 69.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -30.56 68.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 0.0 110.575 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -29.95 70.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.09 -1.006 . . . . 0.0 110.365 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -95.02 -17.93 21.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.579 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.16 17.61 60.67 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -59.38 -33.53 71.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.256 . . . . 0.0 110.061 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 38.4 mt -90.97 -63.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.153 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.93 -37.81 2.15 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.31 -1.112 . . . . 0.0 110.177 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.293 0.568 . . . . 50.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -101.12 47.12 0.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 50.0 110.104 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.77 119.22 0.2 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.393 -1.483 . . . . 50.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.1 ttm -126.49 -59.77 1.28 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -1.168 . . . . 50.0 110.454 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.16 23.88 0.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.185 -0.947 . . . . 50.0 110.51 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 166.01 16.35 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.609 -0.682 . . . . 50.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.9 164.08 63.7 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 43.64 110.191 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 11' ' ' LEU . 44.1 Cg_endo -70.3 145.83 55.12 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.594 1.313 . . . . 29.79 110.426 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -64.16 -14.49 55.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 110.729 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.48 ' CE1' ' HG3' ' B' ' 8' ' ' PRO . 89.9 t80 -71.77 -28.79 63.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.108 -0.995 . . . . 12.57 110.169 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.483 HD22 ' CE3' ' A' ' 14' ' ' TRP . 65.9 mt -93.77 30.21 1.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.176 -0.953 . . . . 0.0 110.272 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.82 -23.91 61.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -19.63 25.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.91 . . . . 0.0 110.449 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.486 ' CZ2' ' HA ' ' B' ' 38' ' ' TYR . 13.1 m0 -69.56 132.47 89.3 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.256 -0.903 . . . . 11.57 109.236 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.66 167.2 23.51 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.411 1.216 . . . . 13.83 111.082 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -67.98 -25.77 65.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.614 -0.679 . . . . 48.43 110.791 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.5 -51.92 51.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 46.64 110.611 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.49 -39.5 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 16.14 110.526 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.7 -29.92 70.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 12.61 110.639 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.08 -27.47 68.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.059 -1.026 . . . . 23.17 109.504 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.478 HD21 ' CD2' ' B' ' 45' ' ' PHE . 50.1 tp -84.88 -39.53 18.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.561 -0.712 . . . . 19.0 110.066 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.26 -47.25 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.44 -0.788 . . . . 18.87 110.574 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 24' ' ' LYS . 9.6 ptp180 -61.52 -28.62 69.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.316 -0.865 . . . . 23.61 110.849 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.453 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -86.01 -20.68 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.029 -1.044 . . . . 30.11 110.14 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.4 -23.75 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.873 . . . . 16.22 110.204 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.76 -34.61 67.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.305 -0.872 . . . . 26.6 109.528 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.44 -9.78 59.3 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.333 -0.854 . . . . 45.21 110.425 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.47 -59.96 2.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 37.85 110.399 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -58.61 -30.17 67.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 35.36 110.444 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.04 32.68 3.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 35.1 109.555 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -136.74 -165.13 1.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.122 . . . . 32.72 109.94 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.24 -173.36 2.65 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.408 -0.807 . . . . 19.61 108.842 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -83.44 -15.5 11.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.171 -0.956 . . . . 17.56 110.099 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.469 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 60.6 t30 -80.84 -33.18 34.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 21.3 108.496 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.84 -40.0 49.27 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.835 -0.802 . . . . 16.38 108.835 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' O ' ' CD ' ' A' ' 40' ' ' ARG . 1.5 tt0 -59.53 -51.24 70.71 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.247 -0.908 . . . . 12.61 109.256 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.415 HD13 ' CH2' ' A' ' 14' ' ' TRP . 35.3 mm -64.0 -24.42 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.373 -0.829 . . . . 10.95 109.584 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.485 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 35.2 t80 -73.98 -30.35 62.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.297 -0.877 . . . . 18.87 110.427 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 -78.12 -46.09 21.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.083 -1.011 . . . . 36.88 110.137 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.417 ' CD ' ' O ' ' A' ' 36' ' ' GLU . 2.7 mpt_? -60.98 -26.68 67.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 22.85 109.697 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.505 HG12 ' CZ3' ' B' ' 14' ' ' TRP . 19.2 t -85.63 -30.58 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.491 -0.756 . . . . 13.02 109.352 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.5 mtp -71.4 -20.33 62.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.759 . . . . 18.84 110.487 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.04 -26.65 26.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 29.96 110.532 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.48 -58.81 6.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 18.65 110.317 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.504 ' CG ' HD21 ' B' ' 21' ' ' LEU . 30.1 m-85 -55.13 -42.31 72.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 16.26 110.374 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -51.86 -35.79 46.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.161 -0.962 . . . . 36.71 110.615 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -53.92 -62.36 1.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 41.6 110.522 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.0 -59.45 5.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 24.83 110.305 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 131.86 35.33 0.35 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.072 -1.211 . . . . 18.81 110.072 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -83.73 -36.55 23.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -1.202 . . . . 23.01 109.475 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.19 -169.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.531 -0.731 . . . . 27.08 109.613 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.4 -38.67 0.14 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.749 -1.34 . . . . 32.03 109.749 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.297 -1.12 . . . . 0.0 110.331 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.284 0.564 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -100.97 47.15 0.92 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.163 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.61 119.63 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 22.1 ttm -126.87 -59.47 1.26 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -1.128 . . . . 0.0 110.468 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.46 23.9 0.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.2 -0.937 . . . . 0.0 110.517 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.78 166.19 16.01 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.512 -0.743 . . . . 0.0 110.456 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -74.21 164.11 63.55 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.48 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 45.0 Cg_endo -70.65 145.25 51.53 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.678 1.357 . . . . 0.0 110.392 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -63.62 -14.46 51.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 0.0 110.749 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 34' ' ' ASN . 90.7 t80 -71.8 -28.46 63.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.047 -1.033 . . . . 0.0 110.209 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.479 HD22 ' CE3' ' B' ' 14' ' ' TRP . 64.2 mt -94.05 30.31 1.91 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.248 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.99 -23.95 61.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -0.847 . . . . 0.0 110.221 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -19.58 25.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.928 . . . . 0.0 110.451 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.505 ' CZ3' HG12 ' A' ' 41' ' ' VAL . 13.2 m0 -69.86 132.18 88.9 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.351 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.5 167.24 23.11 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.551 1.29 . . . . 0.0 111.153 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -68.07 -25.67 65.46 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.735 -0.603 . . . . 0.0 110.698 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.98 -51.72 51.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 110.526 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.64 -39.48 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.103 -0.998 . . . . 0.0 110.237 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 14.3 mt -65.77 -29.83 70.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 110.715 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.37 -27.61 68.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.041 -1.037 . . . . 0.0 109.617 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.504 HD21 ' CG ' ' A' ' 45' ' ' PHE . 45.7 tp -84.87 -39.1 18.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.633 -0.667 . . . . 0.0 110.03 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.88 -46.32 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.0 110.606 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' B' ' 24' ' ' LYS . 9.6 ptp180 -62.31 -28.31 69.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.197 -0.939 . . . . 0.0 110.759 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.451 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 0.1 OUTLIER -86.06 -20.82 28.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.031 -1.043 . . . . 0.0 110.116 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 95.3 t -87.42 -23.75 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.853 . . . . 0.0 110.119 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.27 66.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.52 -9.91 59.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.46 -0.775 . . . . 0.0 110.371 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -86.51 -59.99 2.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.015 . . . . 0.0 110.379 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -58.56 -30.09 66.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.87 . . . . 0.0 110.345 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.94 32.56 3.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -136.44 -164.82 1.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -1.183 . . . . 0.0 109.973 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.54 -173.55 2.67 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.37 -0.831 . . . . 0.0 108.879 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 69.4 t -83.26 -15.65 11.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.175 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 60.2 t30 -80.86 -32.98 34.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.097 -1.002 . . . . 0.0 108.436 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -40.47 48.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' B' ' 40' ' ' ARG . 1.5 tt0 -59.1 -51.55 69.55 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.214 -0.929 . . . . 0.0 109.273 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.403 HD13 ' CH2' ' B' ' 14' ' ' TRP . 37.0 mm -63.53 -24.58 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.58 -0.7 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.486 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 37.8 t80 -74.2 -29.84 61.93 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 110.508 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -78.6 -46.2 19.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.404 ' CD ' ' O ' ' B' ' 36' ' ' GLU . 2.7 mpt_? -60.36 -27.64 67.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.567 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.485 HG12 ' CZ3' ' A' ' 14' ' ' TRP . 18.6 t -84.9 -30.42 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.512 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.5 mtp -72.19 -19.54 61.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 110.499 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.45 -26.94 26.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 110.354 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -58.9 6.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 0.0 110.391 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.478 ' CD2' HD21 ' A' ' 21' ' ' LEU . 31.2 m-85 -55.23 -41.93 72.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.469 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -52.27 -36.08 51.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.249 -0.907 . . . . 0.0 110.518 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -53.61 -62.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.579 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -60.94 -59.55 5.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.332 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.04 35.15 0.35 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -83.77 -36.61 23.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.308 . . . . 0.0 109.415 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 pt -127.96 -168.91 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.427 -0.796 . . . . 0.0 109.794 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.12 -38.85 0.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.308 -1.113 . . . . 0.0 110.241 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.248 0.547 . . . . 50.0 110.128 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -113.26 174.34 5.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 50.0 110.102 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.52 37.53 10.63 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.587 -1.405 . . . . 50.0 109.587 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.67 -162.78 0.93 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -1.145 . . . . 50.0 110.2 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.6 m -82.41 140.48 33.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.271 -0.893 . . . . 50.0 110.217 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -112.98 38.59 2.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 50.0 110.394 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 18.4 mtp -110.32 106.06 57.67 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 43.64 110.209 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.423 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.0 Cg_endo -71.33 153.5 61.44 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.569 1.3 . . . . 29.79 110.487 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.15 -17.58 64.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 110.456 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.434 ' HB3' ' CB ' ' B' ' 10' ' ' PHE . 87.7 t80 -76.26 -28.45 57.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 12.57 110.352 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.477 HD21 ' CD2' ' A' ' 14' ' ' TRP . 81.5 mt -91.53 21.14 4.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.954 . . . . 0.0 110.455 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -72.45 -22.65 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 110.059 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.79 -11.99 46.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.635 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.479 ' CZ3' HG13 ' B' ' 41' ' ' VAL . 14.2 m0 -79.73 141.94 56.39 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.029 -1.045 . . . . 11.57 109.682 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.19 177.83 7.33 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.572 1.301 . . . . 13.83 110.685 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.77 -21.95 34.46 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.385 -0.822 . . . . 48.43 109.153 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -69.32 -28.01 65.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.885 . . . . 46.64 109.887 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.5 t -94.85 -40.46 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 16.14 110.034 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.89 -28.79 69.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 12.61 110.547 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -73.08 -22.61 60.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 23.17 109.936 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.485 HD23 ' CG ' ' B' ' 45' ' ' PHE . 50.6 tp -90.1 -33.52 16.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 19.0 110.018 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 ' CG1' HD12 ' A' ' 37' ' ' ILE . 24.0 t -67.14 -50.18 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.419 -0.801 . . . . 18.87 110.345 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -59.17 -27.25 65.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.309 -0.869 . . . . 23.61 110.788 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -24.11 33.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 30.11 110.165 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.4 t -78.83 -39.34 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.433 -0.792 . . . . 16.22 110.351 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.425 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -63.53 -40.76 97.86 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.204 -0.935 . . . . 26.6 109.654 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -68.13 -16.09 63.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 45.21 110.452 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.78 -59.84 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.979 -1.076 . . . . 37.85 110.411 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -59.07 -28.03 66.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 35.36 110.703 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.59 41.03 3.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.461 -1.456 . . . . 35.1 109.461 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mtt-85 -141.96 -154.01 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -1.121 . . . . 32.72 110.069 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 t -108.59 175.94 5.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.48 -0.763 . . . . 19.61 109.476 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG21 ' CB ' ' A' ' 26' ' ' ALA . 88.9 t -78.64 -20.56 13.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.157 -0.965 . . . . 17.56 110.229 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.18 -26.57 63.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.069 -1.019 . . . . 21.3 109.104 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.82 -30.53 22.9 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.384 -0.823 . . . . 16.38 109.566 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -48.48 67.86 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.251 -0.906 . . . . 12.61 109.724 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.423 HD12 ' CG1' ' A' ' 22' ' ' VAL . 47.3 mm -66.36 -30.88 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.837 . . . . 10.95 109.679 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.475 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 36.9 t80 -67.67 -39.4 84.51 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 18.87 110.635 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.53 -45.81 61.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.185 -0.947 . . . . 36.88 109.743 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -60.84 -24.69 66.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 22.85 109.4 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.502 HG13 ' CZ3' ' B' ' 14' ' ' TRP . 52.1 t -90.14 -23.36 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.586 -0.696 . . . . 13.02 110.161 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -56.99 4.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.505 -0.747 . . . . 18.84 110.977 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -50.74 -33.22 22.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.121 -0.987 . . . . 29.96 111.189 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.3 m -60.79 -51.24 70.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.121 -0.987 . . . . 18.65 110.598 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.5 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 15.0 m-85 -59.77 -29.88 68.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.98 . . . . 16.26 110.814 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.09 -30.08 58.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.006 -1.059 . . . . 36.71 110.677 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -54.56 -49.63 69.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.104 -0.998 . . . . 41.6 110.356 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -80.15 -58.32 3.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.181 -0.95 . . . . 24.83 110.314 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.38 42.49 0.25 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.464 -1.455 . . . . 18.81 109.464 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.47 -28.13 31.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.397 -1.06 . . . . 23.01 110.437 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.7 mt -81.72 -20.66 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.009 -1.057 . . . . 27.08 110.38 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.64 -28.47 3.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.744 -1.342 . . . . 32.03 109.744 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.283 -1.128 . . . . 0.0 110.149 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.262 0.553 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -113.21 173.73 6.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.23 37.43 9.88 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.66 -162.89 0.94 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -1.122 . . . . 0.0 110.193 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 4.5 m -82.16 140.34 33.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 110.228 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -113.12 38.81 2.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 110.256 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 18.3 mtp -110.49 105.89 57.48 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.141 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.421 ' CG ' HD12 ' B' ' 11' ' ' LEU . 45.4 Cg_endo -71.46 153.55 60.71 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.65 1.342 . . . . 0.0 110.42 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.04 -17.74 65.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.458 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.434 ' CB ' ' HB3' ' A' ' 10' ' ' PHE . 87.6 t80 -76.15 -28.32 57.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.157 -0.964 . . . . 0.0 110.326 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.478 HD21 ' CD2' ' B' ' 14' ' ' TRP . 83.5 mt -91.8 21.7 4.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 110.407 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.09 -22.53 60.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.974 . . . . 0.0 110.015 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.74 -12.02 46.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 110.644 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.502 ' CZ3' HG13 ' A' ' 41' ' ' VAL . 14.2 m0 -79.83 142.05 56.1 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.841 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.21 177.42 7.86 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.551 1.29 . . . . 0.0 110.18 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -21.6 34.61 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.439 -0.788 . . . . 0.0 109.226 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -69.38 -28.02 65.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.978 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 80.2 t -94.66 -40.64 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.551 -0.718 . . . . 0.0 109.845 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.95 -28.44 68.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.563 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.38 -22.85 60.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.845 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.5 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 51.7 tp -89.82 -33.73 16.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.704 -0.623 . . . . 0.0 110.12 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.43 ' CG1' HD12 ' B' ' 37' ' ' ILE . 24.0 t -66.92 -50.1 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -0.829 . . . . 0.0 110.37 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -59.14 -27.52 65.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.289 -0.882 . . . . 0.0 110.801 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -24.3 34.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 110.114 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' B' ' 21' ' ' LEU . 88.8 t -78.66 -39.46 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.804 . . . . 0.0 110.299 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.423 ' CB ' HG21 ' B' ' 33' ' ' VAL . . . -63.18 -41.47 99.22 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.342 -0.849 . . . . 0.0 109.59 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -67.53 -16.24 64.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.528 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -82.56 -59.94 2.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.041 -1.037 . . . . 0.0 110.503 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -58.97 -28.16 66.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.136 -0.978 . . . . 0.0 110.794 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.47 41.7 2.9 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -142.6 -154.19 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.433 -1.04 . . . . 0.0 110.002 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.7 t -108.87 175.8 5.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.451 -0.781 . . . . 0.0 109.466 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.423 HG21 ' CB ' ' B' ' 26' ' ' ALA . 93.7 t -78.27 -20.5 13.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 110.451 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.6 -26.32 62.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.079 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.02 -30.38 22.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.429 -0.794 . . . . 0.0 109.467 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -48.35 67.61 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.43 HD12 ' CG1' ' B' ' 22' ' ' VAL . 47.2 mm -66.81 -30.31 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -68.0 -39.41 83.22 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.381 -0.825 . . . . 0.0 110.608 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -45.83 61.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.895 . . . . 0.0 109.759 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -60.93 -24.52 66.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 109.383 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.479 HG13 ' CZ3' ' A' ' 14' ' ' TRP . 49.9 t -90.22 -23.4 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.62 -0.675 . . . . 0.0 110.011 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -57.66 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.507 -0.746 . . . . 0.0 111.081 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -50.22 -33.37 19.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.163 -0.961 . . . . 0.0 111.249 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 38.1 m -60.96 -50.85 71.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.1 -1.0 . . . . 0.0 110.637 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.485 ' CG ' HD23 ' A' ' 21' ' ' LEU . 15.9 m-85 -60.04 -30.04 68.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.79 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.93 -29.78 58.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.251 -0.905 . . . . 0.0 110.835 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -54.77 -49.39 71.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 110.468 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -80.3 -58.04 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.083 -1.011 . . . . 0.0 110.397 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.01 42.47 0.26 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -28.6 31.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -1.176 . . . . 0.0 110.379 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 65.2 mt -81.4 -20.65 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.479 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.7 -28.8 3.2 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.125 . . . . 0.0 110.264 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tmm? . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.231 0.538 . . . . 50.0 110.118 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -160.1 -174.49 4.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 50.0 110.184 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.52 46.16 1.07 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.568 -1.413 . . . . 50.0 109.568 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.73 -170.53 1.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -1.197 . . . . 50.0 110.279 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 m -106.81 130.65 54.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 50.0 110.412 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.73 155.57 27.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 50.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.405 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 1.9 ptm -53.86 163.8 1.06 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 43.64 110.358 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 44.0 Cg_endo -70.86 157.77 57.34 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.711 1.374 . . . . 29.79 110.466 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.28 -21.59 62.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.891 . . . . 0.0 110.449 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.496 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 87.4 t80 -70.12 -22.16 63.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.843 . . . . 12.57 110.574 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD21 ' CD2' ' A' ' 14' ' ' TRP . 85.1 mt -100.23 27.43 5.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.139 -0.975 . . . . 0.0 110.541 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.81 -21.64 44.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.952 . . . . 0.0 110.006 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -85.58 -22.9 27.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.494 ' CZ3' HG12 ' B' ' 41' ' ' VAL . 14.7 m0 -66.16 144.81 98.9 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 121.424 -0.798 . . . . 11.57 109.533 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HD2' ' CE1' ' B' ' 38' ' ' TYR . 40.6 Cg_endo -70.85 160.35 49.67 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.496 1.261 . . . . 13.83 111.336 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -40.15 88.9 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.603 0.716 . . . . 48.43 110.934 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.09 -47.29 86.51 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.69 -0.631 . . . . 46.64 111.49 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.429 ' CG2' ' HG2' ' A' ' 15' ' ' PRO . 77.0 t -66.89 -48.82 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.038 -1.039 . . . . 16.14 111.021 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 74.8 mt -64.02 -24.97 67.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.069 -1.019 . . . . 12.61 110.685 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.69 -23.68 61.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 23.17 109.898 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.513 HD22 ' CD1' ' B' ' 45' ' ' PHE . 0.8 OUTLIER -90.29 -43.72 10.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 19.0 110.043 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.405 ' CG1' ' CG1' ' A' ' 33' ' ' VAL . 40.6 t -51.32 -39.44 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.392 -0.818 . . . . 18.87 110.477 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -66.03 -36.21 82.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 23.61 110.622 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -19.4 58.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 30.11 110.524 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -86.88 -35.09 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.263 -0.898 . . . . 16.22 110.184 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.91 83.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -0.909 . . . . 26.6 109.738 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.98 -19.45 63.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 45.21 110.271 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -82.77 -56.53 3.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 37.85 110.35 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -53.41 -42.64 67.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 35.36 110.386 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.73 44.54 0.54 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.541 -1.424 . . . . 35.1 109.541 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.33 -158.58 0.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -1.123 . . . . 32.72 110.189 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.83 176.93 5.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 19.61 109.561 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.405 ' CG1' ' CG1' ' A' ' 22' ' ' VAL . 75.1 t -76.14 -19.42 15.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.356 -0.84 . . . . 17.56 110.265 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -71.12 -27.72 63.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 21.3 108.869 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 m -86.3 -33.64 20.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.555 -0.716 . . . . 16.38 109.531 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.55 -53.59 49.42 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.187 -0.946 . . . . 12.61 109.412 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 25.8 mm -63.37 -21.73 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.458 -0.776 . . . . 10.95 109.653 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.492 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 32.9 t80 -76.2 -35.59 59.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.155 -0.966 . . . . 18.87 110.362 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -76.8 -52.03 10.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 36.88 109.6 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -55.46 -24.56 31.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.456 -0.778 . . . . 22.85 109.732 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.503 HG12 ' CZ3' ' B' ' 14' ' ' TRP . 37.5 t -89.97 -29.79 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 13.02 109.867 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -64.07 0.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 18.84 110.48 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.88 -29.13 18.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.19 -0.944 . . . . 29.96 110.425 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.65 -46.45 81.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 18.65 109.928 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.511 ' CD1' HD22 ' B' ' 21' ' ' LEU . 15.4 m-85 -66.75 -29.07 68.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 16.26 110.167 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.15 -26.46 65.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 36.71 110.502 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -63.95 -25.66 68.24 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 41.6 110.299 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.3 17.45 18.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 24.83 110.592 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.5 22.26 30.87 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.01 -1.236 . . . . 18.81 110.01 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -54.16 -52.89 59.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -1.171 . . . . 23.01 109.931 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.7 pt -101.99 -175.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.973 -1.08 . . . . 27.08 109.932 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.2 -63.76 0.16 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.664 -1.374 . . . . 32.03 109.664 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.157 -1.202 . . . . 0.0 110.28 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.7 tmm? . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.299 0.571 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -160.0 -174.38 4.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 110.232 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.9 46.53 1.05 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.94 -170.46 1.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -1.115 . . . . 0.0 110.323 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -107.0 131.15 54.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.359 -0.838 . . . . 0.0 110.299 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 155.33 28.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.884 . . . . 0.0 110.096 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' MET . . . . . 0.416 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 2.0 ptm -53.6 163.81 0.98 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.284 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.496 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 43.9 Cg_endo -71.04 157.99 56.41 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.621 1.327 . . . . 0.0 110.449 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.53 -21.23 61.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 110.386 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.489 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 86.6 t80 -70.53 -22.08 62.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.441 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.45 HD21 ' CD2' ' B' ' 14' ' ' TRP . 85.1 mt -100.37 27.55 5.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 110.542 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.01 -21.4 43.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 110.034 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -85.86 -22.9 27.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.873 . . . . 0.0 110.189 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.503 ' CZ3' HG12 ' A' ' 41' ' ' VAL . 14.8 m0 -66.34 145.2 98.96 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.288 -0.883 . . . . 0.0 109.425 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.437 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 41.0 Cg_endo -71.4 159.71 50.77 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.308 1.162 . . . . 0.0 111.341 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -40.4 86.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.676 0.75 . . . . 0.0 110.997 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.15 -47.21 86.87 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.774 -0.579 . . . . 0.0 111.481 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.437 ' CG2' ' HG2' ' B' ' 15' ' ' PRO . 78.9 t -67.11 -48.61 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.304 -0.872 . . . . 0.0 110.902 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.04 -24.63 67.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.079 -1.013 . . . . 0.0 110.662 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -71.99 -24.14 61.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.231 -0.918 . . . . 0.0 109.754 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.511 HD22 ' CD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -90.03 -43.45 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.502 -0.748 . . . . 0.0 110.096 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.412 ' CG1' ' CG1' ' B' ' 33' ' ' VAL . 40.7 t -51.6 -39.62 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.41 -0.806 . . . . 0.0 110.458 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -65.84 -36.29 83.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.706 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -19.57 58.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.459 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -86.71 -35.25 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.923 . . . . 0.0 110.32 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 -39.35 84.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 109.701 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.49 -19.92 63.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 110.245 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -82.45 -56.53 3.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.128 -0.982 . . . . 0.0 110.373 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -53.6 -42.38 67.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 110.46 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.51 44.48 0.55 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.35 -158.68 0.69 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -1.176 . . . . 0.0 110.258 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.69 176.92 5.06 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.363 -0.835 . . . . 0.0 109.617 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.412 ' CG1' ' CG1' ' B' ' 22' ' ' VAL . 76.3 t -76.14 -19.26 15.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.261 -0.899 . . . . 0.0 110.308 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -71.18 -27.84 63.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -0.989 . . . . 0.0 108.856 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 45.6 m -86.15 -33.72 20.77 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.549 -0.719 . . . . 0.0 109.536 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.4 -53.66 48.88 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.249 -0.907 . . . . 0.0 109.492 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' B' ' 41' ' ' VAL . 26.4 mm -63.32 -21.81 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.528 -0.732 . . . . 0.0 109.596 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.487 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 33.3 t80 -76.15 -35.51 59.17 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.113 -0.992 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -76.78 -52.08 10.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.146 -0.971 . . . . 0.0 109.645 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -55.44 -24.46 30.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.461 -0.774 . . . . 0.0 109.817 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.494 HG12 ' CZ3' ' A' ' 14' ' ' TRP . 37.7 t -90.07 -29.97 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 0.0 109.898 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -63.92 1.01 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 110.451 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.03 -29.35 20.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.156 -0.965 . . . . 0.0 110.325 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -46.7 80.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 110.011 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.513 ' CD1' HD22 ' A' ' 21' ' ' LEU . 15.7 m-85 -66.73 -28.95 68.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 110.125 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -68.3 -26.23 65.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 110.481 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -63.91 -25.85 68.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.162 -0.962 . . . . 0.0 110.28 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.16 17.54 18.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.897 . . . . 0.0 110.602 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.2 22.62 30.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -54.32 -52.82 60.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.153 -1.204 . . . . 0.0 110.012 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 28.0 pt -101.79 -175.68 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.441 -0.787 . . . . 0.0 110.102 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.01 -63.23 0.16 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.194 -1.18 . . . . 0.0 110.25 -179.942 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.282 0.563 . . . . 50.0 110.26 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -144.0 -165.94 2.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.319 -0.863 . . . . 50.0 110.176 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.52 94.29 1.29 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.749 -1.34 . . . . 50.0 109.749 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.7 ttt -111.8 30.23 7.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -1.145 . . . . 50.0 110.085 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m -142.68 162.8 34.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 50.0 109.96 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.41 -162.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.147 -0.971 . . . . 50.0 109.966 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 mtp 56.2 104.37 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.237 -0.914 . . . . 43.64 110.381 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.9 Cg_endo -71.12 170.59 17.79 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.565 1.297 . . . . 29.79 110.791 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -87.0 -17.55 32.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 110.327 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.502 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 74.2 t80 -72.62 -26.12 61.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 12.57 110.564 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.48 HD22 ' CD2' ' A' ' 14' ' ' TRP . 71.6 mt -94.34 27.1 3.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 110.14 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.7 -18.11 61.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 110.414 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.7 -3.84 29.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.086 -1.008 . . . . 0.0 110.726 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.48 ' CD2' HD22 ' A' ' 11' ' ' LEU . 13.8 m0 -81.87 138.33 46.69 Favored Pre-proline 0 C--N 1.305 -1.332 0 O-C-N 120.95 -1.094 . . . . 11.57 109.635 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.23 159.59 51.5 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.482 1.254 . . . . 13.83 111.228 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -40.97 96.93 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.856 0.836 . . . . 48.43 110.382 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -52.71 -21.01 3.56 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.691 -0.631 . . . . 46.64 111.223 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.6 t -104.0 -44.77 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.974 -1.079 . . . . 16.14 111.227 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.0 mt -63.12 -24.64 67.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.134 -0.979 . . . . 12.61 111.11 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -25.75 60.48 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.248 -0.907 . . . . 23.17 109.56 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.484 HD21 ' CG ' ' B' ' 45' ' ' PHE . 42.9 tp -85.54 -42.47 14.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.599 -0.688 . . . . 19.0 109.849 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.419 HG12 ' CG1' ' A' ' 37' ' ' ILE . 25.3 t -55.3 -37.94 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 18.87 110.205 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -67.5 -50.49 58.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 23.61 110.439 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -19.48 65.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.218 -0.926 . . . . 30.11 110.338 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.84 -32.58 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 16.22 110.061 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 33' ' ' VAL . . . -71.74 -39.13 70.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.199 -0.938 . . . . 26.6 109.306 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 -19.37 62.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.529 -0.732 . . . . 45.21 109.77 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.84 -57.12 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 37.85 110.153 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -56.29 -53.69 54.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 35.36 110.227 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.75 52.43 0.08 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.669 -1.372 . . . . 35.1 109.669 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -169.33 -159.19 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -1.21 . . . . 32.72 110.223 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.8 p -98.4 -176.43 3.39 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.462 -0.774 . . . . 19.61 109.778 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.417 ' CG1' HG11 ' A' ' 22' ' ' VAL . 86.4 t -81.5 -9.94 12.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.155 -0.966 . . . . 17.56 110.708 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.72 -29.87 59.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.007 -1.058 . . . . 21.3 109.318 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -90.42 -28.63 18.51 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.372 -0.83 . . . . 16.38 110.058 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -65.05 -51.15 63.12 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.134 -0.979 . . . . 12.61 109.66 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.464 HD11 ' CZ3' ' A' ' 14' ' ' TRP . 2.7 mt -67.08 -20.6 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.398 -0.814 . . . . 10.95 109.729 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -69.61 -39.15 77.41 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.112 -0.992 . . . . 18.87 110.27 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -71.82 -43.5 65.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 36.88 110.223 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.0 mtt-85 -63.3 -31.98 73.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 22.85 109.519 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 71.3 t -83.33 -22.8 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.626 -0.671 . . . . 13.02 110.284 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.25 -34.89 48.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.408 -0.807 . . . . 18.84 110.587 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -72.48 -32.4 66.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 29.96 110.268 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -54.79 40.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 18.65 110.071 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.508 ' CG ' HD21 ' B' ' 21' ' ' LEU . 27.0 m-85 -62.02 -19.46 62.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 16.26 110.572 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -81.79 -26.5 34.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 36.71 110.162 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -67.28 -37.15 82.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.375 -0.828 . . . . 41.6 110.215 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.15 -28.1 29.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.398 -0.814 . . . . 24.83 110.262 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.28 28.27 11.95 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.332 -1.507 . . . . 18.81 109.332 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.53 -43.14 50.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -1.108 . . . . 23.01 110.405 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.435 ' CG2' HD22 ' B' ' 21' ' ' LEU . 27.4 pt -102.59 -179.75 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.732 -0.787 . . . . 27.08 110.526 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.83 38.34 0.62 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.204 -1.559 . . . . 32.03 109.204 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 120.799 -1.412 . . . . 0.0 109.993 -179.952 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.422 0.629 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -143.91 -166.09 2.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.53 94.74 1.34 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 7.6 ttt -112.05 30.13 7.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -1.207 . . . . 0.0 110.012 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.7 m -142.73 162.79 34.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.902 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.31 -162.07 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.104 -0.998 . . . . 0.0 110.028 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 2.1 mtp 56.13 104.38 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 0.0 110.441 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.502 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 45.6 Cg_endo -71.19 170.71 17.55 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.555 1.292 . . . . 0.0 110.782 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -87.27 -17.51 32.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.408 -0.808 . . . . 0.0 110.398 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 76.9 t80 -72.69 -26.0 61.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.867 . . . . 0.0 110.477 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.475 HD22 ' CD2' ' B' ' 14' ' ' TRP . 71.8 mt -94.57 27.22 3.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.181 -0.949 . . . . 0.0 110.174 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.82 -18.12 60.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 110.489 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.6 -3.7 29.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.086 -1.009 . . . . 0.0 110.786 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.496 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.9 m0 -82.13 138.6 45.71 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.103 -0.998 . . . . 0.0 109.67 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.36 159.54 51.38 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.175 1.092 . . . . 0.0 110.95 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.74 96.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.636 0.731 . . . . 0.0 110.301 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -52.65 -21.09 3.58 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.701 -0.624 . . . . 0.0 111.105 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -104.05 -44.61 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.441 -1.412 . . . . 0.0 111.14 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 19.9 mt -63.26 -24.76 68.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.132 -0.98 . . . . 0.0 111.081 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -25.37 60.07 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.251 -0.906 . . . . 0.0 109.683 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.508 HD21 ' CG ' ' A' ' 45' ' ' PHE . 44.8 tp -85.7 -42.29 14.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.577 -0.702 . . . . 0.0 109.968 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.424 HG12 ' CG1' ' B' ' 37' ' ' ILE . 26.2 t -55.42 -37.97 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.107 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -67.3 -50.81 58.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.305 -0.872 . . . . 0.0 110.455 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -19.55 64.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.229 -0.919 . . . . 0.0 110.5 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 87.6 t -86.7 -32.62 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 110.1 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' B' ' 33' ' ' VAL . . . -71.52 -39.09 70.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.25 -19.34 62.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.529 -0.732 . . . . 0.0 109.764 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.83 -57.12 3.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 110.227 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -56.37 -53.82 52.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 110.284 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.09 52.44 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -169.36 -159.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.267 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 54.5 p -98.31 -176.32 3.37 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.314 -0.866 . . . . 0.0 109.867 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.418 ' CG1' HG11 ' B' ' 22' ' ' VAL . 88.0 t -81.62 -9.97 12.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.17 -0.956 . . . . 0.0 110.819 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.61 -29.88 59.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.982 . . . . 0.0 109.367 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -90.39 -28.68 18.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.952 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -65.14 -50.96 63.99 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.194 -0.941 . . . . 0.0 109.732 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.473 HD11 ' CZ3' ' B' ' 14' ' ' TRP . 2.5 mt -67.13 -20.82 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -69.66 -39.3 77.13 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.214 -0.929 . . . . 0.0 110.252 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -71.51 -43.48 66.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.83 . . . . 0.0 110.198 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -63.5 -32.05 73.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.95 . . . . 0.0 109.502 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.454 HG11 ' CZ3' ' A' ' 14' ' ' TRP . 76.9 t -82.92 -22.87 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 110.34 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.36 -34.98 47.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.819 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.45 -32.35 66.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.136 -0.977 . . . . 0.0 110.208 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.22 -54.78 41.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 110.105 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.484 ' CG ' HD21 ' A' ' 21' ' ' LEU . 27.2 m-85 -61.85 -19.42 62.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 110.54 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -81.98 -26.52 33.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.219 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -67.3 -37.39 83.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.927 . . . . 0.0 110.232 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -82.89 -28.09 30.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.311 -0.868 . . . . 0.0 110.273 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.54 27.63 12.73 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -42.85 53.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.326 -1.102 . . . . 0.0 110.411 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.443 ' CG2' HD22 ' A' ' 21' ' ' LEU . 27.4 pt -102.89 -179.78 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.142 -0.974 . . . . 0.0 110.424 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.98 37.97 0.63 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.232 -1.158 . . . . 0.0 110.299 179.984 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.287 0.565 . . . . 50.0 110.283 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -72.97 147.12 45.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 50.0 110.178 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -151.59 -69.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.482 -1.447 . . . . 50.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mtt -79.38 137.28 37.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -1.128 . . . . 50.0 110.115 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 m -139.83 -168.81 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.955 . . . . 50.0 110.407 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.57 47.73 1.03 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 50.0 110.178 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mtt -95.39 135.23 23.4 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 43.64 110.114 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.4 156.8 50.12 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.516 1.272 . . . . 29.79 110.495 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -76.53 -11.64 59.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.614 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' B' ' 11' ' ' LEU . 89.1 t80 -79.31 -34.35 42.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.014 -1.054 . . . . 12.57 110.291 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.477 HD11 ' CE1' ' B' ' 10' ' ' PHE . 66.1 mt -88.27 14.89 8.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.096 -1.003 . . . . 0.0 110.586 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.58 -27.44 69.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -82.34 -23.78 34.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.92 . . . . 0.0 110.519 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.488 ' CZ3' HG13 ' B' ' 41' ' ' VAL . 13.0 m0 -63.43 141.72 97.86 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.312 -0.867 . . . . 11.57 109.21 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.39 173.63 9.41 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.458 1.241 . . . . 13.83 111.082 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -77.82 -22.03 50.63 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.499 -0.751 . . . . 48.43 109.769 -179.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.7 -46.22 39.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 46.64 110.428 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -68.72 -39.58 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 16.14 110.157 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.26 -31.52 72.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 12.61 110.654 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 3.4 t0 -70.75 -22.33 62.42 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 23.17 110.074 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.492 ' CD2' ' CG ' ' B' ' 45' ' ' PHE . 51.0 tp -88.83 -37.62 15.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.372 -0.83 . . . . 19.0 109.951 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.424 ' CG1' HD13 ' A' ' 37' ' ' ILE . 15.6 t -65.84 -49.51 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 18.87 109.959 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' CD ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -59.91 -35.76 75.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 23.61 110.483 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 23' ' ' ARG . 2.1 tmtt? -73.43 -24.55 60.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.113 -0.992 . . . . 30.11 109.943 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 21' ' ' LEU . 99.4 t -86.63 -20.89 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.497 -0.752 . . . . 16.22 110.311 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.22 -30.21 30.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.217 -0.927 . . . . 26.6 109.539 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.43 -19.51 49.78 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.471 -0.768 . . . . 45.21 110.307 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 29' ' ' ASN . 22.8 pt-20 -90.82 -30.82 16.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.191 -0.943 . . . . 37.85 110.279 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.41 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -82.97 7.68 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 35.36 110.558 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.45 23.98 70.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.517 -1.433 . . . . 35.1 109.517 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -129.19 -158.02 0.86 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -1.194 . . . . 32.72 110.362 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m -115.06 -179.65 3.69 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.511 -0.743 . . . . 19.61 109.286 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 99.1 t -77.97 -14.86 14.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.129 -0.982 . . . . 17.56 110.448 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -77.03 -41.69 41.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.102 -0.998 . . . . 21.3 109.004 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.8 t -71.18 -35.9 71.76 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.386 -0.821 . . . . 16.38 109.56 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.68 -50.54 66.6 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.233 -0.917 . . . . 12.61 109.405 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 HD13 ' CG1' ' A' ' 22' ' ' VAL . 35.6 mm -63.94 -26.82 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 10.95 109.53 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -71.89 -37.19 70.19 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.374 -0.829 . . . . 18.87 110.753 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.74 -36.34 59.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -0.932 . . . . 36.88 110.253 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -71.99 -24.16 61.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 22.85 109.64 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.508 HG13 ' CZ3' ' B' ' 14' ' ' TRP . 7.0 t -87.09 -28.68 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.8 . . . . 13.02 109.217 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -43.45 60.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.603 -0.685 . . . . 18.84 110.531 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -28.93 68.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 29.96 110.137 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -49.81 70.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.89 . . . . 18.65 110.07 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.52 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 31.1 m-85 -66.01 -22.87 66.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 16.26 110.371 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -73.79 -36.54 65.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.19 -0.944 . . . . 36.71 110.525 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -57.4 -54.77 43.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 41.6 110.346 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -61.58 -40.88 96.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.997 . . . . 24.83 110.269 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.92 30.48 3.44 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.543 -1.423 . . . . 18.81 109.543 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.9 mmt-85 -81.22 -42.01 21.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.015 -1.285 . . . . 23.01 109.952 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 pt -114.57 -163.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.783 -0.767 . . . . 27.08 109.896 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.94 58.29 0.25 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.559 -1.416 . . . . 32.03 109.559 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.398 -1.06 . . . . 0.0 110.208 179.984 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.29 0.567 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -72.56 147.06 46.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.853 -1.154 . . . . 0.0 110.204 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -151.29 -69.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 2.5 mtt -78.9 137.45 37.66 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.608 -0.936 . . . . 0.0 110.369 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 48.6 m -139.72 -168.78 2.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 110.217 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.58 47.97 1.03 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 0.0 110.163 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mtt -95.47 135.45 23.17 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.41 156.96 50.0 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.522 1.275 . . . . 0.0 110.384 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -76.8 -11.93 59.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.588 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . 0.477 ' CE1' HD11 ' A' ' 11' ' ' LEU . 89.5 t80 -79.01 -34.09 44.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.078 -1.014 . . . . 0.0 110.322 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.477 HD21 ' CD2' ' B' ' 14' ' ' TRP . 64.6 mt -88.84 15.62 8.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 110.601 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.49 -26.85 68.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -82.77 -23.98 33.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 110.382 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' TRP . . . . . 0.508 ' CZ3' HG13 ' A' ' 41' ' ' VAL . 13.0 m0 -63.17 142.07 97.75 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.278 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.9 173.97 9.42 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.431 1.227 . . . . 0.0 111.259 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' B' ' 20' ' ' ASP . 0.0 OUTLIER -78.36 -21.85 48.83 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.333 -0.854 . . . . 0.0 109.722 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.39 -46.11 42.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 110.696 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -68.8 -39.57 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.145 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.36 -31.33 72.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 110.574 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' B' ' 16' ' ' ARG . 3.5 t0 -70.83 -23.08 62.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.072 -1.018 . . . . 0.0 109.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.52 ' CD2' ' CG ' ' A' ' 45' ' ' PHE . 50.0 tp -87.83 -37.68 16.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -0.932 . . . . 0.0 109.936 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.407 ' CG1' HD13 ' B' ' 37' ' ' ILE . 15.7 t -66.05 -49.57 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.391 -0.818 . . . . 0.0 109.967 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.452 ' CD ' ' N ' ' B' ' 24' ' ' LYS . 0.0 OUTLIER -59.76 -35.52 74.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 110.52 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' B' ' 23' ' ' ARG . 2.1 tmtt? -73.94 -24.24 59.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.065 -1.022 . . . . 0.0 109.981 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' B' ' 21' ' ' LEU . 97.3 t -86.71 -20.75 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.256 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.59 -30.41 29.57 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.165 -0.959 . . . . 0.0 109.57 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.16 -19.63 50.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.481 -0.762 . . . . 0.0 110.254 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' B' ' 29' ' ' ASN . 22.5 pt-20 -90.72 -30.76 16.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.092 -1.005 . . . . 0.0 110.195 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.425 ' N ' ' HG3' ' B' ' 28' ' ' GLU . 0.5 OUTLIER -83.11 7.71 15.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.631 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.4 24.11 70.58 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -129.33 -157.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 110.235 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m -115.24 -179.38 3.62 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.451 -0.781 . . . . 0.0 109.258 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 98.1 t -78.15 -14.6 13.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.09 -1.006 . . . . 0.0 110.645 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -77.2 -41.67 40.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.123 -0.985 . . . . 0.0 109.06 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 8.7 t -71.29 -36.05 71.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.415 -0.803 . . . . 0.0 109.375 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.58 -50.52 66.89 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.407 HD13 ' CG1' ' B' ' 22' ' ' VAL . 34.0 mm -63.81 -27.2 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.404 -0.81 . . . . 0.0 109.526 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -71.54 -37.28 71.15 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 0.0 110.807 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.81 -36.32 59.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -71.92 -23.94 61.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.695 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.488 HG13 ' CZ3' ' A' ' 14' ' ' TRP . 6.5 t -87.54 -28.4 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -43.73 59.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.609 -0.682 . . . . 0.0 110.447 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -29.16 68.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -50.04 70.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.492 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 31.2 m-85 -65.88 -22.86 66.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.49 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -73.69 -36.78 65.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.292 -0.88 . . . . 0.0 110.517 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -57.17 -54.54 45.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.434 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -61.78 -40.92 96.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.346 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.22 30.01 3.53 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 mmt-85 -81.38 -41.55 21.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -1.156 . . . . 0.0 110.092 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 5.6 pt -114.7 -162.89 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 109.916 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.46 58.38 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.271 -1.135 . . . . 0.0 110.251 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.997 -0.371 . . . . 43.64 109.997 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.0 Cg_endo -72.61 143.77 38.61 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.736 1.387 . . . . 29.79 110.478 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -61.05 -17.61 53.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.833 . . . . 0.0 110.15 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.5 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 69.6 t80 -67.9 -37.48 81.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 12.57 110.36 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.606 ' HB3' HD21 ' A' ' 19' ' ' LEU . 80.8 mt -91.6 21.52 4.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.352 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -74.23 -19.26 60.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.08 -17.93 21.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.134 -0.979 . . . . 0.0 110.653 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.432 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.8 m0 -64.9 144.03 98.93 Favored Pre-proline 0 C--N 1.304 -1.387 0 O-C-N 121.145 -0.972 . . . . 11.57 109.171 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 40.1 Cg_endo -69.23 169.45 18.22 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.384 1.202 . . . . 13.83 110.56 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -25.81 43.94 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.572 -0.705 . . . . 48.43 109.592 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -69.14 -19.26 64.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.173 -0.955 . . . . 46.64 110.078 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.817 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.9 t -102.76 -36.27 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 16.14 109.888 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' A' ' 11' ' ' LEU . 17.5 mt -66.51 -33.91 76.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.416 -0.802 . . . . 12.61 110.509 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.31 -30.28 70.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 23.17 109.851 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.803 ' O ' HG23 ' A' ' 25' ' ' VAL . 28.0 tp -80.76 -38.0 29.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.521 -0.737 . . . . 19.0 109.852 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 18' ' ' VAL . 48.3 t -59.66 -51.72 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 18.87 110.211 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.63 -41.77 82.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.421 -0.799 . . . . 23.61 110.781 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -73.41 -18.2 61.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.118 -0.989 . . . . 30.11 110.841 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 21' ' ' LEU . 59.2 t -84.15 -35.73 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.081 -1.012 . . . . 16.22 110.481 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.594 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -66.5 -36.23 82.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 26.6 109.712 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -72.59 -23.31 60.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.811 . . . . 45.21 109.935 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -78.1 -42.21 32.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 37.85 109.863 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -67.86 -44.48 77.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 35.36 110.105 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.35 37.08 0.95 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.076 -1.21 . . . . 35.1 110.076 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.74 -165.43 1.65 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.042 -1.27 . . . . 32.72 110.601 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -84.0 174.41 10.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 19.61 110.372 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.594 HG22 ' CB ' ' A' ' 26' ' ' ALA . 88.0 t -84.44 -26.72 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.39 -0.818 . . . . 17.56 110.235 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -59.18 -27.1 65.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 21.3 108.977 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.2 t -89.81 -29.71 18.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.519 -0.738 . . . . 16.38 109.536 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.419 ' OE1' ' HB2' ' A' ' 26' ' ' ALA . 30.9 tt0 -61.49 -57.47 12.02 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.116 -0.99 . . . . 12.61 109.519 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.535 HG23 HG21 ' B' ' 41' ' ' VAL . 41.1 mm -58.12 -27.1 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.359 -0.838 . . . . 10.95 109.711 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.477 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 38.9 t80 -70.69 -34.37 71.9 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.135 -0.978 . . . . 18.87 110.15 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -75.06 -53.73 8.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 36.88 110.169 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -57.64 -23.06 49.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.114 -0.991 . . . . 22.85 109.802 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.611 HG21 HG23 ' B' ' 37' ' ' ILE . 39.8 t -89.42 -27.5 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.396 -0.815 . . . . 13.02 109.51 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -25.86 60.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.528 -0.733 . . . . 18.84 110.569 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.78 -21.62 29.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.088 -1.008 . . . . 29.96 110.555 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -66.18 -47.47 73.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 18.65 110.165 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.73 ' CE1' HG21 ' B' ' 25' ' ' VAL . 28.5 m-85 -61.01 -37.44 82.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 16.26 110.373 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 mttt . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 36.71 110.314 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.5 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 44.6 Cg_endo -72.72 143.77 38.15 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.721 1.38 . . . . 0.0 110.523 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -60.9 -17.58 51.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.242 -0.911 . . . . 0.0 110.16 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.529 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 68.4 t80 -67.83 -37.63 82.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 110.375 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.621 ' HB3' HD21 ' B' ' 19' ' ' LEU . 80.6 mt -91.57 21.79 4.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.363 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -74.41 -19.29 60.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.421 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.99 -18.11 21.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.16 -0.962 . . . . 0.0 110.613 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.444 ' CZ2' ' HA ' ' A' ' 38' ' ' TYR . 14.0 m0 -64.83 144.2 98.89 Favored Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.023 -1.048 . . . . 0.0 109.229 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.477 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.4 Cg_endo -69.28 169.64 17.84 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.519 1.273 . . . . 0.0 110.651 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.17 -25.46 42.82 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.384 -0.822 . . . . 0.0 109.474 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -69.35 -19.34 63.85 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.808 ' O ' HG23 ' B' ' 22' ' ' VAL . 58.2 t -102.6 -36.65 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.16 -0.963 . . . . 0.0 109.756 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' B' ' 11' ' ' LEU . 17.9 mt -65.76 -33.99 77.15 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.16 -0.963 . . . . 0.0 110.662 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.4 -30.6 71.01 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.826 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.793 ' O ' HG23 ' B' ' 25' ' ' VAL . 26.9 tp -80.44 -38.05 30.84 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.862 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.808 HG23 ' O ' ' B' ' 18' ' ' VAL . 48.2 t -59.77 -51.52 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 110.258 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.62 -41.85 82.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.783 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -73.42 -18.2 61.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.18 -0.95 . . . . 0.0 110.851 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.793 HG23 ' O ' ' B' ' 21' ' ' LEU . 58.3 t -84.15 -35.88 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.164 -0.96 . . . . 0.0 110.473 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.587 ' CB ' HG22 ' B' ' 33' ' ' VAL . . . -66.41 -36.14 82.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.043 -1.036 . . . . 0.0 109.828 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -72.58 -23.21 60.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.928 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -78.24 -42.17 31.99 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.342 -0.849 . . . . 0.0 109.923 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.04 -44.42 76.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.83 . . . . 0.0 110.025 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.34 36.99 0.96 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.64 -165.47 1.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.019 -1.283 . . . . 0.0 110.571 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m -84.04 174.4 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.356 -0.84 . . . . 0.0 110.364 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.587 HG22 ' CB ' ' B' ' 26' ' ' ALA . 85.8 t -84.52 -26.46 7.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.411 -0.806 . . . . 0.0 110.278 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.404 ' ND2' ' CD1' ' A' ' 10' ' ' PHE . 3.7 t-20 -59.4 -27.01 65.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.179 -0.95 . . . . 0.0 108.942 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 6.2 t -89.85 -29.9 18.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.72 . . . . 0.0 109.465 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.416 ' OE1' ' HB2' ' B' ' 26' ' ' ALA . 31.0 tt0 -61.21 -57.61 11.71 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.132 -0.98 . . . . 0.0 109.532 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.611 HG23 HG21 ' A' ' 41' ' ' VAL . 40.8 mm -58.19 -27.45 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.38 -0.825 . . . . 0.0 109.65 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.407 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 36.5 t80 -70.19 -34.52 73.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.196 -0.94 . . . . 0.0 110.133 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -75.02 -53.72 8.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 110.183 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' B' ' 36' ' ' GLU . 7.5 mtt85 -57.6 -23.13 49.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.843 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.535 HG21 HG23 ' A' ' 37' ' ' ILE . 39.6 t -89.15 -27.72 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.436 -0.79 . . . . 0.0 109.523 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -26.01 60.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.745 . . . . 0.0 110.61 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.86 -21.6 29.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.212 -0.93 . . . . 0.0 110.508 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -66.1 -47.47 74.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 110.163 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.616 ' HE1' HG21 ' A' ' 25' ' ' VAL . 27.8 m-85 -61.17 -37.46 83.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttt . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.361 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.4 mtp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.206 -0.294 . . . . 43.64 110.206 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 48.9 Cg_endo -75.79 160.22 37.76 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.627 1.33 . . . . 29.79 110.431 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -18.28 60.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.115 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.444 ' CE1' ' OD1' ' B' ' 34' ' ' ASN . 56.3 t80 -71.3 -35.8 71.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 12.57 110.348 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.594 ' HB3' HD21 ' A' ' 19' ' ' LEU . 93.8 mt -89.64 16.77 7.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.44 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.55 -31.22 66.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 110.024 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -12.47 59.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.35 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.482 ' CE3' HD22 ' A' ' 11' ' ' LEU . 16.5 m0 -77.48 142.2 66.56 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.173 -0.955 . . . . 11.57 109.451 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.38 173.63 10.36 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.586 1.309 . . . . 13.83 110.551 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -22.66 42.18 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.396 -0.815 . . . . 48.43 109.605 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HG3' HG23 ' A' ' 18' ' ' VAL . 10.2 pt-20 -71.5 -36.37 71.07 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.149 -0.969 . . . . 46.64 110.35 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 22' ' ' VAL . 93.8 t -81.27 -43.06 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 16.14 110.254 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 11' ' ' LEU . 73.3 mt -65.1 -32.03 73.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 12.61 110.28 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.45 -24.39 66.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 23.17 109.68 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.876 ' O ' HG23 ' A' ' 25' ' ' VAL . 26.9 tp -87.09 -40.06 15.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.791 . . . . 19.0 109.895 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.963 HG12 HG13 ' A' ' 33' ' ' VAL . 38.5 t -56.48 -40.62 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 18.87 109.488 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -59.81 4.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.675 -0.641 . . . . 23.61 110.297 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.26 -28.67 59.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.229 -0.92 . . . . 30.11 110.937 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 21' ' ' LEU . 50.7 t -71.82 -39.31 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.991 -1.068 . . . . 16.22 110.423 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.72 -40.29 88.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.067 -1.021 . . . . 26.6 109.539 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -71.69 -20.99 61.85 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.449 -0.782 . . . . 45.21 109.941 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -54.41 9.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 37.85 109.809 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -71.38 -25.02 62.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.873 . . . . 35.36 110.26 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.48 69.53 1.04 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.71 -1.356 . . . . 35.1 109.71 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.73 -162.91 0.13 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.254 -1.145 . . . . 32.72 110.287 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.8 t -93.2 171.97 8.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 19.61 110.091 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.963 HG13 HG12 ' A' ' 22' ' ' VAL . 69.2 t -83.89 -23.33 7.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.23 -0.919 . . . . 17.56 110.073 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' OD1' ' CE1' ' B' ' 10' ' ' PHE . 0.8 OUTLIER -63.78 -28.14 69.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 21.3 109.255 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -90.15 -32.24 16.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.446 -0.784 . . . . 16.38 109.825 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' CG ' HG12 ' A' ' 25' ' ' VAL . 11.0 tp10 -61.67 -37.95 85.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.144 -0.973 . . . . 12.61 109.319 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 41' ' ' VAL . 21.6 mm -76.95 -25.3 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.529 -0.732 . . . . 10.95 109.156 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 33.4 t80 -74.72 -27.38 60.35 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.271 -0.893 . . . . 18.87 110.198 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -81.71 -49.34 10.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 36.88 109.512 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.417 ' CZ ' HG11 ' A' ' 25' ' ' VAL . 55.9 mtt-85 -59.0 -28.79 66.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 22.85 109.189 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.5 t -82.82 -26.95 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.581 -0.699 . . . . 13.02 109.329 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp -76.68 -23.82 53.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.467 -0.77 . . . . 18.84 110.27 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.14 -33.91 56.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.264 -0.897 . . . . 29.96 110.294 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.437 ' CB ' ' HD3' ' B' ' 40' ' ' ARG . 81.8 p -58.47 -41.22 84.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 18.65 110.278 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.643 ' CD1' HD21 ' B' ' 21' ' ' LEU . 25.5 m-85 -74.43 -35.5 63.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 16.26 110.371 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 36.71 110.476 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtp . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.444 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 48.9 Cg_endo -75.66 159.6 38.79 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.632 1.332 . . . . 0.0 110.422 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -18.32 61.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.156 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.5 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 58.3 t80 -71.27 -36.0 71.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.971 . . . . 0.0 110.453 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' B' ' 19' ' ' LEU . 94.4 mt -89.37 16.78 6.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.928 . . . . 0.0 110.571 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.48 -31.26 66.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.128 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -12.36 59.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 110.337 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.469 ' CE3' HD22 ' B' ' 11' ' ' LEU . 16.0 m0 -77.52 141.94 66.04 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.246 -0.909 . . . . 0.0 109.489 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.47 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.5 Cg_endo -69.38 173.89 9.98 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.625 1.329 . . . . 0.0 110.543 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -23.26 41.82 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' B' ' 18' ' ' VAL . 10.2 pt-20 -71.34 -36.39 71.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.851 . . . . 0.0 110.368 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.707 ' O ' HG23 ' B' ' 22' ' ' VAL . 92.9 t -81.23 -43.48 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 O-C-N 121.072 -1.017 . . . . 0.0 110.014 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' B' ' 11' ' ' LEU . 72.8 mt -64.35 -32.54 74.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.05 -24.73 66.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.747 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.875 ' O ' HG23 ' B' ' 25' ' ' VAL . 27.9 tp -86.71 -40.1 15.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.404 -0.81 . . . . 0.0 109.904 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.944 HG12 HG13 ' B' ' 33' ' ' VAL . 35.1 t -56.4 -40.45 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.597 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.22 -59.63 5.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.645 -0.66 . . . . 0.0 110.267 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -28.27 59.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.267 -0.895 . . . . 0.0 110.963 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.875 HG23 ' O ' ' B' ' 21' ' ' LEU . 53.2 t -72.17 -39.48 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.013 . . . . 0.0 110.361 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.11 88.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.14 -0.975 . . . . 0.0 109.509 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -71.79 -20.85 61.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.341 -0.849 . . . . 0.0 110.044 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -54.23 9.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.863 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.34 -25.32 62.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.42 -0.8 . . . . 0.0 110.089 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.43 69.99 1.06 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.01 -163.27 0.13 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.321 -1.106 . . . . 0.0 110.191 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -92.9 172.93 8.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 110.082 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.944 HG13 HG12 ' B' ' 22' ' ' VAL . 68.4 t -85.08 -22.69 7.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.278 -0.889 . . . . 0.0 110.001 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.444 ' OD1' ' CE1' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -64.26 -27.85 69.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.157 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -90.2 -33.56 16.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.487 -0.758 . . . . 0.0 109.707 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.419 ' CG ' HG12 ' B' ' 25' ' ' VAL . 10.8 tp10 -60.31 -38.18 82.87 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.157 -0.964 . . . . 0.0 109.403 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.462 ' O ' HG23 ' B' ' 41' ' ' VAL . 21.2 mm -77.11 -24.85 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.51 -0.744 . . . . 0.0 109.228 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.417 ' HB2' ' NE1' ' A' ' 14' ' ' TRP . 34.0 t80 -75.32 -26.58 58.77 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.261 -0.899 . . . . 0.0 110.109 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -82.28 -49.53 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.58 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.437 ' HD3' ' CB ' ' A' ' 44' ' ' SER . 55.7 mtt-85 -58.81 -28.98 66.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.442 -0.786 . . . . 0.0 109.184 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 37' ' ' ILE . 45.1 t -82.54 -27.46 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.546 0.688 . . . . 0.0 109.414 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp -76.08 -23.41 55.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.468 -0.77 . . . . 0.0 110.269 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.47 -34.31 54.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.158 -0.964 . . . . 0.0 110.24 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 85.4 p -57.86 -41.5 82.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 110.156 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.68 ' CD1' HD21 ' A' ' 21' ' ' LEU . 25.3 m-85 -74.5 -35.78 63.22 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.37 -179.855 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 110.244 -0.28 . . . . 43.64 110.244 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HG3' ' CE1' ' B' ' 10' ' ' PHE . 43.0 Cg_endo -71.47 147.52 52.32 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.626 1.33 . . . . 29.79 110.545 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.49 -19.38 61.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 110.631 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.519 ' CE1' ' HG3' ' B' ' 8' ' ' PRO . 87.3 t80 -69.25 -32.09 71.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.952 . . . . 12.57 110.11 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HB3' HD21 ' A' ' 19' ' ' LEU . 96.8 mt -91.99 19.07 7.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.371 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -71.65 -25.52 62.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 110.205 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -16.12 46.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.477 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.739 ' HH2' HG21 ' B' ' 41' ' ' VAL . 15.1 m0 -72.69 145.59 87.28 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.306 -0.871 . . . . 11.57 109.815 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HG2' HG23 ' A' ' 18' ' ' VAL . 43.1 Cg_endo -73.4 166.33 30.18 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.559 1.294 . . . . 13.83 111.24 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.87 85.68 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.995 0.902 . . . . 48.43 110.33 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.46 -34.76 74.49 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.918 -0.583 . . . . 46.64 111.575 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 22' ' ' VAL . 91.2 t -82.84 -44.91 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.924 -1.11 . . . . 16.14 110.817 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 11' ' ' LEU . 61.2 mt -64.54 -27.31 68.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.143 -0.973 . . . . 12.61 110.722 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.44 -23.15 63.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 23.17 109.76 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.75 HD21 ' CD1' ' B' ' 45' ' ' PHE . 4.8 tp -89.39 -42.22 11.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.45 -0.781 . . . . 19.0 109.985 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.866 HG12 HG13 ' A' ' 33' ' ' VAL . 48.0 t -51.8 -46.22 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 18.87 110.699 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -54.59 -58.5 7.27 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.361 -0.837 . . . . 23.61 110.85 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -54.12 -22.65 11.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.908 . . . . 30.11 111.054 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.629 HG12 ' CD ' ' A' ' 36' ' ' GLU . 58.9 t -82.54 -38.61 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 16.22 110.961 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.67 74.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.036 . . . . 26.6 110.112 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.39 -9.86 58.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -0.887 . . . . 45.21 110.528 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -88.88 -53.59 4.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.083 -1.011 . . . . 37.85 110.095 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.34 -32.45 73.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 35.36 110.117 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.73 30.81 4.15 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.414 -1.475 . . . . 35.1 109.414 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -133.44 -155.18 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -1.137 . . . . 32.72 110.164 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -107.56 175.34 5.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.539 -0.725 . . . . 19.61 109.55 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.866 HG13 HG12 ' A' ' 22' ' ' VAL . 85.5 t -75.97 -23.58 16.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.105 -0.997 . . . . 17.56 110.138 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' B' ' 10' ' ' PHE . 9.5 t-20 -77.15 -28.11 54.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 21.3 108.843 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.07 -27.31 24.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.557 -0.714 . . . . 16.38 109.203 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.629 ' CD ' HG12 ' A' ' 25' ' ' VAL . 8.5 tp10 -71.98 -42.96 65.87 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.277 -0.89 . . . . 12.61 108.916 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' O ' HG23 ' A' ' 41' ' ' VAL . 24.5 mm -66.59 -31.07 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.595 -0.891 . . . . 10.95 108.595 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.425 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 32.6 t80 -63.56 -36.78 84.92 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.62 -0.675 . . . . 18.87 109.968 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -73.96 -43.99 56.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 36.88 109.716 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -61.09 -25.59 67.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 22.85 109.289 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.742 HG21 ' HH2' ' B' ' 14' ' ' TRP . 62.4 t -88.18 -25.14 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.547 0.689 . . . . 13.02 109.635 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtp -77.56 -25.33 49.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.529 -0.732 . . . . 18.84 110.299 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -83.24 -27.48 29.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.194 -0.941 . . . . 29.96 110.353 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.8 p -67.1 -48.91 66.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.255 -0.903 . . . . 18.65 110.357 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.742 ' CD1' HD21 ' B' ' 21' ' ' LEU . 22.4 m-85 -62.89 -22.5 66.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.958 . . . . 16.26 110.417 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 36.71 110.455 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.403 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.519 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 43.4 Cg_endo -71.38 147.65 53.15 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.717 1.377 . . . . 0.0 110.483 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -19.5 62.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.36 -0.837 . . . . 0.0 110.577 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.522 ' CE1' ' HG3' ' A' ' 8' ' ' PRO . 87.2 t80 -69.01 -32.13 71.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.039 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.518 ' HB3' HD21 ' B' ' 19' ' ' LEU . 96.5 mt -91.94 19.12 6.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.448 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.66 -25.36 62.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 110.303 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.71 -16.16 45.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 110.412 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.742 ' HH2' HG21 ' A' ' 41' ' ' VAL . 15.1 m0 -72.88 145.65 86.86 Favored Pre-proline 0 C--N 1.304 -1.389 0 O-C-N 121.242 -0.911 . . . . 0.0 109.831 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' B' ' 18' ' ' VAL . 42.5 Cg_endo -73.45 166.66 29.3 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.258 1.136 . . . . 0.0 111.21 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -37.94 85.11 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 110.321 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -60.3 -34.72 74.17 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.907 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.609 ' O ' HG23 ' B' ' 22' ' ' VAL . 91.1 t -82.72 -45.22 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.86 -1.15 . . . . 0.0 110.591 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' B' ' 11' ' ' LEU . 61.1 mt -64.39 -27.28 68.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.031 -1.043 . . . . 0.0 110.763 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.27 -23.4 63.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 109.738 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.742 HD21 ' CD1' ' A' ' 45' ' ' PHE . 4.7 tp -89.34 -42.11 11.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.502 -0.748 . . . . 0.0 109.992 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.876 HG12 HG13 ' B' ' 33' ' ' VAL . 47.9 t -51.71 -46.1 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 110.733 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -54.83 -58.44 7.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.333 -0.854 . . . . 0.0 110.849 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -54.14 -22.27 10.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.065 -1.022 . . . . 0.0 111.037 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.62 HG23 ' O ' ' B' ' 21' ' ' LEU . 59.7 t -82.93 -38.77 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.001 . . . . 0.0 110.873 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.87 -32.6 74.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.061 -1.024 . . . . 0.0 110.11 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.46 -10.07 58.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 110.383 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -88.64 -53.57 4.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.133 -0.98 . . . . 0.0 110.113 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.34 -32.47 73.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.142 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.75 30.82 4.14 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -133.53 -155.69 0.69 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -1.103 . . . . 0.0 110.208 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -107.03 175.41 5.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.409 -0.807 . . . . 0.0 109.658 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.876 HG13 HG12 ' B' ' 22' ' ' VAL . 85.9 t -76.1 -23.33 15.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.477 ' ND2' ' CE1' ' A' ' 10' ' ' PHE . 9.4 t-20 -77.35 -28.34 52.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 108.844 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.91 -27.42 25.0 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.194 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.619 ' CD ' HG12 ' B' ' 25' ' ' VAL . 8.5 tp10 -71.94 -42.6 66.44 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.372 -0.83 . . . . 0.0 108.997 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.527 ' O ' HG23 ' B' ' 41' ' ' VAL . 24.7 mm -66.84 -30.89 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.42 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 32.6 t80 -63.8 -37.08 86.05 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.614 -0.679 . . . . 0.0 109.771 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -73.57 -44.39 57.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 109.687 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -60.64 -25.75 66.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.94 . . . . 0.0 109.243 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.739 HG21 ' HH2' ' A' ' 14' ' ' TRP . 63.5 t -88.16 -25.23 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.575 0.703 . . . . 0.0 109.688 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtp -77.47 -25.17 50.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.494 -0.754 . . . . 0.0 110.387 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -83.42 -27.46 29.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.189 -0.944 . . . . 0.0 110.437 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 77.8 p -67.16 -48.7 67.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.415 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.75 ' CD1' HD21 ' A' ' 21' ' ' LEU . 21.9 m-85 -63.08 -22.6 66.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.128 -0.982 . . . . 0.0 110.286 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.167 -0.958 . . . . 0.0 110.37 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.494 -0.558 . . . . 43.64 109.494 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.541 ' HG2' HD12 ' A' ' 11' ' ' LEU . 45.7 Cg_endo -71.68 158.16 54.03 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.378 1.199 . . . . 29.79 110.671 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -82.1 -19.4 40.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.379 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.501 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 73.1 t80 -58.95 -23.84 61.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 12.57 110.448 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.693 ' HB3' HD21 ' A' ' 19' ' ' LEU . 42.7 mt -98.52 31.65 2.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.148 -0.97 . . . . 0.0 110.478 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -30.99 67.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.224 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -81.01 -22.9 39.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 110.155 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.711 ' HH2' HG21 ' B' ' 41' ' ' VAL . 13.8 m0 -64.64 136.98 96.99 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.345 -0.847 . . . . 11.57 109.259 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HG2' HG23 ' A' ' 18' ' ' VAL . 39.0 Cg_endo -70.36 153.34 66.26 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.365 1.192 . . . . 13.83 111.054 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -41.62 73.29 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.664 0.745 . . . . 48.43 110.897 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.24 -41.05 75.09 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.548 -0.72 . . . . 46.64 111.507 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.514 HG23 ' HG2' ' A' ' 15' ' ' PRO . 85.5 t -76.42 -49.87 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.888 -1.132 . . . . 16.14 111.087 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.693 HD21 ' HB3' ' A' ' 11' ' ' LEU . 13.3 mt -53.7 -36.5 62.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 12.61 110.673 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -62.57 -38.03 88.51 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.436 -0.79 . . . . 23.17 109.864 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.854 ' O ' HG23 ' A' ' 25' ' ' VAL . 40.8 tp -69.42 -40.59 77.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.494 -0.754 . . . . 19.0 109.893 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.913 HG12 HG13 ' A' ' 33' ' ' VAL . 40.3 t -58.94 -48.26 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 18.87 110.512 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 10.9 mtm180 -53.67 -49.36 68.14 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 23.61 110.54 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -29.33 70.72 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 30.11 110.682 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 21' ' ' LEU . 48.1 t -77.03 -29.19 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 16.22 110.479 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.434 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -74.04 -46.0 46.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.169 -0.957 . . . . 26.6 109.215 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.95 -12.63 61.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.348 -0.845 . . . . 45.21 110.135 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -78.61 -58.73 3.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 37.85 110.001 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -66.06 -22.36 66.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 35.36 110.115 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.54 16.17 20.85 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.027 -1.229 . . . . 35.1 110.027 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -116.53 -162.84 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.132 -1.216 . . . . 32.72 110.387 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.434 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 67.7 m -102.81 -176.77 3.19 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.419 -0.8 . . . . 19.61 109.411 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.913 HG13 HG12 ' A' ' 22' ' ' VAL . 63.0 t -81.23 -16.65 12.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.222 -0.924 . . . . 17.56 110.281 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -77.84 -32.08 51.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.978 . . . . 21.3 108.752 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 t -79.71 -36.56 37.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.572 -0.705 . . . . 16.38 109.335 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.4 tp10 -64.78 -51.74 60.65 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 121.255 -0.903 . . . . 12.61 109.366 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 41' ' ' VAL . 37.9 mm -63.3 -32.93 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.784 . . . . 10.95 109.517 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -65.79 -33.76 76.61 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.429 -0.795 . . . . 18.87 110.226 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -47.38 42.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 36.88 109.536 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -60.87 -23.36 65.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.46 -0.775 . . . . 22.85 109.642 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.664 HG21 ' HH2' ' B' ' 14' ' ' TRP . 53.0 t -87.95 -28.24 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.518 -0.739 . . . . 13.02 109.554 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -20.36 52.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.539 -0.725 . . . . 18.84 110.272 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.92 -18.77 53.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 29.96 110.348 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.89 -46.89 16.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.073 -1.017 . . . . 18.65 110.215 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.81 ' CD1' HD21 ' B' ' 21' ' ' LEU . 37.9 m-85 -67.72 -12.01 59.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 16.26 110.734 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.03 -1.044 . . . . 36.71 110.417 -179.725 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.549 ' HG2' HD12 ' B' ' 11' ' ' LEU . 45.1 Cg_endo -71.64 157.76 55.04 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.439 1.231 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -81.83 -19.4 41.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.364 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.511 ' CE1' ' HG3' ' A' ' 8' ' ' PRO . 72.8 t80 -58.95 -23.85 61.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 110.454 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.682 ' HB3' HD21 ' B' ' 19' ' ' LEU . 42.3 mt -98.37 31.62 2.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 110.489 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.06 -31.1 67.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 110.108 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -80.95 -22.89 39.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.22 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.664 ' HH2' HG21 ' A' ' 41' ' ' VAL . 13.8 m0 -64.71 136.51 96.8 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.394 -0.816 . . . . 0.0 109.306 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.512 ' HG2' HG23 ' B' ' 18' ' ' VAL . 39.5 Cg_endo -70.24 152.45 66.83 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.626 1.33 . . . . 0.0 111.368 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -42.13 69.75 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.631 0.729 . . . . 0.0 110.905 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.17 -40.91 74.65 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.614 -0.679 . . . . 0.0 111.29 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.512 HG23 ' HG2' ' B' ' 15' ' ' PRO . 85.5 t -76.59 -50.0 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.917 -1.114 . . . . 0.0 110.754 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.682 HD21 ' HB3' ' B' ' 11' ' ' LEU . 13.4 mt -53.67 -36.32 61.99 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 110.682 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -62.99 -37.77 88.48 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.298 -0.876 . . . . 0.0 109.973 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.841 ' O ' HG23 ' B' ' 25' ' ' VAL . 40.5 tp -69.63 -40.31 76.64 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.415 -0.803 . . . . 0.0 109.858 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.897 HG12 HG13 ' B' ' 33' ' ' VAL . 40.3 t -59.31 -48.07 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 110.467 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' B' ' 19' ' ' LEU . 11.0 mtm180 -53.7 -49.41 68.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.215 -0.928 . . . . 0.0 110.535 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -29.13 70.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.4 -0.812 . . . . 0.0 110.698 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.841 HG23 ' O ' ' B' ' 21' ' ' LEU . 48.4 t -77.08 -29.25 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.501 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.436 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -74.04 -46.06 45.7 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 109.196 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.97 -12.58 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 110.152 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.41 -59.0 2.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 109.97 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -65.88 -22.33 66.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.059 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.48 16.26 20.74 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -116.65 -162.64 0.86 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.012 -1.287 . . . . 0.0 110.405 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.436 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 69.2 m -102.95 -176.76 3.18 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.352 -0.843 . . . . 0.0 109.375 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.897 HG13 HG12 ' B' ' 22' ' ' VAL . 62.2 t -81.2 -16.64 12.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 110.407 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -77.84 -32.14 51.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.067 -1.021 . . . . 0.0 108.695 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 41.0 t -79.67 -36.39 37.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.585 -0.697 . . . . 0.0 109.294 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.498 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.4 tp10 -65.0 -51.64 60.55 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.381 -0.824 . . . . 0.0 109.295 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.558 ' O ' HG23 ' B' ' 41' ' ' VAL . 37.3 mm -63.39 -32.59 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.576 -0.703 . . . . 0.0 109.428 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.434 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 26.5 t80 -65.97 -33.82 76.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.442 -0.787 . . . . 0.0 110.308 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -47.1 45.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.52 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -61.17 -23.42 65.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 0.0 109.639 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.711 HG21 ' HH2' ' A' ' 14' ' ' TRP . 56.4 t -88.08 -28.3 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.749 . . . . 0.0 109.502 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -20.14 53.35 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.566 -0.708 . . . . 0.0 110.161 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.17 -18.73 52.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.082 -1.011 . . . . 0.0 110.36 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.82 -47.27 15.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.046 -1.034 . . . . 0.0 110.097 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.77 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.5 m-85 -67.42 -11.96 59.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 110.799 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 110.389 -179.694 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 120.594 0.235 . . . . 43.64 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 48.3 Cg_endo -76.55 164.79 30.03 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.852 1.448 . . . . 29.79 110.343 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -74.98 -13.7 60.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.394 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.526 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 90.8 t80 -81.16 -29.15 34.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 12.57 110.46 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 11' ' ' LEU . 57.0 mt -92.69 14.68 16.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.784 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.94 -24.56 64.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 0.0 109.816 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.96 -21.89 43.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.314 -0.866 . . . . 0.0 110.163 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.576 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 15.0 m0 -73.54 143.59 82.5 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.453 -0.779 . . . . 11.57 109.67 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' CD ' ' OH ' ' B' ' 38' ' ' TYR . 42.3 Cg_endo -71.11 176.44 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.562 1.296 . . . . 13.83 110.726 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -24.29 37.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.402 -0.811 . . . . 48.43 109.372 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HG3' HG23 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -68.6 -20.15 64.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 46.64 110.463 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.664 ' O ' HG23 ' A' ' 22' ' ' VAL . 76.3 t -99.82 -46.3 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 16.14 109.961 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.13 -25.91 68.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.339 -0.851 . . . . 12.61 110.806 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -74.02 -31.74 63.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.299 -0.876 . . . . 23.17 110.068 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.737 ' O ' HG23 ' A' ' 25' ' ' VAL . 7.4 tp -79.82 -47.39 15.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 19.0 109.971 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.955 HG12 HG13 ' A' ' 33' ' ' VAL . 27.9 t -51.68 -45.93 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 18.87 109.918 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.509 ' HA ' HG22 ' A' ' 33' ' ' VAL . 3.0 ttm180 -51.44 -63.02 1.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.682 -0.636 . . . . 23.61 110.695 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -52.75 -33.88 50.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.283 -0.885 . . . . 30.11 110.969 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 21' ' ' LEU . 61.9 t -66.93 -36.48 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 16.22 110.523 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -67.02 -44.91 79.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 26.6 109.896 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -71.69 -14.7 62.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 45.21 110.359 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.79 -59.99 2.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.084 -1.01 . . . . 37.85 110.114 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -65.8 -22.03 66.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 35.36 110.358 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.39 16.69 24.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.85 -1.3 . . . . 35.1 109.85 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -114.15 -156.53 0.6 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.085 -1.244 . . . . 32.72 110.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.418 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 1.3 m -111.21 171.11 7.67 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.332 -0.855 . . . . 19.61 109.652 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.955 HG13 HG12 ' A' ' 22' ' ' VAL . 48.5 t -70.59 -18.89 21.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.204 -0.935 . . . . 17.56 110.451 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.78 -35.04 39.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.133 -0.98 . . . . 21.3 109.3 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.6 m -76.48 -33.54 58.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.811 . . . . 16.38 109.543 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.627 ' CG ' HG12 ' A' ' 25' ' ' VAL . 2.9 tp10 -63.37 -51.94 63.8 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.348 -0.845 . . . . 12.61 109.245 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.553 HD11 HG11 ' A' ' 22' ' ' VAL . 4.9 mt -68.4 -21.34 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.465 -0.772 . . . . 10.95 109.62 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.405 ' OH ' ' CD ' ' B' ' 15' ' ' PRO . 32.0 t80 -75.4 -29.54 59.83 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.267 -0.896 . . . . 18.87 109.716 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.01 -45.36 18.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.498 -0.751 . . . . 36.88 109.744 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt-85 -60.7 -45.06 95.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 22.85 109.159 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.609 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 61.2 t -68.93 -24.2 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.625 -0.672 . . . . 13.02 109.997 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -65.21 0.79 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.422 -0.799 . . . . 18.84 110.908 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -54.73 -31.75 58.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.332 -0.855 . . . . 29.96 111.037 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.15 -56.63 10.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.95 -1.094 . . . . 18.65 110.679 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.575 ' CD1' HD21 ' B' ' 21' ' ' LEU . 27.4 m-85 -61.99 -39.12 91.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 16.26 110.817 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.127 -0.983 . . . . 36.71 110.871 -179.12 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 120.775 0.321 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.526 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 48.5 Cg_endo -76.84 164.62 29.76 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.792 1.417 . . . . 0.0 110.318 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -74.89 -13.84 60.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.429 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.519 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 90.6 t80 -81.13 -28.79 34.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 110.47 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' B' ' 11' ' ' LEU . 55.8 mt -93.09 15.0 16.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.709 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.38 -24.19 63.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.919 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -22.2 42.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 110.114 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.609 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 14.9 m0 -73.27 143.71 83.49 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.493 -0.754 . . . . 0.0 109.723 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.405 ' CD ' ' OH ' ' A' ' 38' ' ' TYR . 42.6 Cg_endo -71.23 176.39 7.94 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.56 1.295 . . . . 0.0 110.827 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -24.44 37.1 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.562 -0.711 . . . . 0.0 109.443 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.427 ' HG3' HG23 ' B' ' 18' ' ' VAL . 1.0 OUTLIER -68.21 -20.89 64.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 110.712 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.652 ' O ' HG23 ' B' ' 22' ' ' VAL . 76.9 t -98.98 -47.05 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.139 -0.976 . . . . 0.0 109.883 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.51 -26.08 67.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 110.863 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.01 -31.45 62.94 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.727 ' O ' HG23 ' B' ' 25' ' ' VAL . 7.7 tp -79.88 -48.02 14.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.467 -0.771 . . . . 0.0 109.942 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.974 HG12 HG13 ' B' ' 33' ' ' VAL . 27.5 t -51.16 -45.57 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 109.938 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.501 ' HA ' HG22 ' B' ' 33' ' ' VAL . 3.0 ttm180 -52.12 -62.6 1.53 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.552 -0.717 . . . . 0.0 110.651 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -52.93 -33.82 52.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.931 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.727 HG23 ' O ' ' B' ' 21' ' ' LEU . 61.2 t -67.13 -36.03 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.084 -1.01 . . . . 0.0 110.577 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.429 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -67.55 -44.64 77.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.872 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -71.66 -15.05 62.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.963 . . . . 0.0 110.393 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.53 -60.2 2.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.044 . . . . 0.0 110.016 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -65.72 -21.93 66.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.266 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.33 16.68 24.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -114.39 -156.88 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.276 . . . . 0.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.429 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 1.3 m -110.73 171.04 7.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.565 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.974 HG13 HG12 ' B' ' 22' ' ' VAL . 49.3 t -70.23 -19.82 22.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.245 -0.91 . . . . 0.0 110.365 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 -35.61 43.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 64.5 m -75.84 -33.85 60.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.631 ' CG ' HG12 ' B' ' 25' ' ' VAL . 2.8 tp10 -63.26 -51.59 65.55 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.342 -0.849 . . . . 0.0 109.351 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.56 HD11 HG11 ' B' ' 22' ' ' VAL . 4.9 mt -68.74 -21.6 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.613 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.41 ' OH ' ' CD ' ' A' ' 15' ' ' PRO . 33.4 t80 -75.18 -29.25 60.34 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.22 -0.925 . . . . 0.0 109.775 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -45.54 17.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.671 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -60.53 -44.94 95.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.118 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.576 HG11 ' CZ3' ' A' ' 14' ' ' TRP . 58.0 t -68.88 -24.4 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.647 -0.658 . . . . 0.0 109.958 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -65.15 0.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.379 -0.826 . . . . 0.0 110.83 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -54.66 -31.73 58.09 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.247 -0.908 . . . . 0.0 111.001 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.34 -56.61 10.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.064 -1.023 . . . . 0.0 110.89 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.568 ' CD1' HD21 ' A' ' 21' ' ' LEU . 29.0 m-85 -62.05 -38.65 89.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 110.792 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.183 -0.948 . . . . 0.0 110.978 -179.288 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.424 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 13.1 ptp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.922 -0.399 . . . . 43.64 109.922 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 41.4 Cg_endo -68.79 151.56 74.27 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.553 1.291 . . . . 29.79 110.557 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -66.05 -20.32 66.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.246 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.502 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 91.2 t80 -68.38 -20.99 64.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 12.57 110.394 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.547 ' HB3' HD21 ' A' ' 19' ' ' LEU . 89.0 mt -100.54 20.91 14.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.596 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.19 -26.9 62.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -83.18 -23.51 32.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.107 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.618 ' CH2' HG11 ' B' ' 41' ' ' VAL . 14.0 m0 -67.09 139.55 95.36 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.363 -0.836 . . . . 11.57 109.384 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HG2' HG23 ' A' ' 18' ' ' VAL . 42.0 Cg_endo -70.21 168.76 21.21 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.528 1.278 . . . . 13.83 110.904 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.21 -20.47 55.28 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.513 -0.742 . . . . 48.43 109.433 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -72.84 -28.63 62.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 46.64 109.758 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.1 t -87.33 -45.15 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 16.14 109.865 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 11' ' ' LEU . 55.1 mt -63.26 -30.48 71.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -0.857 . . . . 12.61 110.593 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -66.01 -25.88 67.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -0.962 . . . . 23.17 109.605 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.728 ' O ' HG23 ' A' ' 25' ' ' VAL . 15.1 tp -86.78 -44.83 11.46 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.446 -0.784 . . . . 19.0 109.745 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.743 HG12 HG13 ' A' ' 33' ' ' VAL . 44.4 t -52.83 -43.14 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.263 -0.898 . . . . 18.87 109.778 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -51.01 -61.69 2.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.562 -0.711 . . . . 23.61 110.594 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -54.35 -24.9 21.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.577 -0.702 . . . . 30.11 110.901 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 21' ' ' LEU . 38.4 t -80.48 -30.72 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.168 -0.957 . . . . 16.22 110.783 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.406 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -78.01 -27.72 49.01 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.11 -0.994 . . . . 26.6 110.0 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.38 -15.31 33.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 45.21 110.713 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 19.8 pt-20 -90.73 -33.13 15.88 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.882 -1.136 . . . . 37.85 110.436 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.441 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 9.7 m-80 -79.48 -26.88 41.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 35.36 110.159 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.84 23.72 8.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.538 -1.425 . . . . 35.1 109.538 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -131.73 -158.97 0.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.21 -1.171 . . . . 32.72 109.93 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.406 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -109.4 -178.61 3.6 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.525 -0.734 . . . . 19.61 109.086 179.038 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.743 HG13 HG12 ' A' ' 22' ' ' VAL . 97.8 t -76.79 -19.18 14.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.184 -0.947 . . . . 17.56 110.29 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 42.2 t30 -74.66 -30.65 61.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 21.3 108.747 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -37.85 23.61 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.501 -0.749 . . . . 16.38 109.214 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HG3' HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -59.78 -51.55 69.26 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.322 -0.861 . . . . 12.61 109.574 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.533 HG23 HG21 ' B' ' 41' ' ' VAL . 38.6 mm -62.95 -28.01 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.325 -0.859 . . . . 10.95 109.2 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 42' ' ' MET . 37.5 t80 -74.17 -24.83 59.44 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.395 -0.816 . . . . 18.87 110.175 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -50.91 9.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.45 -0.781 . . . . 36.88 109.833 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 36' ' ' GLU . 2.9 mpt_? -60.74 -28.82 68.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.816 . . . . 22.85 109.255 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 65.4 t -84.35 -22.43 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.622 -0.674 . . . . 13.02 109.676 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -74.31 -51.23 15.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 18.84 111.101 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -69.52 -23.79 63.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.257 -0.902 . . . . 29.96 111.473 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.5 p -57.31 -52.61 64.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.014 -1.054 . . . . 18.65 110.282 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.676 ' CD1' HD21 ' B' ' 21' ' ' LEU . 36.9 m-85 -63.12 -40.1 96.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -0.999 . . . . 16.26 110.311 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.318 -0.864 . . . . 36.71 110.599 -179.633 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.432 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 13.2 ptp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.502 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 42.6 Cg_endo -68.68 151.79 74.63 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.538 1.283 . . . . 0.0 110.518 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.01 -20.72 66.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.883 . . . . 0.0 110.211 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.517 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 91.9 t80 -67.93 -21.24 65.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 0.0 110.458 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.527 ' HB3' HD21 ' B' ' 19' ' ' LEU . 88.1 mt -100.35 20.82 14.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 110.611 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -26.72 62.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.979 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -83.34 -23.3 32.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 110.103 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.496 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.8 m0 -67.42 139.56 94.53 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.384 -0.823 . . . . 0.0 109.355 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.525 ' HG2' HG23 ' B' ' 18' ' ' VAL . 41.0 Cg_endo -70.3 168.84 21.11 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.412 1.217 . . . . 0.0 110.543 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.27 -20.51 54.99 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.578 -0.701 . . . . 0.0 109.307 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -72.73 -28.8 62.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.164 -0.96 . . . . 0.0 109.448 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.6 ' O ' HG23 ' B' ' 22' ' ' VAL . 74.6 t -87.45 -45.18 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 109.637 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' B' ' 11' ' ' LEU . 54.0 mt -63.28 -30.1 71.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 110.581 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -66.32 -26.19 67.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.116 -0.99 . . . . 0.0 109.429 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.733 ' O ' HG23 ' B' ' 25' ' ' VAL . 15.4 tp -86.57 -44.54 11.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.221 0.534 . . . . 0.0 109.61 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.724 HG12 HG13 ' B' ' 33' ' ' VAL . 44.1 t -53.37 -43.25 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.815 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -50.78 -61.39 2.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.554 -0.716 . . . . 0.0 110.675 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -54.59 -24.75 22.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.749 . . . . 0.0 111.01 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.733 HG23 ' O ' ' B' ' 21' ' ' LEU . 38.2 t -80.61 -30.91 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.092 -1.005 . . . . 0.0 110.667 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.408 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -77.84 -27.75 49.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.097 -1.002 . . . . 0.0 109.955 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.37 -15.16 33.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 110.733 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' B' ' 25' ' ' VAL . 19.7 pt-20 -90.84 -33.11 15.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.006 -1.059 . . . . 0.0 110.49 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.435 ' N ' ' HG3' ' B' ' 28' ' ' GLU . 9.5 m-80 -79.54 -26.7 41.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.72 23.98 8.0 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -132.09 -159.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.203 -1.175 . . . . 0.0 109.836 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.408 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 0.4 OUTLIER -109.36 -178.81 3.66 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.459 -0.776 . . . . 0.0 109.187 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.724 HG13 HG12 ' B' ' 22' ' ' VAL . 97.4 t -76.4 -19.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 110.191 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 41.7 t30 -74.66 -29.99 61.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 108.825 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.52 -38.35 21.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.562 -0.711 . . . . 0.0 109.115 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.54 ' HG3' HG12 ' B' ' 25' ' ' VAL . 0.5 OUTLIER -58.97 -51.76 68.67 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.315 -0.865 . . . . 0.0 109.648 179.017 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.463 ' O ' HG23 ' B' ' 41' ' ' VAL . 39.1 mm -63.0 -27.6 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.457 -0.777 . . . . 0.0 109.235 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 36.3 t80 -74.62 -24.96 58.93 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.38 -0.825 . . . . 0.0 110.103 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -50.63 10.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.875 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' B' ' 36' ' ' GLU . 2.9 mpt_? -61.11 -28.72 69.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.372 -0.83 . . . . 0.0 109.246 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.618 HG11 ' CH2' ' A' ' 14' ' ' TRP . 62.5 t -84.45 -21.91 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.516 0.674 . . . . 0.0 109.873 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' B' ' 38' ' ' TYR . 0.0 OUTLIER -74.66 -51.21 15.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 111.088 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -69.4 -24.28 63.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.166 -0.959 . . . . 0.0 111.42 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 56.3 p -56.9 -52.73 64.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.92 -1.113 . . . . 0.0 110.199 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.646 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.6 m-85 -62.98 -40.48 97.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 110.382 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 110.645 -179.422 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 110.242 -0.281 . . . . 43.64 110.242 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HG2' HD12 ' A' ' 11' ' ' LEU . 50.8 Cg_endo -77.05 157.93 34.17 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.508 1.267 . . . . 29.79 110.551 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.01 0.38 35.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.409 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.42 ' CB ' ' HB3' ' B' ' 10' ' ' PHE . 75.1 t80 -88.67 -23.59 22.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.994 -1.066 . . . . 12.57 109.881 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.703 HD12 ' HG2' ' A' ' 8' ' ' PRO . 54.7 mt -99.6 28.18 4.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 110.312 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.48 -22.12 57.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.168 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.08 -10.28 45.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.504 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.9 m0 -75.61 142.43 73.98 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.092 -1.005 . . . . 11.57 109.874 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HG2' HG23 ' A' ' 18' ' ' VAL . 43.4 Cg_endo -72.1 176.25 8.72 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.568 1.299 . . . . 13.83 110.744 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.0 -23.31 38.76 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.381 -0.824 . . . . 48.43 109.437 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -70.26 -27.45 64.44 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.248 -0.907 . . . . 46.64 109.885 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 22' ' ' VAL . 81.2 t -93.2 -43.82 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -0.858 . . . . 16.14 110.086 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.661 HD21 ' HB3' ' A' ' 11' ' ' LEU . 40.1 mt -63.74 -31.86 73.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 12.61 110.531 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -66.94 -31.21 71.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 23.17 109.92 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.822 ' O ' HG23 ' A' ' 25' ' ' VAL . 52.6 tp -79.88 -40.21 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.841 . . . . 19.0 110.111 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.058 HG12 HG13 ' A' ' 33' ' ' VAL . 39.7 t -54.43 -50.13 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.905 . . . . 18.87 110.139 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -58.33 -49.32 77.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.763 . . . . 23.61 110.437 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -18.57 63.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 30.11 110.635 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 21' ' ' LEU . 90.6 t -88.94 -29.21 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 16.22 110.44 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.02 -26.98 36.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.168 -0.958 . . . . 26.6 109.818 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -89.51 -15.87 32.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.405 -0.81 . . . . 45.21 110.688 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 18.6 pt-20 -90.69 -28.18 18.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.983 -1.073 . . . . 37.85 110.396 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -90.92 -18.72 24.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 35.36 110.392 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.9 23.66 22.35 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.484 -1.446 . . . . 35.1 109.484 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -121.17 -164.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.119 . . . . 32.72 110.211 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.0 m -106.61 168.58 9.07 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.819 -0.808 . . . . 19.61 108.819 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.058 HG13 HG12 ' A' ' 22' ' ' VAL . 92.2 t -73.82 -23.21 18.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.05 -1.031 . . . . 17.56 110.086 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -75.22 -28.93 60.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 21.3 108.896 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.1 m -85.42 -27.84 25.49 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.484 -0.76 . . . . 16.38 109.589 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.736 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.6 tp10 -70.96 -38.47 72.82 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.249 -0.907 . . . . 12.61 109.171 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.576 ' O ' HG23 ' A' ' 41' ' ' VAL . 17.5 mm -80.13 -25.16 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.564 -0.71 . . . . 10.95 109.345 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.43 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 22.3 t80 -72.99 -38.26 66.72 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.265 -0.897 . . . . 18.87 110.218 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -42.7 65.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.192 -0.943 . . . . 36.88 109.911 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -64.65 -27.08 68.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 22.85 109.304 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.8 t -82.65 -26.97 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.627 0.727 . . . . 13.02 109.329 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -40.44 65.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.668 -0.645 . . . . 18.84 110.736 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.89 -20.99 61.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 29.96 110.599 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 t -64.94 -53.13 51.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -0.976 . . . . 18.65 110.433 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.577 ' CE1' HG21 ' B' ' 25' ' ' VAL . 31.5 m-85 -62.58 -27.27 69.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 16.26 110.775 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 36.71 110.637 -179.42 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.734 ' HG2' HD12 ' B' ' 11' ' ' LEU . 50.2 Cg_endo -76.87 157.39 34.93 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.612 1.322 . . . . 0.0 110.627 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.49 0.63 32.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 110.576 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 74.7 t80 -88.83 -23.85 22.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.07 -1.019 . . . . 0.0 109.826 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.734 HD12 ' HG2' ' B' ' 8' ' ' PRO . 54.7 mt -99.36 28.18 4.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.328 -0.858 . . . . 0.0 110.219 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.47 -21.89 57.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.918 . . . . 0.0 110.219 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -10.32 44.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.18 -0.95 . . . . 0.0 110.5 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.483 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.8 m0 -75.79 142.28 73.15 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.133 -0.979 . . . . 0.0 109.858 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.479 ' HG2' HG23 ' B' ' 18' ' ' VAL . 43.3 Cg_endo -72.04 176.25 8.69 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.24 1.126 . . . . 0.0 110.721 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.04 -23.47 38.56 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 109.446 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.94 -27.44 64.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.129 -0.982 . . . . 0.0 110.071 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.717 ' O ' HG23 ' B' ' 22' ' ' VAL . 90.1 t -93.38 -44.07 13.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.989 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' B' ' 11' ' ' LEU . 41.0 mt -63.31 -31.87 73.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.542 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -67.16 -30.96 71.07 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.807 ' O ' HG23 ' B' ' 25' ' ' VAL . 53.5 tp -79.85 -40.2 28.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.411 -0.805 . . . . 0.0 110.163 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 1.061 HG12 HG13 ' B' ' 33' ' ' VAL . 40.2 t -54.51 -50.2 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.857 . . . . 0.0 109.952 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -58.26 -49.75 76.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.432 -0.793 . . . . 0.0 110.268 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -18.91 63.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 110.775 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.807 HG23 ' O ' ' B' ' 21' ' ' LEU . 92.2 t -88.66 -28.83 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.083 -1.011 . . . . 0.0 110.542 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.5 -26.4 35.18 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.87 -15.99 31.0 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.435 -0.791 . . . . 0.0 110.555 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.461 ' HG2' ' HA ' ' B' ' 25' ' ' VAL . 18.3 pt-20 -90.68 -27.97 18.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.36 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -91.19 -18.64 24.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 0.0 110.471 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.85 23.61 22.61 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -121.2 -164.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -1.141 . . . . 0.0 110.217 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -106.35 168.4 9.18 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 1.061 HG13 HG12 ' B' ' 22' ' ' VAL . 92.1 t -73.65 -23.25 19.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.018 -1.051 . . . . 0.0 110.157 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -75.27 -28.64 59.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 108.925 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -85.59 -27.85 25.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.54 -0.725 . . . . 0.0 109.518 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.724 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.6 tp10 -70.9 -38.32 73.02 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.262 -0.899 . . . . 0.0 109.366 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.579 ' O ' HG23 ' B' ' 41' ' ' VAL . 17.6 mm -80.19 -25.19 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 0.0 109.297 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.425 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 22.6 t80 -73.01 -38.02 66.75 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.8 -42.34 64.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -64.94 -26.9 68.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 37' ' ' ILE . 42.7 t -82.83 -26.92 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.464 -0.772 . . . . 0.0 109.154 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -39.95 65.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.639 -0.663 . . . . 0.0 110.785 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.26 -21.03 61.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 110.538 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -64.71 -53.28 49.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.435 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.566 ' CE1' HG21 ' A' ' 25' ' ' VAL . 31.3 m-85 -62.66 -27.23 69.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.973 . . . . 0.0 110.816 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.066 -1.021 . . . . 0.0 110.639 -179.501 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.341 -0.244 . . . . 43.64 110.341 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HG3' ' CE1' ' B' ' 10' ' ' PHE . 46.2 Cg_endo -72.88 157.61 51.28 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.635 1.334 . . . . 29.79 110.347 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -75.98 -10.54 59.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.873 . . . . 0.0 110.705 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' B' ' 10' ' ' PHE . 79.1 t80 -74.78 -27.63 60.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.063 -1.023 . . . . 12.57 110.331 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 19' ' ' LEU . 41.0 mt -96.17 23.43 6.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 110.203 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.2 -18.26 61.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.675 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -97.24 1.22 49.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.947 . . . . 0.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.436 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.4 m0 -82.32 153.81 68.9 Favored Pre-proline 0 N--CA 1.485 1.313 0 O-C-N 121.076 -1.015 . . . . 11.57 109.796 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 42.0 Cg_endo -70.61 162.5 42.27 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.535 1.281 . . . . 13.83 111.379 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -40.76 97.6 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.615 0.721 . . . . 48.43 110.67 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -53.78 53.25 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.815 -0.553 . . . . 46.64 111.086 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 22' ' ' VAL . 85.7 t -60.96 -44.59 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.099 -1.0 . . . . 16.14 110.737 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 11' ' ' LEU . 70.7 mt -62.57 -30.66 71.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.218 -0.926 . . . . 12.61 110.779 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -72.64 -23.13 60.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.987 . . . . 23.17 110.264 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.2 tp -87.3 -37.46 17.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.32 -0.862 . . . . 19.0 110.21 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.941 HG12 HG13 ' A' ' 33' ' ' VAL . 27.3 t -57.15 -45.23 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 18.87 110.267 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.459 ' HG3' ' N ' ' A' ' 24' ' ' LYS . 8.8 ptp180 -65.56 -29.87 70.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -0.906 . . . . 23.61 110.681 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -83.58 -10.46 58.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.043 -1.036 . . . . 30.11 110.563 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 21' ' ' LEU . 71.5 t -100.15 -28.0 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 16.22 110.453 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.06 -30.55 58.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 26.6 109.742 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.92 -12.17 58.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.2 -0.938 . . . . 45.21 110.387 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -87.23 -54.13 4.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.068 -1.02 . . . . 37.85 110.536 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -61.01 -22.44 64.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.128 -0.982 . . . . 35.36 110.561 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.2 36.99 4.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.529 -1.428 . . . . 35.1 109.529 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -141.5 -154.89 0.54 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.378 -1.072 . . . . 32.72 110.104 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 p -113.43 171.67 7.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.52 -0.738 . . . . 19.61 109.253 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.941 HG13 HG12 ' A' ' 22' ' ' VAL . 71.4 t -72.64 -23.04 20.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.097 -1.002 . . . . 17.56 110.412 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -70.08 -29.88 66.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.998 . . . . 21.3 109.021 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.71 -29.33 21.17 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.454 -0.778 . . . . 16.38 109.432 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' HG3' HG12 ' A' ' 25' ' ' VAL . 4.2 tt0 -64.36 -59.43 4.38 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.306 -0.871 . . . . 12.61 109.349 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.65 HG23 HG21 ' B' ' 41' ' ' VAL . 24.9 mm -60.31 -22.56 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.369 -0.832 . . . . 10.95 109.284 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -73.62 -33.25 64.48 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.367 -0.833 . . . . 18.87 110.065 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -46.36 21.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 36.88 109.817 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 mtt-85 -61.31 -25.94 67.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.445 -0.784 . . . . 22.85 109.601 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.638 HG21 HG23 ' B' ' 37' ' ' ILE . 53.9 t -88.66 -29.81 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.506 -0.747 . . . . 13.02 109.999 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.0 -67.48 0.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 18.84 110.54 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -55.82 -20.68 16.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.975 . . . . 29.96 110.479 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.0 t -60.35 -53.66 54.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 18.65 109.998 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.537 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 17.0 m-85 -60.52 -30.46 69.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.352 -0.843 . . . . 16.26 110.129 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 36.71 110.579 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.487 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 45.8 Cg_endo -73.02 157.57 50.83 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.75 1.395 . . . . 0.0 110.35 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -75.86 -10.55 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 79.0 t80 -74.84 -27.8 60.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.29 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.479 ' HB3' HD21 ' B' ' 19' ' ' LEU . 41.7 mt -96.09 23.36 6.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.179 -0.951 . . . . 0.0 110.225 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.18 -18.35 61.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.134 -0.979 . . . . 0.0 110.601 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -97.13 1.22 49.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.048 -1.032 . . . . 0.0 110.855 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.452 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.3 m0 -82.48 153.82 68.46 Favored Pre-proline 0 N--CA 1.485 1.31 0 O-C-N 120.986 -1.071 . . . . 0.0 109.852 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.473 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 42.2 Cg_endo -70.47 162.11 43.62 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.419 1.221 . . . . 0.0 111.525 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -40.6 97.18 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.784 0.802 . . . . 0.0 110.768 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -53.87 52.14 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.037 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.714 ' O ' HG23 ' B' ' 22' ' ' VAL . 85.8 t -60.7 -45.09 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.586 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' B' ' 11' ' ' LEU . 71.6 mt -61.92 -30.8 71.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.827 -1.171 . . . . 0.0 111.111 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -72.73 -23.32 60.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.097 -1.002 . . . . 0.0 110.287 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.602 ' O ' HG23 ' B' ' 25' ' ' VAL . 1.2 tp -87.0 -37.58 17.38 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.423 -0.798 . . . . 0.0 110.301 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.947 HG12 HG13 ' B' ' 33' ' ' VAL . 26.3 t -57.02 -45.28 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 110.267 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.459 ' HG3' ' N ' ' B' ' 24' ' ' LYS . 8.8 ptp180 -65.59 -29.73 70.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.24 -0.913 . . . . 0.0 110.709 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 0.0 OUTLIER -83.7 -10.45 58.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.064 -1.022 . . . . 0.0 110.527 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 21' ' ' LEU . 71.1 t -100.12 -27.94 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 110.459 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.05 -30.54 58.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.12 -0.987 . . . . 0.0 109.734 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.0 -11.96 58.57 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.378 -0.826 . . . . 0.0 110.46 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.38 -54.0 4.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.991 . . . . 0.0 110.545 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -61.2 -22.35 64.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 110.63 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.15 37.1 4.72 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -141.53 -154.88 0.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.399 -1.059 . . . . 0.0 110.094 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 2.2 p -113.32 171.66 7.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.528 -0.732 . . . . 0.0 109.311 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.947 HG13 HG12 ' B' ' 22' ' ' VAL . 70.9 t -72.64 -23.17 20.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.124 -0.985 . . . . 0.0 110.454 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -69.96 -29.75 66.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.0 109.042 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.87 -29.46 20.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.497 -0.752 . . . . 0.0 109.356 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.48 ' HG3' HG12 ' B' ' 25' ' ' VAL . 4.2 tt0 -64.3 -59.4 4.43 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.297 -0.877 . . . . 0.0 109.295 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.638 HG23 HG21 ' A' ' 41' ' ' VAL . 24.9 mm -60.37 -22.64 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.315 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.412 ' OH ' ' HG3' ' A' ' 15' ' ' PRO . 19.5 t80 -73.71 -33.24 64.3 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.265 -0.897 . . . . 0.0 109.977 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -46.52 21.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 109.723 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 mtt-85 -61.14 -25.84 67.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.81 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.65 HG21 HG23 ' A' ' 37' ' ' ILE . 54.7 t -88.66 -29.85 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.968 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -67.41 0.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 110.465 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -55.86 -20.83 17.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.95 . . . . 0.0 110.396 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 19.6 t -60.25 -53.65 55.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.235 -0.915 . . . . 0.0 109.97 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.543 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 17.4 m-85 -60.36 -30.75 69.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 0.0 110.575 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.409 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 110.191 -0.3 . . . . 43.64 110.191 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HG2' HD12 ' A' ' 11' ' ' LEU . 44.1 Cg_endo -70.3 145.83 55.12 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.594 1.313 . . . . 29.79 110.426 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -64.16 -14.49 55.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 110.729 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CE1' ' HG3' ' B' ' 8' ' ' PRO . 89.9 t80 -71.77 -28.79 63.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.108 -0.995 . . . . 12.57 110.169 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.707 HD12 ' HG2' ' A' ' 8' ' ' PRO . 65.9 mt -93.77 30.21 1.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.176 -0.953 . . . . 0.0 110.272 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.82 -23.91 61.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -19.63 25.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.91 . . . . 0.0 110.449 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.542 ' CE3' HD22 ' A' ' 11' ' ' LEU . 13.1 m0 -69.56 132.47 89.3 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.256 -0.903 . . . . 11.57 109.236 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.66 167.2 23.51 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.411 1.216 . . . . 13.83 111.082 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -67.98 -25.77 65.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.614 -0.679 . . . . 48.43 110.791 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.5 -51.92 51.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 46.64 110.611 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.9 t -67.49 -39.5 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 16.14 110.526 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.7 -29.92 70.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 12.61 110.639 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.08 -27.47 68.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.059 -1.026 . . . . 23.17 109.504 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.736 ' O ' HG23 ' A' ' 25' ' ' VAL . 50.1 tp -84.88 -39.53 18.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.561 -0.712 . . . . 19.0 110.066 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.821 HG12 HG13 ' A' ' 33' ' ' VAL . 39.9 t -60.26 -47.25 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.44 -0.788 . . . . 18.87 110.574 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HG3' ' N ' ' A' ' 24' ' ' LYS . 9.6 ptp180 -61.52 -28.62 69.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.316 -0.865 . . . . 23.61 110.849 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.468 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -86.01 -20.68 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.029 -1.044 . . . . 30.11 110.14 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 21' ' ' LEU . 93.6 t -87.4 -23.75 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.873 . . . . 16.22 110.204 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.76 -34.61 67.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.305 -0.872 . . . . 26.6 109.528 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.44 -9.78 59.3 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.333 -0.854 . . . . 45.21 110.425 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.47 -59.96 2.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 37.85 110.399 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -58.61 -30.17 67.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 35.36 110.444 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.04 32.68 3.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 35.1 109.555 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -136.74 -165.13 1.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.122 . . . . 32.72 109.94 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.24 -173.36 2.65 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.408 -0.807 . . . . 19.61 108.842 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.821 HG13 HG12 ' A' ' 22' ' ' VAL . 69.7 t -83.44 -15.5 11.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.171 -0.956 . . . . 17.56 110.099 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 60.6 t30 -80.84 -33.18 34.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 21.3 108.496 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.84 -40.0 49.27 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.835 -0.802 . . . . 16.38 108.835 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.623 ' HG3' HG12 ' A' ' 25' ' ' VAL . 1.5 tt0 -59.53 -51.24 70.71 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.247 -0.908 . . . . 12.61 109.256 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.59 HG23 HG21 ' B' ' 41' ' ' VAL . 35.3 mm -64.0 -24.42 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.373 -0.829 . . . . 10.95 109.584 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.439 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 35.2 t80 -73.98 -30.35 62.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.297 -0.877 . . . . 18.87 110.427 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 -78.12 -46.09 21.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.083 -1.011 . . . . 36.88 110.137 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.417 ' CD ' ' O ' ' A' ' 36' ' ' GLU . 2.7 mpt_? -60.98 -26.68 67.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 22.85 109.697 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.594 HG21 HG23 ' B' ' 37' ' ' ILE . 19.2 t -85.63 -30.58 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.491 -0.756 . . . . 13.02 109.352 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.5 mtp -71.4 -20.33 62.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.759 . . . . 18.84 110.487 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.04 -26.65 26.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 29.96 110.532 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.48 -58.81 6.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 18.65 110.317 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.64 ' CD1' HD21 ' B' ' 21' ' ' LEU . 30.1 m-85 -55.13 -42.31 72.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 16.26 110.374 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mttt . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.161 -0.962 . . . . 36.71 110.615 -179.795 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.405 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.733 ' HG2' HD12 ' B' ' 11' ' ' LEU . 45.0 Cg_endo -70.65 145.25 51.53 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.678 1.357 . . . . 0.0 110.392 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -63.62 -14.46 51.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 0.0 110.749 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 34' ' ' ASN . 90.7 t80 -71.8 -28.46 63.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.047 -1.033 . . . . 0.0 110.209 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.733 HD12 ' HG2' ' B' ' 8' ' ' PRO . 64.2 mt -94.05 30.31 1.91 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.248 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.99 -23.95 61.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -0.847 . . . . 0.0 110.221 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -19.58 25.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.928 . . . . 0.0 110.451 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.554 ' CE3' HD22 ' B' ' 11' ' ' LEU . 13.2 m0 -69.86 132.18 88.9 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.351 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.5 167.24 23.11 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.551 1.29 . . . . 0.0 111.153 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' B' ' 20' ' ' ASP . 1.5 ptm180 -68.07 -25.67 65.46 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.735 -0.603 . . . . 0.0 110.698 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.98 -51.72 51.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 110.526 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.714 ' O ' HG23 ' B' ' 22' ' ' VAL . 61.9 t -67.64 -39.48 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.103 -0.998 . . . . 0.0 110.237 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 14.3 mt -65.77 -29.83 70.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 110.715 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 16' ' ' ARG . 1.0 OUTLIER -66.37 -27.61 68.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.041 -1.037 . . . . 0.0 109.617 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.726 ' O ' HG23 ' B' ' 25' ' ' VAL . 45.7 tp -84.87 -39.1 18.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.633 -0.667 . . . . 0.0 110.03 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.8 HG12 HG13 ' B' ' 33' ' ' VAL . 39.3 t -60.88 -46.32 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.0 110.606 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' B' ' 24' ' ' LYS . 9.6 ptp180 -62.31 -28.31 69.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.197 -0.939 . . . . 0.0 110.759 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.464 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 0.1 OUTLIER -86.06 -20.82 28.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.031 -1.043 . . . . 0.0 110.116 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.726 HG23 ' O ' ' B' ' 21' ' ' LEU . 95.3 t -87.42 -23.75 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.853 . . . . 0.0 110.119 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.27 66.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.52 -9.91 59.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.46 -0.775 . . . . 0.0 110.371 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -86.51 -59.99 2.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.015 . . . . 0.0 110.379 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -58.56 -30.09 66.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.87 . . . . 0.0 110.345 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.94 32.56 3.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -136.44 -164.82 1.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -1.183 . . . . 0.0 109.973 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.54 -173.55 2.67 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.37 -0.831 . . . . 0.0 108.879 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.8 HG13 HG12 ' B' ' 22' ' ' VAL . 69.4 t -83.26 -15.65 11.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.175 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 60.2 t30 -80.86 -32.98 34.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.097 -1.002 . . . . 0.0 108.436 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -40.47 48.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.639 ' HG3' HG12 ' B' ' 25' ' ' VAL . 1.5 tt0 -59.1 -51.55 69.55 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.214 -0.929 . . . . 0.0 109.273 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.594 HG23 HG21 ' A' ' 41' ' ' VAL . 37.0 mm -63.53 -24.58 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.58 -0.7 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.435 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 37.8 t80 -74.2 -29.84 61.93 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 110.508 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -78.6 -46.2 19.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.404 ' CD ' ' O ' ' B' ' 36' ' ' GLU . 2.7 mpt_? -60.36 -27.64 67.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.567 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.59 HG21 HG23 ' A' ' 37' ' ' ILE . 18.6 t -84.9 -30.42 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.512 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.5 mtp -72.19 -19.54 61.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 110.499 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.45 -26.94 26.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 110.354 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -58.9 6.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 0.0 110.391 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.59 ' CD1' HD21 ' A' ' 21' ' ' LEU . 31.2 m-85 -55.23 -41.93 72.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.469 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mttt . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.249 -0.907 . . . . 0.0 110.518 -179.638 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 18.4 mtp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 110.209 -0.293 . . . . 43.64 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.608 ' CG ' HD12 ' A' ' 11' ' ' LEU . 45.0 Cg_endo -71.33 153.5 61.44 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.569 1.3 . . . . 29.79 110.487 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.15 -17.58 64.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 110.456 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.457 ' HB3' ' CB ' ' B' ' 10' ' ' PHE . 87.7 t80 -76.26 -28.45 57.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 12.57 110.352 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.608 HD12 ' CG ' ' A' ' 8' ' ' PRO . 81.5 mt -91.53 21.14 4.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.954 . . . . 0.0 110.455 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -72.45 -22.65 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 110.059 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.79 -11.99 46.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.635 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.511 ' HH2' HG21 ' B' ' 41' ' ' VAL . 14.2 m0 -79.73 141.94 56.39 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.029 -1.045 . . . . 11.57 109.682 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.19 177.83 7.33 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.572 1.301 . . . . 13.83 110.685 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.77 -21.95 34.46 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.385 -0.822 . . . . 48.43 109.153 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -69.32 -28.01 65.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.885 . . . . 46.64 109.887 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.869 ' O ' HG23 ' A' ' 22' ' ' VAL . 78.5 t -94.85 -40.46 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 16.14 110.034 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.89 -28.79 69.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 12.61 110.547 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -73.08 -22.61 60.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 23.17 109.936 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.821 ' O ' HG23 ' A' ' 25' ' ' VAL . 50.6 tp -90.1 -33.52 16.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 19.0 110.018 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 18' ' ' VAL . 24.0 t -67.14 -50.18 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.419 -0.801 . . . . 18.87 110.345 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -59.17 -27.25 65.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.309 -0.869 . . . . 23.61 110.788 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -24.11 33.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 30.11 110.165 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 21' ' ' LEU . 88.4 t -78.83 -39.34 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.433 -0.792 . . . . 16.22 110.351 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.76 97.86 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.204 -0.935 . . . . 26.6 109.654 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -68.13 -16.09 63.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 45.21 110.452 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.78 -59.84 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.979 -1.076 . . . . 37.85 110.411 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -59.07 -28.03 66.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 35.36 110.703 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.59 41.03 3.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.461 -1.456 . . . . 35.1 109.461 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mtt-85 -141.96 -154.01 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -1.121 . . . . 32.72 110.069 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 t -108.59 175.94 5.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.48 -0.763 . . . . 19.61 109.476 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.765 HG13 HG12 ' A' ' 22' ' ' VAL . 88.9 t -78.64 -20.56 13.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.157 -0.965 . . . . 17.56 110.229 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.18 -26.57 63.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.069 -1.019 . . . . 21.3 109.104 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.82 -30.53 22.9 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.384 -0.823 . . . . 16.38 109.566 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HG3' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -67.16 -48.48 67.86 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.251 -0.906 . . . . 12.61 109.724 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.618 HG23 HG21 ' B' ' 41' ' ' VAL . 47.3 mm -66.36 -30.88 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.837 . . . . 10.95 109.679 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HE1' HG11 ' B' ' 18' ' ' VAL . 36.9 t80 -67.67 -39.4 84.51 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 18.87 110.635 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.53 -45.81 61.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.185 -0.947 . . . . 36.88 109.743 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 36' ' ' GLU . 2.1 mmt-85 -60.84 -24.69 66.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 22.85 109.4 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.699 HG21 HG23 ' B' ' 37' ' ' ILE . 52.1 t -90.14 -23.36 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.586 -0.696 . . . . 13.02 110.161 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -56.99 4.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.505 -0.747 . . . . 18.84 110.977 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -50.74 -33.22 22.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.121 -0.987 . . . . 29.96 111.189 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.3 m -60.79 -51.24 70.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.121 -0.987 . . . . 18.65 110.598 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.629 ' CD1' HD21 ' B' ' 21' ' ' LEU . 15.0 m-85 -59.77 -29.88 68.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.98 . . . . 16.26 110.814 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.006 -1.059 . . . . 36.71 110.677 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 18.3 mtp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.599 ' CG ' HD12 ' B' ' 11' ' ' LEU . 45.4 Cg_endo -71.46 153.55 60.71 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.65 1.342 . . . . 0.0 110.42 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.04 -17.74 65.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.458 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.457 ' CB ' ' HB3' ' A' ' 10' ' ' PHE . 87.6 t80 -76.15 -28.32 57.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.157 -0.964 . . . . 0.0 110.326 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.599 HD12 ' CG ' ' B' ' 8' ' ' PRO . 83.5 mt -91.8 21.7 4.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 110.407 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.09 -22.53 60.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.974 . . . . 0.0 110.015 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.74 -12.02 46.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 110.644 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.529 ' HH2' HG21 ' A' ' 41' ' ' VAL . 14.2 m0 -79.83 142.05 56.1 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.841 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.21 177.42 7.86 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.551 1.29 . . . . 0.0 110.18 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -21.6 34.61 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.439 -0.788 . . . . 0.0 109.226 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -69.38 -28.02 65.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.978 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.846 ' O ' HG23 ' B' ' 22' ' ' VAL . 80.2 t -94.66 -40.64 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.551 -0.718 . . . . 0.0 109.845 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 19' ' ' LEU . 85.3 mt -65.95 -28.44 68.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.563 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.38 -22.85 60.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.845 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.84 ' O ' HG23 ' B' ' 25' ' ' VAL . 51.7 tp -89.82 -33.73 16.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.704 -0.623 . . . . 0.0 110.12 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.846 HG23 ' O ' ' B' ' 18' ' ' VAL . 24.0 t -66.92 -50.1 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -0.829 . . . . 0.0 110.37 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -59.14 -27.52 65.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.289 -0.882 . . . . 0.0 110.801 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -24.3 34.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 110.114 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.84 HG23 ' O ' ' B' ' 21' ' ' LEU . 88.8 t -78.66 -39.46 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.804 . . . . 0.0 110.299 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.47 99.22 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.342 -0.849 . . . . 0.0 109.59 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -67.53 -16.24 64.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.528 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -82.56 -59.94 2.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.041 -1.037 . . . . 0.0 110.503 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -58.97 -28.16 66.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.136 -0.978 . . . . 0.0 110.794 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.47 41.7 2.9 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -142.6 -154.19 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.433 -1.04 . . . . 0.0 110.002 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.7 t -108.87 175.8 5.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.451 -0.781 . . . . 0.0 109.466 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.784 HG13 HG12 ' B' ' 22' ' ' VAL . 93.7 t -78.27 -20.5 13.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 110.451 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.6 -26.32 62.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.079 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.02 -30.38 22.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.429 -0.794 . . . . 0.0 109.467 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.501 ' HG3' HG12 ' B' ' 25' ' ' VAL . 0.0 OUTLIER -67.41 -48.35 67.61 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.699 HG23 HG21 ' A' ' 41' ' ' VAL . 47.2 mm -66.81 -30.31 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.427 ' HE1' HG11 ' A' ' 18' ' ' VAL . 36.3 t80 -68.0 -39.41 83.22 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.381 -0.825 . . . . 0.0 110.608 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -45.83 61.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.895 . . . . 0.0 109.759 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' B' ' 36' ' ' GLU . 2.0 mmt-85 -60.93 -24.52 66.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 109.383 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.618 HG21 HG23 ' A' ' 37' ' ' ILE . 49.9 t -90.22 -23.4 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.62 -0.675 . . . . 0.0 110.011 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -57.66 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.507 -0.746 . . . . 0.0 111.081 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -50.22 -33.37 19.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.163 -0.961 . . . . 0.0 111.249 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 38.1 m -60.96 -50.85 71.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.1 -1.0 . . . . 0.0 110.637 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.667 ' CD1' HD21 ' A' ' 21' ' ' LEU . 15.9 m-85 -60.04 -30.04 68.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.79 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.251 -0.905 . . . . 0.0 110.835 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.41 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 1.9 ptm . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 110.358 -0.238 . . . . 43.64 110.358 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.768 ' CG ' HD12 ' A' ' 11' ' ' LEU . 44.0 Cg_endo -70.86 157.77 57.34 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.711 1.374 . . . . 29.79 110.466 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.28 -21.59 62.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.891 . . . . 0.0 110.449 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.514 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 87.4 t80 -70.12 -22.16 63.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.843 . . . . 12.57 110.574 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.768 HD12 ' CG ' ' A' ' 8' ' ' PRO . 85.1 mt -100.23 27.43 5.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.139 -0.975 . . . . 0.0 110.541 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.81 -21.64 44.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.952 . . . . 0.0 110.006 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -85.58 -22.9 27.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.556 ' HB2' HD11 ' A' ' 19' ' ' LEU . 14.7 m0 -66.16 144.81 98.9 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 121.424 -0.798 . . . . 11.57 109.533 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HD2' ' CE1' ' B' ' 38' ' ' TYR . 40.6 Cg_endo -70.85 160.35 49.67 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.496 1.261 . . . . 13.83 111.336 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -40.15 88.9 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.603 0.716 . . . . 48.43 110.934 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.09 -47.29 86.51 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.69 -0.631 . . . . 46.64 111.49 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.0 t -66.89 -48.82 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.038 -1.039 . . . . 16.14 111.021 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 14' ' ' TRP . 74.8 mt -64.02 -24.97 67.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.069 -1.019 . . . . 12.61 110.685 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HA ' ' CD ' ' A' ' 23' ' ' ARG . 13.9 t70 -71.69 -23.68 61.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 23.17 109.898 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.536 HD23 ' CZ ' ' B' ' 45' ' ' PHE . 0.8 OUTLIER -90.29 -43.72 10.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 19.0 110.043 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.993 HG12 HG13 ' A' ' 33' ' ' VAL . 40.6 t -51.32 -39.44 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.392 -0.818 . . . . 18.87 110.477 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.45 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 8.3 ptm180 -66.03 -36.21 82.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 23.61 110.622 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -19.4 58.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 30.11 110.524 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.451 HG12 ' HG3' ' A' ' 36' ' ' GLU . 69.9 t -86.88 -35.09 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.263 -0.898 . . . . 16.22 110.184 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.91 83.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -0.909 . . . . 26.6 109.738 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.98 -19.45 63.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 45.21 110.271 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -82.77 -56.53 3.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 37.85 110.35 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -53.41 -42.64 67.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 35.36 110.386 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.73 44.54 0.54 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.541 -1.424 . . . . 35.1 109.541 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.33 -158.58 0.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -1.123 . . . . 32.72 110.189 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.83 176.93 5.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 19.61 109.561 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.993 HG13 HG12 ' A' ' 22' ' ' VAL . 75.1 t -76.14 -19.42 15.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.356 -0.84 . . . . 17.56 110.265 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -71.12 -27.72 63.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 21.3 108.869 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 m -86.3 -33.64 20.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.555 -0.716 . . . . 16.38 109.531 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG3' HG12 ' A' ' 25' ' ' VAL . 1.1 tt0 -63.55 -53.59 49.42 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.187 -0.946 . . . . 12.61 109.412 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.576 HG23 HG21 ' B' ' 41' ' ' VAL . 25.8 mm -63.37 -21.73 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.458 -0.776 . . . . 10.95 109.653 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 32.9 t80 -76.2 -35.59 59.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.155 -0.966 . . . . 18.87 110.362 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -76.8 -52.03 10.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 36.88 109.6 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -55.46 -24.56 31.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.456 -0.778 . . . . 22.85 109.732 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.587 HG21 HG23 ' B' ' 37' ' ' ILE . 37.5 t -89.97 -29.79 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 13.02 109.867 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -64.07 0.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 18.84 110.48 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.88 -29.13 18.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.19 -0.944 . . . . 29.96 110.425 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.65 -46.45 81.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 18.65 109.928 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.55 ' CZ ' HD23 ' B' ' 21' ' ' LEU . 15.4 m-85 -66.75 -29.07 68.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 16.26 110.167 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 36.71 110.502 -179.807 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.421 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 2.0 ptm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.774 ' CG ' HD12 ' B' ' 11' ' ' LEU . 43.9 Cg_endo -71.04 157.99 56.41 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.621 1.327 . . . . 0.0 110.449 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.53 -21.23 61.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 110.386 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.506 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 86.6 t80 -70.53 -22.08 62.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.441 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.774 HD12 ' CG ' ' B' ' 8' ' ' PRO . 85.1 mt -100.37 27.55 5.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 110.542 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.01 -21.4 43.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 110.034 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -85.86 -22.9 27.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.873 . . . . 0.0 110.189 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.549 ' HB2' HD11 ' B' ' 19' ' ' LEU . 14.8 m0 -66.34 145.2 98.96 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.288 -0.883 . . . . 0.0 109.425 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.461 ' HG2' HG23 ' B' ' 18' ' ' VAL . 41.0 Cg_endo -71.4 159.71 50.77 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.308 1.162 . . . . 0.0 111.341 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -40.4 86.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.676 0.75 . . . . 0.0 110.997 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.15 -47.21 86.87 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.774 -0.579 . . . . 0.0 111.481 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.63 ' O ' HG23 ' B' ' 22' ' ' VAL . 78.9 t -67.11 -48.61 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.304 -0.872 . . . . 0.0 110.902 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' B' ' 14' ' ' TRP . 77.0 mt -64.04 -24.63 67.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.079 -1.013 . . . . 0.0 110.662 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' CD ' ' B' ' 23' ' ' ARG . 13.5 t70 -71.99 -24.14 61.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.231 -0.918 . . . . 0.0 109.754 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.55 HD23 ' CZ ' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -90.03 -43.45 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.502 -0.748 . . . . 0.0 110.096 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.971 HG12 HG13 ' B' ' 33' ' ' VAL . 40.7 t -51.6 -39.62 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.41 -0.806 . . . . 0.0 110.458 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.447 ' CD ' ' HA ' ' B' ' 20' ' ' ASP . 8.3 ptm180 -65.84 -36.29 83.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.706 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -19.57 58.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.459 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.461 HG12 ' HG3' ' B' ' 36' ' ' GLU . 69.9 t -86.71 -35.25 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.923 . . . . 0.0 110.32 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 -39.35 84.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 109.701 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.49 -19.92 63.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 110.245 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -82.45 -56.53 3.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.128 -0.982 . . . . 0.0 110.373 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -53.6 -42.38 67.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 110.46 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.51 44.48 0.55 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.35 -158.68 0.69 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -1.176 . . . . 0.0 110.258 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.69 176.92 5.06 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.363 -0.835 . . . . 0.0 109.617 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.971 HG13 HG12 ' B' ' 22' ' ' VAL . 76.3 t -76.14 -19.26 15.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.261 -0.899 . . . . 0.0 110.308 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -71.18 -27.84 63.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -0.989 . . . . 0.0 108.856 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 45.6 m -86.15 -33.72 20.77 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.549 -0.719 . . . . 0.0 109.536 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.461 ' HG3' HG12 ' B' ' 25' ' ' VAL . 1.1 tt0 -63.4 -53.66 48.88 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.249 -0.907 . . . . 0.0 109.492 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.587 HG23 HG21 ' A' ' 41' ' ' VAL . 26.4 mm -63.32 -21.81 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.528 -0.732 . . . . 0.0 109.596 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.481 ' CE1' ' HD2' ' A' ' 15' ' ' PRO . 33.3 t80 -76.15 -35.51 59.17 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.113 -0.992 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -76.78 -52.08 10.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.146 -0.971 . . . . 0.0 109.645 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -55.44 -24.46 30.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.461 -0.774 . . . . 0.0 109.817 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 37' ' ' ILE . 37.7 t -90.07 -29.97 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 0.0 109.898 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -63.92 1.01 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 110.451 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.03 -29.35 20.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.156 -0.965 . . . . 0.0 110.325 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -46.7 80.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 110.011 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.536 ' CZ ' HD23 ' A' ' 21' ' ' LEU . 15.7 m-85 -66.73 -28.95 68.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 110.125 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 110.481 -179.82 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 mtp . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 110.381 -0.229 . . . . 43.64 110.381 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.9 Cg_endo -71.12 170.59 17.79 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.565 1.297 . . . . 29.79 110.791 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -87.0 -17.55 32.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 110.327 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.513 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 74.2 t80 -72.62 -26.12 61.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 12.57 110.564 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.705 ' HB3' HD21 ' A' ' 19' ' ' LEU . 71.6 mt -94.34 27.1 3.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 110.14 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.7 -18.11 61.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 110.414 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.7 -3.84 29.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.086 -1.008 . . . . 0.0 110.726 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.8 m0 -81.87 138.33 46.69 Favored Pre-proline 0 C--N 1.305 -1.332 0 O-C-N 120.95 -1.094 . . . . 11.57 109.635 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.23 159.59 51.5 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.482 1.254 . . . . 13.83 111.228 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -40.97 96.93 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.856 0.836 . . . . 48.43 110.382 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -52.71 -21.01 3.56 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.691 -0.631 . . . . 46.64 111.223 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 22' ' ' VAL . 92.6 t -104.0 -44.77 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.974 -1.079 . . . . 16.14 111.227 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.705 HD21 ' HB3' ' A' ' 11' ' ' LEU . 20.0 mt -63.12 -24.64 67.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.134 -0.979 . . . . 12.61 111.11 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -25.75 60.48 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.248 -0.907 . . . . 23.17 109.56 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.704 ' O ' HG23 ' A' ' 25' ' ' VAL . 42.9 tp -85.54 -42.47 14.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.599 -0.688 . . . . 19.0 109.849 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.037 HG12 HG13 ' A' ' 33' ' ' VAL . 25.3 t -55.3 -37.94 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 18.87 110.205 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -67.5 -50.49 58.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 23.61 110.439 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -19.48 65.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.218 -0.926 . . . . 30.11 110.338 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.751 HG12 ' CD ' ' A' ' 36' ' ' GLU . 86.9 t -86.84 -32.58 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 16.22 110.061 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.419 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -71.74 -39.13 70.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.199 -0.938 . . . . 26.6 109.306 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 -19.37 62.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.529 -0.732 . . . . 45.21 109.77 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.84 -57.12 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 37.85 110.153 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -56.29 -53.69 54.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 35.36 110.227 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.75 52.43 0.08 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.669 -1.372 . . . . 35.1 109.669 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -169.33 -159.19 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -1.21 . . . . 32.72 110.223 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.419 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 56.8 p -98.4 -176.43 3.39 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.462 -0.774 . . . . 19.61 109.778 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG13 HG12 ' A' ' 22' ' ' VAL . 86.4 t -81.5 -9.94 12.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.155 -0.966 . . . . 17.56 110.708 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -75.72 -29.87 59.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.007 -1.058 . . . . 21.3 109.318 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -90.42 -28.63 18.51 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.372 -0.83 . . . . 16.38 110.058 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.751 ' CD ' HG12 ' A' ' 25' ' ' VAL . 12.0 tp10 -65.05 -51.15 63.12 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.134 -0.979 . . . . 12.61 109.66 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.601 HD11 HG11 ' A' ' 22' ' ' VAL . 2.7 mt -67.08 -20.6 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.398 -0.814 . . . . 10.95 109.729 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.415 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 46.7 t80 -69.61 -39.15 77.41 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.112 -0.992 . . . . 18.87 110.27 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -71.82 -43.5 65.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 36.88 110.223 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HD3' ' HB3' ' B' ' 44' ' ' SER . 17.0 mtt-85 -63.3 -31.98 73.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 22.85 109.519 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.616 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 71.3 t -83.33 -22.8 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.626 -0.671 . . . . 13.02 110.284 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.25 -34.89 48.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.408 -0.807 . . . . 18.84 110.587 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -72.48 -32.4 66.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 29.96 110.268 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.413 ' HB3' ' HD3' ' B' ' 40' ' ' ARG . 0.1 OUTLIER -56.13 -54.79 40.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 18.65 110.071 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.643 ' CD1' HD21 ' B' ' 21' ' ' LEU . 27.0 m-85 -62.02 -19.46 62.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 16.26 110.572 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 36.71 110.162 179.894 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 120.554 0.216 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.513 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 45.6 Cg_endo -71.19 170.71 17.55 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.555 1.292 . . . . 0.0 110.782 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -87.27 -17.51 32.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.408 -0.808 . . . . 0.0 110.398 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.489 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 76.9 t80 -72.69 -26.0 61.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.867 . . . . 0.0 110.477 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.714 ' HB3' HD21 ' B' ' 19' ' ' LEU . 71.8 mt -94.57 27.22 3.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.181 -0.949 . . . . 0.0 110.174 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.82 -18.12 60.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 110.489 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.6 -3.7 29.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.086 -1.009 . . . . 0.0 110.786 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.616 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.9 m0 -82.13 138.6 45.71 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.103 -0.998 . . . . 0.0 109.67 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.0 Cg_endo -71.36 159.54 51.38 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.175 1.092 . . . . 0.0 110.95 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.74 96.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.636 0.731 . . . . 0.0 110.301 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -52.65 -21.09 3.58 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.701 -0.624 . . . . 0.0 111.105 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.636 ' O ' HG23 ' B' ' 22' ' ' VAL . 98.5 t -104.05 -44.61 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.441 -1.412 . . . . 0.0 111.14 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' B' ' 11' ' ' LEU . 19.9 mt -63.26 -24.76 68.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.132 -0.98 . . . . 0.0 111.081 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -25.37 60.07 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.251 -0.906 . . . . 0.0 109.683 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.726 ' O ' HG23 ' B' ' 25' ' ' VAL . 44.8 tp -85.7 -42.29 14.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.577 -0.702 . . . . 0.0 109.968 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 1.075 HG12 HG13 ' B' ' 33' ' ' VAL . 26.2 t -55.42 -37.97 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.107 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -67.3 -50.81 58.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.305 -0.872 . . . . 0.0 110.455 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -19.55 64.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.229 -0.919 . . . . 0.0 110.5 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.749 HG12 ' CD ' ' B' ' 36' ' ' GLU . 87.6 t -86.7 -32.62 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 110.1 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.418 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -71.52 -39.09 70.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.25 -19.34 62.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.529 -0.732 . . . . 0.0 109.764 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.83 -57.12 3.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 110.227 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -56.37 -53.82 52.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 110.284 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.09 52.44 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -169.36 -159.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.267 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.418 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 54.5 p -98.31 -176.32 3.37 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.314 -0.866 . . . . 0.0 109.867 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 1.075 HG13 HG12 ' B' ' 22' ' ' VAL . 88.0 t -81.62 -9.97 12.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.17 -0.956 . . . . 0.0 110.819 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -75.61 -29.88 59.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.982 . . . . 0.0 109.367 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -90.39 -28.68 18.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.952 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.749 ' CD ' HG12 ' B' ' 25' ' ' VAL . 12.0 tp10 -65.14 -50.96 63.99 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.194 -0.941 . . . . 0.0 109.732 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.594 HD11 HG11 ' B' ' 22' ' ' VAL . 2.5 mt -67.13 -20.82 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -69.66 -39.3 77.13 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.214 -0.929 . . . . 0.0 110.252 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -71.51 -43.48 66.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.83 . . . . 0.0 110.198 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.413 ' HD3' ' HB3' ' A' ' 44' ' ' SER . 17.3 mtt-85 -63.5 -32.05 73.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.95 . . . . 0.0 109.502 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 37' ' ' ILE . 76.9 t -82.92 -22.87 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 110.34 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.36 -34.98 47.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.819 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.45 -32.35 66.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.136 -0.977 . . . . 0.0 110.208 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.416 ' HB3' ' HD3' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -56.22 -54.78 41.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 110.105 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.641 ' CD1' HD21 ' A' ' 21' ' ' LEU . 27.2 m-85 -61.85 -19.42 62.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 110.54 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.219 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.465 ' CE ' HD13 ' A' ' 19' ' ' LEU . 4.2 mtt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 110.114 -0.328 . . . . 43.64 110.114 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.747 ' CG ' HD12 ' A' ' 11' ' ' LEU . 46.9 Cg_endo -73.4 156.8 50.12 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.516 1.272 . . . . 29.79 110.495 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -76.53 -11.64 59.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.614 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -79.31 -34.35 42.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.014 -1.054 . . . . 12.57 110.291 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.747 HD12 ' CG ' ' A' ' 8' ' ' PRO . 66.1 mt -88.27 14.89 8.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.096 -1.003 . . . . 0.0 110.586 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.58 -27.44 69.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -82.34 -23.78 34.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.92 . . . . 0.0 110.519 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.501 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.0 m0 -63.43 141.72 97.86 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.312 -0.867 . . . . 11.57 109.21 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.39 173.63 9.41 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.458 1.241 . . . . 13.83 111.082 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -77.82 -22.03 50.63 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.499 -0.751 . . . . 48.43 109.769 -179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.7 -46.22 39.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 46.64 110.428 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.85 ' O ' HG23 ' A' ' 22' ' ' VAL . 97.9 t -68.72 -39.58 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 16.14 110.157 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 11' ' ' LEU . 24.8 mt -66.26 -31.52 72.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 12.61 110.654 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 3.4 t0 -70.75 -22.33 62.42 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 23.17 110.074 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.784 ' O ' HG23 ' A' ' 25' ' ' VAL . 51.0 tp -88.83 -37.62 15.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.372 -0.83 . . . . 19.0 109.951 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.981 HG12 HG13 ' A' ' 33' ' ' VAL . 15.6 t -65.84 -49.51 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 18.87 109.959 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HA ' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -59.91 -35.76 75.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 23.61 110.483 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 23' ' ' ARG . 2.1 tmtt? -73.43 -24.55 60.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.113 -0.992 . . . . 30.11 109.943 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 21' ' ' LEU . 99.4 t -86.63 -20.89 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.497 -0.752 . . . . 16.22 110.311 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.578 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -82.22 -30.21 30.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.217 -0.927 . . . . 26.6 109.539 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.43 -19.51 49.78 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.471 -0.768 . . . . 45.21 110.307 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 22.8 pt-20 -90.82 -30.82 16.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.191 -0.943 . . . . 37.85 110.279 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.426 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -82.97 7.68 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 35.36 110.558 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.45 23.98 70.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.517 -1.433 . . . . 35.1 109.517 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 8.8 mtt-85 -129.19 -158.02 0.86 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -1.194 . . . . 32.72 110.362 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.578 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 1.8 m -115.06 -179.65 3.69 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.511 -0.743 . . . . 19.61 109.286 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.981 HG13 HG12 ' A' ' 22' ' ' VAL . 99.1 t -77.97 -14.86 14.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.129 -0.982 . . . . 17.56 110.448 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -77.03 -41.69 41.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.102 -0.998 . . . . 21.3 109.004 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.8 t -71.18 -35.9 71.76 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.386 -0.821 . . . . 16.38 109.56 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.9 tp10 -64.68 -50.54 66.6 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.233 -0.917 . . . . 12.61 109.405 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.722 HG23 HG21 ' B' ' 41' ' ' VAL . 35.6 mm -63.94 -26.82 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 10.95 109.53 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' B' ' 18' ' ' VAL . 53.4 t80 -71.89 -37.19 70.19 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.374 -0.829 . . . . 18.87 110.753 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.74 -36.34 59.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -0.932 . . . . 36.88 110.253 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -71.99 -24.16 61.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 22.85 109.64 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.787 HG21 HG23 ' B' ' 37' ' ' ILE . 7.0 t -87.09 -28.68 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.8 . . . . 13.02 109.217 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -43.45 60.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.603 -0.685 . . . . 18.84 110.531 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -28.93 68.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 29.96 110.137 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -49.81 70.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.89 . . . . 18.65 110.07 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.584 ' CD1' HD21 ' B' ' 21' ' ' LEU . 31.1 m-85 -66.01 -22.87 66.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 16.26 110.371 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.19 -0.944 . . . . 36.71 110.525 -179.644 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.453 ' CE ' HD13 ' B' ' 19' ' ' LEU . 4.3 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.755 ' CG ' HD12 ' B' ' 11' ' ' LEU . 47.4 Cg_endo -73.41 156.96 50.0 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.522 1.275 . . . . 0.0 110.384 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -76.8 -11.93 59.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.588 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.411 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 89.5 t80 -79.01 -34.09 44.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.078 -1.014 . . . . 0.0 110.322 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.755 HD12 ' CG ' ' B' ' 8' ' ' PRO . 64.6 mt -88.84 15.62 8.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 110.601 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.49 -26.85 68.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -82.77 -23.98 33.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 110.382 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' TRP . . . . . 0.53 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.0 m0 -63.17 142.07 97.75 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.278 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.9 173.97 9.42 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.431 1.227 . . . . 0.0 111.259 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 20' ' ' ASP . 0.0 OUTLIER -78.36 -21.85 48.83 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.333 -0.854 . . . . 0.0 109.722 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.39 -46.11 42.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 110.696 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.837 ' O ' HG23 ' B' ' 22' ' ' VAL . 98.2 t -68.8 -39.57 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.145 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.538 HD21 ' HB3' ' B' ' 11' ' ' LEU . 25.3 mt -66.36 -31.33 72.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 110.574 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' B' ' 16' ' ' ARG . 3.5 t0 -70.83 -23.08 62.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.072 -1.018 . . . . 0.0 109.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.769 ' O ' HG23 ' B' ' 25' ' ' VAL . 50.0 tp -87.83 -37.68 16.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -0.932 . . . . 0.0 109.936 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.98 HG12 HG13 ' B' ' 33' ' ' VAL . 15.7 t -66.05 -49.57 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.391 -0.818 . . . . 0.0 109.967 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.485 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -59.76 -35.52 74.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 110.52 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' B' ' 23' ' ' ARG . 2.1 tmtt? -73.94 -24.24 59.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.065 -1.022 . . . . 0.0 109.981 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.769 HG23 ' O ' ' B' ' 21' ' ' LEU . 97.3 t -86.71 -20.75 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.256 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.574 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -82.59 -30.41 29.57 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.165 -0.959 . . . . 0.0 109.57 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.16 -19.63 50.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.481 -0.762 . . . . 0.0 110.254 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' B' ' 25' ' ' VAL . 22.5 pt-20 -90.72 -30.76 16.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.092 -1.005 . . . . 0.0 110.195 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.439 ' N ' ' HG3' ' B' ' 28' ' ' GLU . 0.5 OUTLIER -83.11 7.71 15.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.631 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.4 24.11 70.58 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 29' ' ' ASN . 8.7 mtt-85 -129.33 -157.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 110.235 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.574 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 1.8 m -115.24 -179.38 3.62 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.451 -0.781 . . . . 0.0 109.258 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.98 HG13 HG12 ' B' ' 22' ' ' VAL . 98.1 t -78.15 -14.6 13.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.09 -1.006 . . . . 0.0 110.645 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -77.2 -41.67 40.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.123 -0.985 . . . . 0.0 109.06 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 8.7 t -71.29 -36.05 71.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.415 -0.803 . . . . 0.0 109.375 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.425 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.9 tp10 -64.58 -50.52 66.89 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.787 HG23 HG21 ' A' ' 41' ' ' VAL . 34.0 mm -63.81 -27.2 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.404 -0.81 . . . . 0.0 109.526 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -71.54 -37.28 71.15 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 0.0 110.807 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.81 -36.32 59.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -71.92 -23.94 61.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.695 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.777 HG23 HG23 ' A' ' 41' ' ' VAL . 6.5 t -87.54 -28.4 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -43.73 59.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.609 -0.682 . . . . 0.0 110.447 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -29.16 68.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -50.04 70.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.642 ' CD1' HD21 ' A' ' 21' ' ' LEU . 31.2 m-85 -65.88 -22.86 66.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.49 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.292 -0.88 . . . . 0.0 110.517 -179.628 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mtt . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.149 0.499 . . . . 50.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.95 85.81 6.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 50.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.34 155.07 20.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.56 -1.416 . . . . 50.0 109.56 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.53 -53.35 2.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -1.164 . . . . 50.0 110.221 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.4 p -68.13 168.12 12.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 50.0 110.231 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -166.12 143.26 5.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 50.0 110.206 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.63 142.32 77.82 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.169 -0.957 . . . . 43.64 109.997 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.0 Cg_endo -72.61 143.77 38.61 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.736 1.387 . . . . 29.79 110.478 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -61.05 -17.61 53.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.833 . . . . 0.0 110.15 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.5 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 69.6 t80 -67.9 -37.48 81.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 12.57 110.36 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.606 ' HB3' HD21 ' A' ' 19' ' ' LEU . 80.8 mt -91.6 21.52 4.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.352 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -74.23 -19.26 60.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.08 -17.93 21.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.134 -0.979 . . . . 0.0 110.653 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.432 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.8 m0 -64.9 144.03 98.93 Favored Pre-proline 0 C--N 1.304 -1.387 0 O-C-N 121.145 -0.972 . . . . 11.57 109.171 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 40.1 Cg_endo -69.23 169.45 18.22 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.384 1.202 . . . . 13.83 110.56 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -25.81 43.94 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.572 -0.705 . . . . 48.43 109.592 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -69.14 -19.26 64.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.173 -0.955 . . . . 46.64 110.078 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.817 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.9 t -102.76 -36.27 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 16.14 109.888 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' A' ' 11' ' ' LEU . 17.5 mt -66.51 -33.91 76.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.416 -0.802 . . . . 12.61 110.509 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.31 -30.28 70.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 23.17 109.851 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.803 ' O ' HG23 ' A' ' 25' ' ' VAL . 28.0 tp -80.76 -38.0 29.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.521 -0.737 . . . . 19.0 109.852 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 18' ' ' VAL . 48.3 t -59.66 -51.72 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 18.87 110.211 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.63 -41.77 82.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.421 -0.799 . . . . 23.61 110.781 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -73.41 -18.2 61.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.118 -0.989 . . . . 30.11 110.841 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 21' ' ' LEU . 59.2 t -84.15 -35.73 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.081 -1.012 . . . . 16.22 110.481 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.594 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -66.5 -36.23 82.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 26.6 109.712 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -72.59 -23.31 60.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.811 . . . . 45.21 109.935 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -78.1 -42.21 32.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 37.85 109.863 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -67.86 -44.48 77.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 35.36 110.105 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.35 37.08 0.95 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.076 -1.21 . . . . 35.1 110.076 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.74 -165.43 1.65 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.042 -1.27 . . . . 32.72 110.601 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -84.0 174.41 10.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 19.61 110.372 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.594 HG22 ' CB ' ' A' ' 26' ' ' ALA . 88.0 t -84.44 -26.72 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.39 -0.818 . . . . 17.56 110.235 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -59.18 -27.1 65.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 21.3 108.977 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.2 t -89.81 -29.71 18.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.519 -0.738 . . . . 16.38 109.536 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.419 ' OE1' ' HB2' ' A' ' 26' ' ' ALA . 30.9 tt0 -61.49 -57.47 12.02 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.116 -0.99 . . . . 12.61 109.519 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.535 HG23 HG21 ' B' ' 41' ' ' VAL . 41.1 mm -58.12 -27.1 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.359 -0.838 . . . . 10.95 109.711 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.477 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 38.9 t80 -70.69 -34.37 71.9 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.135 -0.978 . . . . 18.87 110.15 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -75.06 -53.73 8.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 36.88 110.169 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -57.64 -23.06 49.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.114 -0.991 . . . . 22.85 109.802 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.611 HG21 HG23 ' B' ' 37' ' ' ILE . 39.8 t -89.42 -27.5 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.396 -0.815 . . . . 13.02 109.51 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -25.86 60.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.528 -0.733 . . . . 18.84 110.569 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.78 -21.62 29.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.088 -1.008 . . . . 29.96 110.555 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -66.18 -47.47 73.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 18.65 110.165 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.73 ' CE1' HG21 ' B' ' 25' ' ' VAL . 28.5 m-85 -61.01 -37.44 82.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 16.26 110.373 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -65.98 -26.75 67.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 36.71 110.314 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -51.51 -42.75 61.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.183 -0.948 . . . . 41.6 110.454 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.71 -22.83 17.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 24.83 110.202 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.32 45.15 3.32 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.637 -1.385 . . . . 18.81 109.637 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -88.23 -33.38 18.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.606 -0.938 . . . . 23.01 110.52 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.0 mt -81.3 -48.63 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 119.61 -0.836 . . . . 27.08 110.468 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.57 50.58 0.6 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.731 -1.348 . . . . 32.03 109.731 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 O-C-N 120.996 -1.297 . . . . 0.0 110.165 179.981 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.8 mtt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.201 0.524 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.77 85.73 6.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.23 155.29 21.18 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.77 -53.3 2.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -1.124 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 27.9 p -68.34 168.23 12.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.228 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -166.2 143.15 5.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 110.186 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.43 142.53 76.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.018 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.5 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 44.6 Cg_endo -72.72 143.77 38.15 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.721 1.38 . . . . 0.0 110.523 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -60.9 -17.58 51.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.242 -0.911 . . . . 0.0 110.16 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.529 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 68.4 t80 -67.83 -37.63 82.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 110.375 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.621 ' HB3' HD21 ' B' ' 19' ' ' LEU . 80.6 mt -91.57 21.79 4.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.363 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -74.41 -19.29 60.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.421 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.99 -18.11 21.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.16 -0.962 . . . . 0.0 110.613 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.444 ' CZ2' ' HA ' ' A' ' 38' ' ' TYR . 14.0 m0 -64.83 144.2 98.89 Favored Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.023 -1.048 . . . . 0.0 109.229 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.477 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.4 Cg_endo -69.28 169.64 17.84 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.519 1.273 . . . . 0.0 110.651 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.17 -25.46 42.82 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.384 -0.822 . . . . 0.0 109.474 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -69.35 -19.34 63.85 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.808 ' O ' HG23 ' B' ' 22' ' ' VAL . 58.2 t -102.6 -36.65 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.16 -0.963 . . . . 0.0 109.756 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' B' ' 11' ' ' LEU . 17.9 mt -65.76 -33.99 77.15 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.16 -0.963 . . . . 0.0 110.662 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.4 -30.6 71.01 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.826 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.793 ' O ' HG23 ' B' ' 25' ' ' VAL . 26.9 tp -80.44 -38.05 30.84 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.862 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.808 HG23 ' O ' ' B' ' 18' ' ' VAL . 48.2 t -59.77 -51.52 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 110.258 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.62 -41.85 82.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.783 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -73.42 -18.2 61.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.18 -0.95 . . . . 0.0 110.851 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.793 HG23 ' O ' ' B' ' 21' ' ' LEU . 58.3 t -84.15 -35.88 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.164 -0.96 . . . . 0.0 110.473 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.587 ' CB ' HG22 ' B' ' 33' ' ' VAL . . . -66.41 -36.14 82.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.043 -1.036 . . . . 0.0 109.828 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -72.58 -23.21 60.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.928 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -78.24 -42.17 31.99 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.342 -0.849 . . . . 0.0 109.923 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.04 -44.42 76.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.83 . . . . 0.0 110.025 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.34 36.99 0.96 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.64 -165.47 1.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.019 -1.283 . . . . 0.0 110.571 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m -84.04 174.4 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.356 -0.84 . . . . 0.0 110.364 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.587 HG22 ' CB ' ' B' ' 26' ' ' ALA . 85.8 t -84.52 -26.46 7.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.411 -0.806 . . . . 0.0 110.278 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.404 ' ND2' ' CD1' ' A' ' 10' ' ' PHE . 3.7 t-20 -59.4 -27.01 65.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.179 -0.95 . . . . 0.0 108.942 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 6.2 t -89.85 -29.9 18.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.72 . . . . 0.0 109.465 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.416 ' OE1' ' HB2' ' B' ' 26' ' ' ALA . 31.0 tt0 -61.21 -57.61 11.71 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.132 -0.98 . . . . 0.0 109.532 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.611 HG23 HG21 ' A' ' 41' ' ' VAL . 40.8 mm -58.19 -27.45 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.38 -0.825 . . . . 0.0 109.65 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.407 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 36.5 t80 -70.19 -34.52 73.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.196 -0.94 . . . . 0.0 110.133 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -75.02 -53.72 8.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 110.183 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' B' ' 36' ' ' GLU . 7.5 mtt85 -57.6 -23.13 49.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.843 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.535 HG21 HG23 ' A' ' 37' ' ' ILE . 39.6 t -89.15 -27.72 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.436 -0.79 . . . . 0.0 109.523 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -26.01 60.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.745 . . . . 0.0 110.61 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.86 -21.6 29.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.212 -0.93 . . . . 0.0 110.508 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -66.1 -47.47 74.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 110.163 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.616 ' HE1' HG21 ' A' ' 25' ' ' VAL . 27.8 m-85 -61.17 -37.46 83.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -65.72 -26.79 67.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.361 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -51.64 -42.55 62.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.887 . . . . 0.0 110.527 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.91 -22.87 17.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.153 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.34 45.53 3.23 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -88.62 -33.32 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.421 -1.046 . . . . 0.0 110.365 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 92.6 mt -81.47 -48.83 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.179 -0.95 . . . . 0.0 110.24 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.79 50.38 0.6 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 110.203 -179.948 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.243 0.544 . . . . 50.0 110.239 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.58 123.23 39.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 50.0 110.216 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 5' ' ' SER . . . -100.64 -25.56 8.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.467 -1.453 . . . . 50.0 109.467 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.3 mtm 55.42 -89.76 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.474 -1.015 . . . . 50.0 110.377 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.5 p -138.97 140.22 38.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.916 -1.115 . . . . 50.0 110.323 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -125.29 173.99 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 50.0 110.11 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.4 mtp -56.0 143.26 62.91 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 43.64 110.206 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 48.9 Cg_endo -75.79 160.22 37.76 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.627 1.33 . . . . 29.79 110.431 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -18.28 60.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.115 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.444 ' CE1' ' OD1' ' B' ' 34' ' ' ASN . 56.3 t80 -71.3 -35.8 71.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 12.57 110.348 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.594 ' HB3' HD21 ' A' ' 19' ' ' LEU . 93.8 mt -89.64 16.77 7.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.44 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.55 -31.22 66.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 110.024 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -12.47 59.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.35 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.482 ' CE3' HD22 ' A' ' 11' ' ' LEU . 16.5 m0 -77.48 142.2 66.56 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.173 -0.955 . . . . 11.57 109.451 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.38 173.63 10.36 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.586 1.309 . . . . 13.83 110.551 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -22.66 42.18 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.396 -0.815 . . . . 48.43 109.605 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HG3' HG23 ' A' ' 18' ' ' VAL . 10.2 pt-20 -71.5 -36.37 71.07 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.149 -0.969 . . . . 46.64 110.35 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 22' ' ' VAL . 93.8 t -81.27 -43.06 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 16.14 110.254 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 11' ' ' LEU . 73.3 mt -65.1 -32.03 73.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 12.61 110.28 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.45 -24.39 66.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 23.17 109.68 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.876 ' O ' HG23 ' A' ' 25' ' ' VAL . 26.9 tp -87.09 -40.06 15.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.791 . . . . 19.0 109.895 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.963 HG12 HG13 ' A' ' 33' ' ' VAL . 38.5 t -56.48 -40.62 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 18.87 109.488 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -59.81 4.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.675 -0.641 . . . . 23.61 110.297 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.26 -28.67 59.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.229 -0.92 . . . . 30.11 110.937 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 21' ' ' LEU . 50.7 t -71.82 -39.31 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.991 -1.068 . . . . 16.22 110.423 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.72 -40.29 88.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.067 -1.021 . . . . 26.6 109.539 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -71.69 -20.99 61.85 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.449 -0.782 . . . . 45.21 109.941 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -54.41 9.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 37.85 109.809 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -71.38 -25.02 62.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.873 . . . . 35.36 110.26 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.48 69.53 1.04 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.71 -1.356 . . . . 35.1 109.71 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.73 -162.91 0.13 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.254 -1.145 . . . . 32.72 110.287 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.8 t -93.2 171.97 8.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 19.61 110.091 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.963 HG13 HG12 ' A' ' 22' ' ' VAL . 69.2 t -83.89 -23.33 7.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.23 -0.919 . . . . 17.56 110.073 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' OD1' ' CE1' ' B' ' 10' ' ' PHE . 0.8 OUTLIER -63.78 -28.14 69.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 21.3 109.255 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -90.15 -32.24 16.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.446 -0.784 . . . . 16.38 109.825 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' CG ' HG12 ' A' ' 25' ' ' VAL . 11.0 tp10 -61.67 -37.95 85.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.144 -0.973 . . . . 12.61 109.319 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 41' ' ' VAL . 21.6 mm -76.95 -25.3 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.529 -0.732 . . . . 10.95 109.156 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 33.4 t80 -74.72 -27.38 60.35 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.271 -0.893 . . . . 18.87 110.198 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -81.71 -49.34 10.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 36.88 109.512 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.417 ' CZ ' HG11 ' A' ' 25' ' ' VAL . 55.9 mtt-85 -59.0 -28.79 66.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 22.85 109.189 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.5 t -82.82 -26.95 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.581 -0.699 . . . . 13.02 109.329 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp -76.68 -23.82 53.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.467 -0.77 . . . . 18.84 110.27 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.14 -33.91 56.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.264 -0.897 . . . . 29.96 110.294 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.437 ' CB ' ' HD3' ' B' ' 40' ' ' ARG . 81.8 p -58.47 -41.22 84.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 18.65 110.278 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.643 ' CD1' HD21 ' B' ' 21' ' ' LEU . 25.5 m-85 -74.43 -35.5 63.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 16.26 110.371 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -57.95 -46.31 85.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 36.71 110.476 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -61.79 -33.74 74.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -0.949 . . . . 41.6 110.286 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' HB3' ' HG2' ' A' ' 50' ' ' ARG . 3.4 mt-10 -82.71 -14.2 55.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 24.83 110.473 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.7 23.19 70.49 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.813 -1.315 . . . . 18.81 109.813 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.408 ' HG2' ' HB3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -70.57 -33.59 71.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.306 -1.114 . . . . 23.01 110.252 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.498 HG22 ' N ' ' A' ' 52' ' ' GLY . 39.4 mt -85.19 173.55 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 27.08 109.813 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 51' ' ' ILE . . . -115.5 -37.65 1.07 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.516 -1.434 . . . . 32.03 109.516 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.186 -1.184 . . . . 0.0 110.371 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.261 0.553 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.48 122.88 38.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.313 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' B' ' 5' ' ' SER . . . -100.29 -25.36 8.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 40.4 mtm 55.1 -89.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.38 -1.07 . . . . 0.0 110.477 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.406 ' N ' ' O ' ' B' ' 3' ' ' GLY . 4.7 p -139.27 139.98 37.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.885 -1.134 . . . . 0.0 110.424 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -125.12 174.0 8.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.13 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtp -55.92 143.04 63.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.444 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 48.9 Cg_endo -75.66 159.6 38.79 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.632 1.332 . . . . 0.0 110.422 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -18.32 61.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.156 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.5 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 58.3 t80 -71.27 -36.0 71.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.971 . . . . 0.0 110.453 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' B' ' 19' ' ' LEU . 94.4 mt -89.37 16.78 6.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.928 . . . . 0.0 110.571 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.48 -31.26 66.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.128 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -12.36 59.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 110.337 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.469 ' CE3' HD22 ' B' ' 11' ' ' LEU . 16.0 m0 -77.52 141.94 66.04 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.246 -0.909 . . . . 0.0 109.489 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.47 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.5 Cg_endo -69.38 173.89 9.98 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.625 1.329 . . . . 0.0 110.543 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -23.26 41.82 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' B' ' 18' ' ' VAL . 10.2 pt-20 -71.34 -36.39 71.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.851 . . . . 0.0 110.368 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.707 ' O ' HG23 ' B' ' 22' ' ' VAL . 92.9 t -81.23 -43.48 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 O-C-N 121.072 -1.017 . . . . 0.0 110.014 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' B' ' 11' ' ' LEU . 72.8 mt -64.35 -32.54 74.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.05 -24.73 66.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.747 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.875 ' O ' HG23 ' B' ' 25' ' ' VAL . 27.9 tp -86.71 -40.1 15.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.404 -0.81 . . . . 0.0 109.904 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.944 HG12 HG13 ' B' ' 33' ' ' VAL . 35.1 t -56.4 -40.45 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.597 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.22 -59.63 5.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.645 -0.66 . . . . 0.0 110.267 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -28.27 59.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.267 -0.895 . . . . 0.0 110.963 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.875 HG23 ' O ' ' B' ' 21' ' ' LEU . 53.2 t -72.17 -39.48 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.013 . . . . 0.0 110.361 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.11 88.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.14 -0.975 . . . . 0.0 109.509 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -71.79 -20.85 61.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.341 -0.849 . . . . 0.0 110.044 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -54.23 9.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.863 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.34 -25.32 62.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.42 -0.8 . . . . 0.0 110.089 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.43 69.99 1.06 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.01 -163.27 0.13 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.321 -1.106 . . . . 0.0 110.191 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -92.9 172.93 8.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 110.082 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.944 HG13 HG12 ' B' ' 22' ' ' VAL . 68.4 t -85.08 -22.69 7.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.278 -0.889 . . . . 0.0 110.001 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.444 ' OD1' ' CE1' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -64.26 -27.85 69.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.157 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -90.2 -33.56 16.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.487 -0.758 . . . . 0.0 109.707 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.419 ' CG ' HG12 ' B' ' 25' ' ' VAL . 10.8 tp10 -60.31 -38.18 82.87 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.157 -0.964 . . . . 0.0 109.403 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.462 ' O ' HG23 ' B' ' 41' ' ' VAL . 21.2 mm -77.11 -24.85 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.51 -0.744 . . . . 0.0 109.228 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.417 ' HB2' ' NE1' ' A' ' 14' ' ' TRP . 34.0 t80 -75.32 -26.58 58.77 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.261 -0.899 . . . . 0.0 110.109 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -82.28 -49.53 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.58 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.437 ' HD3' ' CB ' ' A' ' 44' ' ' SER . 55.7 mtt-85 -58.81 -28.98 66.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.442 -0.786 . . . . 0.0 109.184 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 37' ' ' ILE . 45.1 t -82.54 -27.46 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.546 0.688 . . . . 0.0 109.414 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp -76.08 -23.41 55.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.468 -0.77 . . . . 0.0 110.269 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.47 -34.31 54.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.158 -0.964 . . . . 0.0 110.24 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 85.4 p -57.86 -41.5 82.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 110.156 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.68 ' CD1' HD21 ' A' ' 21' ' ' LEU . 25.3 m-85 -74.5 -35.78 63.22 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -57.76 -46.36 84.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.37 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -61.45 -34.2 75.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.342 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -82.17 -14.66 55.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.207 -0.933 . . . . 0.0 110.606 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.11 23.5 68.61 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -33.51 70.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.184 -1.186 . . . . 0.0 110.06 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.497 HG22 ' N ' ' B' ' 52' ' ' GLY . 40.1 mt -85.19 173.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.239 -0.913 . . . . 0.0 109.707 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.497 ' N ' HG22 ' B' ' 51' ' ' ILE . . . -115.61 -37.61 1.06 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.238 -1.154 . . . . 0.0 110.272 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.236 0.541 . . . . 50.0 110.234 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt 53.06 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 50.0 110.229 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.09 -44.34 29.91 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.757 -1.337 . . . . 50.0 109.757 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 55.03 21.76 3.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.202 -1.175 . . . . 50.0 110.309 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -62.76 -179.3 0.26 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 50.0 110.184 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -73.67 -162.35 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 50.0 109.974 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.33 163.6 33.21 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.26 -0.9 . . . . 43.64 110.244 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HG3' ' CE1' ' B' ' 10' ' ' PHE . 43.0 Cg_endo -71.47 147.52 52.32 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.626 1.33 . . . . 29.79 110.545 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.49 -19.38 61.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 110.631 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.519 ' CE1' ' HG3' ' B' ' 8' ' ' PRO . 87.3 t80 -69.25 -32.09 71.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.952 . . . . 12.57 110.11 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HB3' HD21 ' A' ' 19' ' ' LEU . 96.8 mt -91.99 19.07 7.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.371 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -71.65 -25.52 62.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 110.205 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -16.12 46.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.477 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.739 ' HH2' HG21 ' B' ' 41' ' ' VAL . 15.1 m0 -72.69 145.59 87.28 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.306 -0.871 . . . . 11.57 109.815 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HG2' HG23 ' A' ' 18' ' ' VAL . 43.1 Cg_endo -73.4 166.33 30.18 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.559 1.294 . . . . 13.83 111.24 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.87 85.68 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.995 0.902 . . . . 48.43 110.33 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.46 -34.76 74.49 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.918 -0.583 . . . . 46.64 111.575 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 22' ' ' VAL . 91.2 t -82.84 -44.91 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.924 -1.11 . . . . 16.14 110.817 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 11' ' ' LEU . 61.2 mt -64.54 -27.31 68.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.143 -0.973 . . . . 12.61 110.722 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.44 -23.15 63.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 23.17 109.76 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.75 HD21 ' CD1' ' B' ' 45' ' ' PHE . 4.8 tp -89.39 -42.22 11.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.45 -0.781 . . . . 19.0 109.985 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.866 HG12 HG13 ' A' ' 33' ' ' VAL . 48.0 t -51.8 -46.22 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 18.87 110.699 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -54.59 -58.5 7.27 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.361 -0.837 . . . . 23.61 110.85 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -54.12 -22.65 11.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.908 . . . . 30.11 111.054 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.629 HG12 ' CD ' ' A' ' 36' ' ' GLU . 58.9 t -82.54 -38.61 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 16.22 110.961 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.67 74.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.036 . . . . 26.6 110.112 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.39 -9.86 58.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -0.887 . . . . 45.21 110.528 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -88.88 -53.59 4.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.083 -1.011 . . . . 37.85 110.095 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.34 -32.45 73.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 35.36 110.117 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.73 30.81 4.15 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.414 -1.475 . . . . 35.1 109.414 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -133.44 -155.18 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -1.137 . . . . 32.72 110.164 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -107.56 175.34 5.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.539 -0.725 . . . . 19.61 109.55 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.866 HG13 HG12 ' A' ' 22' ' ' VAL . 85.5 t -75.97 -23.58 16.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.105 -0.997 . . . . 17.56 110.138 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' B' ' 10' ' ' PHE . 9.5 t-20 -77.15 -28.11 54.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 21.3 108.843 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.07 -27.31 24.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.557 -0.714 . . . . 16.38 109.203 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.629 ' CD ' HG12 ' A' ' 25' ' ' VAL . 8.5 tp10 -71.98 -42.96 65.87 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.277 -0.89 . . . . 12.61 108.916 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' O ' HG23 ' A' ' 41' ' ' VAL . 24.5 mm -66.59 -31.07 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.595 -0.891 . . . . 10.95 108.595 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.425 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 32.6 t80 -63.56 -36.78 84.92 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.62 -0.675 . . . . 18.87 109.968 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -73.96 -43.99 56.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 36.88 109.716 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -61.09 -25.59 67.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 22.85 109.289 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.742 HG21 ' HH2' ' B' ' 14' ' ' TRP . 62.4 t -88.18 -25.14 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.547 0.689 . . . . 13.02 109.635 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtp -77.56 -25.33 49.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.529 -0.732 . . . . 18.84 110.299 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -83.24 -27.48 29.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.194 -0.941 . . . . 29.96 110.353 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.8 p -67.1 -48.91 66.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.255 -0.903 . . . . 18.65 110.357 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.742 ' CD1' HD21 ' B' ' 21' ' ' LEU . 22.4 m-85 -62.89 -22.5 66.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.958 . . . . 16.26 110.417 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.87 -25.75 60.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 36.71 110.455 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -55.72 -24.03 32.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.164 -0.96 . . . . 41.6 110.351 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -108.13 -37.21 6.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 24.83 110.23 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.11 32.25 2.25 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.376 -1.489 . . . . 18.81 109.376 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.565 ' HG2' HD11 ' B' ' 21' ' ' LEU . 0.2 OUTLIER -76.22 -47.63 23.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -1.177 . . . . 23.01 110.502 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 pt -100.9 146.6 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 119.541 -0.863 . . . . 27.08 110.701 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.12 -42.79 0.63 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.295 -1.522 . . . . 32.03 109.295 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.418 -1.048 . . . . 0.0 110.287 179.407 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 7.4 mtp . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.222 0.534 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt 52.96 94.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.27 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.2 -44.59 28.39 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 55.2 21.74 4.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.235 -1.156 . . . . 0.0 110.393 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -62.82 -179.22 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 110.14 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -73.66 -162.14 0.12 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 110.09 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.403 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 0.0 OUTLIER -89.46 163.47 33.32 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.232 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.519 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 43.4 Cg_endo -71.38 147.65 53.15 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.717 1.377 . . . . 0.0 110.483 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -19.5 62.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.36 -0.837 . . . . 0.0 110.577 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.522 ' CE1' ' HG3' ' A' ' 8' ' ' PRO . 87.2 t80 -69.01 -32.13 71.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.039 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.518 ' HB3' HD21 ' B' ' 19' ' ' LEU . 96.5 mt -91.94 19.12 6.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.448 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.66 -25.36 62.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 110.303 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.71 -16.16 45.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 110.412 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.742 ' HH2' HG21 ' A' ' 41' ' ' VAL . 15.1 m0 -72.88 145.65 86.86 Favored Pre-proline 0 C--N 1.304 -1.389 0 O-C-N 121.242 -0.911 . . . . 0.0 109.831 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' B' ' 18' ' ' VAL . 42.5 Cg_endo -73.45 166.66 29.3 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.258 1.136 . . . . 0.0 111.21 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -37.94 85.11 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 110.321 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -60.3 -34.72 74.17 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.907 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.609 ' O ' HG23 ' B' ' 22' ' ' VAL . 91.1 t -82.72 -45.22 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.86 -1.15 . . . . 0.0 110.591 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' B' ' 11' ' ' LEU . 61.1 mt -64.39 -27.28 68.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.031 -1.043 . . . . 0.0 110.763 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.27 -23.4 63.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 109.738 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.742 HD21 ' CD1' ' A' ' 45' ' ' PHE . 4.7 tp -89.34 -42.11 11.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.502 -0.748 . . . . 0.0 109.992 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.876 HG12 HG13 ' B' ' 33' ' ' VAL . 47.9 t -51.71 -46.1 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 110.733 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -54.83 -58.44 7.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.333 -0.854 . . . . 0.0 110.849 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -54.14 -22.27 10.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.065 -1.022 . . . . 0.0 111.037 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.62 HG23 ' O ' ' B' ' 21' ' ' LEU . 59.7 t -82.93 -38.77 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.001 . . . . 0.0 110.873 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.87 -32.6 74.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.061 -1.024 . . . . 0.0 110.11 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.46 -10.07 58.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 110.383 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -88.64 -53.57 4.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.133 -0.98 . . . . 0.0 110.113 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.34 -32.47 73.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.142 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.75 30.82 4.14 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -133.53 -155.69 0.69 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -1.103 . . . . 0.0 110.208 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -107.03 175.41 5.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.409 -0.807 . . . . 0.0 109.658 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.876 HG13 HG12 ' B' ' 22' ' ' VAL . 85.9 t -76.1 -23.33 15.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.477 ' ND2' ' CE1' ' A' ' 10' ' ' PHE . 9.4 t-20 -77.35 -28.34 52.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 108.844 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.91 -27.42 25.0 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.194 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.619 ' CD ' HG12 ' B' ' 25' ' ' VAL . 8.5 tp10 -71.94 -42.6 66.44 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.372 -0.83 . . . . 0.0 108.997 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.527 ' O ' HG23 ' B' ' 41' ' ' VAL . 24.7 mm -66.84 -30.89 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.42 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 32.6 t80 -63.8 -37.08 86.05 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.614 -0.679 . . . . 0.0 109.771 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -73.57 -44.39 57.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 109.687 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -60.64 -25.75 66.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.94 . . . . 0.0 109.243 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.739 HG21 ' HH2' ' A' ' 14' ' ' TRP . 63.5 t -88.16 -25.23 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.575 0.703 . . . . 0.0 109.688 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtp -77.47 -25.17 50.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.494 -0.754 . . . . 0.0 110.387 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -83.42 -27.46 29.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.189 -0.944 . . . . 0.0 110.437 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 77.8 p -67.16 -48.7 67.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.415 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.75 ' CD1' HD21 ' A' ' 21' ' ' LEU . 21.9 m-85 -63.08 -22.6 66.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.128 -0.982 . . . . 0.0 110.286 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.79 -25.68 60.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.167 -0.958 . . . . 0.0 110.37 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -55.81 -24.09 34.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.317 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -108.04 -37.14 6.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.267 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.91 31.94 2.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.588 ' HG2' HD11 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -75.94 -47.68 24.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -1.126 . . . . 0.0 110.468 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 pt -101.02 146.66 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.593 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.06 -43.05 0.62 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.376 -1.073 . . . . 0.0 110.099 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.212 0.529 . . . . 50.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -128.28 52.38 1.9 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 50.0 110.22 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.59 99.86 2.45 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.461 -1.455 . . . . 50.0 109.461 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.5 ttm -136.55 151.14 49.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -1.138 . . . . 50.0 110.25 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 m -69.38 -179.39 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 50.0 109.984 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.22 53.37 1.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 50.0 110.569 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.52 126.45 7.43 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.151 -0.968 . . . . 43.64 109.494 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.541 ' HG2' HD12 ' A' ' 11' ' ' LEU . 45.7 Cg_endo -71.68 158.16 54.03 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.378 1.199 . . . . 29.79 110.671 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -82.1 -19.4 40.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.379 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.501 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 73.1 t80 -58.95 -23.84 61.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 12.57 110.448 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.693 ' HB3' HD21 ' A' ' 19' ' ' LEU . 42.7 mt -98.52 31.65 2.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.148 -0.97 . . . . 0.0 110.478 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -30.99 67.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.224 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -81.01 -22.9 39.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 110.155 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.711 ' HH2' HG21 ' B' ' 41' ' ' VAL . 13.8 m0 -64.64 136.98 96.99 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.345 -0.847 . . . . 11.57 109.259 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HG2' HG23 ' A' ' 18' ' ' VAL . 39.0 Cg_endo -70.36 153.34 66.26 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.365 1.192 . . . . 13.83 111.054 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -41.62 73.29 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.664 0.745 . . . . 48.43 110.897 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.24 -41.05 75.09 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.548 -0.72 . . . . 46.64 111.507 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.514 HG23 ' HG2' ' A' ' 15' ' ' PRO . 85.5 t -76.42 -49.87 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.888 -1.132 . . . . 16.14 111.087 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.693 HD21 ' HB3' ' A' ' 11' ' ' LEU . 13.3 mt -53.7 -36.5 62.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 12.61 110.673 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -62.57 -38.03 88.51 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.436 -0.79 . . . . 23.17 109.864 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.854 ' O ' HG23 ' A' ' 25' ' ' VAL . 40.8 tp -69.42 -40.59 77.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.494 -0.754 . . . . 19.0 109.893 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.913 HG12 HG13 ' A' ' 33' ' ' VAL . 40.3 t -58.94 -48.26 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 18.87 110.512 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 10.9 mtm180 -53.67 -49.36 68.14 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 23.61 110.54 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -29.33 70.72 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 30.11 110.682 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 21' ' ' LEU . 48.1 t -77.03 -29.19 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 16.22 110.479 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.434 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -74.04 -46.0 46.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.169 -0.957 . . . . 26.6 109.215 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.95 -12.63 61.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.348 -0.845 . . . . 45.21 110.135 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -78.61 -58.73 3.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 37.85 110.001 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -66.06 -22.36 66.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 35.36 110.115 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.54 16.17 20.85 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.027 -1.229 . . . . 35.1 110.027 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -116.53 -162.84 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.132 -1.216 . . . . 32.72 110.387 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.434 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 67.7 m -102.81 -176.77 3.19 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.419 -0.8 . . . . 19.61 109.411 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.913 HG13 HG12 ' A' ' 22' ' ' VAL . 63.0 t -81.23 -16.65 12.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.222 -0.924 . . . . 17.56 110.281 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -77.84 -32.08 51.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.978 . . . . 21.3 108.752 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 t -79.71 -36.56 37.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.572 -0.705 . . . . 16.38 109.335 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.4 tp10 -64.78 -51.74 60.65 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 121.255 -0.903 . . . . 12.61 109.366 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 41' ' ' VAL . 37.9 mm -63.3 -32.93 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.784 . . . . 10.95 109.517 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -65.79 -33.76 76.61 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.429 -0.795 . . . . 18.87 110.226 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -47.38 42.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 36.88 109.536 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -60.87 -23.36 65.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.46 -0.775 . . . . 22.85 109.642 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.664 HG21 ' HH2' ' B' ' 14' ' ' TRP . 53.0 t -87.95 -28.24 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.518 -0.739 . . . . 13.02 109.554 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -20.36 52.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.539 -0.725 . . . . 18.84 110.272 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.92 -18.77 53.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 29.96 110.348 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.89 -46.89 16.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.073 -1.017 . . . . 18.65 110.215 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.81 ' CD1' HD21 ' B' ' 21' ' ' LEU . 37.9 m-85 -67.72 -12.01 59.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 16.26 110.734 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -75.35 -38.42 60.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.03 -1.044 . . . . 36.71 110.417 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -55.53 -52.63 63.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 41.6 110.174 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -62.55 1.36 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 24.83 110.308 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.94 34.9 0.71 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.706 -1.235 . . . . 18.81 110.084 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -27.48 31.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -1.088 . . . . 23.01 109.97 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.6 pt -112.72 166.95 6.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.079 -1.013 . . . . 27.08 109.968 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.38 38.71 0.11 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.633 -1.387 . . . . 32.03 109.633 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.135 -1.214 . . . . 0.0 110.217 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.308 0.575 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -128.29 52.46 1.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.307 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.79 99.64 2.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 7.4 ttm -136.21 151.3 49.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -1.196 . . . . 0.0 110.313 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.9 m -69.46 -179.19 1.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.943 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.36 53.28 1.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 110.563 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.51 126.41 7.42 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.129 -0.982 . . . . 0.0 109.495 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.549 ' HG2' HD12 ' B' ' 11' ' ' LEU . 45.1 Cg_endo -71.64 157.76 55.04 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.439 1.231 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -81.83 -19.4 41.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.364 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.511 ' CE1' ' HG3' ' A' ' 8' ' ' PRO . 72.8 t80 -58.95 -23.85 61.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 110.454 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.682 ' HB3' HD21 ' B' ' 19' ' ' LEU . 42.3 mt -98.37 31.62 2.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 110.489 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.06 -31.1 67.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 110.108 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -80.95 -22.89 39.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.22 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.664 ' HH2' HG21 ' A' ' 41' ' ' VAL . 13.8 m0 -64.71 136.51 96.8 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.394 -0.816 . . . . 0.0 109.306 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.512 ' HG2' HG23 ' B' ' 18' ' ' VAL . 39.5 Cg_endo -70.24 152.45 66.83 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.626 1.33 . . . . 0.0 111.368 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -42.13 69.75 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.631 0.729 . . . . 0.0 110.905 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.17 -40.91 74.65 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.614 -0.679 . . . . 0.0 111.29 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.512 HG23 ' HG2' ' B' ' 15' ' ' PRO . 85.5 t -76.59 -50.0 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.917 -1.114 . . . . 0.0 110.754 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.682 HD21 ' HB3' ' B' ' 11' ' ' LEU . 13.4 mt -53.67 -36.32 61.99 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 110.682 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -62.99 -37.77 88.48 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.298 -0.876 . . . . 0.0 109.973 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.841 ' O ' HG23 ' B' ' 25' ' ' VAL . 40.5 tp -69.63 -40.31 76.64 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.415 -0.803 . . . . 0.0 109.858 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.897 HG12 HG13 ' B' ' 33' ' ' VAL . 40.3 t -59.31 -48.07 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 110.467 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' B' ' 19' ' ' LEU . 11.0 mtm180 -53.7 -49.41 68.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.215 -0.928 . . . . 0.0 110.535 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -29.13 70.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.4 -0.812 . . . . 0.0 110.698 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.841 HG23 ' O ' ' B' ' 21' ' ' LEU . 48.4 t -77.08 -29.25 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.501 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.436 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -74.04 -46.06 45.7 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 109.196 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.97 -12.58 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 110.152 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.41 -59.0 2.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 109.97 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -65.88 -22.33 66.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.059 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.48 16.26 20.74 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -116.65 -162.64 0.86 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.012 -1.287 . . . . 0.0 110.405 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.436 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 69.2 m -102.95 -176.76 3.18 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.352 -0.843 . . . . 0.0 109.375 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.897 HG13 HG12 ' B' ' 22' ' ' VAL . 62.2 t -81.2 -16.64 12.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 110.407 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -77.84 -32.14 51.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.067 -1.021 . . . . 0.0 108.695 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 41.0 t -79.67 -36.39 37.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.585 -0.697 . . . . 0.0 109.294 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.498 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.4 tp10 -65.0 -51.64 60.55 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.381 -0.824 . . . . 0.0 109.295 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.558 ' O ' HG23 ' B' ' 41' ' ' VAL . 37.3 mm -63.39 -32.59 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.576 -0.703 . . . . 0.0 109.428 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.434 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 26.5 t80 -65.97 -33.82 76.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.442 -0.787 . . . . 0.0 110.308 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -47.1 45.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.52 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -61.17 -23.42 65.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 0.0 109.639 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.711 HG21 ' HH2' ' A' ' 14' ' ' TRP . 56.4 t -88.08 -28.3 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.749 . . . . 0.0 109.502 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -20.14 53.35 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.566 -0.708 . . . . 0.0 110.161 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.17 -18.73 52.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.082 -1.011 . . . . 0.0 110.36 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.82 -47.27 15.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.046 -1.034 . . . . 0.0 110.097 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.77 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.5 m-85 -67.42 -11.96 59.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 110.799 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -75.59 -38.19 59.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 110.389 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -55.64 -52.77 62.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.82 -62.49 1.39 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.215 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.86 35.12 0.7 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.402 ' HB3' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -82.58 -27.93 31.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -1.2 . . . . 0.0 109.97 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.65 166.89 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.954 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.94 38.58 0.11 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.285 -1.126 . . . . 0.0 110.164 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.154 0.502 . . . . 50.0 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -171.69 71.81 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 50.0 110.239 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.26 178.38 40.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.513 -1.435 . . . . 50.0 109.513 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.2 mtm -100.64 27.14 6.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -1.102 . . . . 50.0 110.22 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m 53.19 179.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.91 . . . . 50.0 110.333 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -107.94 172.08 7.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 50.0 110.359 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mtt 57.87 162.26 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.384 -0.823 . . . . 43.64 110.906 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 48.3 Cg_endo -76.55 164.79 30.03 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.852 1.448 . . . . 29.79 110.343 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -74.98 -13.7 60.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.394 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.526 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 90.8 t80 -81.16 -29.15 34.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 12.57 110.46 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 11' ' ' LEU . 57.0 mt -92.69 14.68 16.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.784 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.94 -24.56 64.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 0.0 109.816 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.96 -21.89 43.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.314 -0.866 . . . . 0.0 110.163 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.576 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 15.0 m0 -73.54 143.59 82.5 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.453 -0.779 . . . . 11.57 109.67 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' CD ' ' OH ' ' B' ' 38' ' ' TYR . 42.3 Cg_endo -71.11 176.44 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.562 1.296 . . . . 13.83 110.726 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -24.29 37.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.402 -0.811 . . . . 48.43 109.372 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HG3' HG23 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -68.6 -20.15 64.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 46.64 110.463 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.664 ' O ' HG23 ' A' ' 22' ' ' VAL . 76.3 t -99.82 -46.3 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 16.14 109.961 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.13 -25.91 68.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.339 -0.851 . . . . 12.61 110.806 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -74.02 -31.74 63.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.299 -0.876 . . . . 23.17 110.068 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.737 ' O ' HG23 ' A' ' 25' ' ' VAL . 7.4 tp -79.82 -47.39 15.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 19.0 109.971 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.955 HG12 HG13 ' A' ' 33' ' ' VAL . 27.9 t -51.68 -45.93 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 18.87 109.918 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.509 ' HA ' HG22 ' A' ' 33' ' ' VAL . 3.0 ttm180 -51.44 -63.02 1.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.682 -0.636 . . . . 23.61 110.695 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -52.75 -33.88 50.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.283 -0.885 . . . . 30.11 110.969 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 21' ' ' LEU . 61.9 t -66.93 -36.48 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 16.22 110.523 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -67.02 -44.91 79.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 26.6 109.896 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -71.69 -14.7 62.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 45.21 110.359 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.79 -59.99 2.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.084 -1.01 . . . . 37.85 110.114 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -65.8 -22.03 66.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 35.36 110.358 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.39 16.69 24.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.85 -1.3 . . . . 35.1 109.85 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -114.15 -156.53 0.6 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.085 -1.244 . . . . 32.72 110.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.418 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 1.3 m -111.21 171.11 7.67 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.332 -0.855 . . . . 19.61 109.652 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.955 HG13 HG12 ' A' ' 22' ' ' VAL . 48.5 t -70.59 -18.89 21.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.204 -0.935 . . . . 17.56 110.451 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.78 -35.04 39.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.133 -0.98 . . . . 21.3 109.3 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.6 m -76.48 -33.54 58.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.811 . . . . 16.38 109.543 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.627 ' CG ' HG12 ' A' ' 25' ' ' VAL . 2.9 tp10 -63.37 -51.94 63.8 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.348 -0.845 . . . . 12.61 109.245 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.553 HD11 HG11 ' A' ' 22' ' ' VAL . 4.9 mt -68.4 -21.34 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.465 -0.772 . . . . 10.95 109.62 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.405 ' OH ' ' CD ' ' B' ' 15' ' ' PRO . 32.0 t80 -75.4 -29.54 59.83 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.267 -0.896 . . . . 18.87 109.716 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.01 -45.36 18.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.498 -0.751 . . . . 36.88 109.744 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt-85 -60.7 -45.06 95.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 22.85 109.159 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.609 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 61.2 t -68.93 -24.2 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.625 -0.672 . . . . 13.02 109.997 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -65.21 0.79 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.422 -0.799 . . . . 18.84 110.908 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -54.73 -31.75 58.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.332 -0.855 . . . . 29.96 111.037 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.15 -56.63 10.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.95 -1.094 . . . . 18.65 110.679 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.575 ' CD1' HD21 ' B' ' 21' ' ' LEU . 27.4 m-85 -61.99 -39.12 91.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 16.26 110.817 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -58.47 -18.75 31.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.127 -0.983 . . . . 36.71 110.871 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -82.61 -47.28 12.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.033 -1.042 . . . . 41.6 110.602 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -58.57 -45.08 89.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.182 -0.949 . . . . 24.83 110.244 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.28 10.34 6.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.093 -1.203 . . . . 18.81 110.093 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HB3' HD11 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -73.15 -52.28 14.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.304 . . . . 23.01 110.117 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.7 pt -104.93 -167.9 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.638 -0.825 . . . . 27.08 109.868 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.22 65.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.697 -1.361 . . . . 32.03 109.697 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.44 -1.036 . . . . 0.0 109.973 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.139 0.495 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -171.53 72.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.268 -0.895 . . . . 0.0 110.156 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.12 178.28 40.39 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mtm -100.6 27.24 5.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -1.124 . . . . 0.0 110.223 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m 53.05 179.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.16 -0.962 . . . . 0.0 110.232 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -107.92 172.27 6.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.345 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mtt 57.69 162.52 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.468 -0.77 . . . . 0.0 110.789 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.526 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 48.5 Cg_endo -76.84 164.62 29.76 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.792 1.417 . . . . 0.0 110.318 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -74.89 -13.84 60.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.429 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.519 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 90.6 t80 -81.13 -28.79 34.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 110.47 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' B' ' 11' ' ' LEU . 55.8 mt -93.09 15.0 16.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.709 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.38 -24.19 63.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.919 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -22.2 42.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 110.114 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.609 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 14.9 m0 -73.27 143.71 83.49 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.493 -0.754 . . . . 0.0 109.723 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.405 ' CD ' ' OH ' ' A' ' 38' ' ' TYR . 42.6 Cg_endo -71.23 176.39 7.94 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.56 1.295 . . . . 0.0 110.827 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -24.44 37.1 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.562 -0.711 . . . . 0.0 109.443 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.427 ' HG3' HG23 ' B' ' 18' ' ' VAL . 1.0 OUTLIER -68.21 -20.89 64.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 110.712 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.652 ' O ' HG23 ' B' ' 22' ' ' VAL . 76.9 t -98.98 -47.05 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.139 -0.976 . . . . 0.0 109.883 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.51 -26.08 67.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 110.863 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.01 -31.45 62.94 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.727 ' O ' HG23 ' B' ' 25' ' ' VAL . 7.7 tp -79.88 -48.02 14.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.467 -0.771 . . . . 0.0 109.942 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.974 HG12 HG13 ' B' ' 33' ' ' VAL . 27.5 t -51.16 -45.57 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 109.938 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.501 ' HA ' HG22 ' B' ' 33' ' ' VAL . 3.0 ttm180 -52.12 -62.6 1.53 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.552 -0.717 . . . . 0.0 110.651 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -52.93 -33.82 52.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.931 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.727 HG23 ' O ' ' B' ' 21' ' ' LEU . 61.2 t -67.13 -36.03 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.084 -1.01 . . . . 0.0 110.577 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.429 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -67.55 -44.64 77.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.872 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -71.66 -15.05 62.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.963 . . . . 0.0 110.393 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.53 -60.2 2.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.044 . . . . 0.0 110.016 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -65.72 -21.93 66.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.266 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.33 16.68 24.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -114.39 -156.88 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.276 . . . . 0.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.429 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 1.3 m -110.73 171.04 7.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.565 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.974 HG13 HG12 ' B' ' 22' ' ' VAL . 49.3 t -70.23 -19.82 22.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.245 -0.91 . . . . 0.0 110.365 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 -35.61 43.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 64.5 m -75.84 -33.85 60.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.631 ' CG ' HG12 ' B' ' 25' ' ' VAL . 2.8 tp10 -63.26 -51.59 65.55 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.342 -0.849 . . . . 0.0 109.351 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.56 HD11 HG11 ' B' ' 22' ' ' VAL . 4.9 mt -68.74 -21.6 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.613 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.41 ' OH ' ' CD ' ' A' ' 15' ' ' PRO . 33.4 t80 -75.18 -29.25 60.34 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.22 -0.925 . . . . 0.0 109.775 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -45.54 17.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.671 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -60.53 -44.94 95.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.118 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.576 HG11 ' CZ3' ' A' ' 14' ' ' TRP . 58.0 t -68.88 -24.4 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.647 -0.658 . . . . 0.0 109.958 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -65.15 0.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.379 -0.826 . . . . 0.0 110.83 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -54.66 -31.73 58.09 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.247 -0.908 . . . . 0.0 111.001 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.34 -56.61 10.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.064 -1.023 . . . . 0.0 110.89 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.568 ' CD1' HD21 ' A' ' 21' ' ' LEU . 29.0 m-85 -62.05 -38.65 89.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 110.792 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -58.5 -19.02 33.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.183 -0.948 . . . . 0.0 110.978 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -82.58 -47.59 11.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 110.54 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -58.13 -45.25 87.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.171 -0.956 . . . . 0.0 110.307 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.32 10.63 6.01 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.557 ' HB3' HD11 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -73.34 -52.55 13.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.959 -1.318 . . . . 0.0 109.896 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 pt -104.63 -168.27 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.929 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.33 66.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.264 -1.139 . . . . 0.0 110.131 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.8 mtp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.143 0.497 . . . . 50.0 110.285 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -114.61 -31.55 6.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.26 -0.9 . . . . 50.0 110.038 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.07 -97.54 0.12 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.398 -1.481 . . . . 50.0 109.398 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.32 30.02 7.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.185 -1.185 . . . . 50.0 110.363 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 m -132.35 166.61 21.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 50.0 110.118 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -156.65 69.52 0.61 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 50.0 110.243 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.424 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 13.1 ptp -140.05 164.26 38.73 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 43.64 109.922 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 41.4 Cg_endo -68.79 151.56 74.27 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.553 1.291 . . . . 29.79 110.557 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -66.05 -20.32 66.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.246 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.502 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 91.2 t80 -68.38 -20.99 64.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 12.57 110.394 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.547 ' HB3' HD21 ' A' ' 19' ' ' LEU . 89.0 mt -100.54 20.91 14.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.596 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.19 -26.9 62.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -83.18 -23.51 32.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.107 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.618 ' CH2' HG11 ' B' ' 41' ' ' VAL . 14.0 m0 -67.09 139.55 95.36 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.363 -0.836 . . . . 11.57 109.384 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HG2' HG23 ' A' ' 18' ' ' VAL . 42.0 Cg_endo -70.21 168.76 21.21 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.528 1.278 . . . . 13.83 110.904 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.21 -20.47 55.28 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.513 -0.742 . . . . 48.43 109.433 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -72.84 -28.63 62.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 46.64 109.758 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.1 t -87.33 -45.15 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 16.14 109.865 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 11' ' ' LEU . 55.1 mt -63.26 -30.48 71.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -0.857 . . . . 12.61 110.593 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -66.01 -25.88 67.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -0.962 . . . . 23.17 109.605 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.728 ' O ' HG23 ' A' ' 25' ' ' VAL . 15.1 tp -86.78 -44.83 11.46 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.446 -0.784 . . . . 19.0 109.745 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.743 HG12 HG13 ' A' ' 33' ' ' VAL . 44.4 t -52.83 -43.14 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.263 -0.898 . . . . 18.87 109.778 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -51.01 -61.69 2.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.562 -0.711 . . . . 23.61 110.594 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -54.35 -24.9 21.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.577 -0.702 . . . . 30.11 110.901 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 21' ' ' LEU . 38.4 t -80.48 -30.72 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.168 -0.957 . . . . 16.22 110.783 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.406 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -78.01 -27.72 49.01 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.11 -0.994 . . . . 26.6 110.0 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.38 -15.31 33.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 45.21 110.713 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 19.8 pt-20 -90.73 -33.13 15.88 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.882 -1.136 . . . . 37.85 110.436 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 9.7 m-80 -79.48 -26.88 41.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 35.36 110.159 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.84 23.72 8.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.538 -1.425 . . . . 35.1 109.538 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -131.73 -158.97 0.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.21 -1.171 . . . . 32.72 109.93 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.406 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -109.4 -178.61 3.6 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.525 -0.734 . . . . 19.61 109.086 179.038 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.743 HG13 HG12 ' A' ' 22' ' ' VAL . 97.8 t -76.79 -19.18 14.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.184 -0.947 . . . . 17.56 110.29 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 42.2 t30 -74.66 -30.65 61.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 21.3 108.747 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -37.85 23.61 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.501 -0.749 . . . . 16.38 109.214 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HG3' HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -59.78 -51.55 69.26 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.322 -0.861 . . . . 12.61 109.574 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.533 HG23 HG21 ' B' ' 41' ' ' VAL . 38.6 mm -62.95 -28.01 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.325 -0.859 . . . . 10.95 109.2 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 42' ' ' MET . 37.5 t80 -74.17 -24.83 59.44 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.395 -0.816 . . . . 18.87 110.175 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -50.91 9.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.45 -0.781 . . . . 36.88 109.833 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 36' ' ' GLU . 2.9 mpt_? -60.74 -28.82 68.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.816 . . . . 22.85 109.255 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 65.4 t -84.35 -22.43 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.622 -0.674 . . . . 13.02 109.676 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -74.31 -51.23 15.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 18.84 111.101 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -69.52 -23.79 63.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.257 -0.902 . . . . 29.96 111.473 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.5 p -57.31 -52.61 64.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.014 -1.054 . . . . 18.65 110.282 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.676 ' CD1' HD21 ' B' ' 21' ' ' LEU . 36.9 m-85 -63.12 -40.1 96.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -0.999 . . . . 16.26 110.311 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -57.29 -21.81 37.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.318 -0.864 . . . . 36.71 110.599 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -74.11 -61.82 1.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.993 -1.067 . . . . 41.6 110.251 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -56.04 -30.0 61.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 24.83 110.258 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.68 31.96 4.97 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.901 -1.28 . . . . 18.81 109.901 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -85.35 -45.25 12.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -1.128 . . . . 23.01 110.115 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.0 pt -108.09 167.59 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.836 -0.746 . . . . 27.08 110.299 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.54 -50.05 0.54 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.477 -1.449 . . . . 32.03 109.477 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.254 -1.144 . . . . 0.0 110.262 -179.613 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 42.3 mtp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.279 0.562 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -114.67 -31.49 6.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 110.121 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.98 -97.29 0.12 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.96 30.3 7.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.114 . . . . 0.0 110.494 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.5 m -132.5 166.58 21.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.489 -0.757 . . . . 0.0 109.855 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -156.58 69.52 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.432 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 13.2 ptp -139.95 164.09 40.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.843 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.502 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 42.6 Cg_endo -68.68 151.79 74.63 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.538 1.283 . . . . 0.0 110.518 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.01 -20.72 66.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.883 . . . . 0.0 110.211 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.517 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 91.9 t80 -67.93 -21.24 65.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 0.0 110.458 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.527 ' HB3' HD21 ' B' ' 19' ' ' LEU . 88.1 mt -100.35 20.82 14.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 110.611 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -26.72 62.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.979 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -83.34 -23.3 32.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 110.103 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.496 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.8 m0 -67.42 139.56 94.53 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.384 -0.823 . . . . 0.0 109.355 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.525 ' HG2' HG23 ' B' ' 18' ' ' VAL . 41.0 Cg_endo -70.3 168.84 21.11 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.412 1.217 . . . . 0.0 110.543 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.27 -20.51 54.99 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.578 -0.701 . . . . 0.0 109.307 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -72.73 -28.8 62.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.164 -0.96 . . . . 0.0 109.448 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.6 ' O ' HG23 ' B' ' 22' ' ' VAL . 74.6 t -87.45 -45.18 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 109.637 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' B' ' 11' ' ' LEU . 54.0 mt -63.28 -30.1 71.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 110.581 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -66.32 -26.19 67.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.116 -0.99 . . . . 0.0 109.429 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.733 ' O ' HG23 ' B' ' 25' ' ' VAL . 15.4 tp -86.57 -44.54 11.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.221 0.534 . . . . 0.0 109.61 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.724 HG12 HG13 ' B' ' 33' ' ' VAL . 44.1 t -53.37 -43.25 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.815 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -50.78 -61.39 2.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.554 -0.716 . . . . 0.0 110.675 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -54.59 -24.75 22.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.749 . . . . 0.0 111.01 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.733 HG23 ' O ' ' B' ' 21' ' ' LEU . 38.2 t -80.61 -30.91 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.092 -1.005 . . . . 0.0 110.667 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.408 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -77.84 -27.75 49.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.097 -1.002 . . . . 0.0 109.955 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.37 -15.16 33.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 110.733 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' B' ' 25' ' ' VAL . 19.7 pt-20 -90.84 -33.11 15.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.006 -1.059 . . . . 0.0 110.49 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.435 ' N ' ' HG3' ' B' ' 28' ' ' GLU . 9.5 m-80 -79.54 -26.7 41.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.72 23.98 8.0 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -132.09 -159.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.203 -1.175 . . . . 0.0 109.836 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.408 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 0.4 OUTLIER -109.36 -178.81 3.66 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.459 -0.776 . . . . 0.0 109.187 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.724 HG13 HG12 ' B' ' 22' ' ' VAL . 97.4 t -76.4 -19.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 110.191 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 41.7 t30 -74.66 -29.99 61.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 108.825 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.52 -38.35 21.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.562 -0.711 . . . . 0.0 109.115 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.54 ' HG3' HG12 ' B' ' 25' ' ' VAL . 0.5 OUTLIER -58.97 -51.76 68.67 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.315 -0.865 . . . . 0.0 109.648 179.017 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.463 ' O ' HG23 ' B' ' 41' ' ' VAL . 39.1 mm -63.0 -27.6 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.457 -0.777 . . . . 0.0 109.235 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 36.3 t80 -74.62 -24.96 58.93 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.38 -0.825 . . . . 0.0 110.103 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -50.63 10.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.875 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' B' ' 36' ' ' GLU . 2.9 mpt_? -61.11 -28.72 69.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.372 -0.83 . . . . 0.0 109.246 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.618 HG11 ' CH2' ' A' ' 14' ' ' TRP . 62.5 t -84.45 -21.91 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.516 0.674 . . . . 0.0 109.873 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' B' ' 38' ' ' TYR . 0.0 OUTLIER -74.66 -51.21 15.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 111.088 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -69.4 -24.28 63.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.166 -0.959 . . . . 0.0 111.42 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 56.3 p -56.9 -52.73 64.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.92 -1.113 . . . . 0.0 110.199 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.646 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.6 m-85 -62.98 -40.48 97.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 110.382 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -57.0 -21.7 32.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 110.645 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -74.02 -61.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.978 . . . . 0.0 110.441 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.32 -29.89 61.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 110.243 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.68 32.18 4.89 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -85.59 -45.01 12.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.061 -1.258 . . . . 0.0 110.094 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.474 ' CG2' HD22 ' A' ' 21' ' ' LEU . 13.0 pt -108.22 167.47 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.72 -50.06 0.53 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.161 -1.2 . . . . 0.0 110.226 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 tpt . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.186 0.517 . . . . 50.0 110.168 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -172.53 131.02 0.56 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.37 -0.831 . . . . 50.0 110.113 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.78 38.07 12.41 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.443 -1.463 . . . . 50.0 109.443 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.28 -157.96 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -1.144 . . . . 50.0 110.128 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 m -89.01 -173.2 3.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 50.0 110.341 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.69 -163.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 50.0 110.495 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.5 mtt -56.38 141.56 70.63 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.353 -0.842 . . . . 43.64 110.242 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HG2' HD12 ' A' ' 11' ' ' LEU . 50.8 Cg_endo -77.05 157.93 34.17 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.508 1.267 . . . . 29.79 110.551 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.01 0.38 35.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.409 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.42 ' CB ' ' HB3' ' B' ' 10' ' ' PHE . 75.1 t80 -88.67 -23.59 22.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.994 -1.066 . . . . 12.57 109.881 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.703 HD12 ' HG2' ' A' ' 8' ' ' PRO . 54.7 mt -99.6 28.18 4.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 110.312 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.48 -22.12 57.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.168 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.08 -10.28 45.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.504 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.9 m0 -75.61 142.43 73.98 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.092 -1.005 . . . . 11.57 109.874 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HG2' HG23 ' A' ' 18' ' ' VAL . 43.4 Cg_endo -72.1 176.25 8.72 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.568 1.299 . . . . 13.83 110.744 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.0 -23.31 38.76 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.381 -0.824 . . . . 48.43 109.437 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -70.26 -27.45 64.44 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.248 -0.907 . . . . 46.64 109.885 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 22' ' ' VAL . 81.2 t -93.2 -43.82 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -0.858 . . . . 16.14 110.086 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.661 HD21 ' HB3' ' A' ' 11' ' ' LEU . 40.1 mt -63.74 -31.86 73.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 12.61 110.531 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -66.94 -31.21 71.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 23.17 109.92 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.822 ' O ' HG23 ' A' ' 25' ' ' VAL . 52.6 tp -79.88 -40.21 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.841 . . . . 19.0 110.111 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.058 HG12 HG13 ' A' ' 33' ' ' VAL . 39.7 t -54.43 -50.13 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.905 . . . . 18.87 110.139 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -58.33 -49.32 77.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.763 . . . . 23.61 110.437 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -18.57 63.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 30.11 110.635 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 21' ' ' LEU . 90.6 t -88.94 -29.21 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 16.22 110.44 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.02 -26.98 36.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.168 -0.958 . . . . 26.6 109.818 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -89.51 -15.87 32.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.405 -0.81 . . . . 45.21 110.688 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 18.6 pt-20 -90.69 -28.18 18.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.983 -1.073 . . . . 37.85 110.396 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -90.92 -18.72 24.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 35.36 110.392 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.9 23.66 22.35 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.484 -1.446 . . . . 35.1 109.484 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -121.17 -164.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.119 . . . . 32.72 110.211 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.0 m -106.61 168.58 9.07 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.819 -0.808 . . . . 19.61 108.819 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.058 HG13 HG12 ' A' ' 22' ' ' VAL . 92.2 t -73.82 -23.21 18.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.05 -1.031 . . . . 17.56 110.086 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -75.22 -28.93 60.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 21.3 108.896 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.1 m -85.42 -27.84 25.49 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.484 -0.76 . . . . 16.38 109.589 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.736 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.6 tp10 -70.96 -38.47 72.82 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.249 -0.907 . . . . 12.61 109.171 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.576 ' O ' HG23 ' A' ' 41' ' ' VAL . 17.5 mm -80.13 -25.16 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.564 -0.71 . . . . 10.95 109.345 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.43 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 22.3 t80 -72.99 -38.26 66.72 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.265 -0.897 . . . . 18.87 110.218 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -42.7 65.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.192 -0.943 . . . . 36.88 109.911 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -64.65 -27.08 68.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 22.85 109.304 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.8 t -82.65 -26.97 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.627 0.727 . . . . 13.02 109.329 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -40.44 65.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.668 -0.645 . . . . 18.84 110.736 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.89 -20.99 61.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 29.96 110.599 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 t -64.94 -53.13 51.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -0.976 . . . . 18.65 110.433 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.577 ' CE1' HG21 ' B' ' 25' ' ' VAL . 31.5 m-85 -62.58 -27.27 69.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 16.26 110.775 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -67.32 -30.77 70.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 36.71 110.637 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -53.75 -29.87 41.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.182 -0.948 . . . . 41.6 110.477 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -105.51 -14.44 15.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 24.83 110.656 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.89 48.52 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.342 -1.503 . . . . 18.81 109.342 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -57.92 -42.97 85.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.115 -1.227 . . . . 23.01 110.055 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 22.8 pt -91.34 169.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.448 -0.782 . . . . 27.08 109.99 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.61 66.63 0.54 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.558 -1.417 . . . . 32.03 109.558 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.193 -1.181 . . . . 0.0 110.179 179.88 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.7 tpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.274 0.559 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -172.67 130.95 0.54 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.22 -0.925 . . . . 0.0 110.139 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.69 38.23 12.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.17 -158.16 0.18 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -1.071 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.8 m -88.72 -173.1 3.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 0.0 110.374 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -162.92 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.322 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 9.3 mtt -56.75 141.45 73.92 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.302 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.734 ' HG2' HD12 ' B' ' 11' ' ' LEU . 50.2 Cg_endo -76.87 157.39 34.93 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.612 1.322 . . . . 0.0 110.627 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.49 0.63 32.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 110.576 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 74.7 t80 -88.83 -23.85 22.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.07 -1.019 . . . . 0.0 109.826 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.734 HD12 ' HG2' ' B' ' 8' ' ' PRO . 54.7 mt -99.36 28.18 4.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.328 -0.858 . . . . 0.0 110.219 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.47 -21.89 57.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.918 . . . . 0.0 110.219 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -10.32 44.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.18 -0.95 . . . . 0.0 110.5 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.483 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.8 m0 -75.79 142.28 73.15 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.133 -0.979 . . . . 0.0 109.858 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.479 ' HG2' HG23 ' B' ' 18' ' ' VAL . 43.3 Cg_endo -72.04 176.25 8.69 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.24 1.126 . . . . 0.0 110.721 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.04 -23.47 38.56 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 109.446 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.94 -27.44 64.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.129 -0.982 . . . . 0.0 110.071 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.717 ' O ' HG23 ' B' ' 22' ' ' VAL . 90.1 t -93.38 -44.07 13.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.989 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' B' ' 11' ' ' LEU . 41.0 mt -63.31 -31.87 73.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.542 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -67.16 -30.96 71.07 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.807 ' O ' HG23 ' B' ' 25' ' ' VAL . 53.5 tp -79.85 -40.2 28.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.411 -0.805 . . . . 0.0 110.163 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 1.061 HG12 HG13 ' B' ' 33' ' ' VAL . 40.2 t -54.51 -50.2 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.857 . . . . 0.0 109.952 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -58.26 -49.75 76.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.432 -0.793 . . . . 0.0 110.268 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -18.91 63.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 110.775 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.807 HG23 ' O ' ' B' ' 21' ' ' LEU . 92.2 t -88.66 -28.83 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.083 -1.011 . . . . 0.0 110.542 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.5 -26.4 35.18 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.87 -15.99 31.0 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.435 -0.791 . . . . 0.0 110.555 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.461 ' HG2' ' HA ' ' B' ' 25' ' ' VAL . 18.3 pt-20 -90.68 -27.97 18.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.36 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -91.19 -18.64 24.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 0.0 110.471 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.85 23.61 22.61 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -121.2 -164.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -1.141 . . . . 0.0 110.217 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -106.35 168.4 9.18 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 1.061 HG13 HG12 ' B' ' 22' ' ' VAL . 92.1 t -73.65 -23.25 19.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.018 -1.051 . . . . 0.0 110.157 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -75.27 -28.64 59.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 108.925 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -85.59 -27.85 25.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.54 -0.725 . . . . 0.0 109.518 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.724 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.6 tp10 -70.9 -38.32 73.02 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.262 -0.899 . . . . 0.0 109.366 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.579 ' O ' HG23 ' B' ' 41' ' ' VAL . 17.6 mm -80.19 -25.19 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 0.0 109.297 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.425 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 22.6 t80 -73.01 -38.02 66.75 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.8 -42.34 64.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -64.94 -26.9 68.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 37' ' ' ILE . 42.7 t -82.83 -26.92 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.464 -0.772 . . . . 0.0 109.154 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -39.95 65.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.639 -0.663 . . . . 0.0 110.785 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.26 -21.03 61.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 110.538 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -64.71 -53.28 49.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.435 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.566 ' CE1' HG21 ' A' ' 25' ' ' VAL . 31.3 m-85 -62.66 -27.23 69.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.973 . . . . 0.0 110.816 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -67.23 -30.76 70.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.066 -1.021 . . . . 0.0 110.639 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -53.87 -29.66 42.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.162 -0.961 . . . . 0.0 110.49 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -105.61 -14.45 15.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 110.654 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.8 20.78 49.44 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -57.88 -43.08 85.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -1.182 . . . . 0.0 109.941 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.4 pt -91.22 169.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 110.03 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.14 66.87 0.54 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.236 -1.155 . . . . 0.0 110.184 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.249 0.547 . . . . 50.0 110.218 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -101.87 35.9 2.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 50.0 110.214 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.76 119.3 0.87 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.693 -1.363 . . . . 50.0 109.693 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -114.86 171.09 7.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 50.0 109.795 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -159.39 152.13 21.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.188 -0.945 . . . . 50.0 110.486 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -154.39 -176.22 5.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.341 -0.849 . . . . 50.0 110.12 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.22 163.08 55.34 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 43.64 110.341 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HG3' ' CE1' ' B' ' 10' ' ' PHE . 46.2 Cg_endo -72.88 157.61 51.28 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.635 1.334 . . . . 29.79 110.347 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -75.98 -10.54 59.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.873 . . . . 0.0 110.705 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' B' ' 10' ' ' PHE . 79.1 t80 -74.78 -27.63 60.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.063 -1.023 . . . . 12.57 110.331 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 19' ' ' LEU . 41.0 mt -96.17 23.43 6.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 110.203 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.2 -18.26 61.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.675 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -97.24 1.22 49.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.947 . . . . 0.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.436 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.4 m0 -82.32 153.81 68.9 Favored Pre-proline 0 N--CA 1.485 1.313 0 O-C-N 121.076 -1.015 . . . . 11.57 109.796 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 42.0 Cg_endo -70.61 162.5 42.27 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.535 1.281 . . . . 13.83 111.379 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -40.76 97.6 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.615 0.721 . . . . 48.43 110.67 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -53.78 53.25 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.815 -0.553 . . . . 46.64 111.086 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 22' ' ' VAL . 85.7 t -60.96 -44.59 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.099 -1.0 . . . . 16.14 110.737 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 11' ' ' LEU . 70.7 mt -62.57 -30.66 71.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.218 -0.926 . . . . 12.61 110.779 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -72.64 -23.13 60.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.987 . . . . 23.17 110.264 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.2 tp -87.3 -37.46 17.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.32 -0.862 . . . . 19.0 110.21 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.941 HG12 HG13 ' A' ' 33' ' ' VAL . 27.3 t -57.15 -45.23 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 18.87 110.267 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.459 ' HG3' ' N ' ' A' ' 24' ' ' LYS . 8.8 ptp180 -65.56 -29.87 70.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -0.906 . . . . 23.61 110.681 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -83.58 -10.46 58.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.043 -1.036 . . . . 30.11 110.563 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 21' ' ' LEU . 71.5 t -100.15 -28.0 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 16.22 110.453 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.06 -30.55 58.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 26.6 109.742 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.92 -12.17 58.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.2 -0.938 . . . . 45.21 110.387 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -87.23 -54.13 4.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.068 -1.02 . . . . 37.85 110.536 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -61.01 -22.44 64.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.128 -0.982 . . . . 35.36 110.561 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.2 36.99 4.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.529 -1.428 . . . . 35.1 109.529 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -141.5 -154.89 0.54 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.378 -1.072 . . . . 32.72 110.104 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 p -113.43 171.67 7.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.52 -0.738 . . . . 19.61 109.253 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.941 HG13 HG12 ' A' ' 22' ' ' VAL . 71.4 t -72.64 -23.04 20.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.097 -1.002 . . . . 17.56 110.412 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -70.08 -29.88 66.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.998 . . . . 21.3 109.021 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.71 -29.33 21.17 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.454 -0.778 . . . . 16.38 109.432 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' HG3' HG12 ' A' ' 25' ' ' VAL . 4.2 tt0 -64.36 -59.43 4.38 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.306 -0.871 . . . . 12.61 109.349 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.65 HG23 HG21 ' B' ' 41' ' ' VAL . 24.9 mm -60.31 -22.56 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.369 -0.832 . . . . 10.95 109.284 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -73.62 -33.25 64.48 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.367 -0.833 . . . . 18.87 110.065 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -46.36 21.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 36.88 109.817 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 mtt-85 -61.31 -25.94 67.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.445 -0.784 . . . . 22.85 109.601 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.638 HG21 HG23 ' B' ' 37' ' ' ILE . 53.9 t -88.66 -29.81 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.506 -0.747 . . . . 13.02 109.999 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.0 -67.48 0.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 18.84 110.54 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -55.82 -20.68 16.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.975 . . . . 29.96 110.479 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.0 t -60.35 -53.66 54.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 18.65 109.998 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.537 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 17.0 m-85 -60.52 -30.46 69.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.352 -0.843 . . . . 16.26 110.129 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.15 -30.49 68.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 36.71 110.579 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -29.61 69.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.145 -0.972 . . . . 41.6 110.473 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -95.12 -17.89 21.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.922 . . . . 24.83 110.558 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.1 17.49 61.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.785 -1.326 . . . . 18.81 109.785 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.591 ' HG3' HD11 ' B' ' 21' ' ' LEU . 8.8 tpp180 -59.48 -33.41 71.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.032 -1.276 . . . . 23.01 110.152 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 mt -90.83 -63.51 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.349 -0.844 . . . . 27.08 110.1 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.32 -38.24 2.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.426 -1.47 . . . . 32.03 109.426 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.119 -1.224 . . . . 0.0 110.357 179.795 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.187 0.518 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -101.75 35.89 2.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.416 -0.802 . . . . 0.0 110.333 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.8 119.2 0.86 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -114.77 170.97 7.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -1.128 . . . . 0.0 109.916 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -159.23 152.34 22.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.125 -0.985 . . . . 0.0 110.443 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -154.6 -176.21 5.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.207 -0.933 . . . . 0.0 110.017 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.29 163.16 55.01 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.331 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.487 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 45.8 Cg_endo -73.02 157.57 50.83 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.75 1.395 . . . . 0.0 110.35 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -75.86 -10.55 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 79.0 t80 -74.84 -27.8 60.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.29 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.479 ' HB3' HD21 ' B' ' 19' ' ' LEU . 41.7 mt -96.09 23.36 6.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.179 -0.951 . . . . 0.0 110.225 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.18 -18.35 61.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.134 -0.979 . . . . 0.0 110.601 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -97.13 1.22 49.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.048 -1.032 . . . . 0.0 110.855 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.452 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.3 m0 -82.48 153.82 68.46 Favored Pre-proline 0 N--CA 1.485 1.31 0 O-C-N 120.986 -1.071 . . . . 0.0 109.852 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.473 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 42.2 Cg_endo -70.47 162.11 43.62 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.419 1.221 . . . . 0.0 111.525 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -40.6 97.18 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.784 0.802 . . . . 0.0 110.768 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -53.87 52.14 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.037 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.714 ' O ' HG23 ' B' ' 22' ' ' VAL . 85.8 t -60.7 -45.09 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.586 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' B' ' 11' ' ' LEU . 71.6 mt -61.92 -30.8 71.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.827 -1.171 . . . . 0.0 111.111 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -72.73 -23.32 60.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.097 -1.002 . . . . 0.0 110.287 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.602 ' O ' HG23 ' B' ' 25' ' ' VAL . 1.2 tp -87.0 -37.58 17.38 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.423 -0.798 . . . . 0.0 110.301 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.947 HG12 HG13 ' B' ' 33' ' ' VAL . 26.3 t -57.02 -45.28 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 110.267 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.459 ' HG3' ' N ' ' B' ' 24' ' ' LYS . 8.8 ptp180 -65.59 -29.73 70.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.24 -0.913 . . . . 0.0 110.709 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 0.0 OUTLIER -83.7 -10.45 58.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.064 -1.022 . . . . 0.0 110.527 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 21' ' ' LEU . 71.1 t -100.12 -27.94 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 110.459 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.05 -30.54 58.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.12 -0.987 . . . . 0.0 109.734 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.0 -11.96 58.57 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.378 -0.826 . . . . 0.0 110.46 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.38 -54.0 4.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.991 . . . . 0.0 110.545 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -61.2 -22.35 64.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 110.63 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.15 37.1 4.72 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -141.53 -154.88 0.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.399 -1.059 . . . . 0.0 110.094 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 2.2 p -113.32 171.66 7.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.528 -0.732 . . . . 0.0 109.311 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.947 HG13 HG12 ' B' ' 22' ' ' VAL . 70.9 t -72.64 -23.17 20.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.124 -0.985 . . . . 0.0 110.454 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -69.96 -29.75 66.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.0 109.042 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.87 -29.46 20.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.497 -0.752 . . . . 0.0 109.356 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.48 ' HG3' HG12 ' B' ' 25' ' ' VAL . 4.2 tt0 -64.3 -59.4 4.43 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.297 -0.877 . . . . 0.0 109.295 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.638 HG23 HG21 ' A' ' 41' ' ' VAL . 24.9 mm -60.37 -22.64 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.315 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.412 ' OH ' ' HG3' ' A' ' 15' ' ' PRO . 19.5 t80 -73.71 -33.24 64.3 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.265 -0.897 . . . . 0.0 109.977 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -46.52 21.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 109.723 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 mtt-85 -61.14 -25.84 67.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.81 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.65 HG21 HG23 ' A' ' 37' ' ' ILE . 54.7 t -88.66 -29.85 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.968 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -67.41 0.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 110.465 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -55.86 -20.83 17.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.95 . . . . 0.0 110.396 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 19.6 t -60.25 -53.65 55.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.235 -0.915 . . . . 0.0 109.97 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.543 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 17.4 m-85 -60.36 -30.75 69.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -30.56 68.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 0.0 110.575 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -29.95 70.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.09 -1.006 . . . . 0.0 110.365 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -95.02 -17.93 21.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.579 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.16 17.61 60.67 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.459 ' HG3' HD11 ' A' ' 21' ' ' LEU . 8.7 tpp180 -59.38 -33.53 71.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.256 . . . . 0.0 110.061 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 38.4 mt -90.97 -63.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.153 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.93 -37.81 2.15 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.31 -1.112 . . . . 0.0 110.177 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.293 0.568 . . . . 50.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -101.12 47.12 0.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 50.0 110.104 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.77 119.22 0.2 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.393 -1.483 . . . . 50.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.1 ttm -126.49 -59.77 1.28 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -1.168 . . . . 50.0 110.454 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.16 23.88 0.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.185 -0.947 . . . . 50.0 110.51 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 166.01 16.35 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.609 -0.682 . . . . 50.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.409 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -73.9 164.08 63.7 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 43.64 110.191 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HG2' HD12 ' A' ' 11' ' ' LEU . 44.1 Cg_endo -70.3 145.83 55.12 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.594 1.313 . . . . 29.79 110.426 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -64.16 -14.49 55.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 110.729 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CE1' ' HG3' ' B' ' 8' ' ' PRO . 89.9 t80 -71.77 -28.79 63.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.108 -0.995 . . . . 12.57 110.169 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.707 HD12 ' HG2' ' A' ' 8' ' ' PRO . 65.9 mt -93.77 30.21 1.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.176 -0.953 . . . . 0.0 110.272 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.82 -23.91 61.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -19.63 25.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.91 . . . . 0.0 110.449 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.542 ' CE3' HD22 ' A' ' 11' ' ' LEU . 13.1 m0 -69.56 132.47 89.3 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.256 -0.903 . . . . 11.57 109.236 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.66 167.2 23.51 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.411 1.216 . . . . 13.83 111.082 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -67.98 -25.77 65.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.614 -0.679 . . . . 48.43 110.791 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.5 -51.92 51.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 46.64 110.611 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.9 t -67.49 -39.5 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 16.14 110.526 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.7 -29.92 70.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 12.61 110.639 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.08 -27.47 68.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.059 -1.026 . . . . 23.17 109.504 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.736 ' O ' HG23 ' A' ' 25' ' ' VAL . 50.1 tp -84.88 -39.53 18.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.561 -0.712 . . . . 19.0 110.066 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.821 HG12 HG13 ' A' ' 33' ' ' VAL . 39.9 t -60.26 -47.25 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.44 -0.788 . . . . 18.87 110.574 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HG3' ' N ' ' A' ' 24' ' ' LYS . 9.6 ptp180 -61.52 -28.62 69.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.316 -0.865 . . . . 23.61 110.849 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -86.01 -20.68 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.029 -1.044 . . . . 30.11 110.14 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 21' ' ' LEU . 93.6 t -87.4 -23.75 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.873 . . . . 16.22 110.204 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.76 -34.61 67.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.305 -0.872 . . . . 26.6 109.528 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.44 -9.78 59.3 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.333 -0.854 . . . . 45.21 110.425 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.47 -59.96 2.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 37.85 110.399 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -58.61 -30.17 67.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 35.36 110.444 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.04 32.68 3.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 35.1 109.555 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -136.74 -165.13 1.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.122 . . . . 32.72 109.94 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.24 -173.36 2.65 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.408 -0.807 . . . . 19.61 108.842 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.821 HG13 HG12 ' A' ' 22' ' ' VAL . 69.7 t -83.44 -15.5 11.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.171 -0.956 . . . . 17.56 110.099 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 60.6 t30 -80.84 -33.18 34.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 21.3 108.496 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.84 -40.0 49.27 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.835 -0.802 . . . . 16.38 108.835 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.623 ' HG3' HG12 ' A' ' 25' ' ' VAL . 1.5 tt0 -59.53 -51.24 70.71 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.247 -0.908 . . . . 12.61 109.256 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.59 HG23 HG21 ' B' ' 41' ' ' VAL . 35.3 mm -64.0 -24.42 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.373 -0.829 . . . . 10.95 109.584 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.439 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 35.2 t80 -73.98 -30.35 62.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.297 -0.877 . . . . 18.87 110.427 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 -78.12 -46.09 21.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.083 -1.011 . . . . 36.88 110.137 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.417 ' CD ' ' O ' ' A' ' 36' ' ' GLU . 2.7 mpt_? -60.98 -26.68 67.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 22.85 109.697 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.594 HG21 HG23 ' B' ' 37' ' ' ILE . 19.2 t -85.63 -30.58 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.491 -0.756 . . . . 13.02 109.352 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.5 mtp -71.4 -20.33 62.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.759 . . . . 18.84 110.487 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.04 -26.65 26.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 29.96 110.532 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.48 -58.81 6.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 18.65 110.317 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.64 ' CD1' HD21 ' B' ' 21' ' ' LEU . 30.1 m-85 -55.13 -42.31 72.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 16.26 110.374 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -51.86 -35.79 46.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.161 -0.962 . . . . 36.71 110.615 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -53.92 -62.36 1.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 41.6 110.522 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.0 -59.45 5.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 24.83 110.305 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 131.86 35.33 0.35 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.072 -1.211 . . . . 18.81 110.072 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -83.73 -36.55 23.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -1.202 . . . . 23.01 109.475 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.19 -169.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.531 -0.731 . . . . 27.08 109.613 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.4 -38.67 0.14 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.749 -1.34 . . . . 32.03 109.749 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.297 -1.12 . . . . 0.0 110.331 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.284 0.564 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -100.97 47.15 0.92 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.163 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.61 119.63 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 22.1 ttm -126.87 -59.47 1.26 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -1.128 . . . . 0.0 110.468 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.46 23.9 0.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.2 -0.937 . . . . 0.0 110.517 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.78 166.19 16.01 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.512 -0.743 . . . . 0.0 110.456 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.405 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 0.1 OUTLIER -74.21 164.11 63.55 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 110.092 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.733 ' HG2' HD12 ' B' ' 11' ' ' LEU . 45.0 Cg_endo -70.65 145.25 51.53 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.678 1.357 . . . . 0.0 110.392 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -63.62 -14.46 51.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 0.0 110.749 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 34' ' ' ASN . 90.7 t80 -71.8 -28.46 63.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.047 -1.033 . . . . 0.0 110.209 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.733 HD12 ' HG2' ' B' ' 8' ' ' PRO . 64.2 mt -94.05 30.31 1.91 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.248 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.99 -23.95 61.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -0.847 . . . . 0.0 110.221 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -19.58 25.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.928 . . . . 0.0 110.451 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.554 ' CE3' HD22 ' B' ' 11' ' ' LEU . 13.2 m0 -69.86 132.18 88.9 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.351 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.5 167.24 23.11 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.551 1.29 . . . . 0.0 111.153 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' B' ' 20' ' ' ASP . 1.5 ptm180 -68.07 -25.67 65.46 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.735 -0.603 . . . . 0.0 110.698 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.98 -51.72 51.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 110.526 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.714 ' O ' HG23 ' B' ' 22' ' ' VAL . 61.9 t -67.64 -39.48 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.103 -0.998 . . . . 0.0 110.237 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 14.3 mt -65.77 -29.83 70.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 110.715 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 16' ' ' ARG . 1.0 OUTLIER -66.37 -27.61 68.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.041 -1.037 . . . . 0.0 109.617 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.726 ' O ' HG23 ' B' ' 25' ' ' VAL . 45.7 tp -84.87 -39.1 18.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.633 -0.667 . . . . 0.0 110.03 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.8 HG12 HG13 ' B' ' 33' ' ' VAL . 39.3 t -60.88 -46.32 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.0 110.606 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' B' ' 24' ' ' LYS . 9.6 ptp180 -62.31 -28.31 69.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.197 -0.939 . . . . 0.0 110.759 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.464 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 0.1 OUTLIER -86.06 -20.82 28.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.031 -1.043 . . . . 0.0 110.116 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.726 HG23 ' O ' ' B' ' 21' ' ' LEU . 95.3 t -87.42 -23.75 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.853 . . . . 0.0 110.119 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.27 66.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.52 -9.91 59.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.46 -0.775 . . . . 0.0 110.371 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -86.51 -59.99 2.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.015 . . . . 0.0 110.379 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -58.56 -30.09 66.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.87 . . . . 0.0 110.345 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.94 32.56 3.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -136.44 -164.82 1.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -1.183 . . . . 0.0 109.973 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.54 -173.55 2.67 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.37 -0.831 . . . . 0.0 108.879 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.8 HG13 HG12 ' B' ' 22' ' ' VAL . 69.4 t -83.26 -15.65 11.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.175 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 60.2 t30 -80.86 -32.98 34.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.097 -1.002 . . . . 0.0 108.436 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -40.47 48.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.639 ' HG3' HG12 ' B' ' 25' ' ' VAL . 1.5 tt0 -59.1 -51.55 69.55 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.214 -0.929 . . . . 0.0 109.273 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.594 HG23 HG21 ' A' ' 41' ' ' VAL . 37.0 mm -63.53 -24.58 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.58 -0.7 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.435 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 37.8 t80 -74.2 -29.84 61.93 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 110.508 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -78.6 -46.2 19.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.404 ' CD ' ' O ' ' B' ' 36' ' ' GLU . 2.7 mpt_? -60.36 -27.64 67.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.567 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.59 HG21 HG23 ' A' ' 37' ' ' ILE . 18.6 t -84.9 -30.42 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.512 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.5 mtp -72.19 -19.54 61.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 110.499 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.45 -26.94 26.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 110.354 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -58.9 6.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 0.0 110.391 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.59 ' CD1' HD21 ' A' ' 21' ' ' LEU . 31.2 m-85 -55.23 -41.93 72.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.469 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -52.27 -36.08 51.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.249 -0.907 . . . . 0.0 110.518 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -53.61 -62.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.579 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -60.94 -59.55 5.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.332 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.04 35.15 0.35 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -83.77 -36.61 23.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.308 . . . . 0.0 109.415 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 pt -127.96 -168.91 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.427 -0.796 . . . . 0.0 109.794 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.12 -38.85 0.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.308 -1.113 . . . . 0.0 110.241 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.248 0.547 . . . . 50.0 110.128 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -113.26 174.34 5.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 50.0 110.102 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.52 37.53 10.63 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.587 -1.405 . . . . 50.0 109.587 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.67 -162.78 0.93 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -1.145 . . . . 50.0 110.2 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.6 m -82.41 140.48 33.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.271 -0.893 . . . . 50.0 110.217 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -112.98 38.59 2.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 50.0 110.394 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 18.4 mtp -110.32 106.06 57.67 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 43.64 110.209 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.608 ' CG ' HD12 ' A' ' 11' ' ' LEU . 45.0 Cg_endo -71.33 153.5 61.44 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.569 1.3 . . . . 29.79 110.487 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.15 -17.58 64.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 110.456 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.457 ' HB3' ' CB ' ' B' ' 10' ' ' PHE . 87.7 t80 -76.26 -28.45 57.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 12.57 110.352 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.608 HD12 ' CG ' ' A' ' 8' ' ' PRO . 81.5 mt -91.53 21.14 4.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.954 . . . . 0.0 110.455 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -72.45 -22.65 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 110.059 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.79 -11.99 46.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.635 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.511 ' HH2' HG21 ' B' ' 41' ' ' VAL . 14.2 m0 -79.73 141.94 56.39 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.029 -1.045 . . . . 11.57 109.682 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.19 177.83 7.33 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.572 1.301 . . . . 13.83 110.685 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.77 -21.95 34.46 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.385 -0.822 . . . . 48.43 109.153 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -69.32 -28.01 65.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.885 . . . . 46.64 109.887 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.869 ' O ' HG23 ' A' ' 22' ' ' VAL . 78.5 t -94.85 -40.46 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 16.14 110.034 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.89 -28.79 69.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 12.61 110.547 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -73.08 -22.61 60.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 23.17 109.936 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.821 ' O ' HG23 ' A' ' 25' ' ' VAL . 50.6 tp -90.1 -33.52 16.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 19.0 110.018 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 18' ' ' VAL . 24.0 t -67.14 -50.18 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.419 -0.801 . . . . 18.87 110.345 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -59.17 -27.25 65.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.309 -0.869 . . . . 23.61 110.788 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -24.11 33.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 30.11 110.165 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 21' ' ' LEU . 88.4 t -78.83 -39.34 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.433 -0.792 . . . . 16.22 110.351 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.76 97.86 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.204 -0.935 . . . . 26.6 109.654 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -68.13 -16.09 63.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 45.21 110.452 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.78 -59.84 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.979 -1.076 . . . . 37.85 110.411 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -59.07 -28.03 66.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 35.36 110.703 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.59 41.03 3.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.461 -1.456 . . . . 35.1 109.461 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mtt-85 -141.96 -154.01 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -1.121 . . . . 32.72 110.069 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 t -108.59 175.94 5.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.48 -0.763 . . . . 19.61 109.476 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.765 HG13 HG12 ' A' ' 22' ' ' VAL . 88.9 t -78.64 -20.56 13.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.157 -0.965 . . . . 17.56 110.229 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.18 -26.57 63.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.069 -1.019 . . . . 21.3 109.104 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.82 -30.53 22.9 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.384 -0.823 . . . . 16.38 109.566 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HG3' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -67.16 -48.48 67.86 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.251 -0.906 . . . . 12.61 109.724 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.618 HG23 HG21 ' B' ' 41' ' ' VAL . 47.3 mm -66.36 -30.88 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.837 . . . . 10.95 109.679 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HE1' HG11 ' B' ' 18' ' ' VAL . 36.9 t80 -67.67 -39.4 84.51 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 18.87 110.635 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.53 -45.81 61.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.185 -0.947 . . . . 36.88 109.743 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 36' ' ' GLU . 2.1 mmt-85 -60.84 -24.69 66.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 22.85 109.4 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.699 HG21 HG23 ' B' ' 37' ' ' ILE . 52.1 t -90.14 -23.36 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.586 -0.696 . . . . 13.02 110.161 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -56.99 4.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.505 -0.747 . . . . 18.84 110.977 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -50.74 -33.22 22.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.121 -0.987 . . . . 29.96 111.189 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.3 m -60.79 -51.24 70.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.121 -0.987 . . . . 18.65 110.598 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.629 ' CD1' HD21 ' B' ' 21' ' ' LEU . 15.0 m-85 -59.77 -29.88 68.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.98 . . . . 16.26 110.814 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.09 -30.08 58.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.006 -1.059 . . . . 36.71 110.677 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -54.56 -49.63 69.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.104 -0.998 . . . . 41.6 110.356 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -80.15 -58.32 3.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.181 -0.95 . . . . 24.83 110.314 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.38 42.49 0.25 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.464 -1.455 . . . . 18.81 109.464 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.47 -28.13 31.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.397 -1.06 . . . . 23.01 110.437 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.7 mt -81.72 -20.66 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.009 -1.057 . . . . 27.08 110.38 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.64 -28.47 3.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.744 -1.342 . . . . 32.03 109.744 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.283 -1.128 . . . . 0.0 110.149 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.262 0.553 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -113.21 173.73 6.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.23 37.43 9.88 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.66 -162.89 0.94 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -1.122 . . . . 0.0 110.193 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 4.5 m -82.16 140.34 33.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 110.228 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -113.12 38.81 2.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 110.256 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 18.3 mtp -110.49 105.89 57.48 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.141 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.599 ' CG ' HD12 ' B' ' 11' ' ' LEU . 45.4 Cg_endo -71.46 153.55 60.71 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.65 1.342 . . . . 0.0 110.42 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.04 -17.74 65.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.458 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.457 ' CB ' ' HB3' ' A' ' 10' ' ' PHE . 87.6 t80 -76.15 -28.32 57.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.157 -0.964 . . . . 0.0 110.326 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.599 HD12 ' CG ' ' B' ' 8' ' ' PRO . 83.5 mt -91.8 21.7 4.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 110.407 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.09 -22.53 60.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.974 . . . . 0.0 110.015 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.74 -12.02 46.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 110.644 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.529 ' HH2' HG21 ' A' ' 41' ' ' VAL . 14.2 m0 -79.83 142.05 56.1 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.841 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.21 177.42 7.86 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.551 1.29 . . . . 0.0 110.18 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -21.6 34.61 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.439 -0.788 . . . . 0.0 109.226 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -69.38 -28.02 65.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.978 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.846 ' O ' HG23 ' B' ' 22' ' ' VAL . 80.2 t -94.66 -40.64 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.551 -0.718 . . . . 0.0 109.845 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 19' ' ' LEU . 85.3 mt -65.95 -28.44 68.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.563 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.38 -22.85 60.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.845 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.84 ' O ' HG23 ' B' ' 25' ' ' VAL . 51.7 tp -89.82 -33.73 16.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.704 -0.623 . . . . 0.0 110.12 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.846 HG23 ' O ' ' B' ' 18' ' ' VAL . 24.0 t -66.92 -50.1 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -0.829 . . . . 0.0 110.37 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -59.14 -27.52 65.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.289 -0.882 . . . . 0.0 110.801 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -24.3 34.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 110.114 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.84 HG23 ' O ' ' B' ' 21' ' ' LEU . 88.8 t -78.66 -39.46 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.804 . . . . 0.0 110.299 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.47 99.22 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.342 -0.849 . . . . 0.0 109.59 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -67.53 -16.24 64.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.528 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -82.56 -59.94 2.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.041 -1.037 . . . . 0.0 110.503 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -58.97 -28.16 66.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.136 -0.978 . . . . 0.0 110.794 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.47 41.7 2.9 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -142.6 -154.19 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.433 -1.04 . . . . 0.0 110.002 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.7 t -108.87 175.8 5.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.451 -0.781 . . . . 0.0 109.466 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.784 HG13 HG12 ' B' ' 22' ' ' VAL . 93.7 t -78.27 -20.5 13.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 110.451 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.6 -26.32 62.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.079 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.02 -30.38 22.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.429 -0.794 . . . . 0.0 109.467 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.501 ' HG3' HG12 ' B' ' 25' ' ' VAL . 0.0 OUTLIER -67.41 -48.35 67.61 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.699 HG23 HG21 ' A' ' 41' ' ' VAL . 47.2 mm -66.81 -30.31 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.427 ' HE1' HG11 ' A' ' 18' ' ' VAL . 36.3 t80 -68.0 -39.41 83.22 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.381 -0.825 . . . . 0.0 110.608 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -45.83 61.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.895 . . . . 0.0 109.759 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' B' ' 36' ' ' GLU . 2.0 mmt-85 -60.93 -24.52 66.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 109.383 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.618 HG21 HG23 ' A' ' 37' ' ' ILE . 49.9 t -90.22 -23.4 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.62 -0.675 . . . . 0.0 110.011 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -57.66 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.507 -0.746 . . . . 0.0 111.081 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -50.22 -33.37 19.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.163 -0.961 . . . . 0.0 111.249 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 38.1 m -60.96 -50.85 71.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.1 -1.0 . . . . 0.0 110.637 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.667 ' CD1' HD21 ' A' ' 21' ' ' LEU . 15.9 m-85 -60.04 -30.04 68.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.79 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.93 -29.78 58.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.251 -0.905 . . . . 0.0 110.835 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -54.77 -49.39 71.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 110.468 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -80.3 -58.04 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.083 -1.011 . . . . 0.0 110.397 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.01 42.47 0.26 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -28.6 31.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -1.176 . . . . 0.0 110.379 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 65.2 mt -81.4 -20.65 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.479 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.7 -28.8 3.2 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.125 . . . . 0.0 110.264 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tmm? . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.231 0.538 . . . . 50.0 110.118 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -160.1 -174.49 4.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 50.0 110.184 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.52 46.16 1.07 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.568 -1.413 . . . . 50.0 109.568 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.73 -170.53 1.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -1.197 . . . . 50.0 110.279 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 m -106.81 130.65 54.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 50.0 110.412 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.73 155.57 27.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 50.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.41 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 1.9 ptm -53.86 163.8 1.06 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 43.64 110.358 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.768 ' CG ' HD12 ' A' ' 11' ' ' LEU . 44.0 Cg_endo -70.86 157.77 57.34 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.711 1.374 . . . . 29.79 110.466 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.28 -21.59 62.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.891 . . . . 0.0 110.449 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.514 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 87.4 t80 -70.12 -22.16 63.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.843 . . . . 12.57 110.574 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.768 HD12 ' CG ' ' A' ' 8' ' ' PRO . 85.1 mt -100.23 27.43 5.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.139 -0.975 . . . . 0.0 110.541 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.81 -21.64 44.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.952 . . . . 0.0 110.006 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -85.58 -22.9 27.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.556 ' HB2' HD11 ' A' ' 19' ' ' LEU . 14.7 m0 -66.16 144.81 98.9 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 121.424 -0.798 . . . . 11.57 109.533 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HD2' ' CE1' ' B' ' 38' ' ' TYR . 40.6 Cg_endo -70.85 160.35 49.67 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.496 1.261 . . . . 13.83 111.336 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -40.15 88.9 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.603 0.716 . . . . 48.43 110.934 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.09 -47.29 86.51 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.69 -0.631 . . . . 46.64 111.49 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.0 t -66.89 -48.82 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.038 -1.039 . . . . 16.14 111.021 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 14' ' ' TRP . 74.8 mt -64.02 -24.97 67.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.069 -1.019 . . . . 12.61 110.685 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HA ' ' CD ' ' A' ' 23' ' ' ARG . 13.9 t70 -71.69 -23.68 61.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 23.17 109.898 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.657 HD13 HG22 ' B' ' 51' ' ' ILE . 0.8 OUTLIER -90.29 -43.72 10.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 19.0 110.043 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.993 HG12 HG13 ' A' ' 33' ' ' VAL . 40.6 t -51.32 -39.44 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.392 -0.818 . . . . 18.87 110.477 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 8.3 ptm180 -66.03 -36.21 82.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 23.61 110.622 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -19.4 58.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 30.11 110.524 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.451 HG12 ' HG3' ' A' ' 36' ' ' GLU . 69.9 t -86.88 -35.09 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.263 -0.898 . . . . 16.22 110.184 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.91 83.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -0.909 . . . . 26.6 109.738 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.98 -19.45 63.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 45.21 110.271 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -82.77 -56.53 3.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 37.85 110.35 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -53.41 -42.64 67.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 35.36 110.386 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.73 44.54 0.54 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.541 -1.424 . . . . 35.1 109.541 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.33 -158.58 0.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -1.123 . . . . 32.72 110.189 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.83 176.93 5.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 19.61 109.561 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.993 HG13 HG12 ' A' ' 22' ' ' VAL . 75.1 t -76.14 -19.42 15.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.356 -0.84 . . . . 17.56 110.265 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -71.12 -27.72 63.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 21.3 108.869 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 m -86.3 -33.64 20.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.555 -0.716 . . . . 16.38 109.531 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG3' HG12 ' A' ' 25' ' ' VAL . 1.1 tt0 -63.55 -53.59 49.42 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.187 -0.946 . . . . 12.61 109.412 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.576 HG23 HG21 ' B' ' 41' ' ' VAL . 25.8 mm -63.37 -21.73 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.458 -0.776 . . . . 10.95 109.653 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 32.9 t80 -76.2 -35.59 59.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.155 -0.966 . . . . 18.87 110.362 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -76.8 -52.03 10.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 36.88 109.6 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -55.46 -24.56 31.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.456 -0.778 . . . . 22.85 109.732 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.587 HG21 HG23 ' B' ' 37' ' ' ILE . 37.5 t -89.97 -29.79 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 13.02 109.867 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -64.07 0.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 18.84 110.48 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.88 -29.13 18.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.19 -0.944 . . . . 29.96 110.425 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.65 -46.45 81.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 18.65 109.928 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.55 ' CZ ' HD23 ' B' ' 21' ' ' LEU . 15.4 m-85 -66.75 -29.07 68.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 16.26 110.167 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.15 -26.46 65.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 36.71 110.502 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -63.95 -25.66 68.24 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 41.6 110.299 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.3 17.45 18.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 24.83 110.592 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.5 22.26 30.87 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.01 -1.236 . . . . 18.81 110.01 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -54.16 -52.89 59.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -1.171 . . . . 23.01 109.931 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.612 HG22 HD13 ' B' ' 21' ' ' LEU . 28.7 pt -101.99 -175.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.973 -1.08 . . . . 27.08 109.932 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.2 -63.76 0.16 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.664 -1.374 . . . . 32.03 109.664 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.157 -1.202 . . . . 0.0 110.28 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.7 tmm? . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.299 0.571 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -160.0 -174.38 4.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 110.232 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.9 46.53 1.05 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.94 -170.46 1.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -1.115 . . . . 0.0 110.323 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -107.0 131.15 54.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.359 -0.838 . . . . 0.0 110.299 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 155.33 28.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.884 . . . . 0.0 110.096 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.421 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 2.0 ptm -53.6 163.81 0.98 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.284 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.774 ' CG ' HD12 ' B' ' 11' ' ' LEU . 43.9 Cg_endo -71.04 157.99 56.41 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.621 1.327 . . . . 0.0 110.449 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.53 -21.23 61.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 110.386 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.506 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 86.6 t80 -70.53 -22.08 62.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.441 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.774 HD12 ' CG ' ' B' ' 8' ' ' PRO . 85.1 mt -100.37 27.55 5.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 110.542 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.01 -21.4 43.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 110.034 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -85.86 -22.9 27.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.873 . . . . 0.0 110.189 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.549 ' HB2' HD11 ' B' ' 19' ' ' LEU . 14.8 m0 -66.34 145.2 98.96 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.288 -0.883 . . . . 0.0 109.425 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.461 ' HG2' HG23 ' B' ' 18' ' ' VAL . 41.0 Cg_endo -71.4 159.71 50.77 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.308 1.162 . . . . 0.0 111.341 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -40.4 86.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.676 0.75 . . . . 0.0 110.997 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.15 -47.21 86.87 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.774 -0.579 . . . . 0.0 111.481 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.63 ' O ' HG23 ' B' ' 22' ' ' VAL . 78.9 t -67.11 -48.61 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.304 -0.872 . . . . 0.0 110.902 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' B' ' 14' ' ' TRP . 77.0 mt -64.04 -24.63 67.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.079 -1.013 . . . . 0.0 110.662 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' CD ' ' B' ' 23' ' ' ARG . 13.5 t70 -71.99 -24.14 61.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.231 -0.918 . . . . 0.0 109.754 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.612 HD13 HG22 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -90.03 -43.45 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.502 -0.748 . . . . 0.0 110.096 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.971 HG12 HG13 ' B' ' 33' ' ' VAL . 40.7 t -51.6 -39.62 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.41 -0.806 . . . . 0.0 110.458 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.447 ' CD ' ' HA ' ' B' ' 20' ' ' ASP . 8.3 ptm180 -65.84 -36.29 83.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.706 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -19.57 58.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.459 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.461 HG12 ' HG3' ' B' ' 36' ' ' GLU . 69.9 t -86.71 -35.25 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.923 . . . . 0.0 110.32 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 -39.35 84.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 109.701 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.49 -19.92 63.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 110.245 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -82.45 -56.53 3.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.128 -0.982 . . . . 0.0 110.373 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -53.6 -42.38 67.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 110.46 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.51 44.48 0.55 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.35 -158.68 0.69 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -1.176 . . . . 0.0 110.258 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.69 176.92 5.06 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.363 -0.835 . . . . 0.0 109.617 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.971 HG13 HG12 ' B' ' 22' ' ' VAL . 76.3 t -76.14 -19.26 15.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.261 -0.899 . . . . 0.0 110.308 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -71.18 -27.84 63.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -0.989 . . . . 0.0 108.856 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 45.6 m -86.15 -33.72 20.77 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.549 -0.719 . . . . 0.0 109.536 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.461 ' HG3' HG12 ' B' ' 25' ' ' VAL . 1.1 tt0 -63.4 -53.66 48.88 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.249 -0.907 . . . . 0.0 109.492 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.587 HG23 HG21 ' A' ' 41' ' ' VAL . 26.4 mm -63.32 -21.81 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.528 -0.732 . . . . 0.0 109.596 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.481 ' CE1' ' HD2' ' A' ' 15' ' ' PRO . 33.3 t80 -76.15 -35.51 59.17 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.113 -0.992 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -76.78 -52.08 10.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.146 -0.971 . . . . 0.0 109.645 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -55.44 -24.46 30.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.461 -0.774 . . . . 0.0 109.817 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 37' ' ' ILE . 37.7 t -90.07 -29.97 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 0.0 109.898 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -63.92 1.01 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 110.451 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.03 -29.35 20.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.156 -0.965 . . . . 0.0 110.325 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -46.7 80.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 110.011 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.536 ' CZ ' HD23 ' A' ' 21' ' ' LEU . 15.7 m-85 -66.73 -28.95 68.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 110.125 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -68.3 -26.23 65.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 110.481 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -63.91 -25.85 68.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.162 -0.962 . . . . 0.0 110.28 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.16 17.54 18.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.897 . . . . 0.0 110.602 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.2 22.62 30.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -54.32 -52.82 60.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.153 -1.204 . . . . 0.0 110.012 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.657 HG22 HD13 ' A' ' 21' ' ' LEU . 28.0 pt -101.79 -175.68 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.441 -0.787 . . . . 0.0 110.102 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.01 -63.23 0.16 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.194 -1.18 . . . . 0.0 110.25 -179.942 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.282 0.563 . . . . 50.0 110.26 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -144.0 -165.94 2.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.319 -0.863 . . . . 50.0 110.176 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.52 94.29 1.29 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.749 -1.34 . . . . 50.0 109.749 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.7 ttt -111.8 30.23 7.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -1.145 . . . . 50.0 110.085 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m -142.68 162.8 34.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 50.0 109.96 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.41 -162.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.147 -0.971 . . . . 50.0 109.966 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 mtp 56.2 104.37 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.237 -0.914 . . . . 43.64 110.381 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.9 Cg_endo -71.12 170.59 17.79 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.565 1.297 . . . . 29.79 110.791 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -87.0 -17.55 32.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 110.327 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.513 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 74.2 t80 -72.62 -26.12 61.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 12.57 110.564 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.705 ' HB3' HD21 ' A' ' 19' ' ' LEU . 71.6 mt -94.34 27.1 3.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 110.14 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.7 -18.11 61.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 110.414 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.7 -3.84 29.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.086 -1.008 . . . . 0.0 110.726 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.8 m0 -81.87 138.33 46.69 Favored Pre-proline 0 C--N 1.305 -1.332 0 O-C-N 120.95 -1.094 . . . . 11.57 109.635 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.23 159.59 51.5 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.482 1.254 . . . . 13.83 111.228 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -40.97 96.93 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.856 0.836 . . . . 48.43 110.382 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -52.71 -21.01 3.56 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.691 -0.631 . . . . 46.64 111.223 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 22' ' ' VAL . 92.6 t -104.0 -44.77 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.974 -1.079 . . . . 16.14 111.227 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.705 HD21 ' HB3' ' A' ' 11' ' ' LEU . 20.0 mt -63.12 -24.64 67.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.134 -0.979 . . . . 12.61 111.11 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -25.75 60.48 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.248 -0.907 . . . . 23.17 109.56 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.704 ' O ' HG23 ' A' ' 25' ' ' VAL . 42.9 tp -85.54 -42.47 14.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.599 -0.688 . . . . 19.0 109.849 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.037 HG12 HG13 ' A' ' 33' ' ' VAL . 25.3 t -55.3 -37.94 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 18.87 110.205 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -67.5 -50.49 58.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 23.61 110.439 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -19.48 65.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.218 -0.926 . . . . 30.11 110.338 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.751 HG12 ' CD ' ' A' ' 36' ' ' GLU . 86.9 t -86.84 -32.58 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 16.22 110.061 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.419 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -71.74 -39.13 70.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.199 -0.938 . . . . 26.6 109.306 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 -19.37 62.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.529 -0.732 . . . . 45.21 109.77 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.84 -57.12 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 37.85 110.153 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -56.29 -53.69 54.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 35.36 110.227 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.75 52.43 0.08 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.669 -1.372 . . . . 35.1 109.669 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -169.33 -159.19 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -1.21 . . . . 32.72 110.223 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.419 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 56.8 p -98.4 -176.43 3.39 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.462 -0.774 . . . . 19.61 109.778 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG13 HG12 ' A' ' 22' ' ' VAL . 86.4 t -81.5 -9.94 12.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.155 -0.966 . . . . 17.56 110.708 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -75.72 -29.87 59.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.007 -1.058 . . . . 21.3 109.318 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -90.42 -28.63 18.51 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.372 -0.83 . . . . 16.38 110.058 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.751 ' CD ' HG12 ' A' ' 25' ' ' VAL . 12.0 tp10 -65.05 -51.15 63.12 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.134 -0.979 . . . . 12.61 109.66 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.601 HD11 HG11 ' A' ' 22' ' ' VAL . 2.7 mt -67.08 -20.6 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.398 -0.814 . . . . 10.95 109.729 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.415 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 46.7 t80 -69.61 -39.15 77.41 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.112 -0.992 . . . . 18.87 110.27 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -71.82 -43.5 65.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 36.88 110.223 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HD3' ' HB3' ' B' ' 44' ' ' SER . 17.0 mtt-85 -63.3 -31.98 73.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 22.85 109.519 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.616 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 71.3 t -83.33 -22.8 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.626 -0.671 . . . . 13.02 110.284 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.25 -34.89 48.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.408 -0.807 . . . . 18.84 110.587 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -72.48 -32.4 66.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 29.96 110.268 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.413 ' HB3' ' HD3' ' B' ' 40' ' ' ARG . 0.1 OUTLIER -56.13 -54.79 40.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 18.65 110.071 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.643 ' CD1' HD21 ' B' ' 21' ' ' LEU . 27.0 m-85 -62.02 -19.46 62.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 16.26 110.572 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -81.79 -26.5 34.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 36.71 110.162 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -67.28 -37.15 82.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.375 -0.828 . . . . 41.6 110.215 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.15 -28.1 29.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.398 -0.814 . . . . 24.83 110.262 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.28 28.27 11.95 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.332 -1.507 . . . . 18.81 109.332 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.598 HH21 HG22 ' B' ' 25' ' ' VAL . 0.1 OUTLIER -75.53 -43.14 50.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -1.108 . . . . 23.01 110.405 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.443 ' CG2' HD22 ' B' ' 21' ' ' LEU . 27.4 pt -102.59 -179.75 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.732 -0.787 . . . . 27.08 110.526 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.83 38.34 0.62 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.204 -1.559 . . . . 32.03 109.204 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 120.799 -1.412 . . . . 0.0 109.993 -179.952 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.422 0.629 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -143.91 -166.09 2.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.53 94.74 1.34 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 7.6 ttt -112.05 30.13 7.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -1.207 . . . . 0.0 110.012 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.7 m -142.73 162.79 34.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.902 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.31 -162.07 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.104 -0.998 . . . . 0.0 110.028 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 2.1 mtp 56.13 104.38 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 0.0 110.441 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.513 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 45.6 Cg_endo -71.19 170.71 17.55 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.555 1.292 . . . . 0.0 110.782 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -87.27 -17.51 32.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.408 -0.808 . . . . 0.0 110.398 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.489 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 76.9 t80 -72.69 -26.0 61.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.867 . . . . 0.0 110.477 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.714 ' HB3' HD21 ' B' ' 19' ' ' LEU . 71.8 mt -94.57 27.22 3.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.181 -0.949 . . . . 0.0 110.174 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.82 -18.12 60.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 110.489 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.6 -3.7 29.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.086 -1.009 . . . . 0.0 110.786 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.616 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.9 m0 -82.13 138.6 45.71 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.103 -0.998 . . . . 0.0 109.67 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.0 Cg_endo -71.36 159.54 51.38 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.175 1.092 . . . . 0.0 110.95 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.74 96.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.636 0.731 . . . . 0.0 110.301 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -52.65 -21.09 3.58 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.701 -0.624 . . . . 0.0 111.105 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.636 ' O ' HG23 ' B' ' 22' ' ' VAL . 98.5 t -104.05 -44.61 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.441 -1.412 . . . . 0.0 111.14 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' B' ' 11' ' ' LEU . 19.9 mt -63.26 -24.76 68.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.132 -0.98 . . . . 0.0 111.081 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -25.37 60.07 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.251 -0.906 . . . . 0.0 109.683 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.726 ' O ' HG23 ' B' ' 25' ' ' VAL . 44.8 tp -85.7 -42.29 14.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.577 -0.702 . . . . 0.0 109.968 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 1.075 HG12 HG13 ' B' ' 33' ' ' VAL . 26.2 t -55.42 -37.97 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.107 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -67.3 -50.81 58.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.305 -0.872 . . . . 0.0 110.455 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -19.55 64.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.229 -0.919 . . . . 0.0 110.5 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.749 HG12 ' CD ' ' B' ' 36' ' ' GLU . 87.6 t -86.7 -32.62 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 110.1 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.418 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -71.52 -39.09 70.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.25 -19.34 62.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.529 -0.732 . . . . 0.0 109.764 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.83 -57.12 3.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 110.227 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -56.37 -53.82 52.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 110.284 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.09 52.44 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -169.36 -159.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.267 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.418 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 54.5 p -98.31 -176.32 3.37 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.314 -0.866 . . . . 0.0 109.867 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 1.075 HG13 HG12 ' B' ' 22' ' ' VAL . 88.0 t -81.62 -9.97 12.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.17 -0.956 . . . . 0.0 110.819 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -75.61 -29.88 59.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.982 . . . . 0.0 109.367 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -90.39 -28.68 18.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.952 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.749 ' CD ' HG12 ' B' ' 25' ' ' VAL . 12.0 tp10 -65.14 -50.96 63.99 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.194 -0.941 . . . . 0.0 109.732 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.594 HD11 HG11 ' B' ' 22' ' ' VAL . 2.5 mt -67.13 -20.82 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -69.66 -39.3 77.13 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.214 -0.929 . . . . 0.0 110.252 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -71.51 -43.48 66.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.83 . . . . 0.0 110.198 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.413 ' HD3' ' HB3' ' A' ' 44' ' ' SER . 17.3 mtt-85 -63.5 -32.05 73.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.95 . . . . 0.0 109.502 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 37' ' ' ILE . 76.9 t -82.92 -22.87 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 110.34 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.36 -34.98 47.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.819 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.45 -32.35 66.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.136 -0.977 . . . . 0.0 110.208 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.416 ' HB3' ' HD3' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -56.22 -54.78 41.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 110.105 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.641 ' CD1' HD21 ' A' ' 21' ' ' LEU . 27.2 m-85 -61.85 -19.42 62.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 110.54 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -81.98 -26.52 33.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.219 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -67.3 -37.39 83.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.927 . . . . 0.0 110.232 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -82.89 -28.09 30.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.311 -0.868 . . . . 0.0 110.273 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.54 27.63 12.73 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.489 HH21 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -75.29 -42.85 53.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.326 -1.102 . . . . 0.0 110.411 -179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.45 ' CG2' HD22 ' A' ' 21' ' ' LEU . 27.4 pt -102.89 -179.78 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.142 -0.974 . . . . 0.0 110.424 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.98 37.97 0.63 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.232 -1.158 . . . . 0.0 110.299 179.984 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.287 0.565 . . . . 50.0 110.283 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -72.97 147.12 45.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 50.0 110.178 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -151.59 -69.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.482 -1.447 . . . . 50.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mtt -79.38 137.28 37.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -1.128 . . . . 50.0 110.115 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 m -139.83 -168.81 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.955 . . . . 50.0 110.407 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.57 47.73 1.03 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 50.0 110.178 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.465 ' CE ' HD13 ' A' ' 19' ' ' LEU . 4.2 mtt -95.39 135.23 23.4 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 43.64 110.114 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.747 ' CG ' HD12 ' A' ' 11' ' ' LEU . 46.9 Cg_endo -73.4 156.8 50.12 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.516 1.272 . . . . 29.79 110.495 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -76.53 -11.64 59.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.614 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -79.31 -34.35 42.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.014 -1.054 . . . . 12.57 110.291 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.747 HD12 ' CG ' ' A' ' 8' ' ' PRO . 66.1 mt -88.27 14.89 8.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.096 -1.003 . . . . 0.0 110.586 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.58 -27.44 69.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -82.34 -23.78 34.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.92 . . . . 0.0 110.519 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.501 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.0 m0 -63.43 141.72 97.86 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.312 -0.867 . . . . 11.57 109.21 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.39 173.63 9.41 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.458 1.241 . . . . 13.83 111.082 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -77.82 -22.03 50.63 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.499 -0.751 . . . . 48.43 109.769 -179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.7 -46.22 39.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 46.64 110.428 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.85 ' O ' HG23 ' A' ' 22' ' ' VAL . 97.9 t -68.72 -39.58 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 16.14 110.157 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 11' ' ' LEU . 24.8 mt -66.26 -31.52 72.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 12.61 110.654 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 3.4 t0 -70.75 -22.33 62.42 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 23.17 110.074 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.784 ' O ' HG23 ' A' ' 25' ' ' VAL . 51.0 tp -88.83 -37.62 15.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.372 -0.83 . . . . 19.0 109.951 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.981 HG12 HG13 ' A' ' 33' ' ' VAL . 15.6 t -65.84 -49.51 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 18.87 109.959 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HA ' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -59.91 -35.76 75.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 23.61 110.483 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 23' ' ' ARG . 2.1 tmtt? -73.43 -24.55 60.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.113 -0.992 . . . . 30.11 109.943 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 21' ' ' LEU . 99.4 t -86.63 -20.89 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.497 -0.752 . . . . 16.22 110.311 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.578 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -82.22 -30.21 30.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.217 -0.927 . . . . 26.6 109.539 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.43 -19.51 49.78 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.471 -0.768 . . . . 45.21 110.307 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 22.8 pt-20 -90.82 -30.82 16.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.191 -0.943 . . . . 37.85 110.279 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.426 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -82.97 7.68 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 35.36 110.558 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.45 23.98 70.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.517 -1.433 . . . . 35.1 109.517 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 8.8 mtt-85 -129.19 -158.02 0.86 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -1.194 . . . . 32.72 110.362 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.578 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 1.8 m -115.06 -179.65 3.69 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.511 -0.743 . . . . 19.61 109.286 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.981 HG13 HG12 ' A' ' 22' ' ' VAL . 99.1 t -77.97 -14.86 14.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.129 -0.982 . . . . 17.56 110.448 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -77.03 -41.69 41.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.102 -0.998 . . . . 21.3 109.004 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.8 t -71.18 -35.9 71.76 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.386 -0.821 . . . . 16.38 109.56 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.9 tp10 -64.68 -50.54 66.6 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.233 -0.917 . . . . 12.61 109.405 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.722 HG23 HG21 ' B' ' 41' ' ' VAL . 35.6 mm -63.94 -26.82 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 10.95 109.53 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' B' ' 18' ' ' VAL . 53.4 t80 -71.89 -37.19 70.19 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.374 -0.829 . . . . 18.87 110.753 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.74 -36.34 59.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -0.932 . . . . 36.88 110.253 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -71.99 -24.16 61.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 22.85 109.64 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.787 HG21 HG23 ' B' ' 37' ' ' ILE . 7.0 t -87.09 -28.68 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.8 . . . . 13.02 109.217 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -43.45 60.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.603 -0.685 . . . . 18.84 110.531 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -28.93 68.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 29.96 110.137 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -49.81 70.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.89 . . . . 18.65 110.07 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.584 ' CD1' HD21 ' B' ' 21' ' ' LEU . 31.1 m-85 -66.01 -22.87 66.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 16.26 110.371 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -73.79 -36.54 65.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.19 -0.944 . . . . 36.71 110.525 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -57.4 -54.77 43.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 41.6 110.346 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -61.58 -40.88 96.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.997 . . . . 24.83 110.269 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.92 30.48 3.44 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.543 -1.423 . . . . 18.81 109.543 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.418 ' HD2' HD11 ' B' ' 21' ' ' LEU . 8.9 mmt-85 -81.22 -42.01 21.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.015 -1.285 . . . . 23.01 109.952 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.417 ' CG2' HD22 ' B' ' 21' ' ' LEU . 5.8 pt -114.57 -163.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.783 -0.767 . . . . 27.08 109.896 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.94 58.29 0.25 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.559 -1.416 . . . . 32.03 109.559 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.398 -1.06 . . . . 0.0 110.208 179.984 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.29 0.567 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -72.56 147.06 46.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.853 -1.154 . . . . 0.0 110.204 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -151.29 -69.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 2.5 mtt -78.9 137.45 37.66 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.608 -0.936 . . . . 0.0 110.369 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 48.6 m -139.72 -168.78 2.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 110.217 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.58 47.97 1.03 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 0.0 110.163 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.453 ' CE ' HD13 ' B' ' 19' ' ' LEU . 4.3 mtt -95.47 135.45 23.17 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.755 ' CG ' HD12 ' B' ' 11' ' ' LEU . 47.4 Cg_endo -73.41 156.96 50.0 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.522 1.275 . . . . 0.0 110.384 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -76.8 -11.93 59.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.588 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.411 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 89.5 t80 -79.01 -34.09 44.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.078 -1.014 . . . . 0.0 110.322 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.755 HD12 ' CG ' ' B' ' 8' ' ' PRO . 64.6 mt -88.84 15.62 8.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 110.601 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.49 -26.85 68.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -82.77 -23.98 33.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 110.382 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' TRP . . . . . 0.53 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.0 m0 -63.17 142.07 97.75 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.278 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.9 173.97 9.42 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.431 1.227 . . . . 0.0 111.259 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 20' ' ' ASP . 0.0 OUTLIER -78.36 -21.85 48.83 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.333 -0.854 . . . . 0.0 109.722 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.39 -46.11 42.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 110.696 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.837 ' O ' HG23 ' B' ' 22' ' ' VAL . 98.2 t -68.8 -39.57 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.145 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.538 HD21 ' HB3' ' B' ' 11' ' ' LEU . 25.3 mt -66.36 -31.33 72.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 110.574 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' B' ' 16' ' ' ARG . 3.5 t0 -70.83 -23.08 62.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.072 -1.018 . . . . 0.0 109.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.769 ' O ' HG23 ' B' ' 25' ' ' VAL . 50.0 tp -87.83 -37.68 16.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -0.932 . . . . 0.0 109.936 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.98 HG12 HG13 ' B' ' 33' ' ' VAL . 15.7 t -66.05 -49.57 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.391 -0.818 . . . . 0.0 109.967 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.485 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -59.76 -35.52 74.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 110.52 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' B' ' 23' ' ' ARG . 2.1 tmtt? -73.94 -24.24 59.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.065 -1.022 . . . . 0.0 109.981 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.769 HG23 ' O ' ' B' ' 21' ' ' LEU . 97.3 t -86.71 -20.75 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.256 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.574 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -82.59 -30.41 29.57 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.165 -0.959 . . . . 0.0 109.57 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.16 -19.63 50.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.481 -0.762 . . . . 0.0 110.254 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' B' ' 25' ' ' VAL . 22.5 pt-20 -90.72 -30.76 16.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.092 -1.005 . . . . 0.0 110.195 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.439 ' N ' ' HG3' ' B' ' 28' ' ' GLU . 0.5 OUTLIER -83.11 7.71 15.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.631 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.4 24.11 70.58 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 29' ' ' ASN . 8.7 mtt-85 -129.33 -157.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 110.235 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.574 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 1.8 m -115.24 -179.38 3.62 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.451 -0.781 . . . . 0.0 109.258 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.98 HG13 HG12 ' B' ' 22' ' ' VAL . 98.1 t -78.15 -14.6 13.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.09 -1.006 . . . . 0.0 110.645 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -77.2 -41.67 40.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.123 -0.985 . . . . 0.0 109.06 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 8.7 t -71.29 -36.05 71.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.415 -0.803 . . . . 0.0 109.375 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.425 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.9 tp10 -64.58 -50.52 66.89 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.787 HG23 HG21 ' A' ' 41' ' ' VAL . 34.0 mm -63.81 -27.2 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.404 -0.81 . . . . 0.0 109.526 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -71.54 -37.28 71.15 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 0.0 110.807 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.81 -36.32 59.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -71.92 -23.94 61.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.695 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.777 HG23 HG23 ' A' ' 41' ' ' VAL . 6.5 t -87.54 -28.4 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -43.73 59.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.609 -0.682 . . . . 0.0 110.447 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -29.16 68.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -50.04 70.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.642 ' CD1' HD21 ' A' ' 21' ' ' LEU . 31.2 m-85 -65.88 -22.86 66.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.49 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -73.69 -36.78 65.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.292 -0.88 . . . . 0.0 110.517 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -57.17 -54.54 45.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.434 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -61.78 -40.92 96.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.346 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.22 30.01 3.53 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 mmt-85 -81.38 -41.55 21.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -1.156 . . . . 0.0 110.092 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 5.6 pt -114.7 -162.89 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 109.916 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.46 58.38 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.271 -1.135 . . . . 0.0 110.251 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.997 -0.371 . . . . 43.64 109.997 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.0 Cg_endo -72.61 143.77 38.61 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.736 1.387 . . . . 29.79 110.478 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -61.05 -17.61 53.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.833 . . . . 0.0 110.15 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.5 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 69.6 t80 -67.9 -37.48 81.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 12.57 110.36 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.606 ' HB3' HD21 ' A' ' 19' ' ' LEU . 80.8 mt -91.6 21.52 4.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.352 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -74.23 -19.26 60.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.08 -17.93 21.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.134 -0.979 . . . . 0.0 110.653 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.432 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.8 m0 -64.9 144.03 98.93 Favored Pre-proline 0 C--N 1.304 -1.387 0 O-C-N 121.145 -0.972 . . . . 11.57 109.171 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 40.1 Cg_endo -69.23 169.45 18.22 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.384 1.202 . . . . 13.83 110.56 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -25.81 43.94 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.572 -0.705 . . . . 48.43 109.592 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -69.14 -19.26 64.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.173 -0.955 . . . . 46.64 110.078 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.817 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.9 t -102.76 -36.27 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 16.14 109.888 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' A' ' 11' ' ' LEU . 17.5 mt -66.51 -33.91 76.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.416 -0.802 . . . . 12.61 110.509 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.31 -30.28 70.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 23.17 109.851 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.803 ' O ' HG23 ' A' ' 25' ' ' VAL . 28.0 tp -80.76 -38.0 29.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.521 -0.737 . . . . 19.0 109.852 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 18' ' ' VAL . 48.3 t -59.66 -51.72 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 18.87 110.211 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.63 -41.77 82.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.421 -0.799 . . . . 23.61 110.781 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -73.41 -18.2 61.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.118 -0.989 . . . . 30.11 110.841 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 21' ' ' LEU . 59.2 t -84.15 -35.73 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.081 -1.012 . . . . 16.22 110.481 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.594 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -66.5 -36.23 82.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 26.6 109.712 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -72.59 -23.31 60.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.811 . . . . 45.21 109.935 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -78.1 -42.21 32.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 37.85 109.863 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -67.86 -44.48 77.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 35.36 110.105 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.35 37.08 0.95 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.076 -1.21 . . . . 35.1 110.076 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.74 -165.43 1.65 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.042 -1.27 . . . . 32.72 110.601 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -84.0 174.41 10.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 19.61 110.372 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.594 HG22 ' CB ' ' A' ' 26' ' ' ALA . 88.0 t -84.44 -26.72 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.39 -0.818 . . . . 17.56 110.235 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' B' ' 13' ' ' ARG . 5.4 t30 -59.18 -27.1 65.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 21.3 108.977 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.2 t -89.81 -29.71 18.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.519 -0.738 . . . . 16.38 109.536 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.419 ' OE1' ' HB2' ' A' ' 26' ' ' ALA . 30.9 tt0 -61.49 -57.47 12.02 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.116 -0.99 . . . . 12.61 109.519 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.535 HG23 HG21 ' B' ' 41' ' ' VAL . 41.1 mm -58.12 -27.1 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.359 -0.838 . . . . 10.95 109.711 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.477 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 38.9 t80 -70.69 -34.37 71.9 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.135 -0.978 . . . . 18.87 110.15 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -75.06 -53.73 8.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 36.88 110.169 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -57.64 -23.06 49.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.114 -0.991 . . . . 22.85 109.802 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.611 HG21 HG23 ' B' ' 37' ' ' ILE . 39.8 t -89.42 -27.5 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.396 -0.815 . . . . 13.02 109.51 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -25.86 60.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.528 -0.733 . . . . 18.84 110.569 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.78 -21.62 29.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.088 -1.008 . . . . 29.96 110.555 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -66.18 -47.47 73.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 18.65 110.165 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.73 ' CE1' HG21 ' B' ' 25' ' ' VAL . 28.5 m-85 -61.01 -37.44 82.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 16.26 110.373 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 mttt . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 36.71 110.314 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.5 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 44.6 Cg_endo -72.72 143.77 38.15 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.721 1.38 . . . . 0.0 110.523 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -60.9 -17.58 51.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.242 -0.911 . . . . 0.0 110.16 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.529 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 68.4 t80 -67.83 -37.63 82.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 110.375 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.621 ' HB3' HD21 ' B' ' 19' ' ' LEU . 80.6 mt -91.57 21.79 4.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.363 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -74.41 -19.29 60.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.421 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.434 ' HB2' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -94.99 -18.11 21.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.16 -0.962 . . . . 0.0 110.613 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.444 ' CZ2' ' HA ' ' A' ' 38' ' ' TYR . 14.0 m0 -64.83 144.2 98.89 Favored Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.023 -1.048 . . . . 0.0 109.229 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.477 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.4 Cg_endo -69.28 169.64 17.84 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.519 1.273 . . . . 0.0 110.651 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.17 -25.46 42.82 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.384 -0.822 . . . . 0.0 109.474 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -69.35 -19.34 63.85 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.808 ' O ' HG23 ' B' ' 22' ' ' VAL . 58.2 t -102.6 -36.65 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.16 -0.963 . . . . 0.0 109.756 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' B' ' 11' ' ' LEU . 17.9 mt -65.76 -33.99 77.15 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.16 -0.963 . . . . 0.0 110.662 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.4 -30.6 71.01 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.826 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.793 ' O ' HG23 ' B' ' 25' ' ' VAL . 26.9 tp -80.44 -38.05 30.84 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.862 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.808 HG23 ' O ' ' B' ' 18' ' ' VAL . 48.2 t -59.77 -51.52 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 110.258 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.62 -41.85 82.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.783 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -73.42 -18.2 61.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.18 -0.95 . . . . 0.0 110.851 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.793 HG23 ' O ' ' B' ' 21' ' ' LEU . 58.3 t -84.15 -35.88 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.164 -0.96 . . . . 0.0 110.473 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.587 ' CB ' HG22 ' B' ' 33' ' ' VAL . . . -66.41 -36.14 82.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.043 -1.036 . . . . 0.0 109.828 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -72.58 -23.21 60.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.928 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -78.24 -42.17 31.99 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.342 -0.849 . . . . 0.0 109.923 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.04 -44.42 76.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.83 . . . . 0.0 110.025 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.34 36.99 0.96 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.64 -165.47 1.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.019 -1.283 . . . . 0.0 110.571 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m -84.04 174.4 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.356 -0.84 . . . . 0.0 110.364 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.587 HG22 ' CB ' ' B' ' 26' ' ' ALA . 85.8 t -84.52 -26.46 7.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.411 -0.806 . . . . 0.0 110.278 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -59.4 -27.01 65.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.179 -0.95 . . . . 0.0 108.942 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 6.2 t -89.85 -29.9 18.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.72 . . . . 0.0 109.465 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.416 ' OE1' ' HB2' ' B' ' 26' ' ' ALA . 31.0 tt0 -61.21 -57.61 11.71 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.132 -0.98 . . . . 0.0 109.532 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.611 HG23 HG21 ' A' ' 41' ' ' VAL . 40.8 mm -58.19 -27.45 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.38 -0.825 . . . . 0.0 109.65 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.407 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 36.5 t80 -70.19 -34.52 73.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.196 -0.94 . . . . 0.0 110.133 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -75.02 -53.72 8.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 110.183 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' B' ' 36' ' ' GLU . 7.5 mtt85 -57.6 -23.13 49.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.843 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.535 HG21 HG23 ' A' ' 37' ' ' ILE . 39.6 t -89.15 -27.72 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.436 -0.79 . . . . 0.0 109.523 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -26.01 60.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.745 . . . . 0.0 110.61 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.86 -21.6 29.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.212 -0.93 . . . . 0.0 110.508 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -66.1 -47.47 74.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 110.163 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.616 ' HE1' HG21 ' A' ' 25' ' ' VAL . 27.8 m-85 -61.17 -37.46 83.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttt . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.361 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.4 mtp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.206 -0.294 . . . . 43.64 110.206 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 48.9 Cg_endo -75.79 160.22 37.76 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.627 1.33 . . . . 29.79 110.431 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -18.28 60.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.115 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.444 ' CE1' ' OD1' ' B' ' 34' ' ' ASN . 56.3 t80 -71.3 -35.8 71.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 12.57 110.348 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.594 ' HB3' HD21 ' A' ' 19' ' ' LEU . 93.8 mt -89.64 16.77 7.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.44 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.55 -31.22 66.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 110.024 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -12.47 59.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.35 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.482 ' CE3' HD22 ' A' ' 11' ' ' LEU . 16.5 m0 -77.48 142.2 66.56 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.173 -0.955 . . . . 11.57 109.451 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.38 173.63 10.36 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.586 1.309 . . . . 13.83 110.551 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -22.66 42.18 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.396 -0.815 . . . . 48.43 109.605 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HG3' HG23 ' A' ' 18' ' ' VAL . 10.2 pt-20 -71.5 -36.37 71.07 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.149 -0.969 . . . . 46.64 110.35 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 22' ' ' VAL . 93.8 t -81.27 -43.06 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 16.14 110.254 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 11' ' ' LEU . 73.3 mt -65.1 -32.03 73.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 12.61 110.28 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.45 -24.39 66.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 23.17 109.68 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.876 ' O ' HG23 ' A' ' 25' ' ' VAL . 26.9 tp -87.09 -40.06 15.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.791 . . . . 19.0 109.895 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.963 HG12 HG13 ' A' ' 33' ' ' VAL . 38.5 t -56.48 -40.62 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 18.87 109.488 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -59.81 4.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.675 -0.641 . . . . 23.61 110.297 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.26 -28.67 59.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.229 -0.92 . . . . 30.11 110.937 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 21' ' ' LEU . 50.7 t -71.82 -39.31 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.991 -1.068 . . . . 16.22 110.423 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.72 -40.29 88.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.067 -1.021 . . . . 26.6 109.539 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -71.69 -20.99 61.85 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.449 -0.782 . . . . 45.21 109.941 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -54.41 9.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 37.85 109.809 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -71.38 -25.02 62.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.873 . . . . 35.36 110.26 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.48 69.53 1.04 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.71 -1.356 . . . . 35.1 109.71 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.73 -162.91 0.13 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.254 -1.145 . . . . 32.72 110.287 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.8 t -93.2 171.97 8.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 19.61 110.091 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.963 HG13 HG12 ' A' ' 22' ' ' VAL . 69.2 t -83.89 -23.33 7.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.23 -0.919 . . . . 17.56 110.073 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' OD1' ' CE1' ' B' ' 10' ' ' PHE . 0.8 OUTLIER -63.78 -28.14 69.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 21.3 109.255 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -90.15 -32.24 16.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.446 -0.784 . . . . 16.38 109.825 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' CG ' HG12 ' A' ' 25' ' ' VAL . 11.0 tp10 -61.67 -37.95 85.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.144 -0.973 . . . . 12.61 109.319 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 41' ' ' VAL . 21.6 mm -76.95 -25.3 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.529 -0.732 . . . . 10.95 109.156 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 33.4 t80 -74.72 -27.38 60.35 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.271 -0.893 . . . . 18.87 110.198 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -81.71 -49.34 10.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 36.88 109.512 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.417 ' CZ ' HG11 ' A' ' 25' ' ' VAL . 55.9 mtt-85 -59.0 -28.79 66.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 22.85 109.189 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.5 t -82.82 -26.95 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.581 -0.699 . . . . 13.02 109.329 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp -76.68 -23.82 53.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.467 -0.77 . . . . 18.84 110.27 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.14 -33.91 56.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.264 -0.897 . . . . 29.96 110.294 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.437 ' CB ' ' HD3' ' B' ' 40' ' ' ARG . 81.8 p -58.47 -41.22 84.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 18.65 110.278 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.643 ' CD1' HD21 ' B' ' 21' ' ' LEU . 25.5 m-85 -74.43 -35.5 63.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 16.26 110.371 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 36.71 110.476 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtp . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.444 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 48.9 Cg_endo -75.66 159.6 38.79 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.632 1.332 . . . . 0.0 110.422 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -18.32 61.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.156 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.5 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 58.3 t80 -71.27 -36.0 71.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.971 . . . . 0.0 110.453 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' B' ' 19' ' ' LEU . 94.4 mt -89.37 16.78 6.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.928 . . . . 0.0 110.571 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.48 -31.26 66.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.128 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -12.36 59.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 110.337 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.469 ' CE3' HD22 ' B' ' 11' ' ' LEU . 16.0 m0 -77.52 141.94 66.04 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.246 -0.909 . . . . 0.0 109.489 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.47 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.5 Cg_endo -69.38 173.89 9.98 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.625 1.329 . . . . 0.0 110.543 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -23.26 41.82 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' B' ' 18' ' ' VAL . 10.2 pt-20 -71.34 -36.39 71.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.851 . . . . 0.0 110.368 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.707 ' O ' HG23 ' B' ' 22' ' ' VAL . 92.9 t -81.23 -43.48 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 O-C-N 121.072 -1.017 . . . . 0.0 110.014 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' B' ' 11' ' ' LEU . 72.8 mt -64.35 -32.54 74.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.05 -24.73 66.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.747 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.875 ' O ' HG23 ' B' ' 25' ' ' VAL . 27.9 tp -86.71 -40.1 15.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.404 -0.81 . . . . 0.0 109.904 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.944 HG12 HG13 ' B' ' 33' ' ' VAL . 35.1 t -56.4 -40.45 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.597 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.22 -59.63 5.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.645 -0.66 . . . . 0.0 110.267 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -28.27 59.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.267 -0.895 . . . . 0.0 110.963 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.875 HG23 ' O ' ' B' ' 21' ' ' LEU . 53.2 t -72.17 -39.48 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.013 . . . . 0.0 110.361 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.11 88.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.14 -0.975 . . . . 0.0 109.509 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -71.79 -20.85 61.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.341 -0.849 . . . . 0.0 110.044 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -54.23 9.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.863 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.34 -25.32 62.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.42 -0.8 . . . . 0.0 110.089 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.43 69.99 1.06 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.01 -163.27 0.13 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.321 -1.106 . . . . 0.0 110.191 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -92.9 172.93 8.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 110.082 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.944 HG13 HG12 ' B' ' 22' ' ' VAL . 68.4 t -85.08 -22.69 7.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.278 -0.889 . . . . 0.0 110.001 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.444 ' OD1' ' CE1' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -64.26 -27.85 69.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.157 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -90.2 -33.56 16.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.487 -0.758 . . . . 0.0 109.707 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.419 ' CG ' HG12 ' B' ' 25' ' ' VAL . 10.8 tp10 -60.31 -38.18 82.87 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.157 -0.964 . . . . 0.0 109.403 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.462 ' O ' HG23 ' B' ' 41' ' ' VAL . 21.2 mm -77.11 -24.85 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.51 -0.744 . . . . 0.0 109.228 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.417 ' HB2' ' NE1' ' A' ' 14' ' ' TRP . 34.0 t80 -75.32 -26.58 58.77 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.261 -0.899 . . . . 0.0 110.109 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -82.28 -49.53 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.58 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.437 ' HD3' ' CB ' ' A' ' 44' ' ' SER . 55.7 mtt-85 -58.81 -28.98 66.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.442 -0.786 . . . . 0.0 109.184 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 37' ' ' ILE . 45.1 t -82.54 -27.46 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.546 0.688 . . . . 0.0 109.414 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp -76.08 -23.41 55.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.468 -0.77 . . . . 0.0 110.269 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.47 -34.31 54.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.158 -0.964 . . . . 0.0 110.24 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 85.4 p -57.86 -41.5 82.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 110.156 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.68 ' CD1' HD21 ' A' ' 21' ' ' LEU . 25.3 m-85 -74.5 -35.78 63.22 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.37 -179.855 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 110.244 -0.28 . . . . 43.64 110.244 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HG3' ' CE1' ' B' ' 10' ' ' PHE . 43.0 Cg_endo -71.47 147.52 52.32 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.626 1.33 . . . . 29.79 110.545 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.49 -19.38 61.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 110.631 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.519 ' CE1' ' HG3' ' B' ' 8' ' ' PRO . 87.3 t80 -69.25 -32.09 71.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.952 . . . . 12.57 110.11 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HB3' HD21 ' A' ' 19' ' ' LEU . 96.8 mt -91.99 19.07 7.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.371 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -71.65 -25.52 62.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 110.205 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -16.12 46.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.477 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.739 ' HH2' HG21 ' B' ' 41' ' ' VAL . 15.1 m0 -72.69 145.59 87.28 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.306 -0.871 . . . . 11.57 109.815 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HG2' HG23 ' A' ' 18' ' ' VAL . 43.1 Cg_endo -73.4 166.33 30.18 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.559 1.294 . . . . 13.83 111.24 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.87 85.68 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.995 0.902 . . . . 48.43 110.33 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.46 -34.76 74.49 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.918 -0.583 . . . . 46.64 111.575 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 22' ' ' VAL . 91.2 t -82.84 -44.91 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.924 -1.11 . . . . 16.14 110.817 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 11' ' ' LEU . 61.2 mt -64.54 -27.31 68.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.143 -0.973 . . . . 12.61 110.722 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.44 -23.15 63.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 23.17 109.76 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.75 HD21 ' CD1' ' B' ' 45' ' ' PHE . 4.8 tp -89.39 -42.22 11.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.45 -0.781 . . . . 19.0 109.985 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.866 HG12 HG13 ' A' ' 33' ' ' VAL . 48.0 t -51.8 -46.22 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 18.87 110.699 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -54.59 -58.5 7.27 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.361 -0.837 . . . . 23.61 110.85 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -54.12 -22.65 11.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.908 . . . . 30.11 111.054 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.629 HG12 ' CD ' ' A' ' 36' ' ' GLU . 58.9 t -82.54 -38.61 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 16.22 110.961 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.67 74.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.036 . . . . 26.6 110.112 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.39 -9.86 58.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -0.887 . . . . 45.21 110.528 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -88.88 -53.59 4.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.083 -1.011 . . . . 37.85 110.095 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.34 -32.45 73.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 35.36 110.117 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.73 30.81 4.15 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.414 -1.475 . . . . 35.1 109.414 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -133.44 -155.18 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -1.137 . . . . 32.72 110.164 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -107.56 175.34 5.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.539 -0.725 . . . . 19.61 109.55 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.866 HG13 HG12 ' A' ' 22' ' ' VAL . 85.5 t -75.97 -23.58 16.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.105 -0.997 . . . . 17.56 110.138 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.431 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 44.0 t30 -77.15 -28.11 54.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 21.3 108.843 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.07 -27.31 24.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.557 -0.714 . . . . 16.38 109.203 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.629 ' CD ' HG12 ' A' ' 25' ' ' VAL . 8.5 tp10 -71.98 -42.96 65.87 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.277 -0.89 . . . . 12.61 108.916 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' O ' HG23 ' A' ' 41' ' ' VAL . 24.5 mm -66.59 -31.07 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.595 -0.891 . . . . 10.95 108.595 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.425 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 32.6 t80 -63.56 -36.78 84.92 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.62 -0.675 . . . . 18.87 109.968 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -73.96 -43.99 56.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 36.88 109.716 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -61.09 -25.59 67.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 22.85 109.289 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.742 HG21 ' HH2' ' B' ' 14' ' ' TRP . 62.4 t -88.18 -25.14 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.547 0.689 . . . . 13.02 109.635 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtp -77.56 -25.33 49.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.529 -0.732 . . . . 18.84 110.299 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -83.24 -27.48 29.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.194 -0.941 . . . . 29.96 110.353 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.8 p -67.1 -48.91 66.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.255 -0.903 . . . . 18.65 110.357 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.742 ' CD1' HD21 ' B' ' 21' ' ' LEU . 22.4 m-85 -62.89 -22.5 66.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.958 . . . . 16.26 110.417 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 36.71 110.455 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.403 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.519 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 43.4 Cg_endo -71.38 147.65 53.15 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.717 1.377 . . . . 0.0 110.483 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -19.5 62.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.36 -0.837 . . . . 0.0 110.577 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.522 ' CE1' ' HG3' ' A' ' 8' ' ' PRO . 87.2 t80 -69.01 -32.13 71.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.039 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.518 ' HB3' HD21 ' B' ' 19' ' ' LEU . 96.5 mt -91.94 19.12 6.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.448 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.66 -25.36 62.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 110.303 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.71 -16.16 45.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 110.412 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.742 ' HH2' HG21 ' A' ' 41' ' ' VAL . 15.1 m0 -72.88 145.65 86.86 Favored Pre-proline 0 C--N 1.304 -1.389 0 O-C-N 121.242 -0.911 . . . . 0.0 109.831 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' B' ' 18' ' ' VAL . 42.5 Cg_endo -73.45 166.66 29.3 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.258 1.136 . . . . 0.0 111.21 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -37.94 85.11 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 110.321 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -60.3 -34.72 74.17 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.907 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.609 ' O ' HG23 ' B' ' 22' ' ' VAL . 91.1 t -82.72 -45.22 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.86 -1.15 . . . . 0.0 110.591 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' B' ' 11' ' ' LEU . 61.1 mt -64.39 -27.28 68.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.031 -1.043 . . . . 0.0 110.763 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.27 -23.4 63.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 109.738 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.742 HD21 ' CD1' ' A' ' 45' ' ' PHE . 4.7 tp -89.34 -42.11 11.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.502 -0.748 . . . . 0.0 109.992 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.876 HG12 HG13 ' B' ' 33' ' ' VAL . 47.9 t -51.71 -46.1 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 110.733 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -54.83 -58.44 7.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.333 -0.854 . . . . 0.0 110.849 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -54.14 -22.27 10.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.065 -1.022 . . . . 0.0 111.037 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.62 HG23 ' O ' ' B' ' 21' ' ' LEU . 59.7 t -82.93 -38.77 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.001 . . . . 0.0 110.873 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.87 -32.6 74.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.061 -1.024 . . . . 0.0 110.11 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.46 -10.07 58.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 110.383 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -88.64 -53.57 4.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.133 -0.98 . . . . 0.0 110.113 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.34 -32.47 73.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.142 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.75 30.82 4.14 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -133.53 -155.69 0.69 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -1.103 . . . . 0.0 110.208 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -107.03 175.41 5.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.409 -0.807 . . . . 0.0 109.658 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.876 HG13 HG12 ' B' ' 22' ' ' VAL . 85.9 t -76.1 -23.33 15.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 44.1 t30 -77.35 -28.34 52.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 108.844 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.91 -27.42 25.0 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.194 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.619 ' CD ' HG12 ' B' ' 25' ' ' VAL . 8.5 tp10 -71.94 -42.6 66.44 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.372 -0.83 . . . . 0.0 108.997 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.527 ' O ' HG23 ' B' ' 41' ' ' VAL . 24.7 mm -66.84 -30.89 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.42 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 32.6 t80 -63.8 -37.08 86.05 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.614 -0.679 . . . . 0.0 109.771 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -73.57 -44.39 57.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 109.687 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -60.64 -25.75 66.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.94 . . . . 0.0 109.243 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.739 HG21 ' HH2' ' A' ' 14' ' ' TRP . 63.5 t -88.16 -25.23 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.575 0.703 . . . . 0.0 109.688 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtp -77.47 -25.17 50.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.494 -0.754 . . . . 0.0 110.387 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -83.42 -27.46 29.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.189 -0.944 . . . . 0.0 110.437 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 77.8 p -67.16 -48.7 67.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.415 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.75 ' CD1' HD21 ' A' ' 21' ' ' LEU . 21.9 m-85 -63.08 -22.6 66.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.128 -0.982 . . . . 0.0 110.286 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.167 -0.958 . . . . 0.0 110.37 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.494 -0.558 . . . . 43.64 109.494 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.541 ' HG2' HD12 ' A' ' 11' ' ' LEU . 45.7 Cg_endo -71.68 158.16 54.03 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.378 1.199 . . . . 29.79 110.671 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -82.1 -19.4 40.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.379 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.501 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 73.1 t80 -58.95 -23.84 61.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 12.57 110.448 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.693 ' HB3' HD21 ' A' ' 19' ' ' LEU . 42.7 mt -98.52 31.65 2.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.148 -0.97 . . . . 0.0 110.478 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -30.99 67.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.224 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -81.01 -22.9 39.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 110.155 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.711 ' HH2' HG21 ' B' ' 41' ' ' VAL . 13.8 m0 -64.64 136.98 96.99 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.345 -0.847 . . . . 11.57 109.259 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HG2' HG23 ' A' ' 18' ' ' VAL . 39.0 Cg_endo -70.36 153.34 66.26 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.365 1.192 . . . . 13.83 111.054 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -41.62 73.29 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.664 0.745 . . . . 48.43 110.897 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.24 -41.05 75.09 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.548 -0.72 . . . . 46.64 111.507 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.514 HG23 ' HG2' ' A' ' 15' ' ' PRO . 85.5 t -76.42 -49.87 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.888 -1.132 . . . . 16.14 111.087 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.693 HD21 ' HB3' ' A' ' 11' ' ' LEU . 13.3 mt -53.7 -36.5 62.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 12.61 110.673 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -62.57 -38.03 88.51 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.436 -0.79 . . . . 23.17 109.864 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.854 ' O ' HG23 ' A' ' 25' ' ' VAL . 40.8 tp -69.42 -40.59 77.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.494 -0.754 . . . . 19.0 109.893 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.913 HG12 HG13 ' A' ' 33' ' ' VAL . 40.3 t -58.94 -48.26 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 18.87 110.512 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 10.9 mtm180 -53.67 -49.36 68.14 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 23.61 110.54 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -29.33 70.72 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 30.11 110.682 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 21' ' ' LEU . 48.1 t -77.03 -29.19 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 16.22 110.479 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.434 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -74.04 -46.0 46.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.169 -0.957 . . . . 26.6 109.215 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.95 -12.63 61.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.348 -0.845 . . . . 45.21 110.135 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -78.61 -58.73 3.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 37.85 110.001 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -66.06 -22.36 66.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 35.36 110.115 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.54 16.17 20.85 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.027 -1.229 . . . . 35.1 110.027 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -116.53 -162.84 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.132 -1.216 . . . . 32.72 110.387 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.434 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 67.7 m -102.81 -176.77 3.19 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.419 -0.8 . . . . 19.61 109.411 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.913 HG13 HG12 ' A' ' 22' ' ' VAL . 63.0 t -81.23 -16.65 12.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.222 -0.924 . . . . 17.56 110.281 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -77.84 -32.08 51.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.978 . . . . 21.3 108.752 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 t -79.71 -36.56 37.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.572 -0.705 . . . . 16.38 109.335 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.4 tp10 -64.78 -51.74 60.65 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 121.255 -0.903 . . . . 12.61 109.366 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 41' ' ' VAL . 37.9 mm -63.3 -32.93 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.784 . . . . 10.95 109.517 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -65.79 -33.76 76.61 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.429 -0.795 . . . . 18.87 110.226 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -47.38 42.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 36.88 109.536 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -60.87 -23.36 65.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.46 -0.775 . . . . 22.85 109.642 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.664 HG21 ' HH2' ' B' ' 14' ' ' TRP . 53.0 t -87.95 -28.24 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.518 -0.739 . . . . 13.02 109.554 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -20.36 52.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.539 -0.725 . . . . 18.84 110.272 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.92 -18.77 53.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 29.96 110.348 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.89 -46.89 16.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.073 -1.017 . . . . 18.65 110.215 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.81 ' CD1' HD21 ' B' ' 21' ' ' LEU . 37.9 m-85 -67.72 -12.01 59.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 16.26 110.734 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.03 -1.044 . . . . 36.71 110.417 -179.725 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.549 ' HG2' HD12 ' B' ' 11' ' ' LEU . 45.1 Cg_endo -71.64 157.76 55.04 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.439 1.231 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -81.83 -19.4 41.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.364 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.511 ' CE1' ' HG3' ' A' ' 8' ' ' PRO . 72.8 t80 -58.95 -23.85 61.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 110.454 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.682 ' HB3' HD21 ' B' ' 19' ' ' LEU . 42.3 mt -98.37 31.62 2.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 110.489 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.06 -31.1 67.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 110.108 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -80.95 -22.89 39.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.22 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.664 ' HH2' HG21 ' A' ' 41' ' ' VAL . 13.8 m0 -64.71 136.51 96.8 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.394 -0.816 . . . . 0.0 109.306 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.512 ' HG2' HG23 ' B' ' 18' ' ' VAL . 39.5 Cg_endo -70.24 152.45 66.83 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.626 1.33 . . . . 0.0 111.368 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -42.13 69.75 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.631 0.729 . . . . 0.0 110.905 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.17 -40.91 74.65 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.614 -0.679 . . . . 0.0 111.29 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.512 HG23 ' HG2' ' B' ' 15' ' ' PRO . 85.5 t -76.59 -50.0 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.917 -1.114 . . . . 0.0 110.754 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.682 HD21 ' HB3' ' B' ' 11' ' ' LEU . 13.4 mt -53.67 -36.32 61.99 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 110.682 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -62.99 -37.77 88.48 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.298 -0.876 . . . . 0.0 109.973 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.841 ' O ' HG23 ' B' ' 25' ' ' VAL . 40.5 tp -69.63 -40.31 76.64 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.415 -0.803 . . . . 0.0 109.858 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.897 HG12 HG13 ' B' ' 33' ' ' VAL . 40.3 t -59.31 -48.07 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 110.467 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' B' ' 19' ' ' LEU . 11.0 mtm180 -53.7 -49.41 68.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.215 -0.928 . . . . 0.0 110.535 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -29.13 70.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.4 -0.812 . . . . 0.0 110.698 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.841 HG23 ' O ' ' B' ' 21' ' ' LEU . 48.4 t -77.08 -29.25 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.501 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.436 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -74.04 -46.06 45.7 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 109.196 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.97 -12.58 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 110.152 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.41 -59.0 2.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 109.97 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -65.88 -22.33 66.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.059 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.48 16.26 20.74 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -116.65 -162.64 0.86 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.012 -1.287 . . . . 0.0 110.405 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.436 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 69.2 m -102.95 -176.76 3.18 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.352 -0.843 . . . . 0.0 109.375 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.897 HG13 HG12 ' B' ' 22' ' ' VAL . 62.2 t -81.2 -16.64 12.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 110.407 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -77.84 -32.14 51.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.067 -1.021 . . . . 0.0 108.695 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 41.0 t -79.67 -36.39 37.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.585 -0.697 . . . . 0.0 109.294 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.498 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.4 tp10 -65.0 -51.64 60.55 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.381 -0.824 . . . . 0.0 109.295 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.558 ' O ' HG23 ' B' ' 41' ' ' VAL . 37.3 mm -63.39 -32.59 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.576 -0.703 . . . . 0.0 109.428 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.434 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 26.5 t80 -65.97 -33.82 76.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.442 -0.787 . . . . 0.0 110.308 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -47.1 45.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.52 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -61.17 -23.42 65.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 0.0 109.639 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.711 HG21 ' HH2' ' A' ' 14' ' ' TRP . 56.4 t -88.08 -28.3 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.749 . . . . 0.0 109.502 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -20.14 53.35 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.566 -0.708 . . . . 0.0 110.161 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.17 -18.73 52.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.082 -1.011 . . . . 0.0 110.36 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.82 -47.27 15.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.046 -1.034 . . . . 0.0 110.097 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.77 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.5 m-85 -67.42 -11.96 59.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 110.799 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 110.389 -179.694 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 120.594 0.235 . . . . 43.64 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 48.3 Cg_endo -76.55 164.79 30.03 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.852 1.448 . . . . 29.79 110.343 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -74.98 -13.7 60.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.394 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.526 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 90.8 t80 -81.16 -29.15 34.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 12.57 110.46 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 11' ' ' LEU . 57.0 mt -92.69 14.68 16.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.784 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.94 -24.56 64.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 0.0 109.816 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.96 -21.89 43.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.314 -0.866 . . . . 0.0 110.163 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.576 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 15.0 m0 -73.54 143.59 82.5 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.453 -0.779 . . . . 11.57 109.67 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' CD ' ' OH ' ' B' ' 38' ' ' TYR . 42.3 Cg_endo -71.11 176.44 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.562 1.296 . . . . 13.83 110.726 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -24.29 37.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.402 -0.811 . . . . 48.43 109.372 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HG3' HG23 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -68.6 -20.15 64.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 46.64 110.463 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.664 ' O ' HG23 ' A' ' 22' ' ' VAL . 76.3 t -99.82 -46.3 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 16.14 109.961 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.13 -25.91 68.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.339 -0.851 . . . . 12.61 110.806 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -74.02 -31.74 63.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.299 -0.876 . . . . 23.17 110.068 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.737 ' O ' HG23 ' A' ' 25' ' ' VAL . 7.4 tp -79.82 -47.39 15.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 19.0 109.971 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.955 HG12 HG13 ' A' ' 33' ' ' VAL . 27.9 t -51.68 -45.93 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 18.87 109.918 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.509 ' HA ' HG22 ' A' ' 33' ' ' VAL . 3.0 ttm180 -51.44 -63.02 1.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.682 -0.636 . . . . 23.61 110.695 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -52.75 -33.88 50.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.283 -0.885 . . . . 30.11 110.969 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 21' ' ' LEU . 61.9 t -66.93 -36.48 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 16.22 110.523 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -67.02 -44.91 79.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 26.6 109.896 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -71.69 -14.7 62.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 45.21 110.359 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.79 -59.99 2.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.084 -1.01 . . . . 37.85 110.114 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -65.8 -22.03 66.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 35.36 110.358 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.39 16.69 24.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.85 -1.3 . . . . 35.1 109.85 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -114.15 -156.53 0.6 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.085 -1.244 . . . . 32.72 110.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.418 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 1.3 m -111.21 171.11 7.67 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.332 -0.855 . . . . 19.61 109.652 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.955 HG13 HG12 ' A' ' 22' ' ' VAL . 48.5 t -70.59 -18.89 21.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.204 -0.935 . . . . 17.56 110.451 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.78 -35.04 39.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.133 -0.98 . . . . 21.3 109.3 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.6 m -76.48 -33.54 58.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.811 . . . . 16.38 109.543 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.627 ' CG ' HG12 ' A' ' 25' ' ' VAL . 2.9 tp10 -63.37 -51.94 63.8 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.348 -0.845 . . . . 12.61 109.245 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.553 HD11 HG11 ' A' ' 22' ' ' VAL . 4.9 mt -68.4 -21.34 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.465 -0.772 . . . . 10.95 109.62 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.405 ' OH ' ' CD ' ' B' ' 15' ' ' PRO . 32.0 t80 -75.4 -29.54 59.83 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.267 -0.896 . . . . 18.87 109.716 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.01 -45.36 18.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.498 -0.751 . . . . 36.88 109.744 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt-85 -60.7 -45.06 95.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 22.85 109.159 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.609 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 61.2 t -68.93 -24.2 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.625 -0.672 . . . . 13.02 109.997 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -65.21 0.79 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.422 -0.799 . . . . 18.84 110.908 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -54.73 -31.75 58.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.332 -0.855 . . . . 29.96 111.037 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.15 -56.63 10.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.95 -1.094 . . . . 18.65 110.679 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.575 ' CD1' HD21 ' B' ' 21' ' ' LEU . 27.4 m-85 -61.99 -39.12 91.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 16.26 110.817 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.127 -0.983 . . . . 36.71 110.871 -179.12 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 120.775 0.321 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.526 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 48.5 Cg_endo -76.84 164.62 29.76 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.792 1.417 . . . . 0.0 110.318 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -74.89 -13.84 60.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.429 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.519 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 90.6 t80 -81.13 -28.79 34.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 110.47 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' B' ' 11' ' ' LEU . 55.8 mt -93.09 15.0 16.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.709 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.38 -24.19 63.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.919 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -22.2 42.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 110.114 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.609 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 14.9 m0 -73.27 143.71 83.49 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.493 -0.754 . . . . 0.0 109.723 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.405 ' CD ' ' OH ' ' A' ' 38' ' ' TYR . 42.6 Cg_endo -71.23 176.39 7.94 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.56 1.295 . . . . 0.0 110.827 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -24.44 37.1 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.562 -0.711 . . . . 0.0 109.443 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.427 ' HG3' HG23 ' B' ' 18' ' ' VAL . 1.0 OUTLIER -68.21 -20.89 64.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 110.712 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.652 ' O ' HG23 ' B' ' 22' ' ' VAL . 76.9 t -98.98 -47.05 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.139 -0.976 . . . . 0.0 109.883 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.51 -26.08 67.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 110.863 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.01 -31.45 62.94 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.727 ' O ' HG23 ' B' ' 25' ' ' VAL . 7.7 tp -79.88 -48.02 14.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.467 -0.771 . . . . 0.0 109.942 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.974 HG12 HG13 ' B' ' 33' ' ' VAL . 27.5 t -51.16 -45.57 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 109.938 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.501 ' HA ' HG22 ' B' ' 33' ' ' VAL . 3.0 ttm180 -52.12 -62.6 1.53 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.552 -0.717 . . . . 0.0 110.651 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -52.93 -33.82 52.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.931 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.727 HG23 ' O ' ' B' ' 21' ' ' LEU . 61.2 t -67.13 -36.03 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.084 -1.01 . . . . 0.0 110.577 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.429 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -67.55 -44.64 77.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.872 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -71.66 -15.05 62.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.963 . . . . 0.0 110.393 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.53 -60.2 2.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.044 . . . . 0.0 110.016 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -65.72 -21.93 66.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.266 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.33 16.68 24.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -114.39 -156.88 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.276 . . . . 0.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.429 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 1.3 m -110.73 171.04 7.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.565 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.974 HG13 HG12 ' B' ' 22' ' ' VAL . 49.3 t -70.23 -19.82 22.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.245 -0.91 . . . . 0.0 110.365 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 -35.61 43.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 64.5 m -75.84 -33.85 60.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.631 ' CG ' HG12 ' B' ' 25' ' ' VAL . 2.8 tp10 -63.26 -51.59 65.55 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.342 -0.849 . . . . 0.0 109.351 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.56 HD11 HG11 ' B' ' 22' ' ' VAL . 4.9 mt -68.74 -21.6 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.613 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.41 ' OH ' ' CD ' ' A' ' 15' ' ' PRO . 33.4 t80 -75.18 -29.25 60.34 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.22 -0.925 . . . . 0.0 109.775 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -45.54 17.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.671 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -60.53 -44.94 95.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.118 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.576 HG11 ' CZ3' ' A' ' 14' ' ' TRP . 58.0 t -68.88 -24.4 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.647 -0.658 . . . . 0.0 109.958 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -65.15 0.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.379 -0.826 . . . . 0.0 110.83 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -54.66 -31.73 58.09 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.247 -0.908 . . . . 0.0 111.001 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.34 -56.61 10.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.064 -1.023 . . . . 0.0 110.89 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.568 ' CD1' HD21 ' A' ' 21' ' ' LEU . 29.0 m-85 -62.05 -38.65 89.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 110.792 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.183 -0.948 . . . . 0.0 110.978 -179.288 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.424 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 13.1 ptp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.922 -0.399 . . . . 43.64 109.922 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 41.4 Cg_endo -68.79 151.56 74.27 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.553 1.291 . . . . 29.79 110.557 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -66.05 -20.32 66.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.246 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.502 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 91.2 t80 -68.38 -20.99 64.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 12.57 110.394 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.547 ' HB3' HD21 ' A' ' 19' ' ' LEU . 89.0 mt -100.54 20.91 14.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.596 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.19 -26.9 62.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -83.18 -23.51 32.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.107 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.618 ' CH2' HG11 ' B' ' 41' ' ' VAL . 14.0 m0 -67.09 139.55 95.36 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.363 -0.836 . . . . 11.57 109.384 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HG2' HG23 ' A' ' 18' ' ' VAL . 42.0 Cg_endo -70.21 168.76 21.21 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.528 1.278 . . . . 13.83 110.904 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.21 -20.47 55.28 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.513 -0.742 . . . . 48.43 109.433 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -72.84 -28.63 62.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 46.64 109.758 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.1 t -87.33 -45.15 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 16.14 109.865 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 11' ' ' LEU . 55.1 mt -63.26 -30.48 71.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -0.857 . . . . 12.61 110.593 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -66.01 -25.88 67.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -0.962 . . . . 23.17 109.605 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.728 ' O ' HG23 ' A' ' 25' ' ' VAL . 15.1 tp -86.78 -44.83 11.46 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.446 -0.784 . . . . 19.0 109.745 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.743 HG12 HG13 ' A' ' 33' ' ' VAL . 44.4 t -52.83 -43.14 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.263 -0.898 . . . . 18.87 109.778 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -51.01 -61.69 2.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.562 -0.711 . . . . 23.61 110.594 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -54.35 -24.9 21.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.577 -0.702 . . . . 30.11 110.901 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 21' ' ' LEU . 38.4 t -80.48 -30.72 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.168 -0.957 . . . . 16.22 110.783 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.406 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -78.01 -27.72 49.01 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.11 -0.994 . . . . 26.6 110.0 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.38 -15.31 33.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 45.21 110.713 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 19.8 pt-20 -90.73 -33.13 15.88 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.882 -1.136 . . . . 37.85 110.436 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.441 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 9.7 m-80 -79.48 -26.88 41.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 35.36 110.159 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.84 23.72 8.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.538 -1.425 . . . . 35.1 109.538 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -131.73 -158.97 0.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.21 -1.171 . . . . 32.72 109.93 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.406 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -109.4 -178.61 3.6 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.525 -0.734 . . . . 19.61 109.086 179.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.743 HG13 HG12 ' A' ' 22' ' ' VAL . 97.8 t -76.79 -19.18 14.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.184 -0.947 . . . . 17.56 110.29 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 42.2 t30 -74.66 -30.65 61.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 21.3 108.747 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -37.85 23.61 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.501 -0.749 . . . . 16.38 109.214 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HG3' HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -59.78 -51.55 69.26 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.322 -0.861 . . . . 12.61 109.574 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.533 HG23 HG21 ' B' ' 41' ' ' VAL . 38.6 mm -62.95 -28.01 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.325 -0.859 . . . . 10.95 109.2 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 42' ' ' MET . 37.5 t80 -74.17 -24.83 59.44 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.395 -0.816 . . . . 18.87 110.175 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -50.91 9.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.45 -0.781 . . . . 36.88 109.833 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 36' ' ' GLU . 2.9 mpt_? -60.74 -28.82 68.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.816 . . . . 22.85 109.255 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 65.4 t -84.35 -22.43 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.622 -0.674 . . . . 13.02 109.676 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -74.31 -51.23 15.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 18.84 111.101 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -69.52 -23.79 63.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.257 -0.902 . . . . 29.96 111.473 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.5 p -57.31 -52.61 64.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.014 -1.054 . . . . 18.65 110.282 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.676 ' CD1' HD21 ' B' ' 21' ' ' LEU . 36.9 m-85 -63.12 -40.1 96.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -0.999 . . . . 16.26 110.311 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.318 -0.864 . . . . 36.71 110.599 -179.633 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.432 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 13.2 ptp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.502 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 42.6 Cg_endo -68.68 151.79 74.63 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.538 1.283 . . . . 0.0 110.518 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.01 -20.72 66.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.883 . . . . 0.0 110.211 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.517 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 91.9 t80 -67.93 -21.24 65.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 0.0 110.458 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.527 ' HB3' HD21 ' B' ' 19' ' ' LEU . 88.1 mt -100.35 20.82 14.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 110.611 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -26.72 62.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.979 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -83.34 -23.3 32.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 110.103 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.496 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.8 m0 -67.42 139.56 94.53 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.384 -0.823 . . . . 0.0 109.355 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.525 ' HG2' HG23 ' B' ' 18' ' ' VAL . 41.0 Cg_endo -70.3 168.84 21.11 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.412 1.217 . . . . 0.0 110.543 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.27 -20.51 54.99 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.578 -0.701 . . . . 0.0 109.307 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -72.73 -28.8 62.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.164 -0.96 . . . . 0.0 109.448 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.6 ' O ' HG23 ' B' ' 22' ' ' VAL . 74.6 t -87.45 -45.18 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 109.637 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' B' ' 11' ' ' LEU . 54.0 mt -63.28 -30.1 71.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 110.581 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -66.32 -26.19 67.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.116 -0.99 . . . . 0.0 109.429 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.733 ' O ' HG23 ' B' ' 25' ' ' VAL . 15.4 tp -86.57 -44.54 11.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.221 0.534 . . . . 0.0 109.61 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.724 HG12 HG13 ' B' ' 33' ' ' VAL . 44.1 t -53.37 -43.25 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.815 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -50.78 -61.39 2.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.554 -0.716 . . . . 0.0 110.675 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -54.59 -24.75 22.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.749 . . . . 0.0 111.01 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.733 HG23 ' O ' ' B' ' 21' ' ' LEU . 38.2 t -80.61 -30.91 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.092 -1.005 . . . . 0.0 110.667 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.408 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -77.84 -27.75 49.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.097 -1.002 . . . . 0.0 109.955 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.37 -15.16 33.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 110.733 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' B' ' 25' ' ' VAL . 19.7 pt-20 -90.84 -33.11 15.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.006 -1.059 . . . . 0.0 110.49 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.435 ' N ' ' HG3' ' B' ' 28' ' ' GLU . 9.5 m-80 -79.54 -26.7 41.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.72 23.98 8.0 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -132.09 -159.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.203 -1.175 . . . . 0.0 109.836 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.408 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 0.4 OUTLIER -109.36 -178.81 3.66 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.459 -0.776 . . . . 0.0 109.187 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.724 HG13 HG12 ' B' ' 22' ' ' VAL . 97.4 t -76.4 -19.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 110.191 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 41.7 t30 -74.66 -29.99 61.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 108.825 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.52 -38.35 21.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.562 -0.711 . . . . 0.0 109.115 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.54 ' HG3' HG12 ' B' ' 25' ' ' VAL . 0.5 OUTLIER -58.97 -51.76 68.67 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.315 -0.865 . . . . 0.0 109.648 179.017 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.463 ' O ' HG23 ' B' ' 41' ' ' VAL . 39.1 mm -63.0 -27.6 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.457 -0.777 . . . . 0.0 109.235 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 36.3 t80 -74.62 -24.96 58.93 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.38 -0.825 . . . . 0.0 110.103 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -50.63 10.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.875 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' B' ' 36' ' ' GLU . 2.9 mpt_? -61.11 -28.72 69.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.372 -0.83 . . . . 0.0 109.246 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.618 HG11 ' CH2' ' A' ' 14' ' ' TRP . 62.5 t -84.45 -21.91 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.516 0.674 . . . . 0.0 109.873 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' B' ' 38' ' ' TYR . 0.0 OUTLIER -74.66 -51.21 15.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 111.088 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -69.4 -24.28 63.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.166 -0.959 . . . . 0.0 111.42 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 56.3 p -56.9 -52.73 64.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.92 -1.113 . . . . 0.0 110.199 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.646 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.6 m-85 -62.98 -40.48 97.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 110.382 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 110.645 -179.422 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 110.242 -0.281 . . . . 43.64 110.242 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HG2' HD12 ' A' ' 11' ' ' LEU . 50.8 Cg_endo -77.05 157.93 34.17 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.508 1.267 . . . . 29.79 110.551 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.01 0.38 35.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.409 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.42 ' CB ' ' HB3' ' B' ' 10' ' ' PHE . 75.1 t80 -88.67 -23.59 22.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.994 -1.066 . . . . 12.57 109.881 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.703 HD12 ' HG2' ' A' ' 8' ' ' PRO . 54.7 mt -99.6 28.18 4.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 110.312 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.48 -22.12 57.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.168 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.08 -10.28 45.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.504 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.9 m0 -75.61 142.43 73.98 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.092 -1.005 . . . . 11.57 109.874 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HG2' HG23 ' A' ' 18' ' ' VAL . 43.4 Cg_endo -72.1 176.25 8.72 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.568 1.299 . . . . 13.83 110.744 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.0 -23.31 38.76 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.381 -0.824 . . . . 48.43 109.437 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -70.26 -27.45 64.44 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.248 -0.907 . . . . 46.64 109.885 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 22' ' ' VAL . 81.2 t -93.2 -43.82 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -0.858 . . . . 16.14 110.086 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.661 HD21 ' HB3' ' A' ' 11' ' ' LEU . 40.1 mt -63.74 -31.86 73.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 12.61 110.531 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -66.94 -31.21 71.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 23.17 109.92 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.822 ' O ' HG23 ' A' ' 25' ' ' VAL . 52.6 tp -79.88 -40.21 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.841 . . . . 19.0 110.111 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.058 HG12 HG13 ' A' ' 33' ' ' VAL . 39.7 t -54.43 -50.13 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.905 . . . . 18.87 110.139 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -58.33 -49.32 77.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.763 . . . . 23.61 110.437 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -18.57 63.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 30.11 110.635 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 21' ' ' LEU . 90.6 t -88.94 -29.21 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 16.22 110.44 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.02 -26.98 36.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.168 -0.958 . . . . 26.6 109.818 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -89.51 -15.87 32.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.405 -0.81 . . . . 45.21 110.688 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 18.6 pt-20 -90.69 -28.18 18.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.983 -1.073 . . . . 37.85 110.396 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -90.92 -18.72 24.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 35.36 110.392 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.9 23.66 22.35 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.484 -1.446 . . . . 35.1 109.484 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -121.17 -164.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.119 . . . . 32.72 110.211 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.0 m -106.61 168.58 9.07 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.819 -0.808 . . . . 19.61 108.819 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.058 HG13 HG12 ' A' ' 22' ' ' VAL . 92.2 t -73.82 -23.21 18.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.05 -1.031 . . . . 17.56 110.086 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -75.22 -28.93 60.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 21.3 108.896 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.1 m -85.42 -27.84 25.49 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.484 -0.76 . . . . 16.38 109.589 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.736 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.6 tp10 -70.96 -38.47 72.82 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.249 -0.907 . . . . 12.61 109.171 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.576 ' O ' HG23 ' A' ' 41' ' ' VAL . 17.5 mm -80.13 -25.16 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.564 -0.71 . . . . 10.95 109.345 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.43 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 22.3 t80 -72.99 -38.26 66.72 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.265 -0.897 . . . . 18.87 110.218 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -42.7 65.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.192 -0.943 . . . . 36.88 109.911 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -64.65 -27.08 68.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 22.85 109.304 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.8 t -82.65 -26.97 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.627 0.727 . . . . 13.02 109.329 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -40.44 65.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.668 -0.645 . . . . 18.84 110.736 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.89 -20.99 61.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 29.96 110.599 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 t -64.94 -53.13 51.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -0.976 . . . . 18.65 110.433 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.577 ' CE1' HG21 ' B' ' 25' ' ' VAL . 31.5 m-85 -62.58 -27.27 69.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 16.26 110.775 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 36.71 110.637 -179.42 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.734 ' HG2' HD12 ' B' ' 11' ' ' LEU . 50.2 Cg_endo -76.87 157.39 34.93 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.612 1.322 . . . . 0.0 110.627 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.49 0.63 32.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 110.576 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 74.7 t80 -88.83 -23.85 22.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.07 -1.019 . . . . 0.0 109.826 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.734 HD12 ' HG2' ' B' ' 8' ' ' PRO . 54.7 mt -99.36 28.18 4.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.328 -0.858 . . . . 0.0 110.219 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.47 -21.89 57.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.918 . . . . 0.0 110.219 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -10.32 44.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.18 -0.95 . . . . 0.0 110.5 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.483 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.8 m0 -75.79 142.28 73.15 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.133 -0.979 . . . . 0.0 109.858 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.479 ' HG2' HG23 ' B' ' 18' ' ' VAL . 43.3 Cg_endo -72.04 176.25 8.69 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.24 1.126 . . . . 0.0 110.721 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.04 -23.47 38.56 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 109.446 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.94 -27.44 64.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.129 -0.982 . . . . 0.0 110.071 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.717 ' O ' HG23 ' B' ' 22' ' ' VAL . 90.1 t -93.38 -44.07 13.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.989 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' B' ' 11' ' ' LEU . 41.0 mt -63.31 -31.87 73.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.542 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -67.16 -30.96 71.07 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.807 ' O ' HG23 ' B' ' 25' ' ' VAL . 53.5 tp -79.85 -40.2 28.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.411 -0.805 . . . . 0.0 110.163 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 1.061 HG12 HG13 ' B' ' 33' ' ' VAL . 40.2 t -54.51 -50.2 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.857 . . . . 0.0 109.952 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -58.26 -49.75 76.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.432 -0.793 . . . . 0.0 110.268 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -18.91 63.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 110.775 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.807 HG23 ' O ' ' B' ' 21' ' ' LEU . 92.2 t -88.66 -28.83 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.083 -1.011 . . . . 0.0 110.542 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.5 -26.4 35.18 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.87 -15.99 31.0 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.435 -0.791 . . . . 0.0 110.555 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.461 ' HG2' ' HA ' ' B' ' 25' ' ' VAL . 18.3 pt-20 -90.68 -27.97 18.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.36 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -91.19 -18.64 24.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 0.0 110.471 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.85 23.61 22.61 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -121.2 -164.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -1.141 . . . . 0.0 110.217 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -106.35 168.4 9.18 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 1.061 HG13 HG12 ' B' ' 22' ' ' VAL . 92.1 t -73.65 -23.25 19.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.018 -1.051 . . . . 0.0 110.157 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -75.27 -28.64 59.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 108.925 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -85.59 -27.85 25.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.54 -0.725 . . . . 0.0 109.518 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.724 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.6 tp10 -70.9 -38.32 73.02 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.262 -0.899 . . . . 0.0 109.366 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.579 ' O ' HG23 ' B' ' 41' ' ' VAL . 17.6 mm -80.19 -25.19 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 0.0 109.297 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.425 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 22.6 t80 -73.01 -38.02 66.75 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.8 -42.34 64.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -64.94 -26.9 68.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 37' ' ' ILE . 42.7 t -82.83 -26.92 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.464 -0.772 . . . . 0.0 109.154 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -39.95 65.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.639 -0.663 . . . . 0.0 110.785 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.26 -21.03 61.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 110.538 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -64.71 -53.28 49.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.435 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.566 ' CE1' HG21 ' A' ' 25' ' ' VAL . 31.3 m-85 -62.66 -27.23 69.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.973 . . . . 0.0 110.816 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 tttp . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.066 -1.021 . . . . 0.0 110.639 -179.501 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.341 -0.244 . . . . 43.64 110.341 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HG3' ' CE1' ' B' ' 10' ' ' PHE . 46.2 Cg_endo -72.88 157.61 51.28 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.635 1.334 . . . . 29.79 110.347 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -75.98 -10.54 59.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.873 . . . . 0.0 110.705 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' B' ' 10' ' ' PHE . 79.1 t80 -74.78 -27.63 60.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.063 -1.023 . . . . 12.57 110.331 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 19' ' ' LEU . 41.0 mt -96.17 23.43 6.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 110.203 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.2 -18.26 61.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.675 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -97.24 1.22 49.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.947 . . . . 0.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.436 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.4 m0 -82.32 153.81 68.9 Favored Pre-proline 0 N--CA 1.485 1.313 0 O-C-N 121.076 -1.015 . . . . 11.57 109.796 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 42.0 Cg_endo -70.61 162.5 42.27 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.535 1.281 . . . . 13.83 111.379 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -40.76 97.6 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.615 0.721 . . . . 48.43 110.67 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -53.78 53.25 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.815 -0.553 . . . . 46.64 111.086 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 22' ' ' VAL . 85.7 t -60.96 -44.59 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.099 -1.0 . . . . 16.14 110.737 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 11' ' ' LEU . 70.7 mt -62.57 -30.66 71.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.218 -0.926 . . . . 12.61 110.779 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -72.64 -23.13 60.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.987 . . . . 23.17 110.264 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.2 tp -87.3 -37.46 17.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.32 -0.862 . . . . 19.0 110.21 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.941 HG12 HG13 ' A' ' 33' ' ' VAL . 27.3 t -57.15 -45.23 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 18.87 110.267 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.459 ' HG3' ' N ' ' A' ' 24' ' ' LYS . 8.8 ptp180 -65.56 -29.87 70.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -0.906 . . . . 23.61 110.681 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -83.58 -10.46 58.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.043 -1.036 . . . . 30.11 110.563 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 21' ' ' LEU . 71.5 t -100.15 -28.0 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 16.22 110.453 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.06 -30.55 58.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 26.6 109.742 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.92 -12.17 58.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.2 -0.938 . . . . 45.21 110.387 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -87.23 -54.13 4.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.068 -1.02 . . . . 37.85 110.536 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -61.01 -22.44 64.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.128 -0.982 . . . . 35.36 110.561 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.2 36.99 4.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.529 -1.428 . . . . 35.1 109.529 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -141.5 -154.89 0.54 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.378 -1.072 . . . . 32.72 110.104 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 p -113.43 171.67 7.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.52 -0.738 . . . . 19.61 109.253 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.941 HG13 HG12 ' A' ' 22' ' ' VAL . 71.4 t -72.64 -23.04 20.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.097 -1.002 . . . . 17.56 110.412 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -70.08 -29.88 66.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.998 . . . . 21.3 109.021 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.71 -29.33 21.17 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.454 -0.778 . . . . 16.38 109.432 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' HG3' HG12 ' A' ' 25' ' ' VAL . 4.2 tt0 -64.36 -59.43 4.38 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.306 -0.871 . . . . 12.61 109.349 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.65 HG23 HG21 ' B' ' 41' ' ' VAL . 24.9 mm -60.31 -22.56 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.369 -0.832 . . . . 10.95 109.284 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -73.62 -33.25 64.48 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.367 -0.833 . . . . 18.87 110.065 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -46.36 21.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 36.88 109.817 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 mtt-85 -61.31 -25.94 67.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.445 -0.784 . . . . 22.85 109.601 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.638 HG21 HG23 ' B' ' 37' ' ' ILE . 53.9 t -88.66 -29.81 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.506 -0.747 . . . . 13.02 109.999 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.0 -67.48 0.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 18.84 110.54 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -55.82 -20.68 16.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.975 . . . . 29.96 110.479 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.0 t -60.35 -53.66 54.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 18.65 109.998 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.537 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 17.0 m-85 -60.52 -30.46 69.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.352 -0.843 . . . . 16.26 110.129 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 36.71 110.579 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.487 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 45.8 Cg_endo -73.02 157.57 50.83 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.75 1.395 . . . . 0.0 110.35 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -75.86 -10.55 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 79.0 t80 -74.84 -27.8 60.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.29 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.479 ' HB3' HD21 ' B' ' 19' ' ' LEU . 41.7 mt -96.09 23.36 6.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.179 -0.951 . . . . 0.0 110.225 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.18 -18.35 61.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.134 -0.979 . . . . 0.0 110.601 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -97.13 1.22 49.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.048 -1.032 . . . . 0.0 110.855 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.452 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.3 m0 -82.48 153.82 68.46 Favored Pre-proline 0 N--CA 1.485 1.31 0 O-C-N 120.986 -1.071 . . . . 0.0 109.852 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.473 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 42.2 Cg_endo -70.47 162.11 43.62 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.419 1.221 . . . . 0.0 111.525 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -40.6 97.18 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.784 0.802 . . . . 0.0 110.768 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -53.87 52.14 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.037 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.714 ' O ' HG23 ' B' ' 22' ' ' VAL . 85.8 t -60.7 -45.09 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.586 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' B' ' 11' ' ' LEU . 71.6 mt -61.92 -30.8 71.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.827 -1.171 . . . . 0.0 111.111 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -72.73 -23.32 60.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.097 -1.002 . . . . 0.0 110.287 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.602 ' O ' HG23 ' B' ' 25' ' ' VAL . 1.2 tp -87.0 -37.58 17.38 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.423 -0.798 . . . . 0.0 110.301 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.947 HG12 HG13 ' B' ' 33' ' ' VAL . 26.3 t -57.02 -45.28 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 110.267 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.459 ' HG3' ' N ' ' B' ' 24' ' ' LYS . 8.8 ptp180 -65.59 -29.73 70.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.24 -0.913 . . . . 0.0 110.709 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 0.0 OUTLIER -83.7 -10.45 58.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.064 -1.022 . . . . 0.0 110.527 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 21' ' ' LEU . 71.1 t -100.12 -27.94 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 110.459 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.05 -30.54 58.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.12 -0.987 . . . . 0.0 109.734 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.0 -11.96 58.57 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.378 -0.826 . . . . 0.0 110.46 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.38 -54.0 4.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.991 . . . . 0.0 110.545 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -61.2 -22.35 64.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 110.63 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.15 37.1 4.72 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -141.53 -154.88 0.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.399 -1.059 . . . . 0.0 110.094 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 2.2 p -113.32 171.66 7.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.528 -0.732 . . . . 0.0 109.311 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.947 HG13 HG12 ' B' ' 22' ' ' VAL . 70.9 t -72.64 -23.17 20.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.124 -0.985 . . . . 0.0 110.454 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -69.96 -29.75 66.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.0 109.042 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.87 -29.46 20.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.497 -0.752 . . . . 0.0 109.356 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.48 ' HG3' HG12 ' B' ' 25' ' ' VAL . 4.2 tt0 -64.3 -59.4 4.43 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.297 -0.877 . . . . 0.0 109.295 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.638 HG23 HG21 ' A' ' 41' ' ' VAL . 24.9 mm -60.37 -22.64 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.315 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.412 ' OH ' ' HG3' ' A' ' 15' ' ' PRO . 19.5 t80 -73.71 -33.24 64.3 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.265 -0.897 . . . . 0.0 109.977 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -46.52 21.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 109.723 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 mtt-85 -61.14 -25.84 67.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.81 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.65 HG21 HG23 ' A' ' 37' ' ' ILE . 54.7 t -88.66 -29.85 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.968 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -67.41 0.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 110.465 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -55.86 -20.83 17.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.95 . . . . 0.0 110.396 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 19.6 t -60.25 -53.65 55.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.235 -0.915 . . . . 0.0 109.97 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.543 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 17.4 m-85 -60.36 -30.75 69.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 0.0 110.575 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.409 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 110.191 -0.3 . . . . 43.64 110.191 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HG2' HD12 ' A' ' 11' ' ' LEU . 44.1 Cg_endo -70.3 145.83 55.12 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.594 1.313 . . . . 29.79 110.426 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -64.16 -14.49 55.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 110.729 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CE1' ' HG3' ' B' ' 8' ' ' PRO . 89.9 t80 -71.77 -28.79 63.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.108 -0.995 . . . . 12.57 110.169 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.707 HD12 ' HG2' ' A' ' 8' ' ' PRO . 65.9 mt -93.77 30.21 1.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.176 -0.953 . . . . 0.0 110.272 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.82 -23.91 61.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -19.63 25.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.91 . . . . 0.0 110.449 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.542 ' CE3' HD22 ' A' ' 11' ' ' LEU . 13.1 m0 -69.56 132.47 89.3 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.256 -0.903 . . . . 11.57 109.236 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.66 167.2 23.51 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.411 1.216 . . . . 13.83 111.082 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -67.98 -25.77 65.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.614 -0.679 . . . . 48.43 110.791 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.5 -51.92 51.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 46.64 110.611 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.9 t -67.49 -39.5 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 16.14 110.526 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.7 -29.92 70.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 12.61 110.639 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.08 -27.47 68.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.059 -1.026 . . . . 23.17 109.504 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.736 ' O ' HG23 ' A' ' 25' ' ' VAL . 50.1 tp -84.88 -39.53 18.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.561 -0.712 . . . . 19.0 110.066 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.821 HG12 HG13 ' A' ' 33' ' ' VAL . 39.9 t -60.26 -47.25 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.44 -0.788 . . . . 18.87 110.574 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HG3' ' N ' ' A' ' 24' ' ' LYS . 9.6 ptp180 -61.52 -28.62 69.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.316 -0.865 . . . . 23.61 110.849 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.468 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -86.01 -20.68 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.029 -1.044 . . . . 30.11 110.14 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 21' ' ' LEU . 93.6 t -87.4 -23.75 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.873 . . . . 16.22 110.204 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.76 -34.61 67.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.305 -0.872 . . . . 26.6 109.528 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.44 -9.78 59.3 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.333 -0.854 . . . . 45.21 110.425 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.47 -59.96 2.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 37.85 110.399 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -58.61 -30.17 67.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 35.36 110.444 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.04 32.68 3.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 35.1 109.555 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -136.74 -165.13 1.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.122 . . . . 32.72 109.94 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.24 -173.36 2.65 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.408 -0.807 . . . . 19.61 108.842 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.821 HG13 HG12 ' A' ' 22' ' ' VAL . 69.7 t -83.44 -15.5 11.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.171 -0.956 . . . . 17.56 110.099 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 60.6 t30 -80.84 -33.18 34.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 21.3 108.496 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.84 -40.0 49.27 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.835 -0.802 . . . . 16.38 108.835 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.623 ' HG3' HG12 ' A' ' 25' ' ' VAL . 1.5 tt0 -59.53 -51.24 70.71 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.247 -0.908 . . . . 12.61 109.256 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.59 HG23 HG21 ' B' ' 41' ' ' VAL . 35.3 mm -64.0 -24.42 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.373 -0.829 . . . . 10.95 109.584 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.439 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 35.2 t80 -73.98 -30.35 62.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.297 -0.877 . . . . 18.87 110.427 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 -78.12 -46.09 21.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.083 -1.011 . . . . 36.88 110.137 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.417 ' CD ' ' O ' ' A' ' 36' ' ' GLU . 2.7 mpt_? -60.98 -26.68 67.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 22.85 109.697 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.594 HG21 HG23 ' B' ' 37' ' ' ILE . 19.2 t -85.63 -30.58 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.491 -0.756 . . . . 13.02 109.352 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.5 mtp -71.4 -20.33 62.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.759 . . . . 18.84 110.487 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.04 -26.65 26.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 29.96 110.532 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.48 -58.81 6.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 18.65 110.317 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.64 ' CD1' HD21 ' B' ' 21' ' ' LEU . 30.1 m-85 -55.13 -42.31 72.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 16.26 110.374 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mttt . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.161 -0.962 . . . . 36.71 110.615 -179.795 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.405 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.733 ' HG2' HD12 ' B' ' 11' ' ' LEU . 45.0 Cg_endo -70.65 145.25 51.53 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.678 1.357 . . . . 0.0 110.392 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -63.62 -14.46 51.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 0.0 110.749 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 34' ' ' ASN . 90.7 t80 -71.8 -28.46 63.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.047 -1.033 . . . . 0.0 110.209 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.733 HD12 ' HG2' ' B' ' 8' ' ' PRO . 64.2 mt -94.05 30.31 1.91 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.248 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.99 -23.95 61.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -0.847 . . . . 0.0 110.221 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -19.58 25.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.928 . . . . 0.0 110.451 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.554 ' CE3' HD22 ' B' ' 11' ' ' LEU . 13.2 m0 -69.86 132.18 88.9 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.351 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.5 167.24 23.11 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.551 1.29 . . . . 0.0 111.153 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' B' ' 20' ' ' ASP . 1.5 ptm180 -68.07 -25.67 65.46 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.735 -0.603 . . . . 0.0 110.698 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.98 -51.72 51.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 110.526 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.714 ' O ' HG23 ' B' ' 22' ' ' VAL . 61.9 t -67.64 -39.48 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.103 -0.998 . . . . 0.0 110.237 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 14.3 mt -65.77 -29.83 70.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 110.715 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 16' ' ' ARG . 1.0 OUTLIER -66.37 -27.61 68.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.041 -1.037 . . . . 0.0 109.617 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.726 ' O ' HG23 ' B' ' 25' ' ' VAL . 45.7 tp -84.87 -39.1 18.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.633 -0.667 . . . . 0.0 110.03 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.8 HG12 HG13 ' B' ' 33' ' ' VAL . 39.3 t -60.88 -46.32 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.0 110.606 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' B' ' 24' ' ' LYS . 9.6 ptp180 -62.31 -28.31 69.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.197 -0.939 . . . . 0.0 110.759 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.464 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 0.1 OUTLIER -86.06 -20.82 28.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.031 -1.043 . . . . 0.0 110.116 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.726 HG23 ' O ' ' B' ' 21' ' ' LEU . 95.3 t -87.42 -23.75 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.853 . . . . 0.0 110.119 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.27 66.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.52 -9.91 59.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.46 -0.775 . . . . 0.0 110.371 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -86.51 -59.99 2.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.015 . . . . 0.0 110.379 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -58.56 -30.09 66.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.87 . . . . 0.0 110.345 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.94 32.56 3.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -136.44 -164.82 1.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -1.183 . . . . 0.0 109.973 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.54 -173.55 2.67 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.37 -0.831 . . . . 0.0 108.879 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.8 HG13 HG12 ' B' ' 22' ' ' VAL . 69.4 t -83.26 -15.65 11.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.175 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 60.2 t30 -80.86 -32.98 34.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.097 -1.002 . . . . 0.0 108.436 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -40.47 48.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.639 ' HG3' HG12 ' B' ' 25' ' ' VAL . 1.5 tt0 -59.1 -51.55 69.55 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.214 -0.929 . . . . 0.0 109.273 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.594 HG23 HG21 ' A' ' 41' ' ' VAL . 37.0 mm -63.53 -24.58 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.58 -0.7 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.435 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 37.8 t80 -74.2 -29.84 61.93 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 110.508 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -78.6 -46.2 19.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.404 ' CD ' ' O ' ' B' ' 36' ' ' GLU . 2.7 mpt_? -60.36 -27.64 67.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.567 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.59 HG21 HG23 ' A' ' 37' ' ' ILE . 18.6 t -84.9 -30.42 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.512 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.5 mtp -72.19 -19.54 61.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 110.499 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.45 -26.94 26.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 110.354 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -58.9 6.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 0.0 110.391 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.59 ' CD1' HD21 ' A' ' 21' ' ' LEU . 31.2 m-85 -55.23 -41.93 72.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.469 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mttt . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.249 -0.907 . . . . 0.0 110.518 -179.638 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 18.4 mtp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 110.209 -0.293 . . . . 43.64 110.209 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.608 ' CG ' HD12 ' A' ' 11' ' ' LEU . 45.0 Cg_endo -71.33 153.5 61.44 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.569 1.3 . . . . 29.79 110.487 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.15 -17.58 64.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 110.456 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.457 ' HB3' ' CB ' ' B' ' 10' ' ' PHE . 87.7 t80 -76.26 -28.45 57.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 12.57 110.352 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.608 HD12 ' CG ' ' A' ' 8' ' ' PRO . 81.5 mt -91.53 21.14 4.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.954 . . . . 0.0 110.455 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -72.45 -22.65 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 110.059 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.79 -11.99 46.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.635 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.511 ' HH2' HG21 ' B' ' 41' ' ' VAL . 14.2 m0 -79.73 141.94 56.39 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.029 -1.045 . . . . 11.57 109.682 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.19 177.83 7.33 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.572 1.301 . . . . 13.83 110.685 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.77 -21.95 34.46 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.385 -0.822 . . . . 48.43 109.153 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -69.32 -28.01 65.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.885 . . . . 46.64 109.887 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.869 ' O ' HG23 ' A' ' 22' ' ' VAL . 78.5 t -94.85 -40.46 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 16.14 110.034 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.89 -28.79 69.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 12.61 110.547 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -73.08 -22.61 60.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 23.17 109.936 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.821 ' O ' HG23 ' A' ' 25' ' ' VAL . 50.6 tp -90.1 -33.52 16.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 19.0 110.018 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 18' ' ' VAL . 24.0 t -67.14 -50.18 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.419 -0.801 . . . . 18.87 110.345 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -59.17 -27.25 65.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.309 -0.869 . . . . 23.61 110.788 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -24.11 33.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 30.11 110.165 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 21' ' ' LEU . 88.4 t -78.83 -39.34 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.433 -0.792 . . . . 16.22 110.351 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.76 97.86 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.204 -0.935 . . . . 26.6 109.654 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -68.13 -16.09 63.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 45.21 110.452 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.78 -59.84 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.979 -1.076 . . . . 37.85 110.411 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -59.07 -28.03 66.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 35.36 110.703 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.59 41.03 3.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.461 -1.456 . . . . 35.1 109.461 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mtt-85 -141.96 -154.01 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -1.121 . . . . 32.72 110.069 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 t -108.59 175.94 5.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.48 -0.763 . . . . 19.61 109.476 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.765 HG13 HG12 ' A' ' 22' ' ' VAL . 88.9 t -78.64 -20.56 13.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.157 -0.965 . . . . 17.56 110.229 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.18 -26.57 63.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.069 -1.019 . . . . 21.3 109.104 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.82 -30.53 22.9 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.384 -0.823 . . . . 16.38 109.566 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HG3' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -67.16 -48.48 67.86 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.251 -0.906 . . . . 12.61 109.724 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.618 HG23 HG21 ' B' ' 41' ' ' VAL . 47.3 mm -66.36 -30.88 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.837 . . . . 10.95 109.679 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HE1' HG11 ' B' ' 18' ' ' VAL . 36.9 t80 -67.67 -39.4 84.51 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 18.87 110.635 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.53 -45.81 61.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.185 -0.947 . . . . 36.88 109.743 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 36' ' ' GLU . 2.1 mmt-85 -60.84 -24.69 66.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 22.85 109.4 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.699 HG21 HG23 ' B' ' 37' ' ' ILE . 52.1 t -90.14 -23.36 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.586 -0.696 . . . . 13.02 110.161 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -56.99 4.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.505 -0.747 . . . . 18.84 110.977 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -50.74 -33.22 22.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.121 -0.987 . . . . 29.96 111.189 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.3 m -60.79 -51.24 70.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.121 -0.987 . . . . 18.65 110.598 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.629 ' CD1' HD21 ' B' ' 21' ' ' LEU . 15.0 m-85 -59.77 -29.88 68.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.98 . . . . 16.26 110.814 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.006 -1.059 . . . . 36.71 110.677 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 18.3 mtp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.599 ' CG ' HD12 ' B' ' 11' ' ' LEU . 45.4 Cg_endo -71.46 153.55 60.71 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.65 1.342 . . . . 0.0 110.42 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.04 -17.74 65.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.458 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.457 ' CB ' ' HB3' ' A' ' 10' ' ' PHE . 87.6 t80 -76.15 -28.32 57.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.157 -0.964 . . . . 0.0 110.326 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.599 HD12 ' CG ' ' B' ' 8' ' ' PRO . 83.5 mt -91.8 21.7 4.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 110.407 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.09 -22.53 60.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.974 . . . . 0.0 110.015 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.74 -12.02 46.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 110.644 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.529 ' HH2' HG21 ' A' ' 41' ' ' VAL . 14.2 m0 -79.83 142.05 56.1 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.841 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.21 177.42 7.86 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.551 1.29 . . . . 0.0 110.18 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -21.6 34.61 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.439 -0.788 . . . . 0.0 109.226 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -69.38 -28.02 65.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.978 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.846 ' O ' HG23 ' B' ' 22' ' ' VAL . 80.2 t -94.66 -40.64 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.551 -0.718 . . . . 0.0 109.845 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 19' ' ' LEU . 85.3 mt -65.95 -28.44 68.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.563 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.38 -22.85 60.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.845 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.84 ' O ' HG23 ' B' ' 25' ' ' VAL . 51.7 tp -89.82 -33.73 16.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.704 -0.623 . . . . 0.0 110.12 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.846 HG23 ' O ' ' B' ' 18' ' ' VAL . 24.0 t -66.92 -50.1 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -0.829 . . . . 0.0 110.37 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -59.14 -27.52 65.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.289 -0.882 . . . . 0.0 110.801 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -24.3 34.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 110.114 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.84 HG23 ' O ' ' B' ' 21' ' ' LEU . 88.8 t -78.66 -39.46 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.804 . . . . 0.0 110.299 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.47 99.22 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.342 -0.849 . . . . 0.0 109.59 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -67.53 -16.24 64.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.528 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -82.56 -59.94 2.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.041 -1.037 . . . . 0.0 110.503 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -58.97 -28.16 66.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.136 -0.978 . . . . 0.0 110.794 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.47 41.7 2.9 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -142.6 -154.19 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.433 -1.04 . . . . 0.0 110.002 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.7 t -108.87 175.8 5.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.451 -0.781 . . . . 0.0 109.466 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.784 HG13 HG12 ' B' ' 22' ' ' VAL . 93.7 t -78.27 -20.5 13.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 110.451 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.6 -26.32 62.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.079 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.02 -30.38 22.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.429 -0.794 . . . . 0.0 109.467 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.501 ' HG3' HG12 ' B' ' 25' ' ' VAL . 0.0 OUTLIER -67.41 -48.35 67.61 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.699 HG23 HG21 ' A' ' 41' ' ' VAL . 47.2 mm -66.81 -30.31 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.427 ' HE1' HG11 ' A' ' 18' ' ' VAL . 36.3 t80 -68.0 -39.41 83.22 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.381 -0.825 . . . . 0.0 110.608 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -45.83 61.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.895 . . . . 0.0 109.759 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' B' ' 36' ' ' GLU . 2.0 mmt-85 -60.93 -24.52 66.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 109.383 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.618 HG21 HG23 ' A' ' 37' ' ' ILE . 49.9 t -90.22 -23.4 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.62 -0.675 . . . . 0.0 110.011 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -57.66 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.507 -0.746 . . . . 0.0 111.081 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -50.22 -33.37 19.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.163 -0.961 . . . . 0.0 111.249 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 38.1 m -60.96 -50.85 71.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.1 -1.0 . . . . 0.0 110.637 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.667 ' CD1' HD21 ' A' ' 21' ' ' LEU . 15.9 m-85 -60.04 -30.04 68.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.79 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.251 -0.905 . . . . 0.0 110.835 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.41 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 1.9 ptm . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 110.358 -0.238 . . . . 43.64 110.358 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.768 ' CG ' HD12 ' A' ' 11' ' ' LEU . 44.0 Cg_endo -70.86 157.77 57.34 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.711 1.374 . . . . 29.79 110.466 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.28 -21.59 62.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.891 . . . . 0.0 110.449 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.514 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 87.4 t80 -70.12 -22.16 63.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.843 . . . . 12.57 110.574 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.768 HD12 ' CG ' ' A' ' 8' ' ' PRO . 85.1 mt -100.23 27.43 5.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.139 -0.975 . . . . 0.0 110.541 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.81 -21.64 44.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.952 . . . . 0.0 110.006 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -85.58 -22.9 27.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.556 ' HB2' HD11 ' A' ' 19' ' ' LEU . 14.7 m0 -66.16 144.81 98.9 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 121.424 -0.798 . . . . 11.57 109.533 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HD2' ' CE1' ' B' ' 38' ' ' TYR . 40.6 Cg_endo -70.85 160.35 49.67 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.496 1.261 . . . . 13.83 111.336 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -40.15 88.9 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.603 0.716 . . . . 48.43 110.934 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.09 -47.29 86.51 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.69 -0.631 . . . . 46.64 111.49 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.0 t -66.89 -48.82 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.038 -1.039 . . . . 16.14 111.021 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 14' ' ' TRP . 74.8 mt -64.02 -24.97 67.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.069 -1.019 . . . . 12.61 110.685 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HA ' ' CD ' ' A' ' 23' ' ' ARG . 13.9 t70 -71.69 -23.68 61.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 23.17 109.898 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.536 HD23 ' CZ ' ' B' ' 45' ' ' PHE . 0.8 OUTLIER -90.29 -43.72 10.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 19.0 110.043 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.993 HG12 HG13 ' A' ' 33' ' ' VAL . 40.6 t -51.32 -39.44 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.392 -0.818 . . . . 18.87 110.477 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.45 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 8.3 ptm180 -66.03 -36.21 82.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 23.61 110.622 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -19.4 58.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 30.11 110.524 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.451 HG12 ' HG3' ' A' ' 36' ' ' GLU . 69.9 t -86.88 -35.09 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.263 -0.898 . . . . 16.22 110.184 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.91 83.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -0.909 . . . . 26.6 109.738 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.98 -19.45 63.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 45.21 110.271 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -82.77 -56.53 3.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 37.85 110.35 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -53.41 -42.64 67.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 35.36 110.386 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.73 44.54 0.54 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.541 -1.424 . . . . 35.1 109.541 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.33 -158.58 0.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -1.123 . . . . 32.72 110.189 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.83 176.93 5.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 19.61 109.561 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.993 HG13 HG12 ' A' ' 22' ' ' VAL . 75.1 t -76.14 -19.42 15.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.356 -0.84 . . . . 17.56 110.265 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -71.12 -27.72 63.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 21.3 108.869 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 m -86.3 -33.64 20.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.555 -0.716 . . . . 16.38 109.531 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG3' HG12 ' A' ' 25' ' ' VAL . 1.1 tt0 -63.55 -53.59 49.42 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.187 -0.946 . . . . 12.61 109.412 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.576 HG23 HG21 ' B' ' 41' ' ' VAL . 25.8 mm -63.37 -21.73 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.458 -0.776 . . . . 10.95 109.653 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 32.9 t80 -76.2 -35.59 59.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.155 -0.966 . . . . 18.87 110.362 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -76.8 -52.03 10.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 36.88 109.6 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -55.46 -24.56 31.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.456 -0.778 . . . . 22.85 109.732 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.587 HG21 HG23 ' B' ' 37' ' ' ILE . 37.5 t -89.97 -29.79 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 13.02 109.867 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -64.07 0.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 18.84 110.48 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.88 -29.13 18.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.19 -0.944 . . . . 29.96 110.425 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.65 -46.45 81.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 18.65 109.928 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.55 ' CZ ' HD23 ' B' ' 21' ' ' LEU . 15.4 m-85 -66.75 -29.07 68.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 16.26 110.167 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 36.71 110.502 -179.807 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.421 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 2.0 ptm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.774 ' CG ' HD12 ' B' ' 11' ' ' LEU . 43.9 Cg_endo -71.04 157.99 56.41 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.621 1.327 . . . . 0.0 110.449 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.53 -21.23 61.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 110.386 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.506 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 86.6 t80 -70.53 -22.08 62.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.441 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.774 HD12 ' CG ' ' B' ' 8' ' ' PRO . 85.1 mt -100.37 27.55 5.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 110.542 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.01 -21.4 43.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 110.034 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -85.86 -22.9 27.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.873 . . . . 0.0 110.189 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.549 ' HB2' HD11 ' B' ' 19' ' ' LEU . 14.8 m0 -66.34 145.2 98.96 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.288 -0.883 . . . . 0.0 109.425 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.461 ' HG2' HG23 ' B' ' 18' ' ' VAL . 41.0 Cg_endo -71.4 159.71 50.77 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.308 1.162 . . . . 0.0 111.341 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -40.4 86.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.676 0.75 . . . . 0.0 110.997 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.15 -47.21 86.87 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.774 -0.579 . . . . 0.0 111.481 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.63 ' O ' HG23 ' B' ' 22' ' ' VAL . 78.9 t -67.11 -48.61 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.304 -0.872 . . . . 0.0 110.902 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' B' ' 14' ' ' TRP . 77.0 mt -64.04 -24.63 67.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.079 -1.013 . . . . 0.0 110.662 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' CD ' ' B' ' 23' ' ' ARG . 13.5 t70 -71.99 -24.14 61.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.231 -0.918 . . . . 0.0 109.754 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.55 HD23 ' CZ ' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -90.03 -43.45 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.502 -0.748 . . . . 0.0 110.096 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.971 HG12 HG13 ' B' ' 33' ' ' VAL . 40.7 t -51.6 -39.62 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.41 -0.806 . . . . 0.0 110.458 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.447 ' CD ' ' HA ' ' B' ' 20' ' ' ASP . 8.3 ptm180 -65.84 -36.29 83.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.706 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -19.57 58.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.459 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.461 HG12 ' HG3' ' B' ' 36' ' ' GLU . 69.9 t -86.71 -35.25 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.923 . . . . 0.0 110.32 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 -39.35 84.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 109.701 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.49 -19.92 63.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 110.245 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -82.45 -56.53 3.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.128 -0.982 . . . . 0.0 110.373 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -53.6 -42.38 67.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 110.46 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.51 44.48 0.55 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.35 -158.68 0.69 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -1.176 . . . . 0.0 110.258 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.69 176.92 5.06 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.363 -0.835 . . . . 0.0 109.617 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.971 HG13 HG12 ' B' ' 22' ' ' VAL . 76.3 t -76.14 -19.26 15.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.261 -0.899 . . . . 0.0 110.308 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -71.18 -27.84 63.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -0.989 . . . . 0.0 108.856 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 45.6 m -86.15 -33.72 20.77 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.549 -0.719 . . . . 0.0 109.536 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.461 ' HG3' HG12 ' B' ' 25' ' ' VAL . 1.1 tt0 -63.4 -53.66 48.88 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.249 -0.907 . . . . 0.0 109.492 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.587 HG23 HG21 ' A' ' 41' ' ' VAL . 26.4 mm -63.32 -21.81 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.528 -0.732 . . . . 0.0 109.596 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.481 ' CE1' ' HD2' ' A' ' 15' ' ' PRO . 33.3 t80 -76.15 -35.51 59.17 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.113 -0.992 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -76.78 -52.08 10.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.146 -0.971 . . . . 0.0 109.645 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -55.44 -24.46 30.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.461 -0.774 . . . . 0.0 109.817 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 37' ' ' ILE . 37.7 t -90.07 -29.97 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 0.0 109.898 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -63.92 1.01 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 110.451 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.03 -29.35 20.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.156 -0.965 . . . . 0.0 110.325 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -46.7 80.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 110.011 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.536 ' CZ ' HD23 ' A' ' 21' ' ' LEU . 15.7 m-85 -66.73 -28.95 68.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 110.125 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 110.481 -179.82 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 mtp . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 110.381 -0.229 . . . . 43.64 110.381 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.9 Cg_endo -71.12 170.59 17.79 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.565 1.297 . . . . 29.79 110.791 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -87.0 -17.55 32.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 110.327 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.513 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 74.2 t80 -72.62 -26.12 61.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 12.57 110.564 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.705 ' HB3' HD21 ' A' ' 19' ' ' LEU . 71.6 mt -94.34 27.1 3.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 110.14 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.7 -18.11 61.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 110.414 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.7 -3.84 29.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.086 -1.008 . . . . 0.0 110.726 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.8 m0 -81.87 138.33 46.69 Favored Pre-proline 0 C--N 1.305 -1.332 0 O-C-N 120.95 -1.094 . . . . 11.57 109.635 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.23 159.59 51.5 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.482 1.254 . . . . 13.83 111.228 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -40.97 96.93 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.856 0.836 . . . . 48.43 110.382 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -52.71 -21.01 3.56 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.691 -0.631 . . . . 46.64 111.223 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 22' ' ' VAL . 92.6 t -104.0 -44.77 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.974 -1.079 . . . . 16.14 111.227 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.705 HD21 ' HB3' ' A' ' 11' ' ' LEU . 20.0 mt -63.12 -24.64 67.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.134 -0.979 . . . . 12.61 111.11 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -25.75 60.48 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.248 -0.907 . . . . 23.17 109.56 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.704 ' O ' HG23 ' A' ' 25' ' ' VAL . 42.9 tp -85.54 -42.47 14.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.599 -0.688 . . . . 19.0 109.849 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.037 HG12 HG13 ' A' ' 33' ' ' VAL . 25.3 t -55.3 -37.94 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 18.87 110.205 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -67.5 -50.49 58.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 23.61 110.439 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -19.48 65.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.218 -0.926 . . . . 30.11 110.338 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.751 HG12 ' CD ' ' A' ' 36' ' ' GLU . 86.9 t -86.84 -32.58 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 16.22 110.061 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.419 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -71.74 -39.13 70.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.199 -0.938 . . . . 26.6 109.306 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 -19.37 62.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.529 -0.732 . . . . 45.21 109.77 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.84 -57.12 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 37.85 110.153 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -56.29 -53.69 54.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 35.36 110.227 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.75 52.43 0.08 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.669 -1.372 . . . . 35.1 109.669 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -169.33 -159.19 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -1.21 . . . . 32.72 110.223 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.419 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 56.8 p -98.4 -176.43 3.39 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.462 -0.774 . . . . 19.61 109.778 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG13 HG12 ' A' ' 22' ' ' VAL . 86.4 t -81.5 -9.94 12.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.155 -0.966 . . . . 17.56 110.708 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.72 -29.87 59.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.007 -1.058 . . . . 21.3 109.318 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -90.42 -28.63 18.51 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.372 -0.83 . . . . 16.38 110.058 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.751 ' CD ' HG12 ' A' ' 25' ' ' VAL . 12.0 tp10 -65.05 -51.15 63.12 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.134 -0.979 . . . . 12.61 109.66 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.601 HD11 HG11 ' A' ' 22' ' ' VAL . 2.7 mt -67.08 -20.6 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.398 -0.814 . . . . 10.95 109.729 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.415 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 46.7 t80 -69.61 -39.15 77.41 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.112 -0.992 . . . . 18.87 110.27 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -71.82 -43.5 65.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 36.88 110.223 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HD3' ' HB3' ' B' ' 44' ' ' SER . 17.0 mtt-85 -63.3 -31.98 73.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 22.85 109.519 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.616 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 71.3 t -83.33 -22.8 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.626 -0.671 . . . . 13.02 110.284 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.25 -34.89 48.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.408 -0.807 . . . . 18.84 110.587 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -72.48 -32.4 66.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 29.96 110.268 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.413 ' HB3' ' HD3' ' B' ' 40' ' ' ARG . 0.1 OUTLIER -56.13 -54.79 40.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 18.65 110.071 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.643 ' CD1' HD21 ' B' ' 21' ' ' LEU . 27.0 m-85 -62.02 -19.46 62.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 16.26 110.572 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 36.71 110.162 179.894 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 120.554 0.216 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.513 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 45.6 Cg_endo -71.19 170.71 17.55 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.555 1.292 . . . . 0.0 110.782 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -87.27 -17.51 32.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.408 -0.808 . . . . 0.0 110.398 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.489 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 76.9 t80 -72.69 -26.0 61.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.867 . . . . 0.0 110.477 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.714 ' HB3' HD21 ' B' ' 19' ' ' LEU . 71.8 mt -94.57 27.22 3.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.181 -0.949 . . . . 0.0 110.174 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.82 -18.12 60.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 110.489 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.6 -3.7 29.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.086 -1.009 . . . . 0.0 110.786 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.616 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.9 m0 -82.13 138.6 45.71 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.103 -0.998 . . . . 0.0 109.67 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.0 Cg_endo -71.36 159.54 51.38 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.175 1.092 . . . . 0.0 110.95 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.74 96.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.636 0.731 . . . . 0.0 110.301 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -52.65 -21.09 3.58 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.701 -0.624 . . . . 0.0 111.105 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.636 ' O ' HG23 ' B' ' 22' ' ' VAL . 98.5 t -104.05 -44.61 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.441 -1.412 . . . . 0.0 111.14 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' B' ' 11' ' ' LEU . 19.9 mt -63.26 -24.76 68.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.132 -0.98 . . . . 0.0 111.081 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -25.37 60.07 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.251 -0.906 . . . . 0.0 109.683 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.726 ' O ' HG23 ' B' ' 25' ' ' VAL . 44.8 tp -85.7 -42.29 14.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.577 -0.702 . . . . 0.0 109.968 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 1.075 HG12 HG13 ' B' ' 33' ' ' VAL . 26.2 t -55.42 -37.97 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.107 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -67.3 -50.81 58.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.305 -0.872 . . . . 0.0 110.455 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -19.55 64.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.229 -0.919 . . . . 0.0 110.5 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.749 HG12 ' CD ' ' B' ' 36' ' ' GLU . 87.6 t -86.7 -32.62 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 110.1 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.418 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -71.52 -39.09 70.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.25 -19.34 62.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.529 -0.732 . . . . 0.0 109.764 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.83 -57.12 3.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 110.227 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -56.37 -53.82 52.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 110.284 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.09 52.44 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -169.36 -159.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.267 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.418 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 54.5 p -98.31 -176.32 3.37 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.314 -0.866 . . . . 0.0 109.867 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 1.075 HG13 HG12 ' B' ' 22' ' ' VAL . 88.0 t -81.62 -9.97 12.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.17 -0.956 . . . . 0.0 110.819 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.61 -29.88 59.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.982 . . . . 0.0 109.367 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -90.39 -28.68 18.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.952 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.749 ' CD ' HG12 ' B' ' 25' ' ' VAL . 12.0 tp10 -65.14 -50.96 63.99 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.194 -0.941 . . . . 0.0 109.732 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.594 HD11 HG11 ' B' ' 22' ' ' VAL . 2.5 mt -67.13 -20.82 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -69.66 -39.3 77.13 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.214 -0.929 . . . . 0.0 110.252 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -71.51 -43.48 66.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.83 . . . . 0.0 110.198 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.413 ' HD3' ' HB3' ' A' ' 44' ' ' SER . 17.3 mtt-85 -63.5 -32.05 73.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.95 . . . . 0.0 109.502 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 37' ' ' ILE . 76.9 t -82.92 -22.87 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 110.34 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.36 -34.98 47.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.819 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.45 -32.35 66.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.136 -0.977 . . . . 0.0 110.208 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.416 ' HB3' ' HD3' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -56.22 -54.78 41.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 110.105 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.641 ' CD1' HD21 ' A' ' 21' ' ' LEU . 27.2 m-85 -61.85 -19.42 62.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 110.54 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.219 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.465 ' CE ' HD13 ' A' ' 19' ' ' LEU . 4.2 mtt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 110.114 -0.328 . . . . 43.64 110.114 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.747 ' CG ' HD12 ' A' ' 11' ' ' LEU . 46.9 Cg_endo -73.4 156.8 50.12 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.516 1.272 . . . . 29.79 110.495 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -76.53 -11.64 59.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.614 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -79.31 -34.35 42.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.014 -1.054 . . . . 12.57 110.291 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.747 HD12 ' CG ' ' A' ' 8' ' ' PRO . 66.1 mt -88.27 14.89 8.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.096 -1.003 . . . . 0.0 110.586 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.58 -27.44 69.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -82.34 -23.78 34.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.92 . . . . 0.0 110.519 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.501 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.0 m0 -63.43 141.72 97.86 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.312 -0.867 . . . . 11.57 109.21 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.39 173.63 9.41 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.458 1.241 . . . . 13.83 111.082 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -77.82 -22.03 50.63 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.499 -0.751 . . . . 48.43 109.769 -179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.7 -46.22 39.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 46.64 110.428 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.85 ' O ' HG23 ' A' ' 22' ' ' VAL . 97.9 t -68.72 -39.58 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 16.14 110.157 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 11' ' ' LEU . 24.8 mt -66.26 -31.52 72.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 12.61 110.654 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 3.4 t0 -70.75 -22.33 62.42 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 23.17 110.074 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.784 ' O ' HG23 ' A' ' 25' ' ' VAL . 51.0 tp -88.83 -37.62 15.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.372 -0.83 . . . . 19.0 109.951 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.981 HG12 HG13 ' A' ' 33' ' ' VAL . 15.6 t -65.84 -49.51 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 18.87 109.959 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HA ' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -59.91 -35.76 75.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 23.61 110.483 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 23' ' ' ARG . 2.1 tmtt? -73.43 -24.55 60.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.113 -0.992 . . . . 30.11 109.943 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 21' ' ' LEU . 99.4 t -86.63 -20.89 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.497 -0.752 . . . . 16.22 110.311 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.578 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -82.22 -30.21 30.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.217 -0.927 . . . . 26.6 109.539 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.43 -19.51 49.78 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.471 -0.768 . . . . 45.21 110.307 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 22.8 pt-20 -90.82 -30.82 16.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.191 -0.943 . . . . 37.85 110.279 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.426 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -82.97 7.68 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 35.36 110.558 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.45 23.98 70.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.517 -1.433 . . . . 35.1 109.517 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 8.8 mtt-85 -129.19 -158.02 0.86 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -1.194 . . . . 32.72 110.362 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.578 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 1.8 m -115.06 -179.65 3.69 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.511 -0.743 . . . . 19.61 109.286 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.981 HG13 HG12 ' A' ' 22' ' ' VAL . 99.1 t -77.97 -14.86 14.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.129 -0.982 . . . . 17.56 110.448 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -77.03 -41.69 41.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.102 -0.998 . . . . 21.3 109.004 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.8 t -71.18 -35.9 71.76 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.386 -0.821 . . . . 16.38 109.56 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.417 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.9 tp10 -64.68 -50.54 66.6 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.233 -0.917 . . . . 12.61 109.405 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.722 HG23 HG21 ' B' ' 41' ' ' VAL . 35.6 mm -63.94 -26.82 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 10.95 109.53 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' B' ' 18' ' ' VAL . 53.4 t80 -71.89 -37.19 70.19 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.374 -0.829 . . . . 18.87 110.753 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.74 -36.34 59.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -0.932 . . . . 36.88 110.253 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -71.99 -24.16 61.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 22.85 109.64 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.787 HG21 HG23 ' B' ' 37' ' ' ILE . 7.0 t -87.09 -28.68 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.8 . . . . 13.02 109.217 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -43.45 60.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.603 -0.685 . . . . 18.84 110.531 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -28.93 68.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 29.96 110.137 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -49.81 70.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.89 . . . . 18.65 110.07 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.584 ' CD1' HD21 ' B' ' 21' ' ' LEU . 31.1 m-85 -66.01 -22.87 66.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 16.26 110.371 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.19 -0.944 . . . . 36.71 110.525 -179.644 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.453 ' CE ' HD13 ' B' ' 19' ' ' LEU . 4.3 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.755 ' CG ' HD12 ' B' ' 11' ' ' LEU . 47.4 Cg_endo -73.41 156.96 50.0 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.522 1.275 . . . . 0.0 110.384 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -76.8 -11.93 59.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.588 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.411 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 89.5 t80 -79.01 -34.09 44.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.078 -1.014 . . . . 0.0 110.322 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.755 HD12 ' CG ' ' B' ' 8' ' ' PRO . 64.6 mt -88.84 15.62 8.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 110.601 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.49 -26.85 68.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -82.77 -23.98 33.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 110.382 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' TRP . . . . . 0.53 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.0 m0 -63.17 142.07 97.75 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.278 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.9 173.97 9.42 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.431 1.227 . . . . 0.0 111.259 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 20' ' ' ASP . 0.0 OUTLIER -78.36 -21.85 48.83 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.333 -0.854 . . . . 0.0 109.722 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.39 -46.11 42.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 110.696 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.837 ' O ' HG23 ' B' ' 22' ' ' VAL . 98.2 t -68.8 -39.57 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.145 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.538 HD21 ' HB3' ' B' ' 11' ' ' LEU . 25.3 mt -66.36 -31.33 72.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 110.574 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' B' ' 16' ' ' ARG . 3.5 t0 -70.83 -23.08 62.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.072 -1.018 . . . . 0.0 109.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.769 ' O ' HG23 ' B' ' 25' ' ' VAL . 50.0 tp -87.83 -37.68 16.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -0.932 . . . . 0.0 109.936 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.98 HG12 HG13 ' B' ' 33' ' ' VAL . 15.7 t -66.05 -49.57 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.391 -0.818 . . . . 0.0 109.967 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.485 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -59.76 -35.52 74.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 110.52 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' B' ' 23' ' ' ARG . 2.1 tmtt? -73.94 -24.24 59.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.065 -1.022 . . . . 0.0 109.981 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.769 HG23 ' O ' ' B' ' 21' ' ' LEU . 97.3 t -86.71 -20.75 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.256 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.574 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -82.59 -30.41 29.57 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.165 -0.959 . . . . 0.0 109.57 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.16 -19.63 50.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.481 -0.762 . . . . 0.0 110.254 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' B' ' 25' ' ' VAL . 22.5 pt-20 -90.72 -30.76 16.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.092 -1.005 . . . . 0.0 110.195 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.439 ' N ' ' HG3' ' B' ' 28' ' ' GLU . 0.5 OUTLIER -83.11 7.71 15.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.631 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.4 24.11 70.58 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 29' ' ' ASN . 8.7 mtt-85 -129.33 -157.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 110.235 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.574 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 1.8 m -115.24 -179.38 3.62 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.451 -0.781 . . . . 0.0 109.258 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.98 HG13 HG12 ' B' ' 22' ' ' VAL . 98.1 t -78.15 -14.6 13.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.09 -1.006 . . . . 0.0 110.645 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -77.2 -41.67 40.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.123 -0.985 . . . . 0.0 109.06 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 8.7 t -71.29 -36.05 71.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.415 -0.803 . . . . 0.0 109.375 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.425 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.9 tp10 -64.58 -50.52 66.89 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.787 HG23 HG21 ' A' ' 41' ' ' VAL . 34.0 mm -63.81 -27.2 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.404 -0.81 . . . . 0.0 109.526 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -71.54 -37.28 71.15 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 0.0 110.807 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.81 -36.32 59.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -71.92 -23.94 61.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.695 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.777 HG23 HG23 ' A' ' 41' ' ' VAL . 6.5 t -87.54 -28.4 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -43.73 59.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.609 -0.682 . . . . 0.0 110.447 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -29.16 68.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -50.04 70.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.642 ' CD1' HD21 ' A' ' 21' ' ' LEU . 31.2 m-85 -65.88 -22.86 66.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.49 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.292 -0.88 . . . . 0.0 110.517 -179.628 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mtt . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.149 0.499 . . . . 50.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.95 85.81 6.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 50.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.34 155.07 20.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.56 -1.416 . . . . 50.0 109.56 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.53 -53.35 2.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -1.164 . . . . 50.0 110.221 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.4 p -68.13 168.12 12.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 50.0 110.231 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -166.12 143.26 5.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 50.0 110.206 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.63 142.32 77.82 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.169 -0.957 . . . . 43.64 109.997 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.0 Cg_endo -72.61 143.77 38.61 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.736 1.387 . . . . 29.79 110.478 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -61.05 -17.61 53.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.833 . . . . 0.0 110.15 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.5 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 69.6 t80 -67.9 -37.48 81.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.062 -1.024 . . . . 12.57 110.36 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.606 ' HB3' HD21 ' A' ' 19' ' ' LEU . 80.8 mt -91.6 21.52 4.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.352 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -74.23 -19.26 60.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 110.302 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.08 -17.93 21.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.134 -0.979 . . . . 0.0 110.653 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.432 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.8 m0 -64.9 144.03 98.93 Favored Pre-proline 0 C--N 1.304 -1.387 0 O-C-N 121.145 -0.972 . . . . 11.57 109.171 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 40.1 Cg_endo -69.23 169.45 18.22 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.384 1.202 . . . . 13.83 110.56 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -25.81 43.94 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.572 -0.705 . . . . 48.43 109.592 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -69.14 -19.26 64.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.173 -0.955 . . . . 46.64 110.078 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.817 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.9 t -102.76 -36.27 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 16.14 109.888 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' A' ' 11' ' ' LEU . 17.5 mt -66.51 -33.91 76.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.416 -0.802 . . . . 12.61 110.509 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.31 -30.28 70.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 23.17 109.851 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.803 ' O ' HG23 ' A' ' 25' ' ' VAL . 28.0 tp -80.76 -38.0 29.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.521 -0.737 . . . . 19.0 109.852 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 18' ' ' VAL . 48.3 t -59.66 -51.72 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 18.87 110.211 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.63 -41.77 82.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.421 -0.799 . . . . 23.61 110.781 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -73.41 -18.2 61.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.118 -0.989 . . . . 30.11 110.841 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 21' ' ' LEU . 59.2 t -84.15 -35.73 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.081 -1.012 . . . . 16.22 110.481 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.594 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -66.5 -36.23 82.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 26.6 109.712 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -72.59 -23.31 60.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.811 . . . . 45.21 109.935 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -78.1 -42.21 32.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 37.85 109.863 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -67.86 -44.48 77.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 35.36 110.105 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.35 37.08 0.95 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.076 -1.21 . . . . 35.1 110.076 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.74 -165.43 1.65 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.042 -1.27 . . . . 32.72 110.601 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -84.0 174.41 10.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 19.61 110.372 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.594 HG22 ' CB ' ' A' ' 26' ' ' ALA . 88.0 t -84.44 -26.72 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.39 -0.818 . . . . 17.56 110.235 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' B' ' 13' ' ' ARG . 5.4 t30 -59.18 -27.1 65.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 21.3 108.977 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.2 t -89.81 -29.71 18.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.519 -0.738 . . . . 16.38 109.536 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.419 ' OE1' ' HB2' ' A' ' 26' ' ' ALA . 30.9 tt0 -61.49 -57.47 12.02 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.116 -0.99 . . . . 12.61 109.519 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.535 HG23 HG21 ' B' ' 41' ' ' VAL . 41.1 mm -58.12 -27.1 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.359 -0.838 . . . . 10.95 109.711 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.477 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 38.9 t80 -70.69 -34.37 71.9 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.135 -0.978 . . . . 18.87 110.15 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -75.06 -53.73 8.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.258 -0.901 . . . . 36.88 110.169 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -57.64 -23.06 49.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.114 -0.991 . . . . 22.85 109.802 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.611 HG21 HG23 ' B' ' 37' ' ' ILE . 39.8 t -89.42 -27.5 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.396 -0.815 . . . . 13.02 109.51 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -25.86 60.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.528 -0.733 . . . . 18.84 110.569 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.78 -21.62 29.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.088 -1.008 . . . . 29.96 110.555 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -66.18 -47.47 73.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 18.65 110.165 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.73 ' CE1' HG21 ' B' ' 25' ' ' VAL . 28.5 m-85 -61.01 -37.44 82.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 16.26 110.373 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -65.98 -26.75 67.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 36.71 110.314 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -51.51 -42.75 61.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.183 -0.948 . . . . 41.6 110.454 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.71 -22.83 17.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 24.83 110.202 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.32 45.15 3.32 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.637 -1.385 . . . . 18.81 109.637 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -88.23 -33.38 18.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.606 -0.938 . . . . 23.01 110.52 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.0 mt -81.3 -48.63 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 119.61 -0.836 . . . . 27.08 110.468 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.57 50.58 0.6 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.731 -1.348 . . . . 32.03 109.731 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 O-C-N 120.996 -1.297 . . . . 0.0 110.165 179.981 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.8 mtt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.201 0.524 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.77 85.73 6.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.23 155.29 21.18 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.77 -53.3 2.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -1.124 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 27.9 p -68.34 168.23 12.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 110.228 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -166.2 143.15 5.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 110.186 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.43 142.53 76.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 110.018 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.5 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 44.6 Cg_endo -72.72 143.77 38.15 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.721 1.38 . . . . 0.0 110.523 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -60.9 -17.58 51.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.242 -0.911 . . . . 0.0 110.16 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.529 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 68.4 t80 -67.83 -37.63 82.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 110.375 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.621 ' HB3' HD21 ' B' ' 19' ' ' LEU . 80.6 mt -91.57 21.79 4.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.363 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -74.41 -19.29 60.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.421 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.434 ' HB2' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -94.99 -18.11 21.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.16 -0.962 . . . . 0.0 110.613 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.444 ' CZ2' ' HA ' ' A' ' 38' ' ' TYR . 14.0 m0 -64.83 144.2 98.89 Favored Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.023 -1.048 . . . . 0.0 109.229 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.477 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.4 Cg_endo -69.28 169.64 17.84 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.519 1.273 . . . . 0.0 110.651 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.17 -25.46 42.82 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.384 -0.822 . . . . 0.0 109.474 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -69.35 -19.34 63.85 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.808 ' O ' HG23 ' B' ' 22' ' ' VAL . 58.2 t -102.6 -36.65 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.16 -0.963 . . . . 0.0 109.756 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' B' ' 11' ' ' LEU . 17.9 mt -65.76 -33.99 77.15 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.16 -0.963 . . . . 0.0 110.662 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.4 -30.6 71.01 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.826 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.793 ' O ' HG23 ' B' ' 25' ' ' VAL . 26.9 tp -80.44 -38.05 30.84 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.862 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.808 HG23 ' O ' ' B' ' 18' ' ' VAL . 48.2 t -59.77 -51.52 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 110.258 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.62 -41.85 82.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.783 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -73.42 -18.2 61.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.18 -0.95 . . . . 0.0 110.851 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.793 HG23 ' O ' ' B' ' 21' ' ' LEU . 58.3 t -84.15 -35.88 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.164 -0.96 . . . . 0.0 110.473 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.587 ' CB ' HG22 ' B' ' 33' ' ' VAL . . . -66.41 -36.14 82.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.043 -1.036 . . . . 0.0 109.828 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -72.58 -23.21 60.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 109.928 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -78.24 -42.17 31.99 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.342 -0.849 . . . . 0.0 109.923 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.04 -44.42 76.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.83 . . . . 0.0 110.025 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.34 36.99 0.96 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.64 -165.47 1.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.019 -1.283 . . . . 0.0 110.571 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m -84.04 174.4 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.356 -0.84 . . . . 0.0 110.364 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.587 HG22 ' CB ' ' B' ' 26' ' ' ALA . 85.8 t -84.52 -26.46 7.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.411 -0.806 . . . . 0.0 110.278 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -59.4 -27.01 65.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.179 -0.95 . . . . 0.0 108.942 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 6.2 t -89.85 -29.9 18.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.72 . . . . 0.0 109.465 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.416 ' OE1' ' HB2' ' B' ' 26' ' ' ALA . 31.0 tt0 -61.21 -57.61 11.71 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.132 -0.98 . . . . 0.0 109.532 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.611 HG23 HG21 ' A' ' 41' ' ' VAL . 40.8 mm -58.19 -27.45 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.38 -0.825 . . . . 0.0 109.65 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.407 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 36.5 t80 -70.19 -34.52 73.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.196 -0.94 . . . . 0.0 110.133 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -75.02 -53.72 8.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 110.183 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' B' ' 36' ' ' GLU . 7.5 mtt85 -57.6 -23.13 49.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.843 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.535 HG21 HG23 ' A' ' 37' ' ' ILE . 39.6 t -89.15 -27.72 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.436 -0.79 . . . . 0.0 109.523 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -26.01 60.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.745 . . . . 0.0 110.61 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -84.86 -21.6 29.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.212 -0.93 . . . . 0.0 110.508 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -66.1 -47.47 74.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 110.163 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.616 ' HE1' HG21 ' A' ' 25' ' ' VAL . 27.8 m-85 -61.17 -37.46 83.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -65.72 -26.79 67.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.361 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -51.64 -42.55 62.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.887 . . . . 0.0 110.527 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.91 -22.87 17.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.153 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.34 45.53 3.23 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -88.62 -33.32 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.421 -1.046 . . . . 0.0 110.365 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 92.6 mt -81.47 -48.83 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.179 -0.95 . . . . 0.0 110.24 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.79 50.38 0.6 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 110.203 -179.948 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.243 0.544 . . . . 50.0 110.239 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.58 123.23 39.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 50.0 110.216 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 5' ' ' SER . . . -100.64 -25.56 8.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.467 -1.453 . . . . 50.0 109.467 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.3 mtm 55.42 -89.76 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.474 -1.015 . . . . 50.0 110.377 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.5 p -138.97 140.22 38.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.916 -1.115 . . . . 50.0 110.323 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -125.29 173.99 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 50.0 110.11 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.4 mtp -56.0 143.26 62.91 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 43.64 110.206 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 48.9 Cg_endo -75.79 160.22 37.76 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.627 1.33 . . . . 29.79 110.431 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -18.28 60.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.115 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.444 ' CE1' ' OD1' ' B' ' 34' ' ' ASN . 56.3 t80 -71.3 -35.8 71.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 12.57 110.348 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.594 ' HB3' HD21 ' A' ' 19' ' ' LEU . 93.8 mt -89.64 16.77 7.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.44 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.55 -31.22 66.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 110.024 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -12.47 59.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.35 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.482 ' CE3' HD22 ' A' ' 11' ' ' LEU . 16.5 m0 -77.48 142.2 66.56 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.173 -0.955 . . . . 11.57 109.451 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -69.38 173.63 10.36 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.586 1.309 . . . . 13.83 110.551 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -22.66 42.18 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.396 -0.815 . . . . 48.43 109.605 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HG3' HG23 ' A' ' 18' ' ' VAL . 10.2 pt-20 -71.5 -36.37 71.07 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.149 -0.969 . . . . 46.64 110.35 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 22' ' ' VAL . 93.8 t -81.27 -43.06 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 16.14 110.254 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 11' ' ' LEU . 73.3 mt -65.1 -32.03 73.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 12.61 110.28 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.45 -24.39 66.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 23.17 109.68 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.876 ' O ' HG23 ' A' ' 25' ' ' VAL . 26.9 tp -87.09 -40.06 15.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.434 -0.791 . . . . 19.0 109.895 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.963 HG12 HG13 ' A' ' 33' ' ' VAL . 38.5 t -56.48 -40.62 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 18.87 109.488 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -59.81 4.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.675 -0.641 . . . . 23.61 110.297 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.26 -28.67 59.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.229 -0.92 . . . . 30.11 110.937 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 21' ' ' LEU . 50.7 t -71.82 -39.31 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.991 -1.068 . . . . 16.22 110.423 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.72 -40.29 88.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.067 -1.021 . . . . 26.6 109.539 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -71.69 -20.99 61.85 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.449 -0.782 . . . . 45.21 109.941 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -54.41 9.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 37.85 109.809 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -71.38 -25.02 62.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.873 . . . . 35.36 110.26 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.48 69.53 1.04 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.71 -1.356 . . . . 35.1 109.71 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.73 -162.91 0.13 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.254 -1.145 . . . . 32.72 110.287 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.8 t -93.2 171.97 8.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 19.61 110.091 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.963 HG13 HG12 ' A' ' 22' ' ' VAL . 69.2 t -83.89 -23.33 7.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.23 -0.919 . . . . 17.56 110.073 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' OD1' ' CE1' ' B' ' 10' ' ' PHE . 0.8 OUTLIER -63.78 -28.14 69.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 21.3 109.255 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -90.15 -32.24 16.73 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.446 -0.784 . . . . 16.38 109.825 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' CG ' HG12 ' A' ' 25' ' ' VAL . 11.0 tp10 -61.67 -37.95 85.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.144 -0.973 . . . . 12.61 109.319 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 41' ' ' VAL . 21.6 mm -76.95 -25.3 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.529 -0.732 . . . . 10.95 109.156 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 33.4 t80 -74.72 -27.38 60.35 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.271 -0.893 . . . . 18.87 110.198 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -81.71 -49.34 10.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 36.88 109.512 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.417 ' CZ ' HG11 ' A' ' 25' ' ' VAL . 55.9 mtt-85 -59.0 -28.79 66.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 22.85 109.189 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.5 t -82.82 -26.95 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.581 -0.699 . . . . 13.02 109.329 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp -76.68 -23.82 53.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.467 -0.77 . . . . 18.84 110.27 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.14 -33.91 56.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.264 -0.897 . . . . 29.96 110.294 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.437 ' CB ' ' HD3' ' B' ' 40' ' ' ARG . 81.8 p -58.47 -41.22 84.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 18.65 110.278 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.643 ' CD1' HD21 ' B' ' 21' ' ' LEU . 25.5 m-85 -74.43 -35.5 63.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 16.26 110.371 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -57.95 -46.31 85.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 36.71 110.476 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -61.79 -33.74 74.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -0.949 . . . . 41.6 110.286 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' HB3' ' HG2' ' A' ' 50' ' ' ARG . 3.4 mt-10 -82.71 -14.2 55.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 24.83 110.473 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.7 23.19 70.49 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.813 -1.315 . . . . 18.81 109.813 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.408 ' HG2' ' HB3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -70.57 -33.59 71.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.306 -1.114 . . . . 23.01 110.252 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.498 HG22 ' N ' ' A' ' 52' ' ' GLY . 39.4 mt -85.19 173.55 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 27.08 109.813 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 51' ' ' ILE . . . -115.5 -37.65 1.07 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.516 -1.434 . . . . 32.03 109.516 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.186 -1.184 . . . . 0.0 110.371 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.261 0.553 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.48 122.88 38.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 110.313 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' B' ' 5' ' ' SER . . . -100.29 -25.36 8.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 40.4 mtm 55.1 -89.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.38 -1.07 . . . . 0.0 110.477 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.406 ' N ' ' O ' ' B' ' 3' ' ' GLY . 4.7 p -139.27 139.98 37.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.885 -1.134 . . . . 0.0 110.424 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -125.12 174.0 8.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.13 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 51.3 mtp -55.92 143.04 63.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.444 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 48.9 Cg_endo -75.66 159.6 38.79 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.632 1.332 . . . . 0.0 110.422 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -18.32 61.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 110.156 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.5 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 58.3 t80 -71.27 -36.0 71.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.971 . . . . 0.0 110.453 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' B' ' 19' ' ' LEU . 94.4 mt -89.37 16.78 6.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.928 . . . . 0.0 110.571 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.48 -31.26 66.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.128 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -12.36 59.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 110.337 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.469 ' CE3' HD22 ' B' ' 11' ' ' LEU . 16.0 m0 -77.52 141.94 66.04 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.246 -0.909 . . . . 0.0 109.489 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.47 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.5 Cg_endo -69.38 173.89 9.98 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.625 1.329 . . . . 0.0 110.543 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -23.26 41.82 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' B' ' 18' ' ' VAL . 10.2 pt-20 -71.34 -36.39 71.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -0.851 . . . . 0.0 110.368 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.707 ' O ' HG23 ' B' ' 22' ' ' VAL . 92.9 t -81.23 -43.48 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 O-C-N 121.072 -1.017 . . . . 0.0 110.014 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' B' ' 11' ' ' LEU . 72.8 mt -64.35 -32.54 74.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.05 -24.73 66.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.747 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.875 ' O ' HG23 ' B' ' 25' ' ' VAL . 27.9 tp -86.71 -40.1 15.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.404 -0.81 . . . . 0.0 109.904 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.944 HG12 HG13 ' B' ' 33' ' ' VAL . 35.1 t -56.4 -40.45 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.597 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.22 -59.63 5.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.645 -0.66 . . . . 0.0 110.267 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -28.27 59.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.267 -0.895 . . . . 0.0 110.963 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.875 HG23 ' O ' ' B' ' 21' ' ' LEU . 53.2 t -72.17 -39.48 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.013 . . . . 0.0 110.361 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.11 88.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.14 -0.975 . . . . 0.0 109.509 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -71.79 -20.85 61.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.341 -0.849 . . . . 0.0 110.044 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -54.23 9.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.863 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.34 -25.32 62.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.42 -0.8 . . . . 0.0 110.089 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.43 69.99 1.06 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.01 -163.27 0.13 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.321 -1.106 . . . . 0.0 110.191 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -92.9 172.93 8.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 110.082 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.944 HG13 HG12 ' B' ' 22' ' ' VAL . 68.4 t -85.08 -22.69 7.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.278 -0.889 . . . . 0.0 110.001 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.444 ' OD1' ' CE1' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -64.26 -27.85 69.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.157 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 2.7 m -90.2 -33.56 16.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.487 -0.758 . . . . 0.0 109.707 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.419 ' CG ' HG12 ' B' ' 25' ' ' VAL . 10.8 tp10 -60.31 -38.18 82.87 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.157 -0.964 . . . . 0.0 109.403 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.462 ' O ' HG23 ' B' ' 41' ' ' VAL . 21.2 mm -77.11 -24.85 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.51 -0.744 . . . . 0.0 109.228 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.417 ' HB2' ' NE1' ' A' ' 14' ' ' TRP . 34.0 t80 -75.32 -26.58 58.77 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.261 -0.899 . . . . 0.0 110.109 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -82.28 -49.53 9.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.58 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.437 ' HD3' ' CB ' ' A' ' 44' ' ' SER . 55.7 mtt-85 -58.81 -28.98 66.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.442 -0.786 . . . . 0.0 109.184 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 37' ' ' ILE . 45.1 t -82.54 -27.46 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.546 0.688 . . . . 0.0 109.414 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mtp -76.08 -23.41 55.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.468 -0.77 . . . . 0.0 110.269 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.47 -34.31 54.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.158 -0.964 . . . . 0.0 110.24 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 85.4 p -57.86 -41.5 82.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 110.156 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.68 ' CD1' HD21 ' A' ' 21' ' ' LEU . 25.3 m-85 -74.5 -35.78 63.22 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -57.76 -46.36 84.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.37 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -61.45 -34.2 75.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.342 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -82.17 -14.66 55.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.207 -0.933 . . . . 0.0 110.606 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.11 23.5 68.61 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -33.51 70.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.184 -1.186 . . . . 0.0 110.06 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.497 HG22 ' N ' ' B' ' 52' ' ' GLY . 40.1 mt -85.19 173.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.239 -0.913 . . . . 0.0 109.707 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.497 ' N ' HG22 ' B' ' 51' ' ' ILE . . . -115.61 -37.61 1.06 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.238 -1.154 . . . . 0.0 110.272 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.236 0.541 . . . . 50.0 110.234 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt 53.06 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.258 -0.901 . . . . 50.0 110.229 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.09 -44.34 29.91 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.757 -1.337 . . . . 50.0 109.757 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 55.03 21.76 3.99 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.202 -1.175 . . . . 50.0 110.309 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -62.76 -179.3 0.26 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 50.0 110.184 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -73.67 -162.35 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 50.0 109.974 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.33 163.6 33.21 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.26 -0.9 . . . . 43.64 110.244 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HG3' ' CE1' ' B' ' 10' ' ' PHE . 43.0 Cg_endo -71.47 147.52 52.32 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.626 1.33 . . . . 29.79 110.545 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.49 -19.38 61.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 110.631 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.519 ' CE1' ' HG3' ' B' ' 8' ' ' PRO . 87.3 t80 -69.25 -32.09 71.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.952 . . . . 12.57 110.11 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HB3' HD21 ' A' ' 19' ' ' LEU . 96.8 mt -91.99 19.07 7.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.371 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -71.65 -25.52 62.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 110.205 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -16.12 46.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.477 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.739 ' HH2' HG21 ' B' ' 41' ' ' VAL . 15.1 m0 -72.69 145.59 87.28 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.306 -0.871 . . . . 11.57 109.815 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HG2' HG23 ' A' ' 18' ' ' VAL . 43.1 Cg_endo -73.4 166.33 30.18 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.559 1.294 . . . . 13.83 111.24 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -37.87 85.68 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.995 0.902 . . . . 48.43 110.33 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -60.46 -34.76 74.49 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.918 -0.583 . . . . 46.64 111.575 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 22' ' ' VAL . 91.2 t -82.84 -44.91 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.924 -1.11 . . . . 16.14 110.817 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 11' ' ' LEU . 61.2 mt -64.54 -27.31 68.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.143 -0.973 . . . . 12.61 110.722 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -69.44 -23.15 63.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 23.17 109.76 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.75 HD21 ' CD1' ' B' ' 45' ' ' PHE . 4.8 tp -89.39 -42.22 11.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.45 -0.781 . . . . 19.0 109.985 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.866 HG12 HG13 ' A' ' 33' ' ' VAL . 48.0 t -51.8 -46.22 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 18.87 110.699 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -54.59 -58.5 7.27 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.361 -0.837 . . . . 23.61 110.85 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -54.12 -22.65 11.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.908 . . . . 30.11 111.054 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.629 HG12 ' CD ' ' A' ' 36' ' ' GLU . 58.9 t -82.54 -38.61 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 16.22 110.961 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.67 74.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.036 . . . . 26.6 110.112 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.39 -9.86 58.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -0.887 . . . . 45.21 110.528 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -88.88 -53.59 4.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.083 -1.011 . . . . 37.85 110.095 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.34 -32.45 73.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 35.36 110.117 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.73 30.81 4.15 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.414 -1.475 . . . . 35.1 109.414 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -133.44 -155.18 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -1.137 . . . . 32.72 110.164 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -107.56 175.34 5.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.539 -0.725 . . . . 19.61 109.55 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.866 HG13 HG12 ' A' ' 22' ' ' VAL . 85.5 t -75.97 -23.58 16.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.105 -0.997 . . . . 17.56 110.138 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.431 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 44.0 t30 -77.15 -28.11 54.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 21.3 108.843 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.07 -27.31 24.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.557 -0.714 . . . . 16.38 109.203 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.629 ' CD ' HG12 ' A' ' 25' ' ' VAL . 8.5 tp10 -71.98 -42.96 65.87 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.277 -0.89 . . . . 12.61 108.916 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' O ' HG23 ' A' ' 41' ' ' VAL . 24.5 mm -66.59 -31.07 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.595 -0.891 . . . . 10.95 108.595 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.425 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 32.6 t80 -63.56 -36.78 84.92 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.62 -0.675 . . . . 18.87 109.968 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -73.96 -43.99 56.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 36.88 109.716 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -61.09 -25.59 67.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 22.85 109.289 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.742 HG21 ' HH2' ' B' ' 14' ' ' TRP . 62.4 t -88.18 -25.14 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.547 0.689 . . . . 13.02 109.635 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtp -77.56 -25.33 49.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.529 -0.732 . . . . 18.84 110.299 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -83.24 -27.48 29.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.194 -0.941 . . . . 29.96 110.353 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.8 p -67.1 -48.91 66.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.255 -0.903 . . . . 18.65 110.357 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.742 ' CD1' HD21 ' B' ' 21' ' ' LEU . 22.4 m-85 -62.89 -22.5 66.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.958 . . . . 16.26 110.417 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.87 -25.75 60.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 36.71 110.455 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -55.72 -24.03 32.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.164 -0.96 . . . . 41.6 110.351 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -108.13 -37.21 6.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 24.83 110.23 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.11 32.25 2.25 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.376 -1.489 . . . . 18.81 109.376 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.565 ' HG2' HD11 ' B' ' 21' ' ' LEU . 0.2 OUTLIER -76.22 -47.63 23.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -1.177 . . . . 23.01 110.502 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 pt -100.9 146.6 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 119.541 -0.863 . . . . 27.08 110.701 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.12 -42.79 0.63 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.295 -1.522 . . . . 32.03 109.295 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.418 -1.048 . . . . 0.0 110.287 179.407 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 7.4 mtp . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.222 0.534 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt 52.96 94.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.27 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.2 -44.59 28.39 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 55.2 21.74 4.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.235 -1.156 . . . . 0.0 110.393 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -62.82 -179.22 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 110.14 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -73.66 -162.14 0.12 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 110.09 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.403 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 0.0 OUTLIER -89.46 163.47 33.32 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.232 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.519 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 43.4 Cg_endo -71.38 147.65 53.15 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.717 1.377 . . . . 0.0 110.483 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -19.5 62.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.36 -0.837 . . . . 0.0 110.577 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.522 ' CE1' ' HG3' ' A' ' 8' ' ' PRO . 87.2 t80 -69.01 -32.13 71.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.039 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.518 ' HB3' HD21 ' B' ' 19' ' ' LEU . 96.5 mt -91.94 19.12 6.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.448 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.66 -25.36 62.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 110.303 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.71 -16.16 45.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 110.412 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.742 ' HH2' HG21 ' A' ' 41' ' ' VAL . 15.1 m0 -72.88 145.65 86.86 Favored Pre-proline 0 C--N 1.304 -1.389 0 O-C-N 121.242 -0.911 . . . . 0.0 109.831 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' B' ' 18' ' ' VAL . 42.5 Cg_endo -73.45 166.66 29.3 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.258 1.136 . . . . 0.0 111.21 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -37.94 85.11 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 110.321 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -60.3 -34.72 74.17 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.907 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.609 ' O ' HG23 ' B' ' 22' ' ' VAL . 91.1 t -82.72 -45.22 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.86 -1.15 . . . . 0.0 110.591 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' B' ' 11' ' ' LEU . 61.1 mt -64.39 -27.28 68.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.031 -1.043 . . . . 0.0 110.763 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.27 -23.4 63.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 109.738 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.742 HD21 ' CD1' ' A' ' 45' ' ' PHE . 4.7 tp -89.34 -42.11 11.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.502 -0.748 . . . . 0.0 109.992 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.876 HG12 HG13 ' B' ' 33' ' ' VAL . 47.9 t -51.71 -46.1 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.804 . . . . 0.0 110.733 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -54.83 -58.44 7.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.333 -0.854 . . . . 0.0 110.849 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -54.14 -22.27 10.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.065 -1.022 . . . . 0.0 111.037 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.62 HG23 ' O ' ' B' ' 21' ' ' LEU . 59.7 t -82.93 -38.77 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.001 . . . . 0.0 110.873 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.87 -32.6 74.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.061 -1.024 . . . . 0.0 110.11 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.46 -10.07 58.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 110.383 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -88.64 -53.57 4.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.133 -0.98 . . . . 0.0 110.113 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.34 -32.47 73.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.142 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.75 30.82 4.14 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -133.53 -155.69 0.69 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -1.103 . . . . 0.0 110.208 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 6.6 m -107.03 175.41 5.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.409 -0.807 . . . . 0.0 109.658 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.876 HG13 HG12 ' B' ' 22' ' ' VAL . 85.9 t -76.1 -23.33 15.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 44.1 t30 -77.35 -28.34 52.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 108.844 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.91 -27.42 25.0 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.194 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.619 ' CD ' HG12 ' B' ' 25' ' ' VAL . 8.5 tp10 -71.94 -42.6 66.44 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.372 -0.83 . . . . 0.0 108.997 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.527 ' O ' HG23 ' B' ' 41' ' ' VAL . 24.7 mm -66.84 -30.89 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.42 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 32.6 t80 -63.8 -37.08 86.05 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.614 -0.679 . . . . 0.0 109.771 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -73.57 -44.39 57.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 109.687 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -60.64 -25.75 66.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.94 . . . . 0.0 109.243 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.739 HG21 ' HH2' ' A' ' 14' ' ' TRP . 63.5 t -88.16 -25.23 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.575 0.703 . . . . 0.0 109.688 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mtp -77.47 -25.17 50.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.494 -0.754 . . . . 0.0 110.387 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -83.42 -27.46 29.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.189 -0.944 . . . . 0.0 110.437 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 77.8 p -67.16 -48.7 67.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.415 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.75 ' CD1' HD21 ' A' ' 21' ' ' LEU . 21.9 m-85 -63.08 -22.6 66.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.128 -0.982 . . . . 0.0 110.286 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.79 -25.68 60.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.167 -0.958 . . . . 0.0 110.37 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -55.81 -24.09 34.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.317 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -108.04 -37.14 6.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.267 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.91 31.94 2.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.588 ' HG2' HD11 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -75.94 -47.68 24.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -1.126 . . . . 0.0 110.468 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 pt -101.02 146.66 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.593 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.06 -43.05 0.62 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.376 -1.073 . . . . 0.0 110.099 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.212 0.529 . . . . 50.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -128.28 52.38 1.9 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 50.0 110.22 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.59 99.86 2.45 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.461 -1.455 . . . . 50.0 109.461 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.5 ttm -136.55 151.14 49.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -1.138 . . . . 50.0 110.25 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 m -69.38 -179.39 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 50.0 109.984 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.22 53.37 1.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 50.0 110.569 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.52 126.45 7.43 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.151 -0.968 . . . . 43.64 109.494 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.541 ' HG2' HD12 ' A' ' 11' ' ' LEU . 45.7 Cg_endo -71.68 158.16 54.03 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 O-C-N 123.378 1.199 . . . . 29.79 110.671 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -82.1 -19.4 40.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.379 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.501 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 73.1 t80 -58.95 -23.84 61.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 12.57 110.448 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.693 ' HB3' HD21 ' A' ' 19' ' ' LEU . 42.7 mt -98.52 31.65 2.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.148 -0.97 . . . . 0.0 110.478 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.99 -30.99 67.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.224 -0.922 . . . . 0.0 110.224 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -81.01 -22.9 39.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 110.155 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.711 ' HH2' HG21 ' B' ' 41' ' ' VAL . 13.8 m0 -64.64 136.98 96.99 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.345 -0.847 . . . . 11.57 109.259 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HG2' HG23 ' A' ' 18' ' ' VAL . 39.0 Cg_endo -70.36 153.34 66.26 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.365 1.192 . . . . 13.83 111.054 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -41.62 73.29 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.664 0.745 . . . . 48.43 110.897 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.24 -41.05 75.09 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.548 -0.72 . . . . 46.64 111.507 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.514 HG23 ' HG2' ' A' ' 15' ' ' PRO . 85.5 t -76.42 -49.87 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.888 -1.132 . . . . 16.14 111.087 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.693 HD21 ' HB3' ' A' ' 11' ' ' LEU . 13.3 mt -53.7 -36.5 62.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 12.61 110.673 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -62.57 -38.03 88.51 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.436 -0.79 . . . . 23.17 109.864 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.854 ' O ' HG23 ' A' ' 25' ' ' VAL . 40.8 tp -69.42 -40.59 77.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.494 -0.754 . . . . 19.0 109.893 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.913 HG12 HG13 ' A' ' 33' ' ' VAL . 40.3 t -58.94 -48.26 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 18.87 110.512 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 10.9 mtm180 -53.67 -49.36 68.14 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 23.61 110.54 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -29.33 70.72 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 30.11 110.682 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 21' ' ' LEU . 48.1 t -77.03 -29.19 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 16.22 110.479 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.434 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -74.04 -46.0 46.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.169 -0.957 . . . . 26.6 109.215 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.95 -12.63 61.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.348 -0.845 . . . . 45.21 110.135 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -78.61 -58.73 3.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 37.85 110.001 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -66.06 -22.36 66.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 35.36 110.115 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.54 16.17 20.85 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.027 -1.229 . . . . 35.1 110.027 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -116.53 -162.84 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.132 -1.216 . . . . 32.72 110.387 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.434 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 67.7 m -102.81 -176.77 3.19 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.419 -0.8 . . . . 19.61 109.411 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.913 HG13 HG12 ' A' ' 22' ' ' VAL . 63.0 t -81.23 -16.65 12.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.222 -0.924 . . . . 17.56 110.281 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -77.84 -32.08 51.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.978 . . . . 21.3 108.752 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 t -79.71 -36.56 37.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.572 -0.705 . . . . 16.38 109.335 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.4 tp10 -64.78 -51.74 60.65 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 121.255 -0.903 . . . . 12.61 109.366 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 41' ' ' VAL . 37.9 mm -63.3 -32.93 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.784 . . . . 10.95 109.517 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -65.79 -33.76 76.61 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.429 -0.795 . . . . 18.87 110.226 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -47.38 42.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 36.88 109.536 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -60.87 -23.36 65.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.46 -0.775 . . . . 22.85 109.642 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.664 HG21 ' HH2' ' B' ' 14' ' ' TRP . 53.0 t -87.95 -28.24 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.518 -0.739 . . . . 13.02 109.554 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -20.36 52.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.539 -0.725 . . . . 18.84 110.272 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -78.92 -18.77 53.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 29.96 110.348 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.89 -46.89 16.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.073 -1.017 . . . . 18.65 110.215 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.81 ' CD1' HD21 ' B' ' 21' ' ' LEU . 37.9 m-85 -67.72 -12.01 59.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 16.26 110.734 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -75.35 -38.42 60.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.03 -1.044 . . . . 36.71 110.417 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -55.53 -52.63 63.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 41.6 110.174 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -62.55 1.36 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 24.83 110.308 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.94 34.9 0.71 Allowed Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.706 -1.235 . . . . 18.81 110.084 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -27.48 31.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.351 -1.088 . . . . 23.01 109.97 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.6 pt -112.72 166.95 6.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.079 -1.013 . . . . 27.08 109.968 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.38 38.71 0.11 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.633 -1.387 . . . . 32.03 109.633 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.135 -1.214 . . . . 0.0 110.217 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.308 0.575 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -128.29 52.46 1.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 110.307 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.79 99.64 2.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 7.4 ttm -136.21 151.3 49.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -1.196 . . . . 0.0 110.313 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.9 m -69.46 -179.19 1.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.943 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.36 53.28 1.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 110.563 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.51 126.41 7.42 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.129 -0.982 . . . . 0.0 109.495 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.549 ' HG2' HD12 ' B' ' 11' ' ' LEU . 45.1 Cg_endo -71.64 157.76 55.04 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.439 1.231 . . . . 0.0 110.638 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -81.83 -19.4 41.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.364 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.511 ' CE1' ' HG3' ' A' ' 8' ' ' PRO . 72.8 t80 -58.95 -23.85 61.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.143 -0.973 . . . . 0.0 110.454 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.682 ' HB3' HD21 ' B' ' 19' ' ' LEU . 42.3 mt -98.37 31.62 2.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -0.963 . . . . 0.0 110.489 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.06 -31.1 67.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 110.108 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -80.95 -22.89 39.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.22 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.664 ' HH2' HG21 ' A' ' 41' ' ' VAL . 13.8 m0 -64.71 136.51 96.8 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.394 -0.816 . . . . 0.0 109.306 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.512 ' HG2' HG23 ' B' ' 18' ' ' VAL . 39.5 Cg_endo -70.24 152.45 66.83 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.626 1.33 . . . . 0.0 111.368 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -42.13 69.75 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.631 0.729 . . . . 0.0 110.905 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.17 -40.91 74.65 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.614 -0.679 . . . . 0.0 111.29 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.512 HG23 ' HG2' ' B' ' 15' ' ' PRO . 85.5 t -76.59 -50.0 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.917 -1.114 . . . . 0.0 110.754 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.682 HD21 ' HB3' ' B' ' 11' ' ' LEU . 13.4 mt -53.67 -36.32 61.99 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 110.682 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -62.99 -37.77 88.48 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.298 -0.876 . . . . 0.0 109.973 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.841 ' O ' HG23 ' B' ' 25' ' ' VAL . 40.5 tp -69.63 -40.31 76.64 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.415 -0.803 . . . . 0.0 109.858 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.897 HG12 HG13 ' B' ' 33' ' ' VAL . 40.3 t -59.31 -48.07 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 110.467 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' B' ' 19' ' ' LEU . 11.0 mtm180 -53.7 -49.41 68.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.215 -0.928 . . . . 0.0 110.535 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -29.13 70.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.4 -0.812 . . . . 0.0 110.698 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.841 HG23 ' O ' ' B' ' 21' ' ' LEU . 48.4 t -77.08 -29.25 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.501 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.436 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -74.04 -46.06 45.7 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 109.196 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.97 -12.58 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 110.152 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.41 -59.0 2.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 0.0 109.97 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -65.88 -22.33 66.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.059 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.48 16.26 20.74 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -116.65 -162.64 0.86 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.012 -1.287 . . . . 0.0 110.405 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.436 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 69.2 m -102.95 -176.76 3.18 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.352 -0.843 . . . . 0.0 109.375 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.897 HG13 HG12 ' B' ' 22' ' ' VAL . 62.2 t -81.2 -16.64 12.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 110.407 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -77.84 -32.14 51.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.067 -1.021 . . . . 0.0 108.695 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 41.0 t -79.67 -36.39 37.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.585 -0.697 . . . . 0.0 109.294 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.498 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.4 tp10 -65.0 -51.64 60.55 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.381 -0.824 . . . . 0.0 109.295 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.558 ' O ' HG23 ' B' ' 41' ' ' VAL . 37.3 mm -63.39 -32.59 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.576 -0.703 . . . . 0.0 109.428 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.434 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 26.5 t80 -65.97 -33.82 76.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.442 -0.787 . . . . 0.0 110.308 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.35 -47.1 45.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.52 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 70.4 mtt-85 -61.17 -23.42 65.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 0.0 109.639 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.711 HG21 ' HH2' ' A' ' 14' ' ' TRP . 56.4 t -88.08 -28.3 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.749 . . . . 0.0 109.502 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.93 -20.14 53.35 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.566 -0.708 . . . . 0.0 110.161 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.17 -18.73 52.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.082 -1.011 . . . . 0.0 110.36 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.82 -47.27 15.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.046 -1.034 . . . . 0.0 110.097 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.77 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.5 m-85 -67.42 -11.96 59.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 110.799 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -75.59 -38.19 59.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 110.389 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -55.64 -52.77 62.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.129 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.82 -62.49 1.39 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.215 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.86 35.12 0.7 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.402 ' HB3' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -82.58 -27.93 31.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -1.2 . . . . 0.0 109.97 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.65 166.89 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.954 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.94 38.58 0.11 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.285 -1.126 . . . . 0.0 110.164 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.154 0.502 . . . . 50.0 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -171.69 71.81 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 50.0 110.239 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.26 178.38 40.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.513 -1.435 . . . . 50.0 109.513 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.2 mtm -100.64 27.14 6.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -1.102 . . . . 50.0 110.22 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m 53.19 179.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.91 . . . . 50.0 110.333 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -107.94 172.08 7.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 50.0 110.359 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mtt 57.87 162.26 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.384 -0.823 . . . . 43.64 110.906 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 48.3 Cg_endo -76.55 164.79 30.03 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.852 1.448 . . . . 29.79 110.343 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -74.98 -13.7 60.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.265 -0.897 . . . . 0.0 110.394 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.526 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 90.8 t80 -81.16 -29.15 34.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 12.57 110.46 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 11' ' ' LEU . 57.0 mt -92.69 14.68 16.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.784 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.94 -24.56 64.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.097 -1.002 . . . . 0.0 109.816 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.96 -21.89 43.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.314 -0.866 . . . . 0.0 110.163 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.576 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 15.0 m0 -73.54 143.59 82.5 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.453 -0.779 . . . . 11.57 109.67 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' CD ' ' OH ' ' B' ' 38' ' ' TYR . 42.3 Cg_endo -71.11 176.44 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.562 1.296 . . . . 13.83 110.726 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -24.29 37.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.402 -0.811 . . . . 48.43 109.372 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HG3' HG23 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -68.6 -20.15 64.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 46.64 110.463 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.664 ' O ' HG23 ' A' ' 22' ' ' VAL . 76.3 t -99.82 -46.3 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 16.14 109.961 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.13 -25.91 68.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.339 -0.851 . . . . 12.61 110.806 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -74.02 -31.74 63.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.299 -0.876 . . . . 23.17 110.068 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.737 ' O ' HG23 ' A' ' 25' ' ' VAL . 7.4 tp -79.82 -47.39 15.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 19.0 109.971 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.955 HG12 HG13 ' A' ' 33' ' ' VAL . 27.9 t -51.68 -45.93 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 18.87 109.918 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.509 ' HA ' HG22 ' A' ' 33' ' ' VAL . 3.0 ttm180 -51.44 -63.02 1.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.682 -0.636 . . . . 23.61 110.695 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -52.75 -33.88 50.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.283 -0.885 . . . . 30.11 110.969 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 21' ' ' LEU . 61.9 t -66.93 -36.48 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 16.22 110.523 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -67.02 -44.91 79.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 26.6 109.896 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -71.69 -14.7 62.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 45.21 110.359 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.79 -59.99 2.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.084 -1.01 . . . . 37.85 110.114 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -65.8 -22.03 66.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 35.36 110.358 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.39 16.69 24.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.85 -1.3 . . . . 35.1 109.85 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -114.15 -156.53 0.6 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.085 -1.244 . . . . 32.72 110.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.418 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 1.3 m -111.21 171.11 7.67 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.332 -0.855 . . . . 19.61 109.652 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.955 HG13 HG12 ' A' ' 22' ' ' VAL . 48.5 t -70.59 -18.89 21.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.204 -0.935 . . . . 17.56 110.451 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.78 -35.04 39.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.133 -0.98 . . . . 21.3 109.3 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.6 m -76.48 -33.54 58.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.403 -0.811 . . . . 16.38 109.543 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.627 ' CG ' HG12 ' A' ' 25' ' ' VAL . 2.9 tp10 -63.37 -51.94 63.8 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.348 -0.845 . . . . 12.61 109.245 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.553 HD11 HG11 ' A' ' 22' ' ' VAL . 4.9 mt -68.4 -21.34 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.465 -0.772 . . . . 10.95 109.62 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.405 ' OH ' ' CD ' ' B' ' 15' ' ' PRO . 32.0 t80 -75.4 -29.54 59.83 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.267 -0.896 . . . . 18.87 109.716 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.01 -45.36 18.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.498 -0.751 . . . . 36.88 109.744 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt-85 -60.7 -45.06 95.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.345 -0.847 . . . . 22.85 109.159 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.609 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 61.2 t -68.93 -24.2 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.625 -0.672 . . . . 13.02 109.997 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -65.21 0.79 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.422 -0.799 . . . . 18.84 110.908 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -54.73 -31.75 58.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.332 -0.855 . . . . 29.96 111.037 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.15 -56.63 10.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.95 -1.094 . . . . 18.65 110.679 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.575 ' CD1' HD21 ' B' ' 21' ' ' LEU . 27.4 m-85 -61.99 -39.12 91.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 16.26 110.817 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -58.47 -18.75 31.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.127 -0.983 . . . . 36.71 110.871 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -82.61 -47.28 12.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.033 -1.042 . . . . 41.6 110.602 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -58.57 -45.08 89.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.182 -0.949 . . . . 24.83 110.244 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.28 10.34 6.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.093 -1.203 . . . . 18.81 110.093 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HB3' HD11 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -73.15 -52.28 14.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.304 . . . . 23.01 110.117 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.7 pt -104.93 -167.9 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.638 -0.825 . . . . 27.08 109.868 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.22 65.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.697 -1.361 . . . . 32.03 109.697 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.44 -1.036 . . . . 0.0 109.973 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.139 0.495 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -171.53 72.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.268 -0.895 . . . . 0.0 110.156 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.12 178.28 40.39 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mtm -100.6 27.24 5.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -1.124 . . . . 0.0 110.223 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m 53.05 179.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.16 -0.962 . . . . 0.0 110.232 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -107.92 172.27 6.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.345 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mtt 57.69 162.52 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.468 -0.77 . . . . 0.0 110.789 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.526 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 48.5 Cg_endo -76.84 164.62 29.76 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.792 1.417 . . . . 0.0 110.318 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -74.89 -13.84 60.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.429 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.519 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 90.6 t80 -81.13 -28.79 34.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 110.47 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' B' ' 11' ' ' LEU . 55.8 mt -93.09 15.0 16.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.709 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.38 -24.19 63.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.919 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -22.2 42.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 110.114 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.609 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 14.9 m0 -73.27 143.71 83.49 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.493 -0.754 . . . . 0.0 109.723 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.405 ' CD ' ' OH ' ' A' ' 38' ' ' TYR . 42.6 Cg_endo -71.23 176.39 7.94 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.56 1.295 . . . . 0.0 110.827 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -24.44 37.1 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.562 -0.711 . . . . 0.0 109.443 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.427 ' HG3' HG23 ' B' ' 18' ' ' VAL . 1.0 OUTLIER -68.21 -20.89 64.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 110.712 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.652 ' O ' HG23 ' B' ' 22' ' ' VAL . 76.9 t -98.98 -47.05 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.139 -0.976 . . . . 0.0 109.883 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.51 -26.08 67.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.138 -0.976 . . . . 0.0 110.863 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.01 -31.45 62.94 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.727 ' O ' HG23 ' B' ' 25' ' ' VAL . 7.7 tp -79.88 -48.02 14.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.467 -0.771 . . . . 0.0 109.942 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.974 HG12 HG13 ' B' ' 33' ' ' VAL . 27.5 t -51.16 -45.57 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 109.938 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.501 ' HA ' HG22 ' B' ' 33' ' ' VAL . 3.0 ttm180 -52.12 -62.6 1.53 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.552 -0.717 . . . . 0.0 110.651 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -52.93 -33.82 52.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.931 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.727 HG23 ' O ' ' B' ' 21' ' ' LEU . 61.2 t -67.13 -36.03 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.084 -1.01 . . . . 0.0 110.577 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.429 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -67.55 -44.64 77.79 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.872 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -71.66 -15.05 62.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.963 . . . . 0.0 110.393 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.53 -60.2 2.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.044 . . . . 0.0 110.016 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -65.72 -21.93 66.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.266 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.33 16.68 24.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -114.39 -156.88 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.276 . . . . 0.0 110.196 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.429 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 1.3 m -110.73 171.04 7.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.565 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.974 HG13 HG12 ' B' ' 22' ' ' VAL . 49.3 t -70.23 -19.82 22.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.245 -0.91 . . . . 0.0 110.365 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 -35.61 43.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 64.5 m -75.84 -33.85 60.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.631 ' CG ' HG12 ' B' ' 25' ' ' VAL . 2.8 tp10 -63.26 -51.59 65.55 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.342 -0.849 . . . . 0.0 109.351 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.56 HD11 HG11 ' B' ' 22' ' ' VAL . 4.9 mt -68.74 -21.6 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.613 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.41 ' OH ' ' CD ' ' A' ' 15' ' ' PRO . 33.4 t80 -75.18 -29.25 60.34 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.22 -0.925 . . . . 0.0 109.775 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -45.54 17.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.671 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -60.53 -44.94 95.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.118 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.576 HG11 ' CZ3' ' A' ' 14' ' ' TRP . 58.0 t -68.88 -24.4 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.647 -0.658 . . . . 0.0 109.958 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -65.15 0.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.379 -0.826 . . . . 0.0 110.83 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -54.66 -31.73 58.09 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.247 -0.908 . . . . 0.0 111.001 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.34 -56.61 10.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.064 -1.023 . . . . 0.0 110.89 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.568 ' CD1' HD21 ' A' ' 21' ' ' LEU . 29.0 m-85 -62.05 -38.65 89.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 110.792 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -58.5 -19.02 33.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.183 -0.948 . . . . 0.0 110.978 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -82.58 -47.59 11.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.121 -0.987 . . . . 0.0 110.54 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -58.13 -45.25 87.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.171 -0.956 . . . . 0.0 110.307 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.32 10.63 6.01 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.557 ' HB3' HD11 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -73.34 -52.55 13.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.959 -1.318 . . . . 0.0 109.896 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 pt -104.63 -168.27 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.929 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.33 66.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.264 -1.139 . . . . 0.0 110.131 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.8 mtp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.143 0.497 . . . . 50.0 110.285 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -114.61 -31.55 6.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.26 -0.9 . . . . 50.0 110.038 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.07 -97.54 0.12 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.398 -1.481 . . . . 50.0 109.398 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.32 30.02 7.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.185 -1.185 . . . . 50.0 110.363 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 m -132.35 166.61 21.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 50.0 110.118 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -156.65 69.52 0.61 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 50.0 110.243 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.424 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 13.1 ptp -140.05 164.26 38.73 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 43.64 109.922 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 41.4 Cg_endo -68.79 151.56 74.27 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.553 1.291 . . . . 29.79 110.557 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -66.05 -20.32 66.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.246 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.502 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 91.2 t80 -68.38 -20.99 64.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 12.57 110.394 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.547 ' HB3' HD21 ' A' ' 19' ' ' LEU . 89.0 mt -100.54 20.91 14.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.596 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.19 -26.9 62.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -83.18 -23.51 32.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.107 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.618 ' CH2' HG11 ' B' ' 41' ' ' VAL . 14.0 m0 -67.09 139.55 95.36 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.363 -0.836 . . . . 11.57 109.384 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HG2' HG23 ' A' ' 18' ' ' VAL . 42.0 Cg_endo -70.21 168.76 21.21 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.528 1.278 . . . . 13.83 110.904 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.21 -20.47 55.28 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.513 -0.742 . . . . 48.43 109.433 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -72.84 -28.63 62.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 46.64 109.758 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.1 t -87.33 -45.15 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 16.14 109.865 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 11' ' ' LEU . 55.1 mt -63.26 -30.48 71.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -0.857 . . . . 12.61 110.593 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -66.01 -25.88 67.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -0.962 . . . . 23.17 109.605 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.728 ' O ' HG23 ' A' ' 25' ' ' VAL . 15.1 tp -86.78 -44.83 11.46 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.446 -0.784 . . . . 19.0 109.745 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.743 HG12 HG13 ' A' ' 33' ' ' VAL . 44.4 t -52.83 -43.14 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.263 -0.898 . . . . 18.87 109.778 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -51.01 -61.69 2.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.562 -0.711 . . . . 23.61 110.594 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -54.35 -24.9 21.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.577 -0.702 . . . . 30.11 110.901 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 21' ' ' LEU . 38.4 t -80.48 -30.72 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.168 -0.957 . . . . 16.22 110.783 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.406 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -78.01 -27.72 49.01 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.11 -0.994 . . . . 26.6 110.0 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.38 -15.31 33.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 45.21 110.713 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 19.8 pt-20 -90.73 -33.13 15.88 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.882 -1.136 . . . . 37.85 110.436 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 9.7 m-80 -79.48 -26.88 41.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.889 . . . . 35.36 110.159 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.84 23.72 8.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.538 -1.425 . . . . 35.1 109.538 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -131.73 -158.97 0.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.21 -1.171 . . . . 32.72 109.93 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.406 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -109.4 -178.61 3.6 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.525 -0.734 . . . . 19.61 109.086 179.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.743 HG13 HG12 ' A' ' 22' ' ' VAL . 97.8 t -76.79 -19.18 14.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.184 -0.947 . . . . 17.56 110.29 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 42.2 t30 -74.66 -30.65 61.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 21.3 108.747 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -37.85 23.61 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.501 -0.749 . . . . 16.38 109.214 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HG3' HG12 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -59.78 -51.55 69.26 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.322 -0.861 . . . . 12.61 109.574 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.533 HG23 HG21 ' B' ' 41' ' ' VAL . 38.6 mm -62.95 -28.01 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.325 -0.859 . . . . 10.95 109.2 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 42' ' ' MET . 37.5 t80 -74.17 -24.83 59.44 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.395 -0.816 . . . . 18.87 110.175 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -50.91 9.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.45 -0.781 . . . . 36.88 109.833 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 36' ' ' GLU . 2.9 mpt_? -60.74 -28.82 68.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.816 . . . . 22.85 109.255 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 65.4 t -84.35 -22.43 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.622 -0.674 . . . . 13.02 109.676 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -74.31 -51.23 15.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 18.84 111.101 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -69.52 -23.79 63.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.257 -0.902 . . . . 29.96 111.473 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.5 p -57.31 -52.61 64.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.014 -1.054 . . . . 18.65 110.282 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.676 ' CD1' HD21 ' B' ' 21' ' ' LEU . 36.9 m-85 -63.12 -40.1 96.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.102 -0.999 . . . . 16.26 110.311 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -57.29 -21.81 37.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.318 -0.864 . . . . 36.71 110.599 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -74.11 -61.82 1.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.993 -1.067 . . . . 41.6 110.251 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -56.04 -30.0 61.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 24.83 110.258 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.68 31.96 4.97 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.901 -1.28 . . . . 18.81 109.901 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -85.35 -45.25 12.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -1.128 . . . . 23.01 110.115 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.0 pt -108.09 167.59 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.836 -0.746 . . . . 27.08 110.299 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.54 -50.05 0.54 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.477 -1.449 . . . . 32.03 109.477 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.254 -1.144 . . . . 0.0 110.262 -179.613 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 42.3 mtp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.279 0.562 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -114.67 -31.49 6.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 110.121 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.98 -97.29 0.12 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.96 30.3 7.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.114 . . . . 0.0 110.494 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.5 m -132.5 166.58 21.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.489 -0.757 . . . . 0.0 109.855 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -156.58 69.52 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.432 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 13.2 ptp -139.95 164.09 40.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.843 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.502 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 42.6 Cg_endo -68.68 151.79 74.63 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.538 1.283 . . . . 0.0 110.518 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.01 -20.72 66.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.883 . . . . 0.0 110.211 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.517 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 91.9 t80 -67.93 -21.24 65.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 0.0 110.458 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.527 ' HB3' HD21 ' B' ' 19' ' ' LEU . 88.1 mt -100.35 20.82 14.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 110.611 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -26.72 62.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 109.979 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' B' ' 13' ' ' ARG . 0.0 OUTLIER -83.34 -23.3 32.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 110.103 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.496 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.8 m0 -67.42 139.56 94.53 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.384 -0.823 . . . . 0.0 109.355 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.525 ' HG2' HG23 ' B' ' 18' ' ' VAL . 41.0 Cg_endo -70.3 168.84 21.11 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.412 1.217 . . . . 0.0 110.543 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.27 -20.51 54.99 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.578 -0.701 . . . . 0.0 109.307 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -72.73 -28.8 62.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.164 -0.96 . . . . 0.0 109.448 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.6 ' O ' HG23 ' B' ' 22' ' ' VAL . 74.6 t -87.45 -45.18 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 109.637 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' B' ' 11' ' ' LEU . 54.0 mt -63.28 -30.1 71.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 110.581 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -66.32 -26.19 67.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.116 -0.99 . . . . 0.0 109.429 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.733 ' O ' HG23 ' B' ' 25' ' ' VAL . 15.4 tp -86.57 -44.54 11.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.221 0.534 . . . . 0.0 109.61 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.724 HG12 HG13 ' B' ' 33' ' ' VAL . 44.1 t -53.37 -43.25 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.815 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -50.78 -61.39 2.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.554 -0.716 . . . . 0.0 110.675 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -54.59 -24.75 22.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.749 . . . . 0.0 111.01 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.733 HG23 ' O ' ' B' ' 21' ' ' LEU . 38.2 t -80.61 -30.91 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.092 -1.005 . . . . 0.0 110.667 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.408 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -77.84 -27.75 49.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.097 -1.002 . . . . 0.0 109.955 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -89.37 -15.16 33.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 110.733 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' B' ' 25' ' ' VAL . 19.7 pt-20 -90.84 -33.11 15.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.006 -1.059 . . . . 0.0 110.49 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.435 ' N ' ' HG3' ' B' ' 28' ' ' GLU . 9.5 m-80 -79.54 -26.7 41.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.72 23.98 8.0 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -132.09 -159.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.203 -1.175 . . . . 0.0 109.836 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.408 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 0.4 OUTLIER -109.36 -178.81 3.66 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.459 -0.776 . . . . 0.0 109.187 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.724 HG13 HG12 ' B' ' 22' ' ' VAL . 97.4 t -76.4 -19.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 110.191 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 41.7 t30 -74.66 -29.99 61.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 108.825 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.52 -38.35 21.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.562 -0.711 . . . . 0.0 109.115 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.54 ' HG3' HG12 ' B' ' 25' ' ' VAL . 0.5 OUTLIER -58.97 -51.76 68.67 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.315 -0.865 . . . . 0.0 109.648 179.017 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.463 ' O ' HG23 ' B' ' 41' ' ' VAL . 39.1 mm -63.0 -27.6 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.457 -0.777 . . . . 0.0 109.235 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 36.3 t80 -74.62 -24.96 58.93 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.38 -0.825 . . . . 0.0 110.103 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -50.63 10.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.875 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' B' ' 36' ' ' GLU . 2.9 mpt_? -61.11 -28.72 69.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.372 -0.83 . . . . 0.0 109.246 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.618 HG11 ' CH2' ' A' ' 14' ' ' TRP . 62.5 t -84.45 -21.91 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.516 0.674 . . . . 0.0 109.873 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' B' ' 38' ' ' TYR . 0.0 OUTLIER -74.66 -51.21 15.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 111.088 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -69.4 -24.28 63.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.166 -0.959 . . . . 0.0 111.42 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 56.3 p -56.9 -52.73 64.02 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.92 -1.113 . . . . 0.0 110.199 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.646 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.6 m-85 -62.98 -40.48 97.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 110.382 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -57.0 -21.7 32.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 110.645 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -74.02 -61.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.978 . . . . 0.0 110.441 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.32 -29.89 61.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 110.243 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.68 32.18 4.89 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -85.59 -45.01 12.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.061 -1.258 . . . . 0.0 110.094 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.474 ' CG2' HD22 ' A' ' 21' ' ' LEU . 13.0 pt -108.22 167.47 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.239 -0.913 . . . . 0.0 110.348 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.72 -50.06 0.53 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.161 -1.2 . . . . 0.0 110.226 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 tpt . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.186 0.517 . . . . 50.0 110.168 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -172.53 131.02 0.56 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.37 -0.831 . . . . 50.0 110.113 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.78 38.07 12.41 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.443 -1.463 . . . . 50.0 109.443 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.28 -157.96 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -1.144 . . . . 50.0 110.128 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 m -89.01 -173.2 3.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 50.0 110.341 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.69 -163.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.255 -0.903 . . . . 50.0 110.495 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.5 mtt -56.38 141.56 70.63 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.353 -0.842 . . . . 43.64 110.242 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HG2' HD12 ' A' ' 11' ' ' LEU . 50.8 Cg_endo -77.05 157.93 34.17 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.508 1.267 . . . . 29.79 110.551 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.01 0.38 35.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.409 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.42 ' CB ' ' HB3' ' B' ' 10' ' ' PHE . 75.1 t80 -88.67 -23.59 22.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.994 -1.066 . . . . 12.57 109.881 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.703 HD12 ' HG2' ' A' ' 8' ' ' PRO . 54.7 mt -99.6 28.18 4.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 110.312 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.48 -22.12 57.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.168 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.08 -10.28 45.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.61 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.504 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.9 m0 -75.61 142.43 73.98 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.092 -1.005 . . . . 11.57 109.874 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HG2' HG23 ' A' ' 18' ' ' VAL . 43.4 Cg_endo -72.1 176.25 8.72 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.568 1.299 . . . . 13.83 110.744 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.0 -23.31 38.76 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.381 -0.824 . . . . 48.43 109.437 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -70.26 -27.45 64.44 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.248 -0.907 . . . . 46.64 109.885 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 22' ' ' VAL . 81.2 t -93.2 -43.82 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -0.858 . . . . 16.14 110.086 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.661 HD21 ' HB3' ' A' ' 11' ' ' LEU . 40.1 mt -63.74 -31.86 73.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 12.61 110.531 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -66.94 -31.21 71.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 23.17 109.92 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.822 ' O ' HG23 ' A' ' 25' ' ' VAL . 52.6 tp -79.88 -40.21 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.841 . . . . 19.0 110.111 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.058 HG12 HG13 ' A' ' 33' ' ' VAL . 39.7 t -54.43 -50.13 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.905 . . . . 18.87 110.139 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -58.33 -49.32 77.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.763 . . . . 23.61 110.437 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -18.57 63.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 30.11 110.635 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 21' ' ' LEU . 90.6 t -88.94 -29.21 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 16.22 110.44 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.02 -26.98 36.0 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.168 -0.958 . . . . 26.6 109.818 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -89.51 -15.87 32.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.405 -0.81 . . . . 45.21 110.688 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 18.6 pt-20 -90.69 -28.18 18.51 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.983 -1.073 . . . . 37.85 110.396 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -90.92 -18.72 24.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 35.36 110.392 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.9 23.66 22.35 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.484 -1.446 . . . . 35.1 109.484 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -121.17 -164.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.119 . . . . 32.72 110.211 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.0 m -106.61 168.58 9.07 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.819 -0.808 . . . . 19.61 108.819 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.058 HG13 HG12 ' A' ' 22' ' ' VAL . 92.2 t -73.82 -23.21 18.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.05 -1.031 . . . . 17.56 110.086 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -75.22 -28.93 60.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 21.3 108.896 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.1 m -85.42 -27.84 25.49 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.484 -0.76 . . . . 16.38 109.589 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.736 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.6 tp10 -70.96 -38.47 72.82 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.249 -0.907 . . . . 12.61 109.171 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.576 ' O ' HG23 ' A' ' 41' ' ' VAL . 17.5 mm -80.13 -25.16 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.564 -0.71 . . . . 10.95 109.345 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.43 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 22.3 t80 -72.99 -38.26 66.72 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.265 -0.897 . . . . 18.87 110.218 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -42.7 65.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.192 -0.943 . . . . 36.88 109.911 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -64.65 -27.08 68.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 22.85 109.304 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 37' ' ' ILE . 42.8 t -82.65 -26.97 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.627 0.727 . . . . 13.02 109.329 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -40.44 65.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.668 -0.645 . . . . 18.84 110.736 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.89 -20.99 61.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 29.96 110.599 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 t -64.94 -53.13 51.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.139 -0.976 . . . . 18.65 110.433 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.577 ' CE1' HG21 ' B' ' 25' ' ' VAL . 31.5 m-85 -62.58 -27.27 69.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 16.26 110.775 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -67.32 -30.77 70.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 36.71 110.637 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -53.75 -29.87 41.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.182 -0.948 . . . . 41.6 110.477 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -105.51 -14.44 15.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 24.83 110.656 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.89 48.52 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.342 -1.503 . . . . 18.81 109.342 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -57.92 -42.97 85.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.115 -1.227 . . . . 23.01 110.055 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 22.8 pt -91.34 169.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.448 -0.782 . . . . 27.08 109.99 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.61 66.63 0.54 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.558 -1.417 . . . . 32.03 109.558 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.193 -1.181 . . . . 0.0 110.179 179.88 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 11.7 tpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.274 0.559 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -172.67 130.95 0.54 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.22 -0.925 . . . . 0.0 110.139 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.69 38.23 12.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.17 -158.16 0.18 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -1.071 . . . . 0.0 110.328 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.8 m -88.72 -173.1 3.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 0.0 110.374 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -162.92 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.322 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 9.3 mtt -56.75 141.45 73.92 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.302 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.734 ' HG2' HD12 ' B' ' 11' ' ' LEU . 50.2 Cg_endo -76.87 157.39 34.93 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.612 1.322 . . . . 0.0 110.627 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.49 0.63 32.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 110.576 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 74.7 t80 -88.83 -23.85 22.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.07 -1.019 . . . . 0.0 109.826 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.734 HD12 ' HG2' ' B' ' 8' ' ' PRO . 54.7 mt -99.36 28.18 4.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.328 -0.858 . . . . 0.0 110.219 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.47 -21.89 57.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.918 . . . . 0.0 110.219 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -10.32 44.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.18 -0.95 . . . . 0.0 110.5 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.483 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.8 m0 -75.79 142.28 73.15 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.133 -0.979 . . . . 0.0 109.858 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.479 ' HG2' HG23 ' B' ' 18' ' ' VAL . 43.3 Cg_endo -72.04 176.25 8.69 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.24 1.126 . . . . 0.0 110.721 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.04 -23.47 38.56 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 109.446 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.94 -27.44 64.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.129 -0.982 . . . . 0.0 110.071 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.717 ' O ' HG23 ' B' ' 22' ' ' VAL . 90.1 t -93.38 -44.07 13.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.989 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' B' ' 11' ' ' LEU . 41.0 mt -63.31 -31.87 73.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.542 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -67.16 -30.96 71.07 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.16 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.807 ' O ' HG23 ' B' ' 25' ' ' VAL . 53.5 tp -79.85 -40.2 28.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.411 -0.805 . . . . 0.0 110.163 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 1.061 HG12 HG13 ' B' ' 33' ' ' VAL . 40.2 t -54.51 -50.2 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.857 . . . . 0.0 109.952 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -58.26 -49.75 76.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.432 -0.793 . . . . 0.0 110.268 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -18.91 63.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 110.775 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.807 HG23 ' O ' ' B' ' 21' ' ' LEU . 92.2 t -88.66 -28.83 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.083 -1.011 . . . . 0.0 110.542 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.5 -26.4 35.18 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.87 -15.99 31.0 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.435 -0.791 . . . . 0.0 110.555 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.461 ' HG2' ' HA ' ' B' ' 25' ' ' VAL . 18.3 pt-20 -90.68 -27.97 18.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.36 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -91.19 -18.64 24.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 0.0 110.471 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.85 23.61 22.61 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -121.2 -164.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -1.141 . . . . 0.0 110.217 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -106.35 168.4 9.18 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 1.061 HG13 HG12 ' B' ' 22' ' ' VAL . 92.1 t -73.65 -23.25 19.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.018 -1.051 . . . . 0.0 110.157 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -75.27 -28.64 59.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 108.925 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -85.59 -27.85 25.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.54 -0.725 . . . . 0.0 109.518 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.724 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.6 tp10 -70.9 -38.32 73.02 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.262 -0.899 . . . . 0.0 109.366 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.579 ' O ' HG23 ' B' ' 41' ' ' VAL . 17.6 mm -80.19 -25.19 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.384 -0.823 . . . . 0.0 109.297 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.425 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 22.6 t80 -73.01 -38.02 66.75 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.8 -42.34 64.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -64.94 -26.9 68.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 37' ' ' ILE . 42.7 t -82.83 -26.92 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.464 -0.772 . . . . 0.0 109.154 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -39.95 65.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.639 -0.663 . . . . 0.0 110.785 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.26 -21.03 61.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.162 -0.961 . . . . 0.0 110.538 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -64.71 -53.28 49.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.435 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.566 ' CE1' HG21 ' A' ' 25' ' ' VAL . 31.3 m-85 -62.66 -27.23 69.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.142 -0.973 . . . . 0.0 110.816 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -67.23 -30.76 70.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.066 -1.021 . . . . 0.0 110.639 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -53.87 -29.66 42.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.162 -0.961 . . . . 0.0 110.49 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -105.61 -14.45 15.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 110.654 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.8 20.78 49.44 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -57.88 -43.08 85.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.19 -1.182 . . . . 0.0 109.941 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 23.4 pt -91.22 169.34 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 110.03 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.14 66.87 0.54 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.236 -1.155 . . . . 0.0 110.184 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.249 0.547 . . . . 50.0 110.218 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -101.87 35.9 2.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 50.0 110.214 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.76 119.3 0.87 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.693 -1.363 . . . . 50.0 109.693 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -114.86 171.09 7.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 50.0 109.795 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -159.39 152.13 21.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.188 -0.945 . . . . 50.0 110.486 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -154.39 -176.22 5.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.341 -0.849 . . . . 50.0 110.12 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.22 163.08 55.34 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 43.64 110.341 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HG3' ' CE1' ' B' ' 10' ' ' PHE . 46.2 Cg_endo -72.88 157.61 51.28 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.635 1.334 . . . . 29.79 110.347 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -75.98 -10.54 59.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.304 -0.873 . . . . 0.0 110.705 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' B' ' 10' ' ' PHE . 79.1 t80 -74.78 -27.63 60.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.063 -1.023 . . . . 12.57 110.331 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB3' HD21 ' A' ' 19' ' ' LEU . 41.0 mt -96.17 23.43 6.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 110.203 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.2 -18.26 61.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.675 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -97.24 1.22 49.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.947 . . . . 0.0 110.85 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.436 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.4 m0 -82.32 153.81 68.9 Favored Pre-proline 0 N--CA 1.485 1.313 0 O-C-N 121.076 -1.015 . . . . 11.57 109.796 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HG2' ' CG2' ' A' ' 18' ' ' VAL . 42.0 Cg_endo -70.61 162.5 42.27 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.535 1.281 . . . . 13.83 111.379 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -40.76 97.6 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.615 0.721 . . . . 48.43 110.67 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -53.78 53.25 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.815 -0.553 . . . . 46.64 111.086 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 22' ' ' VAL . 85.7 t -60.96 -44.59 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.099 -1.0 . . . . 16.14 110.737 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 11' ' ' LEU . 70.7 mt -62.57 -30.66 71.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.218 -0.926 . . . . 12.61 110.779 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -72.64 -23.13 60.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.987 . . . . 23.17 110.264 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.2 tp -87.3 -37.46 17.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.32 -0.862 . . . . 19.0 110.21 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.941 HG12 HG13 ' A' ' 33' ' ' VAL . 27.3 t -57.15 -45.23 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 18.87 110.267 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.459 ' HG3' ' N ' ' A' ' 24' ' ' LYS . 8.8 ptp180 -65.56 -29.87 70.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -0.906 . . . . 23.61 110.681 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -83.58 -10.46 58.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.043 -1.036 . . . . 30.11 110.563 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 21' ' ' LEU . 71.5 t -100.15 -28.0 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 16.22 110.453 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.06 -30.55 58.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 26.6 109.742 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.92 -12.17 58.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.2 -0.938 . . . . 45.21 110.387 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -87.23 -54.13 4.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.068 -1.02 . . . . 37.85 110.536 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -61.01 -22.44 64.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.128 -0.982 . . . . 35.36 110.561 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.2 36.99 4.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.529 -1.428 . . . . 35.1 109.529 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -141.5 -154.89 0.54 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.378 -1.072 . . . . 32.72 110.104 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 p -113.43 171.67 7.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.52 -0.738 . . . . 19.61 109.253 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.941 HG13 HG12 ' A' ' 22' ' ' VAL . 71.4 t -72.64 -23.04 20.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.097 -1.002 . . . . 17.56 110.412 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -70.08 -29.88 66.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.998 . . . . 21.3 109.021 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.71 -29.33 21.17 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.454 -0.778 . . . . 16.38 109.432 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' HG3' HG12 ' A' ' 25' ' ' VAL . 4.2 tt0 -64.36 -59.43 4.38 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.306 -0.871 . . . . 12.61 109.349 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.65 HG23 HG21 ' B' ' 41' ' ' VAL . 24.9 mm -60.31 -22.56 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.369 -0.832 . . . . 10.95 109.284 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -73.62 -33.25 64.48 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.367 -0.833 . . . . 18.87 110.065 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.75 -46.36 21.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 36.88 109.817 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 mtt-85 -61.31 -25.94 67.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.445 -0.784 . . . . 22.85 109.601 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.638 HG21 HG23 ' B' ' 37' ' ' ILE . 53.9 t -88.66 -29.81 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.506 -0.747 . . . . 13.02 109.999 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.0 -67.48 0.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 18.84 110.54 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -55.82 -20.68 16.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.975 . . . . 29.96 110.479 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.0 t -60.35 -53.66 54.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 18.65 109.998 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.537 ' CG ' ' CD2' ' B' ' 21' ' ' LEU . 17.0 m-85 -60.52 -30.46 69.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.352 -0.843 . . . . 16.26 110.129 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.15 -30.49 68.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 36.71 110.579 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -29.61 69.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.145 -0.972 . . . . 41.6 110.473 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -95.12 -17.89 21.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.922 . . . . 24.83 110.558 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.1 17.49 61.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.785 -1.326 . . . . 18.81 109.785 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.591 ' HG3' HD11 ' B' ' 21' ' ' LEU . 8.8 tpp180 -59.48 -33.41 71.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.032 -1.276 . . . . 23.01 110.152 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.1 mt -90.83 -63.51 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.349 -0.844 . . . . 27.08 110.1 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.32 -38.24 2.05 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.426 -1.47 . . . . 32.03 109.426 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.119 -1.224 . . . . 0.0 110.357 179.795 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.187 0.518 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -101.75 35.89 2.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.416 -0.802 . . . . 0.0 110.333 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.8 119.2 0.86 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -114.77 170.97 7.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -1.128 . . . . 0.0 109.916 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -159.23 152.34 22.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.125 -0.985 . . . . 0.0 110.443 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -154.6 -176.21 5.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.207 -0.933 . . . . 0.0 110.017 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.29 163.16 55.01 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.331 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.487 ' HG3' ' CE1' ' A' ' 10' ' ' PHE . 45.8 Cg_endo -73.02 157.57 50.83 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.75 1.395 . . . . 0.0 110.35 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -75.86 -10.55 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.533 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 79.0 t80 -74.84 -27.8 60.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.29 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.479 ' HB3' HD21 ' B' ' 19' ' ' LEU . 41.7 mt -96.09 23.36 6.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.179 -0.951 . . . . 0.0 110.225 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.18 -18.35 61.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.134 -0.979 . . . . 0.0 110.601 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -97.13 1.22 49.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.048 -1.032 . . . . 0.0 110.855 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.452 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.3 m0 -82.48 153.82 68.46 Favored Pre-proline 0 N--CA 1.485 1.31 0 O-C-N 120.986 -1.071 . . . . 0.0 109.852 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.473 ' HG2' ' CG2' ' B' ' 18' ' ' VAL . 42.2 Cg_endo -70.47 162.11 43.62 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.419 1.221 . . . . 0.0 111.525 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -40.6 97.18 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.784 0.802 . . . . 0.0 110.768 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -53.87 52.14 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.037 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.714 ' O ' HG23 ' B' ' 22' ' ' VAL . 85.8 t -60.7 -45.09 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.586 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' B' ' 11' ' ' LEU . 71.6 mt -61.92 -30.8 71.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.827 -1.171 . . . . 0.0 111.111 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -72.73 -23.32 60.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.097 -1.002 . . . . 0.0 110.287 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.602 ' O ' HG23 ' B' ' 25' ' ' VAL . 1.2 tp -87.0 -37.58 17.38 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.423 -0.798 . . . . 0.0 110.301 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.947 HG12 HG13 ' B' ' 33' ' ' VAL . 26.3 t -57.02 -45.28 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 110.267 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.459 ' HG3' ' N ' ' B' ' 24' ' ' LYS . 8.8 ptp180 -65.59 -29.73 70.36 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.24 -0.913 . . . . 0.0 110.709 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 0.0 OUTLIER -83.7 -10.45 58.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.064 -1.022 . . . . 0.0 110.527 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 21' ' ' LEU . 71.1 t -100.12 -27.94 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 110.459 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.05 -30.54 58.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.12 -0.987 . . . . 0.0 109.734 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.0 -11.96 58.57 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.378 -0.826 . . . . 0.0 110.46 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.38 -54.0 4.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.991 . . . . 0.0 110.545 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -61.2 -22.35 64.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 110.63 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.15 37.1 4.72 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -141.53 -154.88 0.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.399 -1.059 . . . . 0.0 110.094 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 2.2 p -113.32 171.66 7.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.528 -0.732 . . . . 0.0 109.311 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.947 HG13 HG12 ' B' ' 22' ' ' VAL . 70.9 t -72.64 -23.17 20.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.124 -0.985 . . . . 0.0 110.454 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -69.96 -29.75 66.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.0 109.042 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.87 -29.46 20.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.497 -0.752 . . . . 0.0 109.356 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.48 ' HG3' HG12 ' B' ' 25' ' ' VAL . 4.2 tt0 -64.3 -59.4 4.43 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.297 -0.877 . . . . 0.0 109.295 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.638 HG23 HG21 ' A' ' 41' ' ' VAL . 24.9 mm -60.37 -22.64 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.315 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.412 ' OH ' ' HG3' ' A' ' 15' ' ' PRO . 19.5 t80 -73.71 -33.24 64.3 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.265 -0.897 . . . . 0.0 109.977 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -46.52 21.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.895 . . . . 0.0 109.723 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 25.3 mtt-85 -61.14 -25.84 67.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 0.0 109.81 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.65 HG21 HG23 ' A' ' 37' ' ' ILE . 54.7 t -88.66 -29.85 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.968 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -67.41 0.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.308 -0.87 . . . . 0.0 110.465 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -55.86 -20.83 17.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.95 . . . . 0.0 110.396 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 19.6 t -60.25 -53.65 55.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.235 -0.915 . . . . 0.0 109.97 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.543 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 17.4 m-85 -60.36 -30.75 69.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -30.56 68.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 0.0 110.575 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -29.95 70.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.09 -1.006 . . . . 0.0 110.365 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -95.02 -17.93 21.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.579 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.16 17.61 60.67 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.459 ' HG3' HD11 ' A' ' 21' ' ' LEU . 8.7 tpp180 -59.38 -33.53 71.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.256 . . . . 0.0 110.061 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 38.4 mt -90.97 -63.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.153 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.93 -37.81 2.15 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.31 -1.112 . . . . 0.0 110.177 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.293 0.568 . . . . 50.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -101.12 47.12 0.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 50.0 110.104 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.77 119.22 0.2 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.393 -1.483 . . . . 50.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.1 ttm -126.49 -59.77 1.28 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -1.168 . . . . 50.0 110.454 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.16 23.88 0.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.185 -0.947 . . . . 50.0 110.51 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 166.01 16.35 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.609 -0.682 . . . . 50.0 110.545 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.409 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -73.9 164.08 63.7 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 43.64 110.191 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HG2' HD12 ' A' ' 11' ' ' LEU . 44.1 Cg_endo -70.3 145.83 55.12 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.594 1.313 . . . . 29.79 110.426 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -64.16 -14.49 55.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 110.729 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CE1' ' HG3' ' B' ' 8' ' ' PRO . 89.9 t80 -71.77 -28.79 63.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.108 -0.995 . . . . 12.57 110.169 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.707 HD12 ' HG2' ' A' ' 8' ' ' PRO . 65.9 mt -93.77 30.21 1.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.176 -0.953 . . . . 0.0 110.272 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.82 -23.91 61.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.193 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -19.63 25.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.91 . . . . 0.0 110.449 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.542 ' CE3' HD22 ' A' ' 11' ' ' LEU . 13.1 m0 -69.56 132.47 89.3 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.256 -0.903 . . . . 11.57 109.236 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.66 167.2 23.51 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.411 1.216 . . . . 13.83 111.082 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -67.98 -25.77 65.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.614 -0.679 . . . . 48.43 110.791 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.5 -51.92 51.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 46.64 110.611 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.9 t -67.49 -39.5 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 16.14 110.526 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.7 -29.92 70.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 12.61 110.639 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.08 -27.47 68.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.059 -1.026 . . . . 23.17 109.504 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.736 ' O ' HG23 ' A' ' 25' ' ' VAL . 50.1 tp -84.88 -39.53 18.15 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.561 -0.712 . . . . 19.0 110.066 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.821 HG12 HG13 ' A' ' 33' ' ' VAL . 39.9 t -60.26 -47.25 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.44 -0.788 . . . . 18.87 110.574 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HG3' ' N ' ' A' ' 24' ' ' LYS . 9.6 ptp180 -61.52 -28.62 69.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.316 -0.865 . . . . 23.61 110.849 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -86.01 -20.68 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.029 -1.044 . . . . 30.11 110.14 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 21' ' ' LEU . 93.6 t -87.4 -23.75 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.873 . . . . 16.22 110.204 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.76 -34.61 67.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.305 -0.872 . . . . 26.6 109.528 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.44 -9.78 59.3 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.333 -0.854 . . . . 45.21 110.425 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -86.47 -59.96 2.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 37.85 110.399 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -58.61 -30.17 67.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 35.36 110.444 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.04 32.68 3.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 35.1 109.555 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -136.74 -165.13 1.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.122 . . . . 32.72 109.94 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.24 -173.36 2.65 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.408 -0.807 . . . . 19.61 108.842 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.821 HG13 HG12 ' A' ' 22' ' ' VAL . 69.7 t -83.44 -15.5 11.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.171 -0.956 . . . . 17.56 110.099 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' HA ' ' CZ ' ' B' ' 10' ' ' PHE . 60.6 t30 -80.84 -33.18 34.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 21.3 108.496 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.84 -40.0 49.27 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.835 -0.802 . . . . 16.38 108.835 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.623 ' HG3' HG12 ' A' ' 25' ' ' VAL . 1.5 tt0 -59.53 -51.24 70.71 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.247 -0.908 . . . . 12.61 109.256 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.59 HG23 HG21 ' B' ' 41' ' ' VAL . 35.3 mm -64.0 -24.42 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.373 -0.829 . . . . 10.95 109.584 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.439 ' HA ' ' CZ2' ' B' ' 14' ' ' TRP . 35.2 t80 -73.98 -30.35 62.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.297 -0.877 . . . . 18.87 110.427 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 -78.12 -46.09 21.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.083 -1.011 . . . . 36.88 110.137 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.417 ' CD ' ' O ' ' A' ' 36' ' ' GLU . 2.7 mpt_? -60.98 -26.68 67.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 22.85 109.697 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.594 HG21 HG23 ' B' ' 37' ' ' ILE . 19.2 t -85.63 -30.58 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.491 -0.756 . . . . 13.02 109.352 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.5 mtp -71.4 -20.33 62.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.759 . . . . 18.84 110.487 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.04 -26.65 26.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.119 -0.988 . . . . 29.96 110.532 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.48 -58.81 6.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 18.65 110.317 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.64 ' CD1' HD21 ' B' ' 21' ' ' LEU . 30.1 m-85 -55.13 -42.31 72.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 16.26 110.374 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -51.86 -35.79 46.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.161 -0.962 . . . . 36.71 110.615 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -53.92 -62.36 1.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 41.6 110.522 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.0 -59.45 5.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 24.83 110.305 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 131.86 35.33 0.35 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.072 -1.211 . . . . 18.81 110.072 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -83.73 -36.55 23.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -1.202 . . . . 23.01 109.475 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.19 -169.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.531 -0.731 . . . . 27.08 109.613 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.4 -38.67 0.14 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.749 -1.34 . . . . 32.03 109.749 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.297 -1.12 . . . . 0.0 110.331 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.284 0.564 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -100.97 47.15 0.92 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.163 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.61 119.63 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 22.1 ttm -126.87 -59.47 1.26 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -1.128 . . . . 0.0 110.468 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.46 23.9 0.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.2 -0.937 . . . . 0.0 110.517 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.78 166.19 16.01 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.512 -0.743 . . . . 0.0 110.456 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.405 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 0.1 OUTLIER -74.21 164.11 63.55 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 110.092 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.733 ' HG2' HD12 ' B' ' 11' ' ' LEU . 45.0 Cg_endo -70.65 145.25 51.53 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.678 1.357 . . . . 0.0 110.392 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -63.62 -14.46 51.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 0.0 110.749 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 34' ' ' ASN . 90.7 t80 -71.8 -28.46 63.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.047 -1.033 . . . . 0.0 110.209 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.733 HD12 ' HG2' ' B' ' 8' ' ' PRO . 64.2 mt -94.05 30.31 1.91 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.248 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -71.99 -23.95 61.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -0.847 . . . . 0.0 110.221 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -19.58 25.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.928 . . . . 0.0 110.451 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.554 ' CE3' HD22 ' B' ' 11' ' ' LEU . 13.2 m0 -69.86 132.18 88.9 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.351 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.5 167.24 23.11 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.551 1.29 . . . . 0.0 111.153 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' B' ' 20' ' ' ASP . 1.5 ptm180 -68.07 -25.67 65.46 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.735 -0.603 . . . . 0.0 110.698 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.98 -51.72 51.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 110.526 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.714 ' O ' HG23 ' B' ' 22' ' ' VAL . 61.9 t -67.64 -39.48 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.103 -0.998 . . . . 0.0 110.237 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 14.3 mt -65.77 -29.83 70.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 110.715 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 16' ' ' ARG . 1.0 OUTLIER -66.37 -27.61 68.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.041 -1.037 . . . . 0.0 109.617 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.726 ' O ' HG23 ' B' ' 25' ' ' VAL . 45.7 tp -84.87 -39.1 18.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.633 -0.667 . . . . 0.0 110.03 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.8 HG12 HG13 ' B' ' 33' ' ' VAL . 39.3 t -60.88 -46.32 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 0.0 110.606 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' B' ' 24' ' ' LYS . 9.6 ptp180 -62.31 -28.31 69.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.197 -0.939 . . . . 0.0 110.759 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.464 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 0.1 OUTLIER -86.06 -20.82 28.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.031 -1.043 . . . . 0.0 110.116 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.726 HG23 ' O ' ' B' ' 21' ' ' LEU . 95.3 t -87.42 -23.75 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.853 . . . . 0.0 110.119 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.27 66.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.52 -9.91 59.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.46 -0.775 . . . . 0.0 110.371 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -86.51 -59.99 2.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.015 . . . . 0.0 110.379 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -58.56 -30.09 66.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.87 . . . . 0.0 110.345 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.94 32.56 3.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -136.44 -164.82 1.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -1.183 . . . . 0.0 109.973 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.54 -173.55 2.67 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.37 -0.831 . . . . 0.0 108.879 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.8 HG13 HG12 ' B' ' 22' ' ' VAL . 69.4 t -83.26 -15.65 11.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.175 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 60.2 t30 -80.86 -32.98 34.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.097 -1.002 . . . . 0.0 108.436 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -40.47 48.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.639 ' HG3' HG12 ' B' ' 25' ' ' VAL . 1.5 tt0 -59.1 -51.55 69.55 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.214 -0.929 . . . . 0.0 109.273 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.594 HG23 HG21 ' A' ' 41' ' ' VAL . 37.0 mm -63.53 -24.58 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.58 -0.7 . . . . 0.0 109.778 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.435 ' HA ' ' CZ2' ' A' ' 14' ' ' TRP . 37.8 t80 -74.2 -29.84 61.93 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 110.508 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -78.6 -46.2 19.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.177 -0.952 . . . . 0.0 109.994 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.404 ' CD ' ' O ' ' B' ' 36' ' ' GLU . 2.7 mpt_? -60.36 -27.64 67.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.567 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.59 HG21 HG23 ' A' ' 37' ' ' ILE . 18.6 t -84.9 -30.42 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.512 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 2.5 mtp -72.19 -19.54 61.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 110.499 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.45 -26.94 26.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 110.354 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.03 -58.9 6.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 0.0 110.391 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.59 ' CD1' HD21 ' A' ' 21' ' ' LEU . 31.2 m-85 -55.23 -41.93 72.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 110.469 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -52.27 -36.08 51.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.249 -0.907 . . . . 0.0 110.518 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -53.61 -62.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.579 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -60.94 -59.55 5.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.332 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.04 35.15 0.35 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -83.77 -36.61 23.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.308 . . . . 0.0 109.415 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 pt -127.96 -168.91 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.427 -0.796 . . . . 0.0 109.794 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.12 -38.85 0.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.308 -1.113 . . . . 0.0 110.241 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.248 0.547 . . . . 50.0 110.128 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -113.26 174.34 5.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 50.0 110.102 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.52 37.53 10.63 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.587 -1.405 . . . . 50.0 109.587 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.67 -162.78 0.93 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -1.145 . . . . 50.0 110.2 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.6 m -82.41 140.48 33.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.271 -0.893 . . . . 50.0 110.217 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -112.98 38.59 2.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 50.0 110.394 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 18.4 mtp -110.32 106.06 57.67 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 43.64 110.209 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.608 ' CG ' HD12 ' A' ' 11' ' ' LEU . 45.0 Cg_endo -71.33 153.5 61.44 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.569 1.3 . . . . 29.79 110.487 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.15 -17.58 64.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 110.456 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.457 ' HB3' ' CB ' ' B' ' 10' ' ' PHE . 87.7 t80 -76.26 -28.45 57.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -0.968 . . . . 12.57 110.352 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.608 HD12 ' CG ' ' A' ' 8' ' ' PRO . 81.5 mt -91.53 21.14 4.8 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.954 . . . . 0.0 110.455 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -72.45 -22.65 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 110.059 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.79 -11.99 46.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 110.635 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.511 ' HH2' HG21 ' B' ' 41' ' ' VAL . 14.2 m0 -79.73 141.94 56.39 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.029 -1.045 . . . . 11.57 109.682 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.19 177.83 7.33 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.572 1.301 . . . . 13.83 110.685 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.77 -21.95 34.46 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.385 -0.822 . . . . 48.43 109.153 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -69.32 -28.01 65.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.885 . . . . 46.64 109.887 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.869 ' O ' HG23 ' A' ' 22' ' ' VAL . 78.5 t -94.85 -40.46 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 16.14 110.034 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.89 -28.79 69.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 12.61 110.547 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -73.08 -22.61 60.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 23.17 109.936 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.821 ' O ' HG23 ' A' ' 25' ' ' VAL . 50.6 tp -90.1 -33.52 16.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 19.0 110.018 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 18' ' ' VAL . 24.0 t -67.14 -50.18 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.419 -0.801 . . . . 18.87 110.345 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -59.17 -27.25 65.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.309 -0.869 . . . . 23.61 110.788 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -24.11 33.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 30.11 110.165 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 21' ' ' LEU . 88.4 t -78.83 -39.34 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.433 -0.792 . . . . 16.22 110.351 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.76 97.86 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.204 -0.935 . . . . 26.6 109.654 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -68.13 -16.09 63.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 45.21 110.452 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.78 -59.84 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.979 -1.076 . . . . 37.85 110.411 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -59.07 -28.03 66.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 35.36 110.703 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.59 41.03 3.03 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.461 -1.456 . . . . 35.1 109.461 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mtt-85 -141.96 -154.01 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -1.121 . . . . 32.72 110.069 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 t -108.59 175.94 5.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.48 -0.763 . . . . 19.61 109.476 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.765 HG13 HG12 ' A' ' 22' ' ' VAL . 88.9 t -78.64 -20.56 13.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.157 -0.965 . . . . 17.56 110.229 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.18 -26.57 63.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.069 -1.019 . . . . 21.3 109.104 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.82 -30.53 22.9 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.384 -0.823 . . . . 16.38 109.566 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HG3' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -67.16 -48.48 67.86 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.251 -0.906 . . . . 12.61 109.724 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.618 HG23 HG21 ' B' ' 41' ' ' VAL . 47.3 mm -66.36 -30.88 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.837 . . . . 10.95 109.679 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HE1' HG11 ' B' ' 18' ' ' VAL . 36.9 t80 -67.67 -39.4 84.51 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 18.87 110.635 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.53 -45.81 61.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.185 -0.947 . . . . 36.88 109.743 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 36' ' ' GLU . 2.1 mmt-85 -60.84 -24.69 66.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 22.85 109.4 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.699 HG21 HG23 ' B' ' 37' ' ' ILE . 52.1 t -90.14 -23.36 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.586 -0.696 . . . . 13.02 110.161 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -56.99 4.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.505 -0.747 . . . . 18.84 110.977 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -50.74 -33.22 22.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.121 -0.987 . . . . 29.96 111.189 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.3 m -60.79 -51.24 70.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.121 -0.987 . . . . 18.65 110.598 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.629 ' CD1' HD21 ' B' ' 21' ' ' LEU . 15.0 m-85 -59.77 -29.88 68.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.98 . . . . 16.26 110.814 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.09 -30.08 58.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.006 -1.059 . . . . 36.71 110.677 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -54.56 -49.63 69.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.104 -0.998 . . . . 41.6 110.356 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -80.15 -58.32 3.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.181 -0.95 . . . . 24.83 110.314 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.38 42.49 0.25 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.464 -1.455 . . . . 18.81 109.464 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.47 -28.13 31.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.397 -1.06 . . . . 23.01 110.437 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.7 mt -81.72 -20.66 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.009 -1.057 . . . . 27.08 110.38 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.64 -28.47 3.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.744 -1.342 . . . . 32.03 109.744 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.283 -1.128 . . . . 0.0 110.149 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.262 0.553 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -113.21 173.73 6.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.23 37.43 9.88 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.66 -162.89 0.94 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -1.122 . . . . 0.0 110.193 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 4.5 m -82.16 140.34 33.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 110.228 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -113.12 38.81 2.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 110.256 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 18.3 mtp -110.49 105.89 57.48 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.141 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.599 ' CG ' HD12 ' B' ' 11' ' ' LEU . 45.4 Cg_endo -71.46 153.55 60.71 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.65 1.342 . . . . 0.0 110.42 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.04 -17.74 65.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.458 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.457 ' CB ' ' HB3' ' A' ' 10' ' ' PHE . 87.6 t80 -76.15 -28.32 57.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.157 -0.964 . . . . 0.0 110.326 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.599 HD12 ' CG ' ' B' ' 8' ' ' PRO . 83.5 mt -91.8 21.7 4.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 110.407 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.09 -22.53 60.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.974 . . . . 0.0 110.015 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -87.74 -12.02 46.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 110.644 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.529 ' HH2' HG21 ' A' ' 41' ' ' VAL . 14.2 m0 -79.83 142.05 56.1 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.841 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.21 177.42 7.86 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.551 1.29 . . . . 0.0 110.18 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -21.6 34.61 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.439 -0.788 . . . . 0.0 109.226 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -69.38 -28.02 65.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.978 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.846 ' O ' HG23 ' B' ' 22' ' ' VAL . 80.2 t -94.66 -40.64 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.551 -0.718 . . . . 0.0 109.845 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 19' ' ' LEU . 85.3 mt -65.95 -28.44 68.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.563 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -73.38 -22.85 60.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.845 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.84 ' O ' HG23 ' B' ' 25' ' ' VAL . 51.7 tp -89.82 -33.73 16.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.704 -0.623 . . . . 0.0 110.12 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.846 HG23 ' O ' ' B' ' 18' ' ' VAL . 24.0 t -66.92 -50.1 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -0.829 . . . . 0.0 110.37 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -59.14 -27.52 65.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.289 -0.882 . . . . 0.0 110.801 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -24.3 34.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 110.114 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.84 HG23 ' O ' ' B' ' 21' ' ' LEU . 88.8 t -78.66 -39.46 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.804 . . . . 0.0 110.299 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.47 99.22 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.342 -0.849 . . . . 0.0 109.59 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -67.53 -16.24 64.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.338 -0.851 . . . . 0.0 110.528 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -82.56 -59.94 2.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.041 -1.037 . . . . 0.0 110.503 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -58.97 -28.16 66.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.136 -0.978 . . . . 0.0 110.794 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.47 41.7 2.9 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -142.6 -154.19 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.433 -1.04 . . . . 0.0 110.002 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.7 t -108.87 175.8 5.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.451 -0.781 . . . . 0.0 109.466 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.784 HG13 HG12 ' B' ' 22' ' ' VAL . 93.7 t -78.27 -20.5 13.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 110.451 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -71.6 -26.32 62.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.079 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.02 -30.38 22.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.429 -0.794 . . . . 0.0 109.467 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.501 ' HG3' HG12 ' B' ' 25' ' ' VAL . 0.0 OUTLIER -67.41 -48.35 67.61 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.699 HG23 HG21 ' A' ' 41' ' ' VAL . 47.2 mm -66.81 -30.31 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.427 ' HE1' HG11 ' A' ' 18' ' ' VAL . 36.3 t80 -68.0 -39.41 83.22 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.381 -0.825 . . . . 0.0 110.608 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.52 -45.83 61.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.895 . . . . 0.0 109.759 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' B' ' 36' ' ' GLU . 2.0 mmt-85 -60.93 -24.52 66.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 109.383 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.618 HG21 HG23 ' A' ' 37' ' ' ILE . 49.9 t -90.22 -23.4 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.62 -0.675 . . . . 0.0 110.011 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -57.66 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.507 -0.746 . . . . 0.0 111.081 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -50.22 -33.37 19.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.163 -0.961 . . . . 0.0 111.249 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 38.1 m -60.96 -50.85 71.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.1 -1.0 . . . . 0.0 110.637 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.667 ' CD1' HD21 ' A' ' 21' ' ' LEU . 15.9 m-85 -60.04 -30.04 68.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.79 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.93 -29.78 58.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.251 -0.905 . . . . 0.0 110.835 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -54.77 -49.39 71.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 110.468 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -80.3 -58.04 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.083 -1.011 . . . . 0.0 110.397 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.01 42.47 0.26 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -28.6 31.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -1.176 . . . . 0.0 110.379 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 65.2 mt -81.4 -20.65 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.479 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.7 -28.8 3.2 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.287 -1.125 . . . . 0.0 110.264 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tmm? . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.231 0.538 . . . . 50.0 110.118 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -160.1 -174.49 4.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 50.0 110.184 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.52 46.16 1.07 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.568 -1.413 . . . . 50.0 109.568 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.73 -170.53 1.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -1.197 . . . . 50.0 110.279 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 m -106.81 130.65 54.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 50.0 110.412 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.73 155.57 27.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 50.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.41 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 1.9 ptm -53.86 163.8 1.06 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 43.64 110.358 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.768 ' CG ' HD12 ' A' ' 11' ' ' LEU . 44.0 Cg_endo -70.86 157.77 57.34 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.711 1.374 . . . . 29.79 110.466 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.28 -21.59 62.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.891 . . . . 0.0 110.449 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.514 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 87.4 t80 -70.12 -22.16 63.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.843 . . . . 12.57 110.574 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.768 HD12 ' CG ' ' A' ' 8' ' ' PRO . 85.1 mt -100.23 27.43 5.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.139 -0.975 . . . . 0.0 110.541 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.81 -21.64 44.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.952 . . . . 0.0 110.006 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -85.58 -22.9 27.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.556 ' HB2' HD11 ' A' ' 19' ' ' LEU . 14.7 m0 -66.16 144.81 98.9 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 121.424 -0.798 . . . . 11.57 109.533 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HD2' ' CE1' ' B' ' 38' ' ' TYR . 40.6 Cg_endo -70.85 160.35 49.67 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.496 1.261 . . . . 13.83 111.336 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -40.15 88.9 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.603 0.716 . . . . 48.43 110.934 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.09 -47.29 86.51 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.69 -0.631 . . . . 46.64 111.49 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.0 t -66.89 -48.82 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.038 -1.039 . . . . 16.14 111.021 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 14' ' ' TRP . 74.8 mt -64.02 -24.97 67.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.069 -1.019 . . . . 12.61 110.685 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HA ' ' CD ' ' A' ' 23' ' ' ARG . 13.9 t70 -71.69 -23.68 61.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 23.17 109.898 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.657 HD13 HG22 ' B' ' 51' ' ' ILE . 0.8 OUTLIER -90.29 -43.72 10.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 19.0 110.043 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.993 HG12 HG13 ' A' ' 33' ' ' VAL . 40.6 t -51.32 -39.44 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.392 -0.818 . . . . 18.87 110.477 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' CD ' ' HA ' ' A' ' 20' ' ' ASP . 8.3 ptm180 -66.03 -36.21 82.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 23.61 110.622 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -19.4 58.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 30.11 110.524 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.451 HG12 ' HG3' ' A' ' 36' ' ' GLU . 69.9 t -86.88 -35.09 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.263 -0.898 . . . . 16.22 110.184 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.91 83.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -0.909 . . . . 26.6 109.738 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.98 -19.45 63.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 45.21 110.271 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -82.77 -56.53 3.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 37.85 110.35 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -53.41 -42.64 67.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 35.36 110.386 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.73 44.54 0.54 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.541 -1.424 . . . . 35.1 109.541 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.33 -158.58 0.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -1.123 . . . . 32.72 110.189 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.83 176.93 5.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 19.61 109.561 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.993 HG13 HG12 ' A' ' 22' ' ' VAL . 75.1 t -76.14 -19.42 15.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.356 -0.84 . . . . 17.56 110.265 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -71.12 -27.72 63.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 21.3 108.869 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 m -86.3 -33.64 20.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.555 -0.716 . . . . 16.38 109.531 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG3' HG12 ' A' ' 25' ' ' VAL . 1.1 tt0 -63.55 -53.59 49.42 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.187 -0.946 . . . . 12.61 109.412 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.576 HG23 HG21 ' B' ' 41' ' ' VAL . 25.8 mm -63.37 -21.73 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.458 -0.776 . . . . 10.95 109.653 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 32.9 t80 -76.2 -35.59 59.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.155 -0.966 . . . . 18.87 110.362 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -76.8 -52.03 10.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -0.975 . . . . 36.88 109.6 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -55.46 -24.56 31.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.456 -0.778 . . . . 22.85 109.732 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.587 HG21 HG23 ' B' ' 37' ' ' ILE . 37.5 t -89.97 -29.79 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 13.02 109.867 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -64.07 0.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 18.84 110.48 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.88 -29.13 18.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.19 -0.944 . . . . 29.96 110.425 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.65 -46.45 81.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 18.65 109.928 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.55 ' CZ ' HD23 ' B' ' 21' ' ' LEU . 15.4 m-85 -66.75 -29.07 68.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.195 -0.941 . . . . 16.26 110.167 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.15 -26.46 65.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 36.71 110.502 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -63.95 -25.66 68.24 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 41.6 110.299 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.3 17.45 18.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 24.83 110.592 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.5 22.26 30.87 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.01 -1.236 . . . . 18.81 110.01 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -54.16 -52.89 59.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -1.171 . . . . 23.01 109.931 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.612 HG22 HD13 ' B' ' 21' ' ' LEU . 28.7 pt -101.99 -175.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.973 -1.08 . . . . 27.08 109.932 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.2 -63.76 0.16 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.664 -1.374 . . . . 32.03 109.664 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.157 -1.202 . . . . 0.0 110.28 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.7 tmm? . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.299 0.571 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -160.0 -174.38 4.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 110.232 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.9 46.53 1.05 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.94 -170.46 1.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -1.115 . . . . 0.0 110.323 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -107.0 131.15 54.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.359 -0.838 . . . . 0.0 110.299 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 155.33 28.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.884 . . . . 0.0 110.096 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.421 ' HB2' ' HD2' ' B' ' 8' ' ' PRO . 2.0 ptm -53.6 163.81 0.98 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.284 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.774 ' CG ' HD12 ' B' ' 11' ' ' LEU . 43.9 Cg_endo -71.04 157.99 56.41 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.621 1.327 . . . . 0.0 110.449 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.53 -21.23 61.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 110.386 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.506 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 86.6 t80 -70.53 -22.08 62.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.441 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.774 HD12 ' CG ' ' B' ' 8' ' ' PRO . 85.1 mt -100.37 27.55 5.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.0 110.542 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.01 -21.4 43.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 110.034 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -85.86 -22.9 27.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.873 . . . . 0.0 110.189 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.549 ' HB2' HD11 ' B' ' 19' ' ' LEU . 14.8 m0 -66.34 145.2 98.96 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.288 -0.883 . . . . 0.0 109.425 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.461 ' HG2' HG23 ' B' ' 18' ' ' VAL . 41.0 Cg_endo -71.4 159.71 50.77 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.308 1.162 . . . . 0.0 111.341 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -40.4 86.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.676 0.75 . . . . 0.0 110.997 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.15 -47.21 86.87 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.774 -0.579 . . . . 0.0 111.481 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.63 ' O ' HG23 ' B' ' 22' ' ' VAL . 78.9 t -67.11 -48.61 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.304 -0.872 . . . . 0.0 110.902 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' B' ' 14' ' ' TRP . 77.0 mt -64.04 -24.63 67.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.079 -1.013 . . . . 0.0 110.662 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' CD ' ' B' ' 23' ' ' ARG . 13.5 t70 -71.99 -24.14 61.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.231 -0.918 . . . . 0.0 109.754 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.612 HD13 HG22 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -90.03 -43.45 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.502 -0.748 . . . . 0.0 110.096 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.971 HG12 HG13 ' B' ' 33' ' ' VAL . 40.7 t -51.6 -39.62 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.41 -0.806 . . . . 0.0 110.458 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.447 ' CD ' ' HA ' ' B' ' 20' ' ' ASP . 8.3 ptm180 -65.84 -36.29 83.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.706 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -19.57 58.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.459 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.461 HG12 ' HG3' ' B' ' 36' ' ' GLU . 69.9 t -86.71 -35.25 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.923 . . . . 0.0 110.32 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 -39.35 84.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 109.701 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.49 -19.92 63.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 110.245 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -82.45 -56.53 3.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.128 -0.982 . . . . 0.0 110.373 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -53.6 -42.38 67.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 110.46 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.51 44.48 0.55 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.35 -158.68 0.69 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -1.176 . . . . 0.0 110.258 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.69 176.92 5.06 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.363 -0.835 . . . . 0.0 109.617 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.971 HG13 HG12 ' B' ' 22' ' ' VAL . 76.3 t -76.14 -19.26 15.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.261 -0.899 . . . . 0.0 110.308 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -71.18 -27.84 63.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.118 -0.989 . . . . 0.0 108.856 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 45.6 m -86.15 -33.72 20.77 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.549 -0.719 . . . . 0.0 109.536 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.461 ' HG3' HG12 ' B' ' 25' ' ' VAL . 1.1 tt0 -63.4 -53.66 48.88 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.249 -0.907 . . . . 0.0 109.492 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.587 HG23 HG21 ' A' ' 41' ' ' VAL . 26.4 mm -63.32 -21.81 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.528 -0.732 . . . . 0.0 109.596 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.481 ' CE1' ' HD2' ' A' ' 15' ' ' PRO . 33.3 t80 -76.15 -35.51 59.17 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.113 -0.992 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -76.78 -52.08 10.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.146 -0.971 . . . . 0.0 109.645 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.3 mtt-85 -55.44 -24.46 30.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.461 -0.774 . . . . 0.0 109.817 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.576 HG21 HG23 ' A' ' 37' ' ' ILE . 37.7 t -90.07 -29.97 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 0.0 109.898 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -63.92 1.01 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 110.451 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.03 -29.35 20.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.156 -0.965 . . . . 0.0 110.325 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -46.7 80.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 110.011 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.536 ' CZ ' HD23 ' A' ' 21' ' ' LEU . 15.7 m-85 -66.73 -28.95 68.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 110.125 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -68.3 -26.23 65.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 110.481 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -63.91 -25.85 68.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.162 -0.962 . . . . 0.0 110.28 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -113.16 17.54 18.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.897 . . . . 0.0 110.602 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 55.2 22.62 30.03 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -54.32 -52.82 60.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.153 -1.204 . . . . 0.0 110.012 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.657 HG22 HD13 ' A' ' 21' ' ' LEU . 28.0 pt -101.79 -175.68 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.441 -0.787 . . . . 0.0 110.102 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.01 -63.23 0.16 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.194 -1.18 . . . . 0.0 110.25 -179.942 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.282 0.563 . . . . 50.0 110.26 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -144.0 -165.94 2.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.319 -0.863 . . . . 50.0 110.176 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.52 94.29 1.29 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.749 -1.34 . . . . 50.0 109.749 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.7 ttt -111.8 30.23 7.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -1.145 . . . . 50.0 110.085 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m -142.68 162.8 34.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 50.0 109.96 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.41 -162.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.147 -0.971 . . . . 50.0 109.966 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.0 mtp 56.2 104.37 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.237 -0.914 . . . . 43.64 110.381 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HG3' ' CD1' ' B' ' 10' ' ' PHE . 45.9 Cg_endo -71.12 170.59 17.79 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.565 1.297 . . . . 29.79 110.791 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -87.0 -17.55 32.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.875 . . . . 0.0 110.327 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.513 ' CD1' ' HG3' ' B' ' 8' ' ' PRO . 74.2 t80 -72.62 -26.12 61.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 12.57 110.564 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.705 ' HB3' HD21 ' A' ' 19' ' ' LEU . 71.6 mt -94.34 27.1 3.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.081 -1.012 . . . . 0.0 110.14 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.7 -18.11 61.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.407 -0.808 . . . . 0.0 110.414 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.7 -3.84 29.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.086 -1.008 . . . . 0.0 110.726 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.8 m0 -81.87 138.33 46.69 Favored Pre-proline 0 C--N 1.305 -1.332 0 O-C-N 120.95 -1.094 . . . . 11.57 109.635 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.23 159.59 51.5 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.482 1.254 . . . . 13.83 111.228 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -40.97 96.93 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.856 0.836 . . . . 48.43 110.382 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -52.71 -21.01 3.56 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.691 -0.631 . . . . 46.64 111.223 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 22' ' ' VAL . 92.6 t -104.0 -44.77 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.974 -1.079 . . . . 16.14 111.227 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.705 HD21 ' HB3' ' A' ' 11' ' ' LEU . 20.0 mt -63.12 -24.64 67.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.134 -0.979 . . . . 12.61 111.11 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -25.75 60.48 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.248 -0.907 . . . . 23.17 109.56 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.704 ' O ' HG23 ' A' ' 25' ' ' VAL . 42.9 tp -85.54 -42.47 14.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.599 -0.688 . . . . 19.0 109.849 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.037 HG12 HG13 ' A' ' 33' ' ' VAL . 25.3 t -55.3 -37.94 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 18.87 110.205 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -67.5 -50.49 58.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 23.61 110.439 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -19.48 65.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.218 -0.926 . . . . 30.11 110.338 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.751 HG12 ' CD ' ' A' ' 36' ' ' GLU . 86.9 t -86.84 -32.58 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 16.22 110.061 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.419 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -71.74 -39.13 70.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.199 -0.938 . . . . 26.6 109.306 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 -19.37 62.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.529 -0.732 . . . . 45.21 109.77 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.84 -57.12 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 37.85 110.153 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -56.29 -53.69 54.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 35.36 110.227 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.75 52.43 0.08 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.669 -1.372 . . . . 35.1 109.669 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -169.33 -159.19 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -1.21 . . . . 32.72 110.223 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.419 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 56.8 p -98.4 -176.43 3.39 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.462 -0.774 . . . . 19.61 109.778 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG13 HG12 ' A' ' 22' ' ' VAL . 86.4 t -81.5 -9.94 12.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.155 -0.966 . . . . 17.56 110.708 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.72 -29.87 59.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.007 -1.058 . . . . 21.3 109.318 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -90.42 -28.63 18.51 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.372 -0.83 . . . . 16.38 110.058 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.751 ' CD ' HG12 ' A' ' 25' ' ' VAL . 12.0 tp10 -65.05 -51.15 63.12 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.134 -0.979 . . . . 12.61 109.66 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.601 HD11 HG11 ' A' ' 22' ' ' VAL . 2.7 mt -67.08 -20.6 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.398 -0.814 . . . . 10.95 109.729 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.415 ' CE1' ' HD2' ' B' ' 15' ' ' PRO . 46.7 t80 -69.61 -39.15 77.41 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.112 -0.992 . . . . 18.87 110.27 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -71.82 -43.5 65.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 36.88 110.223 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HD3' ' HB3' ' B' ' 44' ' ' SER . 17.0 mtt-85 -63.3 -31.98 73.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 22.85 109.519 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.616 HG11 ' CZ3' ' B' ' 14' ' ' TRP . 71.3 t -83.33 -22.8 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.626 -0.671 . . . . 13.02 110.284 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.25 -34.89 48.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.408 -0.807 . . . . 18.84 110.587 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -72.48 -32.4 66.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 29.96 110.268 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.413 ' HB3' ' HD3' ' B' ' 40' ' ' ARG . 0.1 OUTLIER -56.13 -54.79 40.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 18.65 110.071 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.643 ' CD1' HD21 ' B' ' 21' ' ' LEU . 27.0 m-85 -62.02 -19.46 62.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 16.26 110.572 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -81.79 -26.5 34.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 36.71 110.162 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -67.28 -37.15 82.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.375 -0.828 . . . . 41.6 110.215 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.15 -28.1 29.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.398 -0.814 . . . . 24.83 110.262 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.28 28.27 11.95 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.332 -1.507 . . . . 18.81 109.332 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.598 HH21 HG22 ' B' ' 25' ' ' VAL . 0.1 OUTLIER -75.53 -43.14 50.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -1.108 . . . . 23.01 110.405 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.443 ' CG2' HD22 ' B' ' 21' ' ' LEU . 27.4 pt -102.59 -179.75 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 119.732 -0.787 . . . . 27.08 110.526 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.83 38.34 0.62 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.204 -1.559 . . . . 32.03 109.204 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 120.799 -1.412 . . . . 0.0 109.993 -179.952 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.422 0.629 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -143.91 -166.09 2.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.53 94.74 1.34 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 7.6 ttt -112.05 30.13 7.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -1.207 . . . . 0.0 110.012 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.7 m -142.73 162.79 34.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.902 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.31 -162.07 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.104 -0.998 . . . . 0.0 110.028 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 2.1 mtp 56.13 104.38 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 0.0 110.441 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.513 ' HG3' ' CD1' ' A' ' 10' ' ' PHE . 45.6 Cg_endo -71.19 170.71 17.55 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.555 1.292 . . . . 0.0 110.782 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -87.27 -17.51 32.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.408 -0.808 . . . . 0.0 110.398 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.489 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 76.9 t80 -72.69 -26.0 61.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.867 . . . . 0.0 110.477 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.714 ' HB3' HD21 ' B' ' 19' ' ' LEU . 71.8 mt -94.57 27.22 3.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.181 -0.949 . . . . 0.0 110.174 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.82 -18.12 60.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 110.489 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.6 -3.7 29.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.086 -1.009 . . . . 0.0 110.786 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.616 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.9 m0 -82.13 138.6 45.71 Favored Pre-proline 0 C--N 1.305 -1.355 0 O-C-N 121.103 -0.998 . . . . 0.0 109.67 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.415 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 40.0 Cg_endo -71.36 159.54 51.38 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.175 1.092 . . . . 0.0 110.95 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.74 96.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.636 0.731 . . . . 0.0 110.301 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -52.65 -21.09 3.58 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.701 -0.624 . . . . 0.0 111.105 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.636 ' O ' HG23 ' B' ' 22' ' ' VAL . 98.5 t -104.05 -44.61 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.441 -1.412 . . . . 0.0 111.14 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' B' ' 11' ' ' LEU . 19.9 mt -63.26 -24.76 68.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.132 -0.98 . . . . 0.0 111.081 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -25.37 60.07 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.251 -0.906 . . . . 0.0 109.683 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.726 ' O ' HG23 ' B' ' 25' ' ' VAL . 44.8 tp -85.7 -42.29 14.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.577 -0.702 . . . . 0.0 109.968 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 1.075 HG12 HG13 ' B' ' 33' ' ' VAL . 26.2 t -55.42 -37.97 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.107 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -67.3 -50.81 58.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.305 -0.872 . . . . 0.0 110.455 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -19.55 64.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.229 -0.919 . . . . 0.0 110.5 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.749 HG12 ' CD ' ' B' ' 36' ' ' GLU . 87.6 t -86.7 -32.62 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 110.1 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.418 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -71.52 -39.09 70.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.25 -19.34 62.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.529 -0.732 . . . . 0.0 109.764 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.83 -57.12 3.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 110.227 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -56.37 -53.82 52.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 110.284 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.09 52.44 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -169.36 -159.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.267 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.418 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 54.5 p -98.31 -176.32 3.37 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.314 -0.866 . . . . 0.0 109.867 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 1.075 HG13 HG12 ' B' ' 22' ' ' VAL . 88.0 t -81.62 -9.97 12.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.17 -0.956 . . . . 0.0 110.819 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.61 -29.88 59.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.982 . . . . 0.0 109.367 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -90.39 -28.68 18.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.952 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.749 ' CD ' HG12 ' B' ' 25' ' ' VAL . 12.0 tp10 -65.14 -50.96 63.99 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.194 -0.941 . . . . 0.0 109.732 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.594 HD11 HG11 ' B' ' 22' ' ' VAL . 2.5 mt -67.13 -20.82 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.322 -0.861 . . . . 0.0 109.695 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -69.66 -39.3 77.13 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.214 -0.929 . . . . 0.0 110.252 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -71.51 -43.48 66.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.83 . . . . 0.0 110.198 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.413 ' HD3' ' HB3' ' A' ' 44' ' ' SER . 17.3 mtt-85 -63.5 -32.05 73.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.181 -0.95 . . . . 0.0 109.502 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 37' ' ' ILE . 76.9 t -82.92 -22.87 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 110.34 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.36 -34.98 47.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.819 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.45 -32.35 66.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.136 -0.977 . . . . 0.0 110.208 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.416 ' HB3' ' HD3' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -56.22 -54.78 41.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 110.105 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.641 ' CD1' HD21 ' A' ' 21' ' ' LEU . 27.2 m-85 -61.85 -19.42 62.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 110.54 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -81.98 -26.52 33.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.219 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -67.3 -37.39 83.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.927 . . . . 0.0 110.232 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -82.89 -28.09 30.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.311 -0.868 . . . . 0.0 110.273 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.54 27.63 12.73 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.489 HH21 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -75.29 -42.85 53.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.326 -1.102 . . . . 0.0 110.411 -179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.45 ' CG2' HD22 ' A' ' 21' ' ' LEU . 27.4 pt -102.89 -179.78 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.142 -0.974 . . . . 0.0 110.424 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.98 37.97 0.63 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.232 -1.158 . . . . 0.0 110.299 179.984 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.287 0.565 . . . . 50.0 110.283 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -72.97 147.12 45.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 50.0 110.178 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -151.59 -69.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.482 -1.447 . . . . 50.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mtt -79.38 137.28 37.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -1.128 . . . . 50.0 110.115 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 m -139.83 -168.81 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.955 . . . . 50.0 110.407 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.57 47.73 1.03 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 50.0 110.178 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.465 ' CE ' HD13 ' A' ' 19' ' ' LEU . 4.2 mtt -95.39 135.23 23.4 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 43.64 110.114 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.747 ' CG ' HD12 ' A' ' 11' ' ' LEU . 46.9 Cg_endo -73.4 156.8 50.12 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.516 1.272 . . . . 29.79 110.495 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -76.53 -11.64 59.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.614 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -79.31 -34.35 42.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.014 -1.054 . . . . 12.57 110.291 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.747 HD12 ' CG ' ' A' ' 8' ' ' PRO . 66.1 mt -88.27 14.89 8.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.096 -1.003 . . . . 0.0 110.586 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.58 -27.44 69.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -82.34 -23.78 34.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.92 . . . . 0.0 110.519 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.501 ' CZ3' HG11 ' B' ' 41' ' ' VAL . 13.0 m0 -63.43 141.72 97.86 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.312 -0.867 . . . . 11.57 109.21 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.39 173.63 9.41 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.458 1.241 . . . . 13.83 111.082 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -77.82 -22.03 50.63 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.499 -0.751 . . . . 48.43 109.769 -179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.7 -46.22 39.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 46.64 110.428 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.85 ' O ' HG23 ' A' ' 22' ' ' VAL . 97.9 t -68.72 -39.58 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 16.14 110.157 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 11' ' ' LEU . 24.8 mt -66.26 -31.52 72.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 12.61 110.654 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 3.4 t0 -70.75 -22.33 62.42 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 23.17 110.074 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.784 ' O ' HG23 ' A' ' 25' ' ' VAL . 51.0 tp -88.83 -37.62 15.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.372 -0.83 . . . . 19.0 109.951 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.981 HG12 HG13 ' A' ' 33' ' ' VAL . 15.6 t -65.84 -49.51 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 18.87 109.959 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HA ' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -59.91 -35.76 75.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 23.61 110.483 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 23' ' ' ARG . 2.1 tmtt? -73.43 -24.55 60.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.113 -0.992 . . . . 30.11 109.943 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 21' ' ' LEU . 99.4 t -86.63 -20.89 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.497 -0.752 . . . . 16.22 110.311 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.578 ' HB1' ' C ' ' A' ' 32' ' ' SER . . . -82.22 -30.21 30.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.217 -0.927 . . . . 26.6 109.539 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.43 -19.51 49.78 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.471 -0.768 . . . . 45.21 110.307 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 25' ' ' VAL . 22.8 pt-20 -90.82 -30.82 16.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.191 -0.943 . . . . 37.85 110.279 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.426 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.5 OUTLIER -82.97 7.68 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 35.36 110.558 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.45 23.98 70.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.517 -1.433 . . . . 35.1 109.517 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 8.8 mtt-85 -129.19 -158.02 0.86 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -1.194 . . . . 32.72 110.362 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.578 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 1.8 m -115.06 -179.65 3.69 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.511 -0.743 . . . . 19.61 109.286 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.981 HG13 HG12 ' A' ' 22' ' ' VAL . 99.1 t -77.97 -14.86 14.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.129 -0.982 . . . . 17.56 110.448 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -77.03 -41.69 41.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.102 -0.998 . . . . 21.3 109.004 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.8 t -71.18 -35.9 71.76 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.386 -0.821 . . . . 16.38 109.56 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' CG ' HG12 ' A' ' 25' ' ' VAL . 3.9 tp10 -64.68 -50.54 66.6 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.233 -0.917 . . . . 12.61 109.405 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.722 HG23 HG21 ' B' ' 41' ' ' VAL . 35.6 mm -63.94 -26.82 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 10.95 109.53 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' B' ' 18' ' ' VAL . 53.4 t80 -71.89 -37.19 70.19 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.374 -0.829 . . . . 18.87 110.753 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.74 -36.34 59.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -0.932 . . . . 36.88 110.253 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -71.99 -24.16 61.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 22.85 109.64 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.787 HG21 HG23 ' B' ' 37' ' ' ILE . 7.0 t -87.09 -28.68 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.8 . . . . 13.02 109.217 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -43.45 60.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.603 -0.685 . . . . 18.84 110.531 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -28.93 68.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 29.96 110.137 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -49.81 70.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.89 . . . . 18.65 110.07 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.584 ' CD1' HD21 ' B' ' 21' ' ' LEU . 31.1 m-85 -66.01 -22.87 66.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 16.26 110.371 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -73.79 -36.54 65.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.19 -0.944 . . . . 36.71 110.525 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -57.4 -54.77 43.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 41.6 110.346 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -61.58 -40.88 96.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.997 . . . . 24.83 110.269 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.92 30.48 3.44 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.543 -1.423 . . . . 18.81 109.543 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.418 ' HD2' HD11 ' B' ' 21' ' ' LEU . 8.9 mmt-85 -81.22 -42.01 21.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.015 -1.285 . . . . 23.01 109.952 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.417 ' CG2' HD22 ' B' ' 21' ' ' LEU . 5.8 pt -114.57 -163.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.783 -0.767 . . . . 27.08 109.896 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.94 58.29 0.25 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.559 -1.416 . . . . 32.03 109.559 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.398 -1.06 . . . . 0.0 110.208 179.984 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.29 0.567 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -72.56 147.06 46.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.853 -1.154 . . . . 0.0 110.204 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -151.29 -69.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' MET . . . . . . . . . . . . . 2.5 mtt -78.9 137.45 37.66 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.608 -0.936 . . . . 0.0 110.369 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 48.6 m -139.72 -168.78 2.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 110.217 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.58 47.97 1.03 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 0.0 110.163 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.453 ' CE ' HD13 ' B' ' 19' ' ' LEU . 4.3 mtt -95.47 135.45 23.17 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.2 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.755 ' CG ' HD12 ' B' ' 11' ' ' LEU . 47.4 Cg_endo -73.41 156.96 50.0 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.522 1.275 . . . . 0.0 110.384 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -76.8 -11.93 59.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.588 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.411 ' CD1' ' HG3' ' A' ' 8' ' ' PRO . 89.5 t80 -79.01 -34.09 44.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.078 -1.014 . . . . 0.0 110.322 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.755 HD12 ' CG ' ' B' ' 8' ' ' PRO . 64.6 mt -88.84 15.62 8.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 110.601 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.49 -26.85 68.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.966 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -82.77 -23.98 33.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 110.382 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' TRP . . . . . 0.53 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 13.0 m0 -63.17 142.07 97.75 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.304 -0.872 . . . . 0.0 109.278 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.9 173.97 9.42 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.431 1.227 . . . . 0.0 111.259 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 20' ' ' ASP . 0.0 OUTLIER -78.36 -21.85 48.83 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.333 -0.854 . . . . 0.0 109.722 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.39 -46.11 42.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 110.696 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.837 ' O ' HG23 ' B' ' 22' ' ' VAL . 98.2 t -68.8 -39.57 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.145 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.538 HD21 ' HB3' ' B' ' 11' ' ' LEU . 25.3 mt -66.36 -31.33 72.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 110.574 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' B' ' 16' ' ' ARG . 3.5 t0 -70.83 -23.08 62.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.072 -1.018 . . . . 0.0 109.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.769 ' O ' HG23 ' B' ' 25' ' ' VAL . 50.0 tp -87.83 -37.68 16.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -0.932 . . . . 0.0 109.936 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.98 HG12 HG13 ' B' ' 33' ' ' VAL . 15.7 t -66.05 -49.57 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.391 -0.818 . . . . 0.0 109.967 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.485 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -59.76 -35.52 74.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 110.52 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' B' ' 23' ' ' ARG . 2.1 tmtt? -73.94 -24.24 59.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.065 -1.022 . . . . 0.0 109.981 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.769 HG23 ' O ' ' B' ' 21' ' ' LEU . 97.3 t -86.71 -20.75 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.374 -0.829 . . . . 0.0 110.256 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.574 ' HB1' ' C ' ' B' ' 32' ' ' SER . . . -82.59 -30.41 29.57 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.165 -0.959 . . . . 0.0 109.57 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.16 -19.63 50.5 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.481 -0.762 . . . . 0.0 110.254 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' B' ' 25' ' ' VAL . 22.5 pt-20 -90.72 -30.76 16.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.092 -1.005 . . . . 0.0 110.195 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.439 ' N ' ' HG3' ' B' ' 28' ' ' GLU . 0.5 OUTLIER -83.11 7.71 15.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.631 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.4 24.11 70.58 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 29' ' ' ASN . 8.7 mtt-85 -129.33 -157.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 110.235 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.574 ' C ' ' HB1' ' B' ' 26' ' ' ALA . 1.8 m -115.24 -179.38 3.62 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.451 -0.781 . . . . 0.0 109.258 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.98 HG13 HG12 ' B' ' 22' ' ' VAL . 98.1 t -78.15 -14.6 13.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.09 -1.006 . . . . 0.0 110.645 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -77.2 -41.67 40.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.123 -0.985 . . . . 0.0 109.06 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 8.7 t -71.29 -36.05 71.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.415 -0.803 . . . . 0.0 109.375 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.425 ' CG ' HG12 ' B' ' 25' ' ' VAL . 3.9 tp10 -64.58 -50.52 66.89 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.787 HG23 HG21 ' A' ' 41' ' ' VAL . 34.0 mm -63.81 -27.2 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.404 -0.81 . . . . 0.0 109.526 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -71.54 -37.28 71.15 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 0.0 110.807 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.81 -36.32 59.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -71.92 -23.94 61.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.695 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.777 HG23 HG23 ' A' ' 41' ' ' VAL . 6.5 t -87.54 -28.4 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -43.73 59.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.609 -0.682 . . . . 0.0 110.447 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -29.16 68.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -50.04 70.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 110.1 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.642 ' CD1' HD21 ' A' ' 21' ' ' LEU . 31.2 m-85 -65.88 -22.86 66.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.49 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -73.69 -36.78 65.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.292 -0.88 . . . . 0.0 110.517 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -57.17 -54.54 45.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.434 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -61.78 -40.92 96.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.346 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.22 30.01 3.53 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 mmt-85 -81.38 -41.55 21.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -1.156 . . . . 0.0 110.092 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 5.6 pt -114.7 -162.89 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 109.916 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.46 58.38 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.271 -1.135 . . . . 0.0 110.251 179.95 . . . . . . . . 0 0 . 1 stop_ save_